data_2kbg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kbg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo . . . . . 0 N--CA 1.501 1.961 0 N-CA-C 111.884 -0.083 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -39.21 164.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.696 2.264 . . . . 0.0 114.732 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 m -163.74 48.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.635 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -126.12 127.4 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.621 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -113.35 113.98 26.0 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.06 141.54 15.59 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -150.37 148.63 24.65 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.767 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.75 88.29 1.39 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.167 1.911 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 14' ' ' SER . 79.7 p -58.12 -87.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.024 0.44 . . . . 0.0 109.971 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.419 ' N ' ' OG ' ' A' ' 13' ' ' SER . 37.9 m -139.29 127.97 23.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.58 -131.31 14.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -93.13 -10.67 35.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.634 0.254 . . . . 0.0 111.226 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 62' ' ' LEU . 34.8 t -63.95 146.56 53.84 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.874 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 130.33 52.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.08 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -88.2 104.83 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.371 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.63 97.4 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 t -73.76 126.94 31.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 mm -87.49 110.44 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -88.89 115.61 26.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.49 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -36.98 105.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.297 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -91.92 170.5 9.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.614 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.94 109.21 1.2 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.12 142.81 58.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -46.38 -19.52 0.45 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.461 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.71 1.24 1.42 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.92 151.87 57.36 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.82 137.82 55.26 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.772 1.648 . . . . 0.0 111.385 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -83.41 131.39 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.357 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 4.1 mm? -85.48 -42.71 14.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.32 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -146.66 161.06 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.266 0.555 . . . . 0.0 111.618 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.98 125.01 53.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.101 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 ' CG2' ' HZ3' ' A' ' 52' ' ' LYS . 80.6 mt -98.3 114.34 35.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.0 t -112.39 127.74 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.784 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -129.12 128.7 44.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -136.64 153.19 50.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -142.36 172.93 12.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.753 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 15.4 m -84.25 137.96 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -63.13 -38.26 90.47 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.847 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.76 -43.04 97.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.529 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 41' ' ' SER . 36.8 mmtt -102.54 117.76 35.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.407 0.622 . . . . 0.0 110.961 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.77 54.91 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.63 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -142.37 5.66 1.65 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.258 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -144.31 152.85 41.34 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.014 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -141.57 110.6 6.23 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.232 0.539 . . . . 0.0 110.65 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.9 mt -73.13 160.08 32.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.72 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -121.71 148.02 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.07 0.462 . . . . 0.0 111.713 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.79 113.61 4.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.517 ' HZ3' ' CG2' ' A' ' 36' ' ' ILE . 72.9 mmtt -97.3 146.16 25.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 160.95 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.436 0.636 . . . . 0.0 111.092 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.415 ' C ' ' H ' ' A' ' 56' ' ' ASN . 55.6 tt0 -82.86 136.11 34.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.51 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.06 -8.12 1.37 Allowed Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.263 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 54' ' ' GLN . 81.8 m-20 -107.12 -9.17 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.673 0.273 . . . . 0.0 110.32 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -64.62 -49.16 72.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.1 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 51.83 33.03 10.56 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.429 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.8 152.93 0.46 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.562 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.33 141.39 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.145 0.498 . . . . 0.0 110.608 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -112.13 112.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.145 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OG ' ' A' ' 17' ' ' SER . 52.2 mt -98.38 136.31 38.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.09 159.52 20.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.999 0.428 . . . . 0.0 111.547 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 t60 71.04 62.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.781 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 66' ' ' GLN . 54.0 mt -119.26 82.59 1.89 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.4 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' LEU . 49.8 mt-30 -36.35 152.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.134 0.493 . . . . 0.0 111.711 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -83.57 -9.65 58.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.81 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.4 p -113.64 13.36 18.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 61.8 mtp -139.25 136.44 34.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 111.492 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.85 161.29 19.42 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.131 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -150.66 139.37 20.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 109.992 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -87.5 148.9 24.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.1 t -125.47 132.72 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -123.39 112.58 17.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.186 0.517 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.97 135.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.13 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -138.5 116.03 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.01 125.47 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.333 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.34 111.73 24.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.4 p30 -111.6 -164.92 0.95 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -54.45 -30.98 54.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.4 mm? -65.02 -41.77 94.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.697 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.22 -48.16 0.98 Allowed Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.5 m-85 -153.75 137.76 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -161.55 170.49 19.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.237 0.541 . . . . 0.0 110.943 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 34.63 57.73 2.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.298 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.47 151.62 59.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.382 2.054 . . . . 0.0 110.898 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.33 110.57 12.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.5 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 m -95.02 95.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.555 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.6 t80 -102.46 138.64 39.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.603 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.5 136.0 34.08 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.744 0.306 . . . . 0.0 110.593 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.2 p90 -171.52 129.58 0.69 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -81.55 162.68 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 77.5 mmm -88.82 149.11 43.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.61 162.94 29.83 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.414 2.076 . . . . 0.0 110.338 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.1 154.8 72.64 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.092 1.861 . . . . 0.0 110.961 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.89 131.47 0.92 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.434 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 121.435 1.423 . . . . 0.0 112.427 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 49.8 Cg_exo . . . . . 0 N--CA 1.499 1.834 0 N-CA-C 112.973 0.336 . . . . 0.0 112.973 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.0 Cg_exo -39.79 175.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.286 2.657 . . . . 0.0 114.545 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -160.11 39.85 0.18 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.568 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.9 mm -126.02 128.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.326 0.584 . . . . 0.0 111.76 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -124.84 117.05 23.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.753 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.38 147.04 17.9 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-O 121.472 0.485 . . . . 0.0 112.568 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -145.48 132.29 9.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.47 100.22 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.475 1.45 . . . . 0.0 112.402 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 9.7 p -80.18 167.23 20.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.2 p -43.88 112.11 0.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.67 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.59 -171.72 20.44 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -75.15 -9.31 58.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.508 0.194 . . . . 0.0 111.284 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 7.4 p -66.23 142.56 57.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.713 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.07 125.87 50.33 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -86.64 100.24 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.262 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.7 mt -96.83 98.25 9.97 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.4 t -71.36 129.29 38.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.36 111.34 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -77.4 128.16 33.79 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.211 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.585 ' HD3' ' H ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -34.57 105.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.878 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 85' ' ' GLU . 88.4 mt-30 -83.6 118.15 23.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.493 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.61 -10.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.358 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.529 ' OD1' ' ND2' ' A' ' 79' ' ' ASN . 25.8 t70 58.05 172.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.917 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.31 -48.14 72.54 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.22 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.82 25.7 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.419 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -152.17 151.87 28.48 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.72 146.5 60.63 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.88 1.72 . . . . 0.0 111.437 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mt -91.05 127.48 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.949 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.3 mm? -75.72 -45.14 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.25 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -151.99 167.07 29.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -115.16 124.41 51.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.401 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 91.9 mt -95.65 109.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.9 t -111.51 128.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -125.81 137.93 53.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -140.99 155.74 46.16 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.935 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.77 175.32 11.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' LYS . 10.1 m -88.52 137.69 32.1 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.206 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -65.46 -34.19 77.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -10.88 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.615 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' SER . 40.5 mtmt -140.84 161.22 38.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 109.959 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -149.03 51.46 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.037 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -139.96 4.96 2.11 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.674 0.274 . . . . 0.0 111.001 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -138.56 144.11 39.72 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.494 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -141.38 112.18 7.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 110.546 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.43 159.89 30.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.18 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -119.67 150.38 40.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.383 0.611 . . . . 0.0 112.026 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? -153.04 114.45 4.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.219 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -95.29 144.36 25.93 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.09 159.08 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.185 0.517 . . . . 0.0 110.875 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -78.43 143.78 36.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.893 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.06 -25.01 59.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -95.3 -12.25 26.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 16.9 mttm -64.06 -45.3 89.4 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.3 p30 47.78 38.61 9.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.819 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.04 154.0 0.65 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.785 0.326 . . . . 0.0 110.822 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -155.07 150.89 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 121.253 0.549 . . . . 0.0 110.758 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.34 109.51 27.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.035 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.75 106.23 18.2 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -84.67 149.26 25.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.685 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.5 t60 79.42 70.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.753 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -126.25 81.35 1.99 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -38.1 140.98 0.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 111.336 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -68.9 -29.53 67.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.797 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 p -97.22 22.1 9.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 42.3 mtp -147.97 128.67 14.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.835 0.35 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.54 167.38 50.34 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.26 132.65 22.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.11 150.73 20.78 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.18 132.83 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -122.86 109.85 14.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.7 131.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.136 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -134.67 120.33 19.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.94 125.96 35.56 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.09 22.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.643 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.98 -171.51 2.0 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.949 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -41.99 -35.11 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.406 . . . . 0.0 110.217 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.14 -40.49 96.26 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 120.86 -41.76 1.85 Allowed Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.0 m-85 -155.96 135.53 12.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -163.03 155.98 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.789 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.537 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 18.8 tt0 45.04 56.19 14.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.25 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.23 154.89 56.72 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.738 2.292 . . . . 0.0 111.119 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.4 m -130.46 121.15 25.3 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.62 0.724 . . . . 0.0 111.018 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.81 94.44 3.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 37.7 t80 -99.86 125.35 45.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.724 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.07 130.38 49.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.73 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.7 p90 -163.79 134.19 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.601 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -80.56 164.46 22.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.6 mmm -94.76 145.75 30.17 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.918 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.39 163.49 37.6 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.323 2.015 . . . . 0.0 110.937 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.22 154.95 72.14 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.455 2.103 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -40.37 132.77 1.63 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.801 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 N--CA 1.492 1.389 0 C-N-CA 121.805 1.67 . . . . 0.0 111.697 178.485 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' PRO . 76.4 Cg_exo . . . . . 0 N--CA 1.497 1.725 0 N-CA-C 112.793 0.267 . . . . 0.0 112.793 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.0 Cg_exo -37.38 164.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.768 2.312 . . . . 0.0 113.629 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.57 53.15 0.78 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.689 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 mm -130.04 128.4 64.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -119.09 114.71 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.47 145.64 17.75 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.659 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.38 116.46 3.99 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -50.02 104.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.248 1.299 . . . . 0.0 112.252 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -80.76 167.32 20.1 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.1 t -43.27 118.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.38 -150.21 21.15 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -82.18 -6.09 58.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 110.576 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -66.37 143.26 57.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.53 121.76 37.3 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -83.7 108.73 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.437 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 mt -101.81 108.83 20.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -83.4 121.96 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.004 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mm -86.06 115.03 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -86.83 127.18 35.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.191 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -47.16 105.2 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.412 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.528 ' C ' ' H ' ' A' ' 27' ' ' ASP . 78.7 mt-30 -81.44 158.35 24.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.858 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 35.1 t0 -51.16 -9.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.603 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER 64.83 131.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -40.05 -19.73 0.02 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 138.46 17.87 0.57 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.47 21.01 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.53 138.91 61.79 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.811 1.674 . . . . 0.0 111.732 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.4 mt -89.22 133.33 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.218 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 10.7 mp -89.51 -25.18 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.177 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -164.64 164.62 21.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.176 0.512 . . . . 0.0 111.436 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -119.37 117.49 28.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.076 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.7 mt -91.54 116.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.2 t -115.36 130.0 70.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.542 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -129.22 129.07 44.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -134.1 155.92 49.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.49 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 26.9 ptt85 -149.58 171.1 17.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' LYS . 4.4 m -80.8 138.07 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.416 ' HZ1' ' HG ' ' A' ' 92' ' ' SER . 81.6 mttt -63.94 -32.17 73.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.702 0.287 . . . . 0.0 111.447 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.99 -29.36 69.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.646 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' SER . 38.5 mtmt -130.96 166.61 20.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.488 0.661 . . . . 0.0 110.996 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -144.74 16.21 1.6 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.558 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -90.14 -0.25 57.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.881 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -149.36 152.14 35.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 111.727 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.434 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 49.9 m95 -141.26 114.37 8.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.863 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.5 mt -75.08 159.55 31.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.915 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -117.65 153.64 32.96 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.18 0.514 . . . . 0.0 111.508 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.47 113.59 2.88 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -95.89 143.73 26.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.567 0.223 . . . . 0.0 110.576 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.4 160.78 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 110.591 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -79.1 148.68 32.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.026 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.21 2.31 14.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -121.54 -15.66 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.67 0.271 . . . . 0.0 110.962 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.81 -47.98 81.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 110.233 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 54.89 34.8 22.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.333 0.587 . . . . 0.0 111.319 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.44 156.66 2.01 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.705 -0.622 . . . . 0.0 110.94 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -156.06 155.46 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.634 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 61' ' ' ILE . 46.0 mm -121.7 107.55 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.5 107.47 19.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.06 157.44 18.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.592 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 m170 73.23 68.6 0.11 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.712 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.5 mt -125.07 82.18 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.064 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 73.3 mt-30 -36.16 141.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.115 0.484 . . . . 0.0 111.555 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -74.75 -7.57 53.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.673 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -112.55 16.67 19.69 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtp -143.5 142.31 31.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.965 0.412 . . . . 0.0 110.188 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.17 164.19 25.83 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -146.49 137.19 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 111.277 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.4 mt-10 -97.96 149.86 21.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.87 133.83 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.48 106.96 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.592 0.71 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.03 132.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.539 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 m -134.79 121.74 21.12 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.55 126.54 39.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.3 112.58 24.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 112.181 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.9 p-10 -119.07 -165.71 1.17 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.986 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.42 -30.53 19.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 8.6 mp -63.46 -39.15 93.7 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 118.64 -46.65 1.11 Allowed Glycine 0 N--CA 1.463 0.474 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 5.2 m-85 -155.8 128.75 8.03 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.502 ' O ' ' C ' ' A' ' 85' ' ' GLU . 3.7 m -113.06 148.32 35.44 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 84' ' ' SER . 1.2 mp0 -12.6 98.03 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 124.225 0.953 . . . . 0.0 111.846 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.55 158.36 53.96 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.133 1.222 . . . . 0.0 111.325 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.8 m -105.71 114.19 28.21 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.534 0.683 . . . . 0.0 110.105 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -91.36 94.46 4.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.2 t80 -98.5 128.16 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.827 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.21 129.76 48.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 14.8 p90 -159.38 126.87 4.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.73 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.416 ' HG ' ' HZ1' ' A' ' 42' ' ' LYS . 0.9 OUTLIER -81.62 161.12 23.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.057 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.4 mmm -90.67 139.12 26.29 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.29 163.05 35.44 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.38 2.053 . . . . 0.0 111.103 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 152.12 82.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.071 1.847 . . . . 0.0 111.04 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -39.71 131.6 1.43 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.408 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 C-N-CA 121.501 1.467 . . . . 0.0 112.317 179.823 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo . . . . . 0 N--CA 1.5 1.902 0 N-CA-C 113.245 0.44 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.78 151.25 26.5 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.125 1.883 . . . . 0.0 114.275 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.02 30.29 3.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.955 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.36 120.06 54.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.283 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -115.73 116.23 27.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.302 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.55 156.29 21.52 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -157.68 133.41 5.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.29 82.73 1.06 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.322 1.348 . . . . 0.0 112.136 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.466 ' HG ' ' H ' ' A' ' 14' ' ' SER . 23.0 t -58.4 -173.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.466 ' H ' ' HG ' ' A' ' 13' ' ' SER . 90.5 p -56.48 122.36 11.76 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.272 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.06 -154.03 31.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.4 mtmm -78.1 -9.09 58.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.473 -0.363 . . . . 0.0 110.897 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 p -64.66 143.4 57.95 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.114 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.91 126.34 49.77 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -87.84 98.39 11.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mt -93.71 99.83 12.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -73.96 119.23 17.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.266 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.88 108.69 17.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -87.62 129.07 35.24 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -44.62 105.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.39 153.53 20.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.03 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -57.84 103.01 0.11 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 55.1 p-10 -57.52 145.39 33.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.103 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.63 -46.71 7.31 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.29 18.68 0.02 OUTLIER Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.397 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.78 156.43 26.89 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.41 0.605 . . . . 0.0 110.231 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.35 144.2 85.17 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.136 1.891 . . . . 0.0 110.967 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mt -91.82 124.37 44.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.248 0.547 . . . . 0.0 111.454 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.78 -41.05 68.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.029 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.33 171.85 19.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.27 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -120.78 114.28 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.832 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.422 HG22 HD12 ' A' ' 36' ' ' ILE . 87.3 mt -89.45 115.4 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 51' ' ' LYS . 96.4 t -111.91 128.54 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -124.34 128.12 48.62 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -135.32 153.74 51.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.691 0.281 . . . . 0.0 110.875 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE1' ' A' ' 72' ' ' GLU . 29.3 ptt85 -147.23 171.72 14.95 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.4 m -81.4 137.77 35.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.494 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.623 ' HZ1' ' N ' ' A' ' 92' ' ' SER . 93.4 mttt -63.36 -29.14 70.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.554 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.15 -31.05 72.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.244 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -119.82 171.73 8.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.769 0.795 . . . . 0.0 111.546 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -152.22 4.68 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.722 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -90.55 -1.33 57.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.426 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -140.62 138.45 34.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.239 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 44.9 m95 -134.62 108.45 8.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.907 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.6 mt -71.65 159.39 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.56 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.475 ' CD ' ' N ' ' A' ' 50' ' ' GLU . 1.3 pm0 -124.42 147.19 48.44 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -145.45 111.89 5.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -84.79 142.35 29.85 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.41 156.03 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -78.42 146.66 34.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.768 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.05 -6.4 45.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -111.47 -15.6 13.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.51 0.195 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -62.06 -49.1 77.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.285 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 53.34 36.07 21.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.412 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.98 154.07 0.67 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -154.68 146.13 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 110.587 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mm -114.82 115.52 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.26 105.59 16.26 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.6 154.19 25.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.7 t60 69.97 67.0 0.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.961 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' GLN . 57.4 mt -107.84 -7.92 16.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 65' ' ' LEU . 74.6 mt-30 55.72 147.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 111.646 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -91.94 -18.4 23.77 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.038 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.3 p -106.48 18.8 21.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 10.8 ttm -146.5 138.84 25.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 170.47 34.34 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -149.35 134.27 17.96 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 5.1 mt-10 -98.87 152.81 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.06 135.37 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.017 0.437 . . . . 0.0 110.767 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -128.22 108.27 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.983 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.18 137.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.543 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -137.19 117.86 13.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.11 126.64 35.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.68 112.23 25.24 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.315 0.578 . . . . 0.0 112.184 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.6 p-10 -114.73 -168.25 1.35 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.804 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -51.31 -30.48 18.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.621 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -63.18 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.11 -47.45 1.02 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -155.53 139.02 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' GLU . 1.3 t -131.84 135.46 46.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.75 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.6 mm-40 11.9 94.04 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 124.365 1.041 . . . . 0.0 112.091 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.38 154.26 55.91 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 120.995 1.13 . . . . 0.0 111.679 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.82 111.76 24.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.64 96.62 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.165 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.481 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -101.8 130.43 48.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.264 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.52 130.68 44.44 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.167 0.508 . . . . 0.0 111.729 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.486 ' C ' ' HZ1' ' A' ' 42' ' ' LYS . 13.0 p90 -165.94 140.14 4.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.064 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.623 ' N ' ' HZ1' ' A' ' 42' ' ' LYS . 1.4 m -91.27 171.29 9.33 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.453 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.0 mmm -96.61 139.74 21.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.08 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.21 163.18 37.12 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.22 1.947 . . . . 0.0 110.955 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.95 147.61 91.89 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.39 2.06 . . . . 0.0 111.764 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -41.45 134.52 2.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 C-N-CA 121.61 1.54 . . . . 0.0 111.435 178.252 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' PRO . 54.4 Cg_exo . . . . . 0 N--CA 1.498 1.76 0 N-CA-C 112.73 0.242 . . . . 0.0 112.73 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -33.96 167.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 123.714 2.943 . . . . 0.0 116.155 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.491 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -165.06 46.47 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.917 -177.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.99 129.28 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 111.579 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -119.26 116.91 27.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.184 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.55 155.95 19.4 Favored Glycine 0 N--CA 1.467 0.712 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.331 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -158.56 132.61 5.08 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 89.5 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.376 1.384 . . . . 0.0 110.923 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 t -60.73 -85.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.349 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 17' ' ' SER . 90.7 p -128.12 127.74 43.59 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.752 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.08 -128.67 31.48 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -89.5 -5.6 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 14' ' ' SER . 85.7 p -61.75 144.87 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.425 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 120.78 27.26 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -88.03 101.18 13.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.272 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 mt -96.5 96.56 8.77 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 t -67.62 130.68 43.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 mm -91.74 117.16 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.3 m -84.17 128.33 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.762 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -63.05 105.23 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' NE2' ' OG ' ' A' ' 7' ' ' SER . 76.0 mm-40 -101.31 167.18 10.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.299 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.63 95.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 26.6 t70 -42.38 -64.55 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.657 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.62 -23.36 0.22 Allowed Glycine 0 C--N 1.318 -0.47 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.36 5.08 0.09 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.684 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.431 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -156.79 142.68 12.85 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 118.187 0.994 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.71 150.73 60.1 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.067 1.178 . . . . 0.0 111.927 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.4 mt -91.79 128.19 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.491 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.8 mt -72.95 -42.56 63.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -155.53 163.66 39.7 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.635 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -110.98 127.12 55.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.058 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.9 mt -99.95 110.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.6 t -109.21 127.09 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.855 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -126.17 128.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -132.9 151.51 52.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -142.34 172.82 12.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.397 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.9 p -84.17 147.24 27.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.527 ' HZ3' ' N ' ' A' ' 92' ' ' SER . 95.4 mttt -75.24 4.64 6.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.74 -49.88 2.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 45' ' ' GLU . 11.2 mmpt? -60.92 -45.42 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.932 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 81.8 tt0 36.18 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.449 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' O ' ' NE2' ' A' ' 47' ' ' GLN . 1.9 m-20 167.15 -15.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.571 0.545 . . . . 0.0 110.493 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 46' ' ' ASP . 96.0 mm-40 -137.24 117.74 13.81 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.56 0.219 . . . . 0.0 110.923 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -99.95 116.67 32.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.851 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.45 160.07 32.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.182 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 25.0 mp0 -117.0 150.55 38.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.341 0.591 . . . . 0.0 112.47 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.24 115.33 4.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -97.52 146.0 25.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.42 155.67 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.034 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.555 ' C ' ' H ' ' A' ' 56' ' ' ASN . 33.3 tt0 -78.08 137.24 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.208 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 7.07 0.16 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 54' ' ' GLN . 66.0 t30 -122.18 -13.97 8.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.793 0.297 . . . . 0.0 110.755 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -69.72 -53.08 20.16 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.811 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 58.28 40.06 24.98 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.648 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -178.05 153.15 0.78 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -152.45 143.31 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.204 0.526 . . . . 0.0 111.428 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.6 mm -114.56 115.79 50.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.14 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.0 mt -103.73 105.52 15.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.5 152.2 23.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.225 0.536 . . . . 0.0 112.188 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 66.06 76.68 0.31 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.28 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 66' ' ' GLN . 86.2 mt -111.52 -4.12 14.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' O ' ' SD ' ' A' ' 93' ' ' MET . 83.3 mt-30 52.49 120.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.877 0.846 . . . . 0.0 112.241 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -61.31 -32.04 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.093 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -94.52 22.87 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.3 tpt -144.46 114.73 7.51 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.395 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.78 155.59 32.09 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -151.29 138.29 19.1 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.54 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.96 156.21 19.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.642 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 132.71 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -126.12 110.82 13.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.373 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.76 137.24 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.768 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.82 117.24 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.59 124.38 34.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.26 113.43 26.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.268 0.556 . . . . 0.0 112.358 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -116.62 -163.38 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -52.75 -33.33 47.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 8.5 mp -64.12 -40.98 97.37 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 126.09 -49.64 0.91 Allowed Glycine 0 N--CA 1.463 0.452 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.8 m-85 -154.46 133.96 12.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.503 ' HG ' ' H ' ' A' ' 85' ' ' GLU . 3.2 t -159.85 170.28 21.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' H ' ' HG ' ' A' ' 84' ' ' SER . 16.6 pt-20 39.91 51.41 3.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.392 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.76 148.37 82.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.941 1.76 . . . . 0.0 111.263 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.426 ' CG2' ' H ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -125.32 110.35 13.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 99.25 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.523 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -104.56 131.75 51.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.956 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -131.84 132.58 43.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 6.6 p90 -173.69 125.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.208 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.527 ' N ' ' HZ3' ' A' ' 42' ' ' LYS . 11.9 p -80.77 166.29 21.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.3 mtp -88.41 147.47 40.01 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.956 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.07 162.66 28.76 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.421 2.081 . . . . 0.0 110.211 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 96' ' ' LYS . 38.2 Cg_endo -65.6 153.64 77.29 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.912 1.741 . . . . 0.0 110.822 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 95' ' ' PRO . 4.1 tppp? -36.62 133.05 0.65 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.555 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.492 1.432 0 C-N-CA 121.465 1.443 . . . . 0.0 111.818 179.499 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.3 Cg_exo . . . . . 0 N--CA 1.495 1.604 0 N-CA-C 112.629 0.203 . . . . 0.0 112.629 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 32.8 Cg_exo -38.7 166.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.85 2.367 . . . . 0.0 113.322 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.25 41.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.683 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.08 124.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.578 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -116.14 118.96 34.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.462 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.64 140.91 15.06 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.474 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -143.73 146.51 35.21 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.2 80.46 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.828 1.685 . . . . 0.0 111.447 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.4 t -48.03 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -139.63 136.99 34.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.064 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.6 -130.76 37.34 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -95.17 -4.01 46.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -68.81 144.11 54.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.001 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.48 128.2 47.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 110.246 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -88.08 103.62 15.91 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mt -99.13 91.98 5.25 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -66.86 124.8 23.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.494 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mm -86.97 115.72 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -95.13 119.3 33.4 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.488 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -38.28 105.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.49 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -95.0 148.87 21.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 97.9 m-20 -54.67 95.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.53 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 30' ' ' ALA . 28.3 t70 -48.02 169.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.609 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.43 84.08 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.67 22.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.811 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.449 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -159.05 151.66 17.96 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.58 140.62 57.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.435 1.423 . . . . 0.0 110.529 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.48 127.71 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.82 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.4 mp -75.18 -43.11 53.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.287 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -152.83 163.33 39.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.387 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -111.39 122.83 48.87 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.954 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -96.47 107.93 20.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.3 t -107.37 125.03 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.26 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -122.35 136.82 54.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -143.18 152.15 41.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.679 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.474 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 35.6 ptt85 -148.39 173.43 13.09 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 111.634 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -79.08 147.83 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.266 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -69.36 -32.03 70.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.679 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -75.15 -47.31 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -57.51 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.856 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 58.18 76.66 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.762 0.791 . . . . 0.0 110.116 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 61.2 t0 -175.61 -21.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.3 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -138.47 158.13 44.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.2 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 63.4 m95 -136.12 134.29 38.17 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 112.209 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.79 160.38 20.25 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -118.07 149.1 41.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.26 0.552 . . . . 0.0 112.091 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.09 114.36 4.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -98.92 144.7 27.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.668 0.27 . . . . 0.0 110.959 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.76 157.77 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.11 0.481 . . . . 0.0 110.648 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -70.6 149.53 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.448 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.89 -7.09 14.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.189 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -121.47 0.13 9.9 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.088 0.444 . . . . 0.0 111.346 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -61.83 -46.77 88.05 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.442 0.639 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 52.99 31.52 11.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.835 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.36 150.55 0.44 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.34 146.86 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.111 0.481 . . . . 0.0 111.243 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mm -113.9 117.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.35 105.65 15.79 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.612 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 65.5 mt-10 -96.93 119.7 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 28.9 m-70 122.65 54.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.997 1.436 . . . . 0.0 111.018 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 93' ' ' MET . 23.1 mt -111.89 105.24 13.64 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.485 ' O ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -59.06 135.85 57.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.237 0.542 . . . . 0.0 111.204 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -66.21 -23.81 66.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.075 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 p -104.82 18.23 22.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.9 mtp -149.79 129.97 13.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.027 0.442 . . . . 0.0 110.706 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.33 44.3 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -157.46 132.11 8.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.286 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -87.27 154.29 20.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.007 0.432 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.53 134.0 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -124.62 110.46 14.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.496 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.82 132.4 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -136.76 118.29 14.84 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.13 126.24 35.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.61 108.41 19.68 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.588 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -114.5 -175.11 2.61 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.303 178.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -40.3 -33.71 0.27 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -63.96 -42.8 97.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.496 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.93 -48.5 0.97 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -155.83 131.63 9.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.04 162.39 20.35 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER 52.88 51.87 9.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 98.0 Cg_endo -74.01 152.83 46.57 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.381 2.054 . . . . 0.0 111.258 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 m -133.93 117.74 17.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.368 0.604 . . . . 0.0 110.714 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -96.6 94.49 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.422 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 34.0 t80 -98.61 134.82 41.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.538 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -137.89 130.5 29.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 23.1 p90 -163.97 131.44 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.982 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -79.83 167.85 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 28.0 mtp -97.89 151.79 37.75 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.966 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.96 163.9 22.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.536 2.157 . . . . 0.0 110.012 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.35 156.38 63.59 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.774 1.649 . . . . 0.0 111.068 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -38.51 130.22 1.08 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.505 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.496 1.634 0 C-N-CA 121.726 1.617 . . . . 0.0 112.725 179.893 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.6 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 N-CA-C 112.601 0.193 . . . . 0.0 112.601 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.5 Cg_exo -37.3 167.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 123.305 2.67 . . . . 0.0 114.091 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.97 54.78 0.52 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.541 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -132.91 130.14 58.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.108 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -123.84 114.31 19.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.81 138.35 14.53 Favored Glycine 0 N--CA 1.46 0.297 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.45 116.95 8.6 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.556 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -52.03 103.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 120.945 1.096 . . . . 0.0 111.664 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.9 p -85.37 172.02 11.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 m -41.55 106.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.819 0.342 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.29 -154.01 21.28 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.005 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -77.23 -19.65 56.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.516 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.6 t -59.01 139.11 57.17 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.171 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.92 122.11 46.67 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -86.1 109.0 18.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.792 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.27 105.72 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 119.09 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mm -84.08 112.47 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 5.9 m -79.35 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.034 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.84 104.89 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.513 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -100.59 158.85 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 27' ' ' ASP . 45.9 m-20 -61.88 95.38 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 32.4 t70 -43.41 168.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.135 0.493 . . . . 0.0 111.183 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.71 -42.44 85.15 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 15.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.905 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.43 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -159.64 151.36 16.77 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.886 0.843 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.45 142.52 80.36 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.988 1.125 . . . . 0.0 111.59 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -86.56 125.17 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.354 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -72.06 -40.76 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.805 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.39 167.27 26.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.07 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -112.06 119.93 40.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.875 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.6 mt -92.18 113.07 26.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 51' ' ' LYS . 61.2 t -113.57 129.34 69.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.286 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -127.78 133.82 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -139.26 154.05 47.91 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.044 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.0 174.02 11.65 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.542 ' OG ' ' CE2' ' A' ' 71' ' ' TYR . 4.3 m -84.21 136.76 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.007 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.83 -35.36 78.01 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.879 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -63.11 -35.49 80.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -98.68 178.05 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.801 0.81 . . . . 0.0 111.432 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -160.05 -5.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.777 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -91.6 9.02 33.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -149.72 150.45 32.1 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.805 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.43 109.06 5.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.722 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.4 mt -72.61 159.91 33.11 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.506 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -121.72 151.72 40.2 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.09 0.472 . . . . 0.0 111.558 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.44 114.66 3.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -96.2 142.3 28.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.29 138.25 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.25 0.548 . . . . 0.0 111.038 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.499 ' C ' ' H ' ' A' ' 56' ' ' ASN . 48.9 tt0 -59.71 142.53 52.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.5 14.8 0.93 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.135 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 m120 -132.09 9.88 4.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 21.3 mttt -91.74 -46.3 7.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.663 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 49.69 39.13 16.88 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.64 0.588 . . . . 0.0 111.887 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -179.57 151.9 0.48 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.707 0.289 . . . . 0.0 110.798 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -151.61 146.58 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.383 0.611 . . . . 0.0 111.092 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -114.86 111.65 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.83 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -100.03 107.75 19.76 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 98.8 mt-10 -84.88 156.06 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.523 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 6.3 t-80 78.76 52.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.6 mm? -107.71 88.22 2.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -51.0 135.96 23.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.646 . . . . 0.0 111.335 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -64.39 -34.13 77.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.444 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.8 p -96.33 20.81 9.89 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.7 mtp -143.34 140.0 30.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.206 0.527 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.8 162.61 24.26 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.542 ' CE2' ' OG ' ' A' ' 41' ' ' SER . 43.3 m-85 -144.34 135.5 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.046 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -94.69 149.86 20.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.33 133.42 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -123.24 108.41 12.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.475 0.655 . . . . 0.0 109.705 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.87 131.21 44.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.923 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -135.47 119.47 17.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.98 126.21 35.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.07 116.05 31.3 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 112.46 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.543 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 4.1 p-10 -115.9 -166.55 1.15 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -51.78 -31.48 27.19 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.625 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.9 mm? -64.05 -42.54 97.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.488 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.82 -45.05 1.19 Allowed Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.488 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.1 m-85 -153.64 140.67 19.31 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -163.76 153.86 15.16 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.574 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.4 ' CD ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER 44.32 60.13 12.46 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.593 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 152.4 43.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.242 1.961 . . . . 0.0 110.965 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.0 m -131.23 118.44 20.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.65 0.738 . . . . 0.0 111.467 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.7 94.22 4.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.701 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -98.96 127.15 44.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.148 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.6 132.97 45.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.253 0.549 . . . . 0.0 110.967 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.581 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.1 p90 -166.49 140.07 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.334 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.9 156.49 19.33 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 85.8 mmm -85.88 147.4 45.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.48 162.76 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.343 2.029 . . . . 0.0 110.98 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.07 158.73 50.23 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.244 1.963 . . . . 0.0 111.121 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.91 129.89 0.95 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.447 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 121.327 1.351 . . . . 0.0 112.425 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' PRO . 79.0 Cg_exo . . . . . 0 N--CA 1.492 1.433 0 N-CA-C 111.913 -0.072 . . . . 0.0 111.913 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 22.3 Cg_exo -38.49 169.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.662 2.241 . . . . 0.0 114.93 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -156.56 46.19 0.43 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.347 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.27 127.11 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.331 0.586 . . . . 0.0 110.554 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -117.53 116.55 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.142 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.0 147.35 18.56 Favored Glycine 0 N--CA 1.464 0.517 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.3 130.43 8.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.94 81.97 1.59 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.43 1.42 . . . . 0.0 111.988 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.595 ' HG ' ' H ' ' A' ' 14' ' ' SER . 47.2 t -60.05 -159.73 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.595 ' H ' ' HG ' ' A' ' 13' ' ' SER . 33.4 t -63.33 134.52 55.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.246 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.53 -146.16 33.87 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.766 0.317 . . . . 0.0 110.62 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -64.97 148.89 50.76 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.775 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.3 121.17 33.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.693 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -83.97 98.51 9.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 90.21 7.25 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -69.72 117.55 11.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.754 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.6 mm -77.63 126.36 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -104.2 116.51 32.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 110.472 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -39.47 104.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.787 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.26 165.18 11.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 43.0 t0 -57.94 109.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.897 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -71.58 165.65 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.98 31.98 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.54 -0.28 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.1 151.58 75.54 Favored Pre-proline 0 N--CA 1.463 0.22 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.21 143.58 65.3 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.865 1.71 . . . . 0.0 111.278 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.1 mt -86.74 126.44 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.761 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.81 -41.38 64.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.138 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.02 165.67 35.76 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.375 0.607 . . . . 0.0 111.481 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -115.38 119.98 38.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.221 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.93 115.11 31.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 51' ' ' LYS . 38.7 t -118.89 131.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.072 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -125.56 139.76 53.33 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -143.6 156.25 44.52 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.278 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.48 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 34.5 ptt85 -149.54 174.8 12.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 m -82.23 143.04 31.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -63.64 -39.46 94.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.437 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 7.0 t0 -76.6 -46.13 27.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.102 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HZ2' ' HB3' ' A' ' 43' ' ' ASP . 1.4 mppt? -89.03 91.38 8.8 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -98.58 65.94 1.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.292 179.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -136.29 -5.87 2.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -146.59 155.87 42.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.991 0.424 . . . . 0.0 111.36 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -136.23 114.28 11.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.156 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.9 mt -77.55 160.31 28.69 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.908 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -111.04 155.62 22.5 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.788 0.328 . . . . 0.0 111.136 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -159.09 112.39 2.29 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -98.71 143.16 29.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.749 0.309 . . . . 0.0 111.289 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.66 156.54 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.42 0.629 . . . . 0.0 110.542 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 48.4 tt0 -82.09 144.35 30.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.307 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.6 81.42 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 32.8 m-20 -67.1 -39.3 86.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.295 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -55.27 -71.87 0.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.549 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 60.34 49.37 7.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.437 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -176.04 140.13 0.4 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -141.85 151.83 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.393 0.616 . . . . 0.0 112.329 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -122.47 101.49 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 9.1 mp -92.06 107.24 19.07 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 64' ' ' HIS . 6.5 tm-20 -96.57 148.76 22.51 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.236 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.489 ' N ' ' CD ' ' A' ' 63' ' ' GLU . 19.2 t-80 93.0 48.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' O ' ' SD ' ' A' ' 93' ' ' MET . 20.9 mt -112.95 94.0 4.69 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.528 ' O ' ' SD ' ' A' ' 93' ' ' MET . 47.1 tt0 -45.48 148.47 0.68 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 110.95 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.18 -8.65 56.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.767 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 p -113.44 19.13 17.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.3 mtp -144.22 133.86 23.56 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.806 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.7 157.37 27.46 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -137.56 133.31 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.794 0.33 . . . . 0.0 110.789 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.48 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.5 mt-10 -92.4 147.94 22.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.63 134.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.93 0.395 . . . . 0.0 109.96 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -124.2 108.27 12.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.267 0.556 . . . . 0.0 109.983 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.38 135.95 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.955 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -136.37 116.57 13.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.76 126.6 35.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.88 112.7 25.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.325 0.583 . . . . 0.0 112.541 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.679 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -114.53 -165.89 1.05 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -49.52 -33.12 13.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.834 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.5 mm? -64.7 -42.65 95.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.248 0.547 . . . . 0.0 109.635 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.35 -48.79 0.95 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.475 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.1 m-85 -154.01 137.71 16.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.2 m -160.22 164.24 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.348 0.594 . . . . 0.0 111.799 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 26' ' ' ASP . 16.9 pt-20 33.38 59.29 1.7 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.403 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 152.02 80.03 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.102 1.868 . . . . 0.0 109.963 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.57 111.24 15.42 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.0 110.714 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.47 95.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -102.28 136.31 42.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -138.3 134.95 34.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 7.0 p90 -162.05 152.83 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.728 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.9 170.85 8.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.974 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 65' ' ' LEU . 36.4 mtp -105.62 145.6 31.17 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.426 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.17 161.95 31.91 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.375 2.05 . . . . 0.0 110.751 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.32 155.39 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.12 1.88 . . . . 0.0 110.872 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -37.94 132.16 0.91 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.541 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 121.677 1.585 . . . . 0.0 112.796 -179.779 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo . . . . . 0 N--CA 1.503 2.074 0 N-CA-C 113.036 0.36 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.49 147.68 37.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.785 1.656 . . . . 0.0 114.449 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.5 34.88 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.201 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mm -107.51 122.49 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.999 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.66 117.14 28.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.9 147.34 18.56 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -159.83 115.82 1.51 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -50.98 94.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.202 1.268 . . . . 0.0 111.984 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -76.55 -48.7 18.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.63 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.439 ' H ' ' HG ' ' A' ' 17' ' ' SER . 69.2 p -144.49 166.77 24.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.037 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -35.99 128.67 0.89 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 39.78 48.37 1.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.167 0.508 . . . . 0.0 111.071 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.439 ' HG ' ' H ' ' A' ' 14' ' ' SER . 11.8 p -142.1 150.89 41.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.484 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.12 120.91 14.41 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -84.81 97.9 9.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.04 89.82 7.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 t -66.88 125.83 27.17 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.542 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mm -85.82 114.89 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.4 m -98.77 117.24 32.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.576 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.74 108.14 0.08 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.359 1.076 . . . . 0.0 110.518 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 26' ' ' ASP . 2.6 pt20 -115.63 101.54 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.152 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 25' ' ' GLN . 4.5 m-20 19.12 82.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.9 0.75 . . . . 0.0 111.779 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 29' ' ' GLY . 85.9 m-20 -50.67 131.47 25.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.046 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' ASP . . . -27.05 -35.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.961 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 163.93 0.08 0.05 OUTLIER Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.728 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.12 155.61 29.35 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 117.848 0.824 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -54.02 138.25 70.13 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 121.094 1.196 . . . . 0.0 111.767 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mt -81.66 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.384 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.91 -40.07 69.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -162.19 170.63 18.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.718 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -116.37 122.33 44.54 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.989 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.4 mt -96.93 114.17 33.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.0 t -115.09 130.41 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.604 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -140.77 152.55 45.31 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.637 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.523 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.2 ptt85 -145.64 172.9 12.59 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 44' ' ' LYS . 11.0 m -79.92 139.86 36.92 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -62.3 -36.27 81.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.249 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.97 -37.38 86.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.543 0.211 . . . . 0.0 110.718 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.3 mmtt -101.13 150.95 22.4 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.499 0.666 . . . . 0.0 110.502 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -138.27 19.82 2.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.186 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 20.8 p-10 -128.19 18.33 6.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 0.0 110.519 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -142.04 112.7 7.25 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.501 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -119.29 118.16 30.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.588 0.708 . . . . 0.0 110.917 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.3 mt -79.9 159.77 26.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.462 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 50' ' ' GLU . 51.5 mp0 -117.93 151.91 36.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.97 113.1 2.68 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -97.64 146.4 25.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.469 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.35 158.4 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.223 0.535 . . . . 0.0 110.081 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.516 ' C ' ' H ' ' A' ' 56' ' ' ASN . 6.2 tp-100 -71.23 146.54 48.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.451 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.45 3.55 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.924 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 t-20 -133.2 0.77 3.44 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.647 -0.325 . . . . 0.0 111.446 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.6 tptp -64.07 -43.22 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 48.56 31.62 3.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.717 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 178.74 152.49 0.34 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.191 0.307 . . . . 0.0 110.744 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 pt -151.29 129.38 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.4 mm -99.38 103.26 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.3 mt -91.58 104.54 17.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 40.1 tt0 -95.77 151.18 19.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.254 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.479 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 3.9 t-160 89.11 60.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.253 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.95 91.84 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.91 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -39.15 143.58 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.422 0.63 . . . . 0.0 111.419 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -75.29 -9.07 58.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.039 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.8 p -114.34 19.7 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.604 0.24 . . . . 0.0 111.414 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -142.92 136.97 29.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.22 163.08 25.15 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -144.69 129.49 18.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.581 0.229 . . . . 0.0 111.603 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.9 mt-10 -88.6 153.62 20.98 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.77 135.55 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.71 108.59 11.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.217 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.54 134.58 33.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.081 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.3 m -136.09 124.26 23.08 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.38 124.94 43.33 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.83 114.06 26.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 112.558 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -122.22 -175.63 3.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.33 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -39.8 -33.01 0.17 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.409 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 81' ' ' LEU . 9.6 mp -63.53 -42.55 98.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.414 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 125.81 -49.94 0.89 Allowed Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 13.1 m-85 -153.73 122.07 6.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.7 p -88.15 176.89 7.07 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.143 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -49.11 112.96 2.76 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.45 159.43 49.2 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.049 1.166 . . . . 0.0 111.669 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.79 113.75 25.98 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.519 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.05 98.33 7.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.469 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 39.4 t80 -103.43 138.2 40.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -135.27 134.55 40.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.252 0.548 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.4 p90 -171.33 129.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.577 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -82.51 165.46 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.531 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.9 mmm -90.66 146.26 33.83 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.0 164.71 29.35 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.364 2.043 . . . . 0.0 111.22 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.45 160.04 41.32 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.35 2.033 . . . . 0.0 111.513 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -40.39 132.8 1.63 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.494 1.524 0 C-N-CA 121.73 1.62 . . . . 0.0 112.757 179.166 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' PRO . 71.0 Cg_exo . . . . . 0 N--CA 1.501 1.952 0 N-CA-C 112.571 0.181 . . . . 0.0 112.571 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 Cg_exo -37.42 175.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.311 2.674 . . . . 0.0 115.441 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.43 46.83 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.646 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.94 123.48 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.24 0.543 . . . . 0.0 110.632 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -114.82 116.52 28.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.213 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.06 141.16 15.44 Favored Glycine 0 N--CA 1.464 0.51 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.952 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -139.71 134.46 16.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.02 88.25 1.34 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.655 1.57 . . . . 0.0 112.501 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 4.7 p -68.27 -179.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -55.82 118.22 4.38 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.516 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.1 -166.76 21.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HE3' ' H ' ' A' ' 66' ' ' GLN . 15.8 mtmt -77.13 -5.75 50.26 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 84.6 p -66.86 150.81 48.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.35 115.31 18.06 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -77.3 109.59 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.29 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.1 101.23 10.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -72.02 122.6 21.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.738 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 mm -87.34 113.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 m -86.09 127.2 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.543 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -44.26 105.38 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.808 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' OE1' ' OE1' ' A' ' 85' ' ' GLU . 74.2 mt-30 -80.68 159.38 25.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.47 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' ASP . 5.4 m-20 -78.35 78.61 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' ASP . 22.2 t70 -39.23 162.18 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.405 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.32 64.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.2 24.31 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.903 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.411 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -153.4 151.49 25.69 Favored Pre-proline 0 C--N 1.333 -0.152 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.96 143.61 55.33 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.687 1.591 . . . . 0.0 111.462 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -89.87 135.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.868 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.91 -48.98 10.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.706 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -146.48 162.04 39.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.282 0.563 . . . . 0.0 111.522 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -109.46 120.19 41.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.185 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.33 107.3 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' LYS . 24.2 t -109.05 127.08 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.01 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -125.22 129.22 49.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.133 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -133.05 148.56 52.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.965 0.412 . . . . 0.0 110.876 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.46 ' NH1' ' CB ' ' A' ' 45' ' ' GLU . 4.8 ptt180 -144.71 167.34 22.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.74 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 43' ' ' ASP . 5.1 m -76.16 143.58 41.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.1 0.41 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 41' ' ' SER . 71.7 m-20 -122.01 -9.74 8.7 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.361 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -122.76 110.49 15.54 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.744 0.307 . . . . 0.0 110.307 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.46 ' CB ' ' NH1' ' A' ' 40' ' ' ARG . 25.4 pt-20 -115.1 -8.4 12.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.8 -7.72 23.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.535 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -161.08 128.67 4.23 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -107.61 128.56 54.65 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 70.8 mt -77.16 158.21 30.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 3.4 pm0 -121.59 148.54 44.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.205 0.526 . . . . 0.0 111.882 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -150.74 113.53 4.74 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.885 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.48 142.52 27.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.91 158.71 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.281 0.562 . . . . 0.0 110.391 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.522 ' C ' ' H ' ' A' ' 56' ' ' ASN . 57.9 tt0 -74.17 130.9 40.67 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.474 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.58 0.17 0.3 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.822 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 54' ' ' GLN . 23.5 m120 -116.18 -26.19 7.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.729 0.264 . . . . 0.0 110.814 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 20.5 mttm -50.35 -68.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER 79.46 35.04 0.17 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.83 149.17 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.137 -0.352 . . . . 0.0 110.485 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.5 pt -147.58 144.85 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.98 115.99 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.1 mt -104.95 108.92 20.69 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.137 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.33 162.15 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.762 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.9 m80 60.6 67.68 0.81 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.852 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -107.91 -9.42 15.71 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.828 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.433 ' H ' ' HE3' ' A' ' 16' ' ' LYS . 49.9 tp60 60.13 152.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.969 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -96.81 -7.2 34.23 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.3 p -119.41 19.96 12.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.6 mmm -143.96 127.86 17.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.58 157.59 32.98 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.96 153.97 36.23 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.8 156.14 19.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.866 0.365 . . . . 0.0 110.278 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.7 130.08 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -122.63 107.28 11.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 110.329 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.27 134.97 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.796 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -136.27 123.77 22.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.17 120.48 36.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.486 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.31 105.06 16.56 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.598 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -108.53 -175.94 2.91 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -41.22 -31.5 0.22 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.2 mm? -65.54 -41.66 92.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.959 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.51 -48.61 0.96 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.485 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.2 m-85 -157.31 131.68 8.46 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.49 160.3 17.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.938 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 3.3 mm-40 53.2 50.43 7.59 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.292 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 84.8 Cg_endo -72.61 149.65 49.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.149 1.9 . . . . 0.0 111.147 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.63 109.31 13.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.157 0.503 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.21 95.97 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 31.2 t80 -102.95 131.5 49.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.496 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.18 134.45 42.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.074 0.464 . . . . 0.0 111.129 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.1 p90 -168.82 133.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.336 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.42 ' H ' ' HG ' ' A' ' 92' ' ' SER . 10.5 p -80.25 164.92 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.156 0.503 . . . . 0.0 111.473 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 95.6 mmm -93.23 141.67 24.3 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.474 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.84 162.62 29.44 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.414 2.076 . . . . 0.0 111.205 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.39 152.7 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.487 2.125 . . . . 0.0 111.638 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -43.74 132.56 3.94 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.632 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.49 1.29 0 C-N-CA 121.885 1.723 . . . . 0.0 110.974 177.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' PRO . 52.5 Cg_exo . . . . . 0 N--CA 1.497 1.7 0 N-CA-C 112.844 0.286 . . . . 0.0 112.844 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 5' ' ' PRO . 30.0 Cg_exo -39.33 175.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.309 2.672 . . . . 0.0 114.849 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.8 53.43 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.082 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -129.51 127.99 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.226 0.536 . . . . 0.0 110.549 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -118.9 116.4 26.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.032 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.72 141.89 15.86 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.472 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -143.6 140.5 17.5 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.45 91.13 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.692 1.595 . . . . 0.0 112.216 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.453 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 60.6 p -72.16 162.93 28.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m -38.44 120.66 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.346 0.594 . . . . 0.0 111.516 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.05 -155.48 23.68 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -80.0 -8.8 59.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.107 0.48 . . . . 0.0 110.075 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.453 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 10.9 p -60.54 136.37 58.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.136 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.57 117.42 28.94 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.87 111.27 18.61 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.457 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -103.42 91.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -66.09 123.78 20.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.171 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 mm -86.27 112.51 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -81.42 143.43 32.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.949 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -66.43 105.5 1.49 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.349 0.595 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -88.3 174.66 8.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.767 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 96.2 m-20 -62.6 -3.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.205 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 29' ' ' GLY . 2.8 p30 46.27 -172.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -9.81 59.19 Favored Glycine 0 N--CA 1.465 0.625 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.037 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . 128.54 2.78 5.75 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.88 142.36 33.46 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.82 142.65 83.43 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.319 1.346 . . . . 0.0 111.677 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.4 mt -87.95 134.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.368 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 2.6 mm? -91.81 -42.11 10.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.211 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -142.68 152.32 42.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -109.47 126.15 53.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.613 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.46 110.51 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.2 t -107.57 124.86 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -125.16 121.43 34.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -126.57 154.65 43.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 31.3 ptt85 -146.47 169.45 18.88 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.255 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 p -79.66 141.21 36.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.773 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.91 -32.5 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.673 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.59 -6.65 42.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.679 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -139.66 174.4 10.55 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.217 0.532 . . . . 0.0 110.516 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -165.08 27.46 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.01 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -107.01 -2.85 20.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.866 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -144.52 145.5 31.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 111.218 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -133.74 117.97 17.56 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.05 160.39 27.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -118.2 155.01 31.25 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.158 0.504 . . . . 0.0 112.352 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 116.53 2.78 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.7 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -99.56 145.64 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.916 0.389 . . . . 0.0 111.34 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.49 152.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.716 HE21 HD21 ' A' ' 56' ' ' ASN . 31.7 tt0 -79.8 130.4 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.563 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.71 3.75 0.02 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.191 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.716 HD21 HE21 ' A' ' 54' ' ' GLN . 14.5 m-20 -112.03 -20.82 11.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.174 0.487 . . . . 0.0 110.004 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -63.66 -50.66 68.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.3 39.31 22.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.769 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.23 153.44 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.876 0.369 . . . . 0.0 111.117 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.17 145.19 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.128 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.5 mm -117.36 101.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.883 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.92 102.94 12.78 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.89 171.0 12.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.967 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.9 m80 51.96 66.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.18 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.3 -173.16 2.27 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -131.8 129.67 40.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -70.06 -7.21 39.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.515 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.2 p -122.65 12.93 10.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.9 ttm -142.65 124.56 15.18 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.763 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.5 162.43 34.69 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.01 143.55 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -94.14 153.19 18.23 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.81 132.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -122.74 104.11 9.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.765 0.793 . . . . 0.0 110.545 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -87.74 130.55 37.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.788 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -134.49 117.63 16.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.75 127.02 35.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.74 106.85 17.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.535 ' ND2' ' N ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -110.02 -168.94 1.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -48.06 -29.09 3.24 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.028 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.7 mm? -64.04 -41.79 97.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 123.59 -48.1 0.98 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.3 m-85 -157.22 132.98 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -169.34 163.86 10.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 5.8 tp10 52.43 52.16 10.61 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.506 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 93.1 Cg_endo -74.45 155.3 45.66 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 123.436 2.757 . . . . 0.0 112.083 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 m -136.59 117.95 14.66 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.929 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -97.25 97.54 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.613 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.55 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 33.4 t80 -102.0 135.81 42.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.637 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.63 134.59 37.5 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.4 p90 -169.18 133.35 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.18 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -79.44 168.64 19.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.5 mmm -95.66 138.51 21.78 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.529 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.39 164.93 32.93 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.62 2.213 . . . . 0.0 111.328 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.18 150.88 87.08 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.292 1.995 . . . . 0.0 111.642 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.82 133.91 1.72 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.154 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.493 1.482 0 C-N-CA 122.264 1.976 . . . . 0.0 111.807 177.769 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 74.2 Cg_exo . . . . . 0 N--CA 1.498 1.75 0 N-CA-C 112.418 0.122 . . . . 0.0 112.418 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.9 Cg_exo -37.32 165.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.755 2.303 . . . . 0.0 113.769 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.528 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -148.4 47.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.617 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.9 mm -131.14 131.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 111.93 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -108.6 -173.13 2.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.79 118.19 0.65 Allowed Glycine 0 C--N 1.321 -0.256 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.359 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -135.39 144.13 48.24 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.65 85.41 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.396 1.397 . . . . 0.0 111.184 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -52.15 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.214 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.8 t -142.58 136.7 29.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.099 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.43 -134.81 33.44 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -93.58 -0.86 56.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.908 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.3 p -68.86 153.06 44.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.644 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 122.72 22.82 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -83.52 97.94 9.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.166 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mt -95.96 92.22 6.38 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 t -67.02 128.37 36.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.167 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.408 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 2.2 mm -88.2 112.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 7' ' ' SER . 18.9 m -83.18 129.09 34.99 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.079 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.583 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.1 102.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.745 -0.782 . . . . 0.0 108.932 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.64 148.56 24.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -50.43 102.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.64 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 29' ' ' GLY . 5.7 m-20 -57.67 142.22 45.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.48 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 27' ' ' ASP . . . -32.43 -28.41 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 159.78 14.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.871 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.5 155.17 22.71 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 118.175 0.987 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.23 138.6 67.54 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.965 1.777 . . . . 0.0 111.062 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mt -86.13 135.76 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.14 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 55' ' ' GLY . 77.3 mt -85.79 -43.59 13.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.43 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -146.21 162.19 38.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.637 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -113.67 122.01 45.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.631 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 HD11 HG21 ' A' ' 36' ' ' ILE . 85.4 mt -99.52 112.15 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' LYS . 58.0 t -111.99 126.78 69.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.547 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -124.49 139.45 53.87 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 22.1 p90 -145.63 157.74 43.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.103 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.09 -176.62 5.43 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.312 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -91.99 138.18 31.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.154 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -66.68 -34.41 77.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.67 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 67.5 t0 -59.96 -34.64 73.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.787 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.1 mtmt -126.36 -172.01 2.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.508 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -173.78 63.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.682 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -131.06 -7.86 3.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.297 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -140.93 155.12 46.33 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -137.55 108.04 6.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.672 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.1 159.79 33.23 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.202 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.69 146.45 43.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.166 0.507 . . . . 0.0 111.866 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -146.68 112.82 5.82 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.401 ' HZ3' ' CG2' ' A' ' 36' ' ' ILE . 73.0 mmtt -100.34 142.57 31.64 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.07 160.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 110.315 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.543 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.5 tp60 -72.75 151.06 42.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.479 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.05 12.96 0.38 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 54' ' ' GLN . 65.4 t30 -145.19 2.6 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.007 0.403 . . . . 0.0 111.639 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -63.49 -47.47 81.62 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.593 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' OD2' ' NZ ' ' A' ' 24' ' ' LYS . 0.7 OUTLIER 59.37 31.03 20.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.976 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.26 151.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.01 147.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.867 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.8 mm -118.52 108.57 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 8.9 mp -94.41 106.58 18.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -85.31 147.55 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.977 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 71.02 77.83 0.18 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.944 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.5 ' O ' ' SD ' ' A' ' 93' ' ' MET . 91.3 mt -115.0 -3.98 12.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.534 ' O ' ' SD ' ' A' ' 93' ' ' MET . 80.4 mt-30 50.53 122.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.814 0.816 . . . . 0.0 112.792 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -61.28 -26.12 67.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.714 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -103.55 22.66 13.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.7 mmm -146.96 118.57 7.99 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.134 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.85 162.6 45.01 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -155.58 132.03 10.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.853 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.1 152.1 22.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.38 134.49 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -124.36 106.85 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.36 0.6 . . . . 0.0 109.722 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -91.68 132.45 36.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.47 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -134.31 121.39 21.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.51 124.15 38.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.26 108.83 21.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 5.7 p-10 -115.79 -164.94 0.99 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.24 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -53.17 -30.09 35.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 5.9 mp -62.53 -39.32 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 120.81 -47.91 0.99 Allowed Glycine 0 N--CA 1.463 0.466 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 9.8 m-85 -156.05 122.64 5.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.7 p -87.43 163.41 16.75 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -44.35 111.78 1.27 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 160.35 48.57 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.304 1.336 . . . . 0.0 112.823 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.41 HG21 ' H ' ' A' ' 7' ' ' SER . 26.3 m -107.24 116.75 32.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.641 0.734 . . . . 0.0 109.674 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.01 96.18 5.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.424 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.579 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -100.39 121.73 41.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.48 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -122.42 129.94 52.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 111.309 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.579 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 9.7 p90 -164.79 128.29 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.405 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -80.4 167.43 20.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.527 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.0 mtp -93.6 147.86 34.39 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.54 162.16 33.46 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.477 2.118 . . . . 0.0 110.384 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.47 154.29 72.51 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.207 1.938 . . . . 0.0 111.587 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -36.06 132.18 0.59 Allowed Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.492 1.396 0 C-N-CA 121.599 1.532 . . . . 0.0 112.478 179.645 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' PRO . 2.1 Cg_endo . . . . . 0 N--CA 1.495 1.614 0 CA-C-O 120.375 0.073 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -37.96 177.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.777 2.985 . . . . 0.0 116.173 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.28 37.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.953 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -125.02 136.56 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.537 0.684 . . . . 0.0 110.64 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -116.83 -172.87 2.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.837 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.28 143.0 8.03 Favored Glycine 0 N--CA 1.462 0.392 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.322 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -150.79 115.56 3.24 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -46.83 104.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.493 1.462 . . . . 0.0 112.689 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 17' ' ' SER . 28.7 p -80.7 172.21 14.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' SER . 58.8 m -40.56 107.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.798 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.89 -158.32 23.98 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -75.71 -11.6 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.871 0.367 . . . . 0.0 110.766 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 13' ' ' SER . 30.7 t -62.5 140.43 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.303 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.0 137.41 51.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.409 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -97.94 98.53 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mt -97.74 103.17 15.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 t -69.78 126.08 28.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.908 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.07 108.74 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -79.84 136.1 36.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.904 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.13 104.64 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.675 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 27' ' ' ASP . 28.3 mt-30 -89.51 137.63 32.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.552 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 27' ' ' ASP . 1.3 m-20 -54.64 93.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 24.7 t70 -44.54 171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.054 0.454 . . . . 0.0 110.881 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.56 -31.95 76.51 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.5 12.62 0.03 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.821 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -147.71 151.91 40.02 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 117.619 0.71 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.0 143.99 68.18 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.82 1.68 . . . . 0.0 111.783 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mt -93.8 133.06 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.262 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 2.3 mm? -95.43 -14.02 24.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.93 155.96 8.79 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -113.32 112.88 24.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.789 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 36' ' ' ILE . 98.5 mt -89.98 106.99 17.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 51' ' ' LYS . 21.6 t -109.35 129.78 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.415 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -123.84 142.86 50.73 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -143.92 158.46 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.891 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 41' ' ' SER . 1.1 ptm180 -151.3 -173.0 4.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.472 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 4.9 p -96.18 140.0 31.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -65.25 -17.9 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.639 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.61 -27.12 16.77 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -117.97 120.36 37.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.296 0.569 . . . . 0.0 110.811 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' NH1' ' A' ' 40' ' ' ARG . 83.9 tt0 -125.2 63.73 1.16 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.38 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.53 -14.71 8.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.953 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -159.64 161.87 35.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.403 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -128.35 136.39 50.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 68.7 mt -80.58 159.83 25.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -118.68 146.29 44.82 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.134 0.492 . . . . 0.0 111.447 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.9 110.27 5.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.5 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -95.65 126.63 41.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 54' ' ' GLN . 43.5 t -132.62 154.89 40.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.995 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.468 ' N ' HG12 ' A' ' 53' ' ' VAL . 71.3 tp60 -68.8 147.36 51.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.62 0.81 55.01 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.412 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -113.67 -14.13 12.64 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.044 0.422 . . . . 0.0 111.339 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.28 -45.14 94.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.723 0.297 . . . . 0.0 110.833 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 58.2 37.1 26.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.886 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.73 141.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -144.01 136.99 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.239 0.542 . . . . 0.0 111.988 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm -108.22 117.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.226 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.01 143.5 35.01 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.589 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 46.4 mt-10 -107.52 169.65 8.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 111.772 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 37.3 p-80 49.06 68.49 0.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.327 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.5 mm? -95.4 -12.3 26.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.296 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.522 ' O ' ' SD ' ' A' ' 93' ' ' MET . 13.0 mm-40 50.76 122.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.864 0.84 . . . . 0.0 112.058 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -61.52 -32.82 72.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.544 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -97.26 22.29 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.63 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.9 ttm -152.17 127.08 9.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.86 34.22 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -136.29 132.71 36.09 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.1 152.97 18.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.36 134.9 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 110.825 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -125.98 109.73 12.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.118 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.429 ' CG2' ' HG1' ' A' ' 87' ' ' THR . 1.7 mp -93.73 135.24 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m -134.83 121.66 20.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.18 123.5 34.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.06 107.8 19.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.28 0.562 . . . . 0.0 112.079 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 1.1 p-10 -110.29 -172.07 1.96 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -49.75 -27.71 5.24 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.789 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.8 mm? -65.64 -41.6 92.44 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.54 -50.3 0.89 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -155.81 134.45 11.79 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.7 t -162.83 157.24 21.13 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.867 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 44.48 61.99 10.55 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.088 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.48 155.51 45.48 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.599 2.199 . . . . 0.0 110.724 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.429 ' HG1' ' CG2' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -122.23 108.85 13.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.3 t -95.0 98.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -103.78 140.26 37.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.742 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -136.49 134.85 38.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.39 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 91' ' ' PHE . 35.3 p90 -165.95 125.36 1.65 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.509 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 p -82.44 171.13 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.575 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 14.8 mtp -99.4 152.59 37.85 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.89 163.53 25.91 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.638 2.225 . . . . 0.0 109.275 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.03 153.45 78.05 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 121.782 1.655 . . . . 0.0 111.533 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -41.47 133.88 2.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.496 1.652 0 C-N-CA 121.986 1.791 . . . . 0.0 111.931 179.116 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 6' ' ' PRO . 8.1 Cg_exo . . . . . 0 N--CA 1.494 1.546 0 CA-C-O 120.679 0.2 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 43.9 Cg_exo -42.53 176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 123.074 2.516 . . . . 0.0 114.109 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -173.41 54.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.743 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -131.25 130.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -121.3 115.37 22.84 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.49 145.37 17.66 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -146.96 111.49 4.12 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.38 98.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.382 1.388 . . . . 0.0 112.702 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -76.82 171.57 14.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -58.2 134.89 56.91 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.799 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.09 -154.54 26.57 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -99.14 46.46 0.98 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.414 ' HG ' ' C ' ' A' ' 62' ' ' LEU . 5.3 t -120.32 149.71 41.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.728 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.94 119.82 27.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.098 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -80.69 98.73 7.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.595 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.41 100.16 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -73.85 126.2 29.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.947 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mm -88.78 112.39 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -86.13 143.35 28.08 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.289 0.566 . . . . 0.0 110.203 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 112.69 10.22 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.519 ' H ' ' CD ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -112.13 170.28 8.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -50.8 112.34 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.608 ' C ' ' H ' ' A' ' 29' ' ' GLY . 69.1 m-20 -71.83 163.83 27.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 -178.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.07 14.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.075 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 101.78 8.81 44.75 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.96 149.42 25.11 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.47 140.06 61.7 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.803 1.669 . . . . 0.0 111.453 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mt -86.28 129.11 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -81.3 -39.69 24.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.37 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -148.78 170.13 18.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -123.23 122.15 37.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.457 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.4 mt -96.47 111.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 51' ' ' LYS . 55.6 t -112.1 128.09 68.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -121.54 134.58 55.04 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.603 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.86 154.84 46.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.59 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 41' ' ' SER . 2.8 ptm180 -144.41 -172.74 3.86 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.336 0.589 . . . . 0.0 110.972 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.521 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 5.9 p -101.58 135.15 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.42 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.12 -11.79 33.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.253 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -90.32 -35.06 15.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -118.58 129.55 55.39 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 110.351 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.3 2.98 11.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.969 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 38.0 p-10 -72.11 -3.57 23.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.389 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -152.77 155.86 37.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.165 0.507 . . . . 0.0 111.922 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -136.85 106.89 6.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.299 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.89 158.73 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.773 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.37 148.24 45.31 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -143.6 113.95 7.43 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.497 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -88.51 136.07 33.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -132.47 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 121.352 0.596 . . . . 0.0 111.951 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.0 144.78 29.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.573 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.01 -24.94 69.01 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -86.39 -22.12 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.621 -0.289 . . . . 0.0 111.515 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 25.7 mttm -60.53 -46.15 91.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.903 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.8 p30 46.52 37.25 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.048 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.55 0.72 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.827 0.346 . . . . 0.0 110.265 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -155.32 151.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.205 0.526 . . . . 0.0 110.564 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.06 112.67 37.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.091 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.414 ' C ' ' HG ' ' A' ' 17' ' ' SER . 54.0 mt -99.82 105.17 16.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.83 152.7 21.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 111.846 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 76.86 58.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.715 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 66' ' ' GLN . 80.6 mt -103.17 -4.84 23.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 65' ' ' LEU . 47.5 mt-30 55.24 159.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.477 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -99.11 -16.01 18.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.194 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.3 p -108.86 19.1 20.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.3 mtp -141.47 141.98 33.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.134 0.493 . . . . 0.0 110.541 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.82 153.4 19.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -138.83 138.02 37.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.95 164.54 12.86 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.63 146.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.142 0.496 . . . . 0.0 110.393 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -137.89 106.36 5.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.465 0.65 . . . . 0.0 109.672 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.82 134.96 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.6 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -137.25 120.69 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.77 125.26 36.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.52 110.82 22.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 9.6 p-10 -112.12 -163.33 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.298 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -32.19 55.37 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 81' ' ' LEU . 9.3 mp -64.55 -42.32 95.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.712 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.86 -46.61 1.07 Allowed Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -154.93 132.51 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -161.56 147.19 13.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.695 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.14 58.14 4.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.19 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.99 151.1 30.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.372 2.048 . . . . 0.0 111.223 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.5 m -131.16 118.62 20.73 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.457 0.646 . . . . 0.0 111.142 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 m -97.97 92.71 2.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.221 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -95.01 151.72 18.93 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -153.29 135.37 14.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.324 0.583 . . . . 0.0 111.571 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -164.92 156.9 15.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.903 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.51 163.98 12.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.633 0.254 . . . . 0.0 110.358 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.4 mmm -89.69 143.96 31.12 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.395 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.63 164.85 31.48 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.755 2.303 . . . . 0.0 110.981 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -65.99 154.91 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.987 1.792 . . . . 0.0 111.696 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -35.37 132.59 0.5 Allowed Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.191 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 121.867 1.711 . . . . 0.0 112.373 178.784 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo . . . . . 0 N--CA 1.494 1.539 0 N-CA-C 112.596 0.191 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -39.4 164.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.408 2.072 . . . . 0.0 114.597 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -154.75 51.16 0.62 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.824 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -128.43 127.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.518 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -122.29 119.1 30.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.137 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.29 158.38 20.52 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -162.78 132.9 3.34 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.85 98.47 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.357 1.371 . . . . 0.0 111.818 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 14' ' ' SER . 87.6 p -80.77 -116.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.659 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 13' ' ' SER . 91.5 p -80.99 112.66 18.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.971 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.03 -133.63 43.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -78.41 -11.28 59.94 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 m -60.8 135.18 57.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.317 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.08 140.42 48.49 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.538 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -99.38 94.85 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.7 90.7 7.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.2 t -66.65 124.46 22.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.217 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.47 113.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.2 m -97.01 114.03 25.61 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.412 0.625 . . . . 0.0 110.091 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -39.09 107.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.593 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.4 OUTLIER -97.79 151.17 20.47 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 85.8 m-20 -43.34 97.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.732 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' GLY . 19.3 m-20 -63.01 152.76 35.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.433 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -38.95 -21.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.773 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 135.42 -3.24 3.94 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.69 146.68 62.22 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.59 138.48 59.44 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.335 1.357 . . . . 0.0 111.133 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.46 126.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.514 0.673 . . . . 0.0 112.39 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -68.47 -41.06 80.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -161.18 168.05 24.94 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.794 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -114.3 119.4 36.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.219 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 HG23 HD13 ' A' ' 36' ' ' ILE . 80.9 mt -96.45 110.83 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.3 t -110.86 125.68 68.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.136 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -120.61 128.91 53.48 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -135.63 151.36 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.587 ' NE ' ' O ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -145.49 -177.87 5.79 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.705 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.587 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 25.4 m -90.72 146.43 24.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.874 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.36 -18.36 52.59 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.7 -49.66 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.535 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HB2' HH22 ' A' ' 40' ' ' ARG . 73.8 mmtt -110.53 -164.36 0.92 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -174.58 75.87 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -154.79 -8.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.075 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.0 129.23 21.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -116.18 131.14 57.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.144 0.497 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.73 160.32 18.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.45 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 54.5 mp0 -114.6 147.82 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.101 0.477 . . . . 0.0 111.44 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.16 113.99 5.39 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.32 146.59 26.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.911 0.386 . . . . 0.0 111.99 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.46 160.45 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.482 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.47 ' C ' ' H ' ' A' ' 56' ' ' ASN . 47.9 tp60 -83.07 148.46 27.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.857 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.13 5.72 3.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 54' ' ' GLN . 64.0 t30 -122.69 -14.45 7.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.027 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 21.3 mttp -67.47 -49.79 61.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.182 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 59.03 35.45 23.98 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.974 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -176.35 155.49 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.763 -0.585 . . . . 0.0 111.386 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -151.18 146.09 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.59 102.7 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.882 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp -87.67 105.62 17.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 79.4 mt-10 -86.77 139.16 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.346 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 2.0 t-160 83.92 79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.375 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.8 mt -131.86 77.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 42.4 tt0 -34.9 143.71 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.344 0.592 . . . . 0.0 111.151 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -70.08 -22.46 63.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.496 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 p -100.76 22.95 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.1 ttm -141.77 132.98 26.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.34 0.59 . . . . 0.0 110.981 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.26 153.4 20.5 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -148.61 133.36 17.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.571 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.94 151.75 23.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.753 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.07 133.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -125.98 108.9 11.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 0.0 109.872 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.35 135.86 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.285 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -134.82 117.73 16.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.85 126.06 35.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.233 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.33 107.88 18.89 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.7 p-10 -109.64 -174.09 2.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.897 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -45.64 -26.28 0.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.608 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -71.84 -40.27 69.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.935 0.397 . . . . 0.0 110.125 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.465 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 128.61 -49.22 0.93 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -153.66 131.74 11.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 t -167.78 162.97 14.09 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.836 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 26' ' ' ASP . 8.3 tp10 50.27 53.89 14.8 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.188 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 92.3 Cg_endo -74.84 156.09 43.69 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.977 2.452 . . . . 0.0 110.943 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.01 110.42 11.64 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.03 0.443 . . . . 0.0 110.785 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 t -94.01 95.76 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.549 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -102.92 133.59 47.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.22 136.95 42.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.17 0.509 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.5 p90 -171.72 132.92 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.199 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.19 167.09 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.8 mmm -96.04 144.22 27.45 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.75 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.14 165.27 28.28 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.776 2.317 . . . . 0.0 110.903 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.98 162.89 33.28 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.992 1.795 . . . . 0.0 111.433 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -40.74 133.21 1.74 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 C-N-CA 121.985 1.79 . . . . 0.0 111.085 177.759 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' PRO . 88.8 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 N-CA-C 112.719 0.238 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' PRO . 15.7 Cg_exo -37.41 163.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.872 2.381 . . . . 0.0 113.707 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 m -151.38 52.2 0.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.444 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -130.18 128.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -122.46 117.11 25.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.1 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.02 161.53 21.75 Favored Glycine 0 N--CA 1.464 0.543 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.968 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -161.95 128.78 2.52 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.92 88.26 0.94 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.3 t -66.87 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -71.29 133.07 45.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.172 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 -160.11 49.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.864 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -79.82 -4.98 54.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.642 -0.279 . . . . 0.0 111.227 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.8 p -68.72 147.39 51.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.121 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.0 124.69 43.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -84.29 100.12 11.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.399 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.65 97.97 9.8 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -71.56 126.28 29.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.037 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mm -88.93 113.79 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 m -85.5 139.07 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.063 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -72.29 104.92 3.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.655 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 168.21 9.42 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.3 t70 -56.85 110.01 0.73 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.31 165.37 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.125 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.37 -23.09 33.0 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.42 16.69 0.08 OUTLIER Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.247 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.91 152.48 20.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 117.169 0.485 . . . . 0.0 109.789 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.51 145.04 86.86 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.86 1.707 . . . . 0.0 111.112 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.4 mt -91.59 129.24 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.467 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.21 -44.56 14.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.24 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.6 161.64 39.34 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -113.88 122.19 46.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.98 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.4 mt -94.25 108.44 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 51' ' ' LYS . 58.1 t -113.77 130.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.113 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -127.95 147.23 50.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -148.55 155.69 41.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.074 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.741 HH21 ' H ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -152.49 -172.83 4.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.032 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -92.74 146.48 23.61 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.792 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.61 15.7 0.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -132.45 -45.92 0.9 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.739 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.561 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.79 37.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.684 0.278 . . . . 0.0 110.821 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 6.7 tm-20 -49.68 84.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 110.753 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 44' ' ' LYS . 73.0 m-20 -153.93 -16.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.966 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.741 ' H ' HH21 ' A' ' 40' ' ' ARG . 19.7 pt20 -156.74 155.68 32.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.063 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -124.39 136.01 53.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.084 0.469 . . . . 0.0 111.898 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.9 158.71 20.5 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -118.35 146.51 44.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.097 0.475 . . . . 0.0 111.319 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -147.45 117.78 7.38 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -100.94 143.53 30.97 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.95 161.38 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.357 0.598 . . . . 0.0 110.646 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 56' ' ' ASN . 66.9 tp60 -79.14 147.71 32.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.606 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.62 0.29 5.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 54' ' ' GLN . 12.1 t-20 -118.62 -6.73 10.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.556 0.217 . . . . 0.0 110.891 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HZ2' ' CE1' ' A' ' 59' ' ' HIS . 10.2 tptp -63.6 -47.83 79.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.31 0.576 . . . . 0.0 109.638 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 53.02 30.17 9.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.686 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.546 ' CE1' ' HZ2' ' A' ' 57' ' ' LYS . 0.4 OUTLIER 178.69 153.39 0.36 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.968 0.414 . . . . 0.0 110.737 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -151.96 145.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.542 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.56 107.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 mt -92.7 133.06 36.38 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 83.4 tt0 -119.77 152.94 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.008 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 36.3 t-80 88.88 49.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.712 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.22 86.96 2.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -41.65 137.88 1.52 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.452 0.644 . . . . 0.0 111.122 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -65.0 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.755 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -98.32 21.42 11.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.384 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 8.8 ttm -145.17 128.64 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 110.145 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.76 161.9 46.48 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.61 129.61 23.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -90.55 154.39 19.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.875 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -135.1 136.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 67.2 tt0 -127.25 107.86 10.37 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.78 131.39 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.283 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -135.54 120.21 18.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.63 127.4 35.9 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.21 111.01 23.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.248 0.547 . . . . 0.0 112.248 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.5 p30 -112.08 -166.44 1.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.237 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -53.0 -30.91 38.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.027 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.494 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -66.37 -41.31 89.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.165 0.507 . . . . 0.0 109.736 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 129.93 -49.07 0.94 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -154.88 137.77 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.6 t -165.38 155.48 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.701 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 26' ' ' ASP . 18.5 tt0 50.06 56.94 17.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.232 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.81 154.37 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.68 2.253 . . . . 0.0 111.367 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -132.34 119.01 20.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 0.0 111.089 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.94 94.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.54 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 40.2 t80 -98.22 131.1 44.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.124 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -133.1 131.5 40.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.54 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 20.9 p90 -161.73 134.73 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.63 160.23 25.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.366 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 91.1 mmm -94.49 140.93 22.86 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.804 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.71 162.81 40.22 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.035 1.823 . . . . 0.0 110.861 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.33 151.99 83.46 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.499 2.133 . . . . 0.0 111.816 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -38.28 133.18 0.96 Allowed Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 N--CA 1.494 1.519 0 C-N-CA 121.477 1.452 . . . . 0.0 111.681 179.118 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 6' ' ' PRO . 80.7 Cg_exo . . . . . 0 N--CA 1.502 1.977 0 N-CA-C 112.545 0.171 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.2 Cg_exo -38.75 163.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.331 2.021 . . . . 0.0 114.276 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.33 33.54 0.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.695 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.58 120.49 60.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.553 0.692 . . . . 0.0 110.788 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -116.26 116.86 28.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.039 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.24 150.44 19.68 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 13' ' ' SER . 21.6 mt-30 -153.62 113.46 2.59 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.41 85.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.171 1.248 . . . . 0.0 111.636 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 11' ' ' GLN . 10.8 t -53.92 -88.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.647 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.25 140.33 41.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.808 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.01 -127.9 39.11 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.499 ' CE ' ' O ' ' A' ' 65' ' ' LEU . 10.4 mtmm -99.39 -2.84 35.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 p -67.01 149.21 50.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.11 135.38 48.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.824 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -96.39 95.18 7.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -90.86 92.28 8.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -68.9 122.59 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.221 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mm -85.95 112.6 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -91.68 117.76 30.04 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.469 ' O ' ' CG ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.19 105.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.391 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -88.96 157.61 18.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -48.62 106.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -58.1 142.69 46.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.649 0.737 . . . . 0.0 111.965 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.99 -20.71 6.7 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.6 -1.65 0.73 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.75 25.78 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.87 133.33 38.41 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.86 1.707 . . . . 0.0 111.992 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.59 130.27 36.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.172 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.3 mp -80.99 -44.67 17.79 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -142.18 163.72 32.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.515 0.674 . . . . 0.0 111.434 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -116.71 113.88 23.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.166 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -87.83 109.94 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 51' ' ' LYS . 44.9 t -114.08 130.55 68.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -125.84 133.32 52.01 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.47 150.73 46.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.839 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.3 ptt85 -143.65 174.78 10.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.027 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 44' ' ' LYS . 16.5 m -84.99 142.57 29.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -63.31 -35.53 80.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.471 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.33 -10.52 59.53 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.564 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 41' ' ' SER . 28.4 mmtt -125.99 154.6 42.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.633 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.2 19.83 1.09 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.708 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.93 1.06 52.64 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -159.89 158.07 30.2 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.94 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -136.44 106.13 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.8 mt -67.59 145.77 54.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.81 151.86 25.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.22 0.533 . . . . 0.0 111.138 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' VAL . 11.2 tppt? -150.58 113.24 4.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.427 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -97.81 139.85 33.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.362 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.77 160.42 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.371 0.605 . . . . 0.0 110.997 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -78.67 142.55 37.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.362 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.68 -3.74 16.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -110.26 -21.36 12.27 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.723 -0.28 . . . . 0.0 110.622 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -61.55 -52.48 64.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.021 0.438 . . . . 0.0 110.687 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 56.57 41.67 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.809 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.81 150.44 0.8 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.525 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.05 140.7 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.2 mm -111.45 103.96 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.407 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 10.3 mp -92.57 107.57 19.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 171.11 10.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 m80 66.57 48.12 1.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.364 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.499 ' O ' ' CE ' ' A' ' 16' ' ' LYS . 23.8 mt -100.16 164.71 11.85 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -119.97 143.07 48.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.201 0.524 . . . . 0.0 110.625 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -68.87 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.1 p -102.44 17.93 22.37 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.6 mtp -143.41 134.12 25.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.41 166.44 31.88 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.147 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -142.82 131.73 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.54 . . . . 0.0 110.351 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.1 mt-10 -88.32 151.47 22.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.58 131.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.565 ' NE2' ' O ' ' A' ' 75' ' ' ILE . 10.0 tp60 -124.34 108.08 11.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.611 0.72 . . . . 0.0 110.371 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 1.6 mp -90.58 134.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.098 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.476 ' HG1' HE21 ' A' ' 74' ' ' GLN . 0.7 OUTLIER -134.46 120.36 19.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.25 127.03 37.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.58 107.24 18.07 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.019 0.438 . . . . 0.0 111.812 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.639 ' ND2' ' H ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.61 -170.58 1.8 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -44.09 -32.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.789 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -64.12 -41.52 97.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.64 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 123.52 -49.04 0.92 Allowed Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 7.0 m-85 -156.45 125.71 6.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.589 ' HG ' ' H ' ' A' ' 85' ' ' GLU . 11.7 t -160.64 169.68 22.37 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.651 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.589 ' H ' ' HG ' ' A' ' 84' ' ' SER . 60.3 mm-40 52.0 49.3 6.65 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.869 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 74.3 Cg_endo -71.35 152.37 60.85 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.068 1.845 . . . . 0.0 111.146 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.31 113.51 12.69 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 110.378 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.87 93.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -101.53 145.32 29.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.224 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.66 138.34 32.43 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 91' ' ' PHE . 16.7 p90 -164.39 127.61 2.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.0 p -83.76 143.06 30.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 94.6 mmm -74.29 140.32 76.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.144 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.05 164.76 34.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.92 152.7 80.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.431 2.087 . . . . 0.0 111.748 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -39.89 129.89 1.54 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.487 1.119 0 C-N-CA 121.498 1.465 . . . . 0.0 112.254 178.778 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' PRO . 14.3 Cg_exo . . . . . 0 N--CA 1.503 2.066 0 CA-C-O 120.581 0.159 . . . . 0.0 112.204 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -35.89 166.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 123.6 2.867 . . . . 0.0 115.384 -179.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.51 43.15 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.518 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.02 132.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.323 0.582 . . . . 0.0 111.318 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -128.89 117.39 20.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.595 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.1 145.72 17.8 Favored Glycine 0 N--CA 1.464 0.562 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.031 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -148.03 118.18 4.29 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -48.96 109.15 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.097 1.198 . . . . 0.0 112.111 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 t -84.4 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.6 m -82.0 134.56 35.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.191 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.46 -135.05 41.76 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.7 ' HZ2' ' HE1' ' A' ' 67' ' ' TRP . 33.7 mttm -77.78 -8.64 58.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.838 0.351 . . . . 0.0 110.994 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.6 t -64.74 141.57 58.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.027 0.442 . . . . 0.0 111.946 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.3 124.3 44.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.898 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -87.57 104.49 16.55 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.251 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 mt -97.26 91.62 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.0 t -65.4 120.48 12.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.039 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.13 123.29 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -93.91 113.65 25.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.423 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -42.17 104.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.322 0.582 . . . . 0.0 110.841 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -85.82 171.34 11.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.093 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.46 108.66 0.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.18 142.4 56.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.444 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -40.88 -74.36 0.16 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.36 13.09 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.87 158.61 29.27 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -57.03 141.81 94.08 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.15 1.234 . . . . 0.0 111.069 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mt -83.95 122.13 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.104 0.478 . . . . 0.0 111.233 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.0 -41.97 85.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.278 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.6 163.17 24.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.255 0.55 . . . . 0.0 111.241 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -107.5 114.61 28.72 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.836 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -88.09 114.72 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.7 t -115.44 129.81 71.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.976 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -125.24 136.08 53.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -140.42 155.82 46.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.041 0.448 . . . . 0.0 110.514 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.554 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 11.1 ptt180 -149.9 178.99 8.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.377 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 p -91.1 140.64 29.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.223 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -68.67 -24.59 64.54 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -33.97 74.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.585 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -158.85 -175.48 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.854 0.835 . . . . 0.0 112.344 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 10.8 pt-20 -142.72 122.06 13.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.753 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 47' ' ' GLN . 63.7 m-20 -161.15 38.01 0.14 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 26.1 mt-30 115.88 126.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.853 1.971 . . . . 0.0 110.927 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.554 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 21.6 m95 -87.89 135.78 33.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.842 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 76.3 mt -72.59 159.83 33.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.75 151.76 40.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.071 0.462 . . . . 0.0 111.567 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.15 113.44 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.506 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -92.8 144.17 25.55 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.01 150.47 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.474 ' C ' ' H ' ' A' ' 56' ' ' ASN . 52.2 tt0 -67.49 140.6 57.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.512 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.01 7.7 0.27 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.57 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 54' ' ' GLN . 8.3 t-20 -132.93 -8.92 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.364 0.582 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 14.7 mttp -64.65 -46.0 84.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.607 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.7 p30 50.04 39.5 19.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.799 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.45 151.95 0.63 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.7 140.87 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 0.0 110.707 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mm -111.87 98.4 6.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.119 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 mt -87.23 105.27 17.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 54.7 mp0 -86.58 175.31 8.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.3 m80 60.91 57.82 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -105.15 -171.68 1.96 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.09 129.57 22.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.579 0.704 . . . . 0.0 110.954 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.7 ' HE1' ' HZ2' ' A' ' 16' ' ' LYS . 68.0 m95 -63.81 -30.39 71.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.977 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 p -100.45 21.0 13.86 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.99 135.03 19.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.301 . . . . 0.0 110.458 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.77 166.17 42.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -144.97 135.0 23.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.501 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 7.5 mt-10 -98.11 151.77 20.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.43 136.95 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.938 0.399 . . . . 0.0 110.678 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -129.62 114.38 15.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.94 136.33 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.923 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -138.8 117.78 12.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.21 129.04 35.45 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.87 116.17 31.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.284 0.564 . . . . 0.0 112.454 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.9 p-10 -117.18 -169.57 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -50.89 -27.96 8.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.611 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -66.24 -37.6 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.529 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 121.52 -52.19 0.75 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.467 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.2 m-85 -151.67 138.22 18.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -161.71 171.68 17.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.407 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 32.03 64.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.408 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.66 151.91 32.72 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.297 1.998 . . . . 0.0 110.691 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.75 110.3 12.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.128 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -96.72 98.76 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -104.47 147.45 27.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.19 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.6 131.67 20.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.934 0.397 . . . . 0.0 111.182 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 38.1 p90 -165.81 142.34 5.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -90.01 161.05 16.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.375 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 92.3 mmm -87.77 137.62 31.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.552 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.38 165.43 31.79 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.306 2.004 . . . . 0.0 111.284 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.92 152.88 80.25 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.035 1.823 . . . . 0.0 110.888 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.615 ' CE ' ' NE1' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -44.49 130.93 4.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.496 1.665 0 C-N-CA 121.71 1.606 . . . . 0.0 113.196 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 6' ' ' PRO . 84.0 Cg_exo . . . . . 0 N--CA 1.501 1.927 0 N-CA-C 113.088 0.38 . . . . 0.0 113.088 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.3 Cg_exo -38.71 163.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.693 2.262 . . . . 0.0 113.339 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.8 m -157.49 58.92 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.8 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.44 130.44 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.228 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -118.99 113.76 21.48 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.26 138.65 14.05 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -152.41 146.88 18.76 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.655 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.64 88.02 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.278 1.985 . . . . 0.0 111.792 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 t -67.98 -68.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.779 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' GLY . 20.0 m -136.88 156.66 48.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . . . 31.99 -116.22 0.1 OUTLIER Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.088 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -96.86 -8.32 31.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.962 0.41 . . . . 0.0 110.274 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.47 136.47 58.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.95 118.65 31.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.326 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.18 109.39 14.6 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.066 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.5 mt -100.93 89.7 3.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -70.3 121.85 18.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.38 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mm -82.65 114.95 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 m -94.72 116.29 28.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.627 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.484 ' CD ' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.29 105.76 0.05 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.531 ' NE2' ' OE1' ' A' ' 85' ' ' GLU . 3.6 pt20 -117.87 101.21 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' GLN . 95.7 m-20 33.1 -154.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 29' ' ' GLY . 46.5 p-10 -165.11 161.61 19.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.37 5.6 2.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 117.13 9.28 10.74 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.61 151.3 23.38 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 117.01 0.405 . . . . 0.0 110.156 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.32 141.69 76.08 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.926 1.751 . . . . 0.0 111.781 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mt -88.06 130.93 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.183 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.79 -41.82 14.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.283 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -146.67 162.12 39.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.299 0.571 . . . . 0.0 111.775 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -114.2 121.61 44.27 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.963 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.1 mt -95.45 110.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.26 130.88 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.563 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -128.56 133.06 48.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.413 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.8 153.3 49.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.446 . . . . 0.0 110.389 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -140.4 -174.1 3.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.459 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -100.68 137.36 39.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.029 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -66.77 -30.63 70.89 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.08 -33.43 73.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.569 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 41' ' ' SER . 12.1 ptpt -131.87 168.75 17.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 111.273 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.91 106.8 3.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.188 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 25.2 p-10 -164.74 -26.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -144.99 162.52 36.71 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -131.9 133.54 44.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.133 0.492 . . . . 0.0 110.939 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.8 mt -77.15 160.48 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.67 152.27 36.42 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.09 0.472 . . . . 0.0 111.8 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.72 113.71 2.27 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -98.83 145.98 26.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.598 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 157.4 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.115 0.483 . . . . 0.0 110.528 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.541 ' C ' ' H ' ' A' ' 56' ' ' ASN . 40.6 tt0 -77.05 137.08 38.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.488 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.95 0.02 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.522 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 54' ' ' GLN . 97.1 m-20 -121.09 -6.26 9.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.875 0.338 . . . . 0.0 110.615 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -64.63 -49.7 70.0 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.53 0.681 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 56.41 34.9 25.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.188 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.45 151.18 0.59 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.03 146.29 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.535 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 61' ' ' ILE . 32.5 mm -117.06 108.89 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.578 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -93.13 105.82 17.86 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 45.4 tt0 -91.63 152.04 20.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.805 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 12.3 t60 80.74 62.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.371 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' GLN . 66.8 mt -119.74 88.37 2.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.861 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' LEU . 86.4 mt-30 -36.91 152.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.151 0.501 . . . . 0.0 111.735 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -83.17 -5.9 59.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.404 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -115.04 15.13 17.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.689 0.28 . . . . 0.0 111.608 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 67.7 mtp -146.0 136.6 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 111.332 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.37 162.22 25.65 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.94 132.38 26.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.595 0.236 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -87.76 149.93 23.89 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.78 137.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -129.32 106.42 8.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.467 0.651 . . . . 0.0 109.423 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -92.51 134.97 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.968 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -138.79 116.01 11.07 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.26 128.16 34.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.189 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.26 107.27 18.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 1.2 p30 -110.7 -168.18 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -49.49 -31.65 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 4.0 mm? -63.07 -41.15 99.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 124.37 -44.2 1.31 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.47 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.8 m-85 -153.17 139.99 19.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.8 p -157.37 162.01 39.05 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.853 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.531 ' OE1' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 32.33 59.1 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.459 178.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.5 150.26 69.55 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 121.567 1.512 . . . . 0.0 110.548 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.8 m -128.21 116.51 20.0 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.492 0.663 . . . . 0.0 111.047 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.9 94.67 4.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.235 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -95.86 147.95 23.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.595 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -144.11 135.88 26.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.054 0.454 . . . . 0.0 110.83 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 18' ' ' PHE . 3.9 p90 -167.54 133.77 2.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -89.01 173.77 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.503 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.88 144.38 28.79 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.093 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.03 165.62 27.97 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.614 2.209 . . . . 0.0 110.41 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.59 152.45 81.74 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.749 1.633 . . . . 0.0 111.741 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -36.1 129.49 0.63 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.764 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 N--CA 1.49 1.277 0 C-N-CA 121.965 1.777 . . . . 0.0 110.939 177.391 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.438 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 49.0 Cg_exo . . . . . 0 N--CA 1.506 2.227 0 N-CA-C 112.389 0.111 . . . . 0.0 112.389 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 5' ' ' PRO . 86.6 Cg_exo -54.7 145.4 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.089 2.526 . . . . 0.0 114.237 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.403 ' HG ' ' CD ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -138.03 50.44 1.91 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.541 -178.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.2 mm -126.21 128.5 71.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.241 0.543 . . . . 0.0 110.896 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -122.15 114.53 21.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.428 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.2 147.5 18.62 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.531 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -156.74 135.34 7.62 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 107.77 2.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.063 1.175 . . . . 0.0 111.51 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -78.18 -81.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.3 m -143.18 133.91 25.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.406 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.6 -145.68 35.97 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.689 ' NZ ' ' H ' ' A' ' 66' ' ' GLN . 2.6 mtmp? -87.76 -3.67 58.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.332 . . . . 0.0 110.71 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 82.6 p -71.72 145.66 48.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.749 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.79 125.75 48.36 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -85.77 104.01 15.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.808 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.89 97.49 8.37 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.4 t -72.39 120.16 17.61 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.689 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mm -80.11 119.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.6 m -85.32 128.26 34.63 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.906 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.98 110.93 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.209 1.004 . . . . 0.0 109.584 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.502 ' C ' ' H ' ' A' ' 27' ' ' ASP . 7.3 mm100 -92.79 169.05 10.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.076 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 17.1 t70 -53.75 -9.28 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.262 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 p30 47.92 34.97 4.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.848 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.2 -13.06 0.17 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 114.52 4.3 21.82 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . -131.44 152.5 80.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 122.633 -0.333 . . . . 0.0 110.358 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.79 144.08 58.02 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.213 1.942 . . . . 0.0 111.837 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -98.44 125.66 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.504 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 mt -72.92 -39.53 66.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.104 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -160.58 170.46 20.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.91 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.38 122.43 43.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.582 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -93.02 108.84 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.4 t -111.12 127.13 68.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.067 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.23 138.22 54.11 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.952 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -142.4 151.04 41.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.086 0.47 . . . . 0.0 111.436 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 37.2 ptt85 -143.94 174.27 10.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.864 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.403 ' HG ' ' H ' ' A' ' 44' ' ' LYS . 9.8 p -80.04 150.98 30.17 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.204 0.315 . . . . 0.0 110.261 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -75.12 12.15 0.97 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.425 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.69 -35.03 2.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.489 0.185 . . . . 0.0 110.776 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.403 ' H ' ' HG ' ' A' ' 41' ' ' SER . 33.7 mmtt -103.01 109.64 21.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.491 0.662 . . . . 0.0 110.741 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -105.07 15.95 26.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.695 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.91 3.39 53.62 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -161.38 136.26 7.36 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.214 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 43.0 m95 -119.59 123.56 44.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.76 160.24 23.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.017 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -120.18 154.68 34.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.428 0.632 . . . . 0.0 111.916 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.14 114.67 3.12 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.75 141.15 32.94 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.354 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.33 161.72 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.355 0.598 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -78.11 146.94 34.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.432 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.0 5.64 7.76 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.828 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -120.7 -15.82 8.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.737 0.304 . . . . 0.0 110.31 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -65.16 -52.06 57.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.238 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 55.9 38.45 30.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.283 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.35 150.96 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.528 0.204 . . . . 0.0 110.535 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.36 152.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.398 0.618 . . . . 0.0 111.667 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 mm -121.57 111.73 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.82 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 17' ' ' SER . 51.0 mt -97.61 112.88 24.57 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -84.93 153.54 22.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 0.0 112.47 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 70.3 t60 59.57 81.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.029 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 66' ' ' GLN . 75.1 mt -118.03 -4.15 11.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.689 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . 22.6 mt-30 57.13 149.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.405 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -90.64 -14.46 32.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.782 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 p -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.75 117.34 15.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.136 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.9 157.83 50.69 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.936 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -139.73 128.03 22.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.309 -0.445 . . . . 0.0 110.259 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -86.48 153.14 22.08 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.61 134.97 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -123.77 106.93 10.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.538 0.685 . . . . 0.0 109.414 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.11 133.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.489 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -139.9 116.2 10.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.37 127.75 35.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.28 110.62 22.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.29 0.567 . . . . 0.0 112.008 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.64 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -116.63 -176.45 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.839 178.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -42.52 -31.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 7.3 mp -64.75 -41.79 95.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.451 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 124.6 -45.38 1.18 Allowed Glycine 0 N--CA 1.465 0.573 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.484 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.7 m-85 -154.52 138.86 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.433 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 73.5 m -148.17 161.53 41.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.564 0.697 . . . . 0.0 111.87 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 85' ' ' GLU . 0.7 OUTLIER 22.75 60.94 0.34 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.417 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.8 150.27 86.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.154 1.236 . . . . 0.0 110.414 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.7 m -125.27 117.92 24.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.577 0.703 . . . . 0.0 111.712 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.92 93.6 4.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.584 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 36.7 t80 -95.81 132.67 40.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.704 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.83 136.46 46.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 111.221 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.1 p90 -172.24 133.44 0.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.165 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.4 p -80.52 162.76 24.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.343 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.6 mmm -89.29 143.31 30.72 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.285 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.93 164.98 34.06 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.684 2.256 . . . . 0.0 111.203 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.1 152.36 81.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.414 2.076 . . . . 0.0 111.507 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.75 131.22 1.83 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.208 1.939 . . . . 0.0 111.525 178.19 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -135.06 81.87 43.95 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -101.2 -164.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 124.008 3.139 . . . . 0.0 110.057 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.441 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -167.83 -179.79 0.81 Allowed Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.149 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 30.1 Cg_exo -59.96 171.01 3.22 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.592 2.195 . . . . 0.0 111.884 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -39.21 164.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.696 2.264 . . . . 0.0 114.732 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 m -163.74 48.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.635 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -126.12 127.4 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.621 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -113.35 113.98 26.0 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.06 141.54 15.59 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -150.37 148.63 24.65 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.767 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.75 88.29 1.39 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.167 1.911 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 14' ' ' SER . 79.7 p -58.12 -87.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.024 0.44 . . . . 0.0 109.971 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.419 ' N ' ' OG ' ' A' ' 13' ' ' SER . 37.9 m -139.29 127.97 23.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.58 -131.31 14.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -93.13 -10.67 35.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.634 0.254 . . . . 0.0 111.226 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 62' ' ' LEU . 34.8 t -63.95 146.56 53.84 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.874 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 130.33 52.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.08 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -88.2 104.83 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.371 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.63 97.4 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 t -73.76 126.94 31.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 mm -87.49 110.44 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -88.89 115.61 26.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.49 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -36.98 105.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.297 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -91.92 170.5 9.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.614 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.94 109.21 1.2 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.12 142.81 58.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -46.38 -19.52 0.45 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.461 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.71 1.24 1.42 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.92 151.87 57.36 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.82 137.82 55.26 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.772 1.648 . . . . 0.0 111.385 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -83.41 131.39 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.357 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 4.1 mm? -85.48 -42.71 14.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.32 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -146.66 161.06 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.266 0.555 . . . . 0.0 111.618 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.98 125.01 53.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.101 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 ' CG2' ' HZ3' ' A' ' 52' ' ' LYS . 80.6 mt -98.3 114.34 35.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.0 t -112.39 127.74 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.784 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -129.12 128.7 44.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -136.64 153.19 50.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -142.36 172.93 12.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.753 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 15.4 m -84.25 137.96 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -63.13 -38.26 90.47 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.847 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.76 -43.04 97.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.529 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 41' ' ' SER . 36.8 mmtt -102.54 117.76 35.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.407 0.622 . . . . 0.0 110.961 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.77 54.91 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.63 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -142.37 5.66 1.65 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.258 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -144.31 152.85 41.34 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.014 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -141.57 110.6 6.23 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.232 0.539 . . . . 0.0 110.65 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.9 mt -73.13 160.08 32.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.72 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -121.71 148.02 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.07 0.462 . . . . 0.0 111.713 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.79 113.61 4.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.517 ' HZ3' ' CG2' ' A' ' 36' ' ' ILE . 72.9 mmtt -97.3 146.16 25.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 160.95 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.436 0.636 . . . . 0.0 111.092 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.415 ' C ' ' H ' ' A' ' 56' ' ' ASN . 55.6 tt0 -82.86 136.11 34.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.51 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.06 -8.12 1.37 Allowed Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.263 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 54' ' ' GLN . 81.8 m-20 -107.12 -9.17 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.673 0.273 . . . . 0.0 110.32 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -64.62 -49.16 72.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.1 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 51.83 33.03 10.56 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.429 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.8 152.93 0.46 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.562 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.33 141.39 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.145 0.498 . . . . 0.0 110.608 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -112.13 112.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.145 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OG ' ' A' ' 17' ' ' SER . 52.2 mt -98.38 136.31 38.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.09 159.52 20.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.999 0.428 . . . . 0.0 111.547 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 t60 71.04 62.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.781 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 66' ' ' GLN . 54.0 mt -119.26 82.59 1.89 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.4 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' LEU . 49.8 mt-30 -36.35 152.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.134 0.493 . . . . 0.0 111.711 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -83.57 -9.65 58.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.81 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.4 p -113.64 13.36 18.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 61.8 mtp -139.25 136.44 34.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 111.492 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.85 161.29 19.42 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.131 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -150.66 139.37 20.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 109.992 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -87.5 148.9 24.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.1 t -125.47 132.72 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -123.39 112.58 17.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.186 0.517 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -95.97 135.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.13 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -138.5 116.03 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.01 125.47 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.333 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.34 111.73 24.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.4 p30 -111.6 -164.92 0.95 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -54.45 -30.98 54.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.4 mm? -65.02 -41.77 94.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.697 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.22 -48.16 0.98 Allowed Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.5 m-85 -153.75 137.76 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -161.55 170.49 19.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.237 0.541 . . . . 0.0 110.943 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 34.63 57.73 2.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.298 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.47 151.62 59.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.382 2.054 . . . . 0.0 110.898 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.33 110.57 12.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.5 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 m -95.02 95.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.555 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.6 t80 -102.46 138.64 39.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.603 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.5 136.0 34.08 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.744 0.306 . . . . 0.0 110.593 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.2 p90 -171.52 129.58 0.69 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -81.55 162.68 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 77.5 mmm -88.82 149.11 43.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.61 162.94 29.83 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.414 2.076 . . . . 0.0 110.338 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.1 154.8 72.64 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.092 1.861 . . . . 0.0 110.961 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.89 131.47 0.92 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.434 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.32 141.18 55.6 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.435 1.423 . . . . 0.0 112.427 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.26 -12.65 17.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 101' ' ' LYS . 38.9 pt -105.26 -7.92 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.686 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.6 pt 39.36 16.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.343 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 99' ' ' ILE . 88.4 tttt -86.99 -72.81 0.49 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.22 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.567 179.8 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 34.84 84.84 0.17 Allowed Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.757 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.41 -163.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.252 2.635 . . . . 0.0 109.28 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.42 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -168.86 179.55 0.83 Allowed Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 119.609 -0.837 . . . . 0.0 110.852 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 49.8 Cg_exo -55.25 161.05 7.51 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.647 2.231 . . . . 0.0 112.973 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.0 Cg_exo -39.79 175.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.286 2.657 . . . . 0.0 114.545 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -160.11 39.85 0.18 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.568 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.9 mm -126.02 128.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.326 0.584 . . . . 0.0 111.76 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -124.84 117.05 23.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.753 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.38 147.04 17.9 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-O 121.472 0.485 . . . . 0.0 112.568 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -145.48 132.29 9.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.47 100.22 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.475 1.45 . . . . 0.0 112.402 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 9.7 p -80.18 167.23 20.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.2 p -43.88 112.11 0.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.67 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.59 -171.72 20.44 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -75.15 -9.31 58.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.508 0.194 . . . . 0.0 111.284 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 7.4 p -66.23 142.56 57.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.713 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.07 125.87 50.33 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -86.64 100.24 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.262 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.7 mt -96.83 98.25 9.97 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.4 t -71.36 129.29 38.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.36 111.34 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -77.4 128.16 33.79 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.211 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.585 ' HD3' ' H ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -34.57 105.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.878 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 85' ' ' GLU . 88.4 mt-30 -83.6 118.15 23.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.493 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.61 -10.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.358 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.529 ' OD1' ' ND2' ' A' ' 79' ' ' ASN . 25.8 t70 58.05 172.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.917 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.31 -48.14 72.54 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.22 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.82 25.7 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -152.17 151.87 28.48 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.72 146.5 60.63 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.88 1.72 . . . . 0.0 111.437 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mt -91.05 127.48 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.949 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.3 mm? -75.72 -45.14 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.25 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -151.99 167.07 29.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -115.16 124.41 51.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.401 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 91.9 mt -95.65 109.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.9 t -111.51 128.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -125.81 137.93 53.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -140.99 155.74 46.16 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.935 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.77 175.32 11.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' LYS . 10.1 m -88.52 137.69 32.1 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.206 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -65.46 -34.19 77.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -10.88 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.615 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' SER . 40.5 mtmt -140.84 161.22 38.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 109.959 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -149.03 51.46 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.037 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -139.96 4.96 2.11 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.674 0.274 . . . . 0.0 111.001 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -138.56 144.11 39.72 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.494 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -141.38 112.18 7.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 110.546 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.1 mt -76.43 159.89 30.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.18 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -119.67 150.38 40.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.383 0.611 . . . . 0.0 112.026 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? -153.04 114.45 4.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.219 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -95.29 144.36 25.93 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.09 159.08 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.185 0.517 . . . . 0.0 110.875 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -78.43 143.78 36.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.893 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.06 -25.01 59.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -95.3 -12.25 26.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 16.9 mttm -64.06 -45.3 89.4 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.3 p30 47.78 38.61 9.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.819 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.04 154.0 0.65 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.785 0.326 . . . . 0.0 110.822 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -155.07 150.89 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 121.253 0.549 . . . . 0.0 110.758 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.34 109.51 27.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.035 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.75 106.23 18.2 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -84.67 149.26 25.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.685 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.5 t60 79.42 70.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.753 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -126.25 81.35 1.99 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -38.1 140.98 0.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 111.336 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -68.9 -29.53 67.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.797 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 p -97.22 22.1 9.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 42.3 mtp -147.97 128.67 14.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.835 0.35 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.54 167.38 50.34 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.26 132.65 22.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.11 150.73 20.78 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.18 132.83 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -122.86 109.85 14.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.7 131.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.136 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -134.67 120.33 19.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.94 125.96 35.56 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.09 22.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.643 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.98 -171.51 2.0 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.949 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -41.99 -35.11 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.406 . . . . 0.0 110.217 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.14 -40.49 96.26 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 120.86 -41.76 1.85 Allowed Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.0 m-85 -155.96 135.53 12.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -163.03 155.98 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.789 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.537 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 18.8 tt0 45.04 56.19 14.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.25 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.23 154.89 56.72 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.738 2.292 . . . . 0.0 111.119 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.4 m -130.46 121.15 25.3 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.62 0.724 . . . . 0.0 111.018 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.81 94.44 3.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 37.7 t80 -99.86 125.35 45.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.724 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.07 130.38 49.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.73 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.7 p90 -163.79 134.19 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.601 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -80.56 164.46 22.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.6 mmm -94.76 145.75 30.17 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.918 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.39 163.49 37.6 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.323 2.015 . . . . 0.0 110.937 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.22 154.95 72.14 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.455 2.103 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -40.37 132.77 1.63 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.801 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.85 155.04 48.74 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.805 1.67 . . . . 0.0 111.697 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -80.73 -75.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.988 0.423 . . . . 0.0 110.123 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 tt -151.7 -48.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.417 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 11.5 tt -44.88 152.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.558 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 102' ' ' ASP . 63.6 mmtt -51.15 175.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.068 0.461 . . . . 0.0 111.008 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 101' ' ' LYS . 67.5 t0 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.777 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 28' ' ' GLY . 10.8 mpt_? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 1' ' ' ARG . 5.3 pt-20 -25.41 86.75 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.684 0 O-C-N 123.879 0.737 . . . . 0.0 112.283 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' N ' ' O ' ' A' ' 1' ' ' ARG . 48.2 Cg_endo -101.93 -164.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.679 2.919 . . . . 0.0 110.517 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -169.29 154.12 5.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.486 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' SER . 76.4 Cg_exo -36.1 162.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.261 2.641 . . . . 0.0 112.793 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.0 Cg_exo -37.38 164.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.768 2.312 . . . . 0.0 113.629 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.57 53.15 0.78 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.689 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 mm -130.04 128.4 64.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -119.09 114.71 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.47 145.64 17.75 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.659 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.38 116.46 3.99 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -50.02 104.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.248 1.299 . . . . 0.0 112.252 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -80.76 167.32 20.1 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.1 t -43.27 118.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.38 -150.21 21.15 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -82.18 -6.09 58.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 110.576 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -66.37 143.26 57.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.53 121.76 37.3 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -83.7 108.73 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.437 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 mt -101.81 108.83 20.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -83.4 121.96 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.004 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mm -86.06 115.03 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -86.83 127.18 35.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.191 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -47.16 105.2 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.412 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.528 ' C ' ' H ' ' A' ' 27' ' ' ASP . 78.7 mt-30 -81.44 158.35 24.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.858 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 35.1 t0 -51.16 -9.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.603 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER 64.83 131.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 1' ' ' ARG . . . -40.05 -19.73 0.02 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 138.46 17.87 0.57 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.47 21.01 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.53 138.91 61.79 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.811 1.674 . . . . 0.0 111.732 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.4 mt -89.22 133.33 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.218 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 10.7 mp -89.51 -25.18 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.177 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -164.64 164.62 21.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.176 0.512 . . . . 0.0 111.436 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -119.37 117.49 28.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.076 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.7 mt -91.54 116.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.2 t -115.36 130.0 70.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.542 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -129.22 129.07 44.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -134.1 155.92 49.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.49 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 26.9 ptt85 -149.58 171.1 17.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' LYS . 4.4 m -80.8 138.07 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.416 ' HZ1' ' HG ' ' A' ' 92' ' ' SER . 81.6 mttt -63.94 -32.17 73.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.702 0.287 . . . . 0.0 111.447 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.99 -29.36 69.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.646 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' SER . 38.5 mtmt -130.96 166.61 20.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.488 0.661 . . . . 0.0 110.996 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -144.74 16.21 1.6 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.558 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -90.14 -0.25 57.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.881 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -149.36 152.14 35.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 111.727 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.434 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 49.9 m95 -141.26 114.37 8.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.863 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.5 mt -75.08 159.55 31.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.915 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -117.65 153.64 32.96 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.18 0.514 . . . . 0.0 111.508 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.47 113.59 2.88 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -95.89 143.73 26.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.567 0.223 . . . . 0.0 110.576 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.4 160.78 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 110.591 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -79.1 148.68 32.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.026 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.21 2.31 14.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -121.54 -15.66 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.67 0.271 . . . . 0.0 110.962 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.81 -47.98 81.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 110.233 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 54.89 34.8 22.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.333 0.587 . . . . 0.0 111.319 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.44 156.66 2.01 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.705 -0.622 . . . . 0.0 110.94 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -156.06 155.46 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.634 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 61' ' ' ILE . 46.0 mm -121.7 107.55 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.5 107.47 19.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.06 157.44 18.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.592 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 m170 73.23 68.6 0.11 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.712 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.5 mt -125.07 82.18 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.064 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 73.3 mt-30 -36.16 141.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.115 0.484 . . . . 0.0 111.555 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -74.75 -7.57 53.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.673 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -112.55 16.67 19.69 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtp -143.5 142.31 31.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.965 0.412 . . . . 0.0 110.188 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.17 164.19 25.83 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -146.49 137.19 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 111.277 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.4 mt-10 -97.96 149.86 21.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.87 133.83 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.48 106.96 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.592 0.71 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.03 132.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.539 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 m -134.79 121.74 21.12 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.55 126.54 39.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.3 112.58 24.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 112.181 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.9 p-10 -119.07 -165.71 1.17 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.986 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.42 -30.53 19.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 8.6 mp -63.46 -39.15 93.7 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 118.64 -46.65 1.11 Allowed Glycine 0 N--CA 1.463 0.474 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 5.2 m-85 -155.8 128.75 8.03 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.502 ' O ' ' C ' ' A' ' 85' ' ' GLU . 3.7 m -113.06 148.32 35.44 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 84' ' ' SER . 1.2 mp0 -12.6 98.03 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 124.225 0.953 . . . . 0.0 111.846 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.55 158.36 53.96 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.133 1.222 . . . . 0.0 111.325 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.8 m -105.71 114.19 28.21 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.534 0.683 . . . . 0.0 110.105 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -91.36 94.46 4.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.2 t80 -98.5 128.16 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.827 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.21 129.76 48.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 14.8 p90 -159.38 126.87 4.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.73 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.416 ' HG ' ' HZ1' ' A' ' 42' ' ' LYS . 0.9 OUTLIER -81.62 161.12 23.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.057 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.4 mmm -90.67 139.12 26.29 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.29 163.05 35.44 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.38 2.053 . . . . 0.0 111.103 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 152.12 82.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.071 1.847 . . . . 0.0 111.04 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -39.71 131.6 1.43 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.408 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.08 144.4 63.41 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.501 1.467 . . . . 0.0 112.317 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -117.88 -77.99 0.58 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.828 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.8 pt -126.19 -1.42 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.424 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 101' ' ' LYS . 20.9 tt -65.72 -41.35 90.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 24.1 ttpt 73.9 167.81 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.601 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.511 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.45 ' H ' ' H ' ' A' ' 2' ' ' GLU . 2.9 ttm180 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.45 ' H ' ' H ' ' A' ' 1' ' ' ARG . 15.8 mt-10 -27.9 92.13 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.809 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -101.36 -164.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 123.902 3.068 . . . . 0.0 109.959 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -168.36 155.32 7.3 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.634 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' SER . 81.7 Cg_exo -38.5 170.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.402 2.735 . . . . 0.0 113.245 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.78 151.25 26.5 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.125 1.883 . . . . 0.0 114.275 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.02 30.29 3.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.955 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.36 120.06 54.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.283 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -115.73 116.23 27.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.302 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.55 156.29 21.52 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -157.68 133.41 5.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.29 82.73 1.06 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.322 1.348 . . . . 0.0 112.136 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.466 ' HG ' ' H ' ' A' ' 14' ' ' SER . 23.0 t -58.4 -173.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.466 ' H ' ' HG ' ' A' ' 13' ' ' SER . 90.5 p -56.48 122.36 11.76 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.272 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.06 -154.03 31.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.4 mtmm -78.1 -9.09 58.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.473 -0.363 . . . . 0.0 110.897 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 p -64.66 143.4 57.95 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.114 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.91 126.34 49.77 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -87.84 98.39 11.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mt -93.71 99.83 12.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -73.96 119.23 17.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.266 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.88 108.69 17.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -87.62 129.07 35.24 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -44.62 105.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.39 153.53 20.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.03 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -57.84 103.01 0.11 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 55.1 p-10 -57.52 145.39 33.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.103 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.63 -46.71 7.31 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.29 18.68 0.02 OUTLIER Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.397 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.78 156.43 26.89 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.41 0.605 . . . . 0.0 110.231 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.35 144.2 85.17 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.136 1.891 . . . . 0.0 110.967 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mt -91.82 124.37 44.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.248 0.547 . . . . 0.0 111.454 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.78 -41.05 68.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.029 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.33 171.85 19.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.27 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -120.78 114.28 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.832 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.422 HG22 HD12 ' A' ' 36' ' ' ILE . 87.3 mt -89.45 115.4 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 51' ' ' LYS . 96.4 t -111.91 128.54 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -124.34 128.12 48.62 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -135.32 153.74 51.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.691 0.281 . . . . 0.0 110.875 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE1' ' A' ' 72' ' ' GLU . 29.3 ptt85 -147.23 171.72 14.95 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.4 m -81.4 137.77 35.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.494 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.623 ' HZ1' ' N ' ' A' ' 92' ' ' SER . 93.4 mttt -63.36 -29.14 70.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.554 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.15 -31.05 72.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.244 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -119.82 171.73 8.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.769 0.795 . . . . 0.0 111.546 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -152.22 4.68 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.722 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -90.55 -1.33 57.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.426 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -140.62 138.45 34.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.239 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 44.9 m95 -134.62 108.45 8.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.907 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.6 mt -71.65 159.39 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.56 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 1.3 pm0 -124.42 147.19 48.44 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -145.45 111.89 5.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -84.79 142.35 29.85 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.41 156.03 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -78.42 146.66 34.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.768 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.05 -6.4 45.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -111.47 -15.6 13.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.51 0.195 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -62.06 -49.1 77.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.285 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 53.34 36.07 21.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.412 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.98 154.07 0.67 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -154.68 146.13 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 110.587 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mm -114.82 115.52 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.26 105.59 16.26 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.6 154.19 25.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.7 t60 69.97 67.0 0.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.961 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' GLN . 57.4 mt -107.84 -7.92 16.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 65' ' ' LEU . 74.6 mt-30 55.72 147.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 111.646 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -91.94 -18.4 23.77 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.038 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.3 p -106.48 18.8 21.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 10.8 ttm -146.5 138.84 25.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 170.47 34.34 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -149.35 134.27 17.96 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 5.1 mt-10 -98.87 152.81 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.06 135.37 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.017 0.437 . . . . 0.0 110.767 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -128.22 108.27 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.983 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.18 137.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.543 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -137.19 117.86 13.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.11 126.64 35.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.68 112.23 25.24 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.315 0.578 . . . . 0.0 112.184 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 3.6 p-10 -114.73 -168.25 1.35 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.804 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -51.31 -30.48 18.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.621 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -63.18 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.11 -47.45 1.02 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -155.53 139.02 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' GLU . 1.3 t -131.84 135.46 46.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.75 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.6 mm-40 11.9 94.04 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 124.365 1.041 . . . . 0.0 112.091 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.38 154.26 55.91 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 120.995 1.13 . . . . 0.0 111.679 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.82 111.76 24.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.64 96.62 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.165 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.481 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -101.8 130.43 48.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.264 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.52 130.68 44.44 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.167 0.508 . . . . 0.0 111.729 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.486 ' C ' ' HZ1' ' A' ' 42' ' ' LYS . 13.0 p90 -165.94 140.14 4.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.064 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.623 ' N ' ' HZ1' ' A' ' 42' ' ' LYS . 1.4 m -91.27 171.29 9.33 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.453 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.0 mmm -96.61 139.74 21.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.08 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.21 163.18 37.12 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.22 1.947 . . . . 0.0 110.955 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.95 147.61 91.89 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.39 2.06 . . . . 0.0 111.764 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -41.45 134.52 2.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.02 158.19 46.11 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 121.61 1.54 . . . . 0.0 111.435 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -66.81 0.77 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.0 tt -177.86 92.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.209 0.528 . . . . 0.0 110.711 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.453 ' CG1' ' N ' ' A' ' 101' ' ' LYS . 6.4 tt -177.77 161.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.824 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 21.2 tptm -51.19 113.86 1.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.086 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.7 m-20 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.936 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 26' ' ' ASP . 1.2 mm-40 -152.33 93.06 3.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.663 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -97.42 -163.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 123.449 2.766 . . . . 0.0 109.142 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 1.9 p -177.26 156.5 1.22 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.542 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' PRO . 54.4 Cg_exo -36.21 161.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.96 2.44 . . . . 0.0 112.73 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -33.96 167.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 123.714 2.943 . . . . 0.0 116.155 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.491 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -165.06 46.47 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.917 -177.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.99 129.28 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 111.579 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -119.26 116.91 27.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.184 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.55 155.95 19.4 Favored Glycine 0 N--CA 1.467 0.712 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.331 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -158.56 132.61 5.08 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 89.5 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.376 1.384 . . . . 0.0 110.923 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 t -60.73 -85.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.349 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 17' ' ' SER . 90.7 p -128.12 127.74 43.59 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.752 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.08 -128.67 31.48 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -89.5 -5.6 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 14' ' ' SER . 85.7 p -61.75 144.87 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.425 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 120.78 27.26 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -88.03 101.18 13.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.272 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 mt -96.5 96.56 8.77 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 t -67.62 130.68 43.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.2 mm -91.74 117.16 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.3 m -84.17 128.33 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.762 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -63.05 105.23 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' NE2' ' OG ' ' A' ' 7' ' ' SER . 76.0 mm-40 -101.31 167.18 10.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.299 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' GLU . 99.3 m-20 -59.63 95.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 26.6 t70 -42.38 -64.55 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.657 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.62 -23.36 0.22 Allowed Glycine 0 C--N 1.318 -0.47 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.36 5.08 0.09 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.684 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.431 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -156.79 142.68 12.85 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 118.187 0.994 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.71 150.73 60.1 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.067 1.178 . . . . 0.0 111.927 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.4 mt -91.79 128.19 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.491 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.8 mt -72.95 -42.56 63.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -155.53 163.66 39.7 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.635 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -110.98 127.12 55.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.058 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.9 mt -99.95 110.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.6 t -109.21 127.09 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.855 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -126.17 128.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -132.9 151.51 52.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -142.34 172.82 12.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.397 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.9 p -84.17 147.24 27.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.527 ' HZ3' ' N ' ' A' ' 92' ' ' SER . 95.4 mttt -75.24 4.64 6.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.74 -49.88 2.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 45' ' ' GLU . 11.2 mmpt? -60.92 -45.42 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.932 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 81.8 tt0 36.18 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.449 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' O ' ' NE2' ' A' ' 47' ' ' GLN . 1.9 m-20 167.15 -15.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.571 0.545 . . . . 0.0 110.493 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 46' ' ' ASP . 96.0 mm-40 -137.24 117.74 13.81 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.56 0.219 . . . . 0.0 110.923 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -99.95 116.67 32.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.851 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.45 160.07 32.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.182 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 25.0 mp0 -117.0 150.55 38.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.341 0.591 . . . . 0.0 112.47 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.24 115.33 4.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -97.52 146.0 25.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.42 155.67 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.034 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.555 ' C ' ' H ' ' A' ' 56' ' ' ASN . 33.3 tt0 -78.08 137.24 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.208 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 7.07 0.16 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 54' ' ' GLN . 66.0 t30 -122.18 -13.97 8.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.793 0.297 . . . . 0.0 110.755 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -69.72 -53.08 20.16 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.811 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 58.28 40.06 24.98 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.648 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -178.05 153.15 0.78 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -152.45 143.31 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.204 0.526 . . . . 0.0 111.428 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.6 mm -114.56 115.79 50.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.14 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.0 mt -103.73 105.52 15.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.5 152.2 23.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.225 0.536 . . . . 0.0 112.188 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 66.06 76.68 0.31 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.28 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 66' ' ' GLN . 86.2 mt -111.52 -4.12 14.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' O ' ' SD ' ' A' ' 93' ' ' MET . 83.3 mt-30 52.49 120.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.877 0.846 . . . . 0.0 112.241 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -61.31 -32.04 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.093 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -94.52 22.87 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.3 tpt -144.46 114.73 7.51 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.395 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.78 155.59 32.09 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -151.29 138.29 19.1 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.54 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.96 156.21 19.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.642 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 132.71 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -126.12 110.82 13.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.373 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.76 137.24 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.768 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.82 117.24 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.59 124.38 34.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.26 113.43 26.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.268 0.556 . . . . 0.0 112.358 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -116.62 -163.38 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -52.75 -33.33 47.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 8.5 mp -64.12 -40.98 97.37 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 126.09 -49.64 0.91 Allowed Glycine 0 N--CA 1.463 0.452 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.8 m-85 -154.46 133.96 12.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.503 ' HG ' ' H ' ' A' ' 85' ' ' GLU . 3.2 t -159.85 170.28 21.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' H ' ' HG ' ' A' ' 84' ' ' SER . 16.6 pt-20 39.91 51.41 3.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.392 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.76 148.37 82.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.941 1.76 . . . . 0.0 111.263 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.426 ' CG2' ' H ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -125.32 110.35 13.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 99.25 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.523 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -104.56 131.75 51.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.956 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -131.84 132.58 43.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 6.6 p90 -173.69 125.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.208 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.527 ' N ' ' HZ3' ' A' ' 42' ' ' LYS . 11.9 p -80.77 166.29 21.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.3 mtp -88.41 147.47 40.01 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.956 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.07 162.66 28.76 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.421 2.081 . . . . 0.0 110.211 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 96' ' ' LYS . 38.2 Cg_endo -65.6 153.64 77.29 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.912 1.741 . . . . 0.0 110.822 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 95' ' ' PRO . 4.1 tppp? -36.62 133.05 0.65 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.555 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.47 144.48 50.39 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.465 1.443 . . . . 0.0 111.818 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -98.13 -17.4 19.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.011 0.434 . . . . 0.0 110.135 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' LYS . 26.7 pt -104.98 -8.26 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.097 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 100' ' ' ILE . 47.4 pt 39.23 16.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.327 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' ILE . 88.6 tttt -82.32 -68.84 0.67 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.387 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.1 t0 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.092 -179.3 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 2' ' ' GLU . 83.7 mtt85 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 1' ' ' ARG . 1.5 pm0 6.26 76.32 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 124.204 0.94 . . . . 0.0 112.936 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -100.13 -165.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.608 2.872 . . . . 0.0 110.82 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -169.76 151.56 4.26 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.637 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.3 Cg_exo -39.8 162.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.508 2.139 . . . . 0.0 112.629 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 32.8 Cg_exo -38.7 166.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.85 2.367 . . . . 0.0 113.322 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.25 41.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.683 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.08 124.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.578 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -116.14 118.96 34.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.462 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.64 140.91 15.06 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.474 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -143.73 146.51 35.21 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.2 80.46 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.828 1.685 . . . . 0.0 111.447 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.4 t -48.03 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -139.63 136.99 34.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.064 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.6 -130.76 37.34 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -95.17 -4.01 46.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -68.81 144.11 54.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.001 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.48 128.2 47.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 110.246 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -88.08 103.62 15.91 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mt -99.13 91.98 5.25 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -66.86 124.8 23.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.494 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mm -86.97 115.72 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -95.13 119.3 33.4 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.488 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -38.28 105.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.49 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -95.0 148.87 21.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 97.9 m-20 -54.67 95.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.53 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 30' ' ' ALA . 28.3 t70 -48.02 169.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.609 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.43 84.08 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.67 22.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.811 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.449 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -159.05 151.66 17.96 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.58 140.62 57.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.435 1.423 . . . . 0.0 110.529 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.48 127.71 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.82 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.4 mp -75.18 -43.11 53.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.287 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -152.83 163.33 39.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.387 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -111.39 122.83 48.87 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.954 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -96.47 107.93 20.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.3 t -107.37 125.03 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.26 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -122.35 136.82 54.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -143.18 152.15 41.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.679 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.474 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 35.6 ptt85 -148.39 173.43 13.09 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 111.634 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -79.08 147.83 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.266 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -69.36 -32.03 70.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.679 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -75.15 -47.31 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -57.51 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.856 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 58.18 76.66 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.762 0.791 . . . . 0.0 110.116 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 61.2 t0 -175.61 -21.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.3 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -138.47 158.13 44.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.2 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 63.4 m95 -136.12 134.29 38.17 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 112.209 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.79 160.38 20.25 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -118.07 149.1 41.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.26 0.552 . . . . 0.0 112.091 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.09 114.36 4.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -98.92 144.7 27.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.668 0.27 . . . . 0.0 110.959 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.76 157.77 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.11 0.481 . . . . 0.0 110.648 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -70.6 149.53 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.448 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.89 -7.09 14.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.189 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -121.47 0.13 9.9 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.088 0.444 . . . . 0.0 111.346 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -61.83 -46.77 88.05 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.442 0.639 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 52.99 31.52 11.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.835 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.36 150.55 0.44 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.34 146.86 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.111 0.481 . . . . 0.0 111.243 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mm -113.9 117.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.35 105.65 15.79 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.612 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 65.5 mt-10 -96.93 119.7 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 28.9 m-70 122.65 54.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.997 1.436 . . . . 0.0 111.018 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 93' ' ' MET . 23.1 mt -111.89 105.24 13.64 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.485 ' O ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -59.06 135.85 57.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.237 0.542 . . . . 0.0 111.204 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -66.21 -23.81 66.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.075 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 p -104.82 18.23 22.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.9 mtp -149.79 129.97 13.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.027 0.442 . . . . 0.0 110.706 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.33 44.3 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -157.46 132.11 8.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.286 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -87.27 154.29 20.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.007 0.432 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.53 134.0 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -124.62 110.46 14.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.496 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.82 132.4 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -136.76 118.29 14.84 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.13 126.24 35.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.61 108.41 19.68 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.588 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -114.5 -175.11 2.61 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.303 178.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -40.3 -33.71 0.27 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -63.96 -42.8 97.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.496 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.93 -48.5 0.97 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -155.83 131.63 9.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.04 162.39 20.35 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER 52.88 51.87 9.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 98.0 Cg_endo -74.01 152.83 46.57 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.381 2.054 . . . . 0.0 111.258 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 m -133.93 117.74 17.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.368 0.604 . . . . 0.0 110.714 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -96.6 94.49 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.422 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 34.0 t80 -98.61 134.82 41.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.538 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -137.89 130.5 29.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 23.1 p90 -163.97 131.44 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.982 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -79.83 167.85 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 28.0 mtp -97.89 151.79 37.75 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.966 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.96 163.9 22.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.536 2.157 . . . . 0.0 110.012 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.35 156.38 63.59 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.774 1.649 . . . . 0.0 111.068 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -38.51 130.22 1.08 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.505 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.7 142.82 49.23 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.726 1.617 . . . . 0.0 112.725 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -95.52 -80.64 0.42 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.5 pt -73.57 -22.37 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.759 0.79 . . . . 0.0 109.066 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.7 mt 72.22 136.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 113.844 -1.526 . . . . 0.0 111.035 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -139.2 152.58 47.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.399 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.642 -179.752 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 26' ' ' ASP . 31.7 mt-10 -151.85 73.89 7.87 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -102.03 -165.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.677 2.918 . . . . 0.0 111.636 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.4 166.2 2.9 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.474 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.6 Cg_exo -39.94 161.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.977 2.451 . . . . 0.0 112.601 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.5 Cg_exo -37.3 167.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 123.305 2.67 . . . . 0.0 114.091 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.97 54.78 0.52 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.541 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -132.91 130.14 58.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.108 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -123.84 114.31 19.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.81 138.35 14.53 Favored Glycine 0 N--CA 1.46 0.297 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.45 116.95 8.6 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.556 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -52.03 103.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 120.945 1.096 . . . . 0.0 111.664 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.9 p -85.37 172.02 11.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 m -41.55 106.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.819 0.342 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.29 -154.01 21.28 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.005 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -77.23 -19.65 56.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.516 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.6 t -59.01 139.11 57.17 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.171 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.92 122.11 46.67 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -86.1 109.0 18.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.792 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.27 105.72 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 119.09 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mm -84.08 112.47 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 5.9 m -79.35 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.034 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.84 104.89 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.513 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -100.59 158.85 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 2' ' ' GLU . 45.9 m-20 -61.88 95.38 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 32.4 t70 -43.41 168.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.135 0.493 . . . . 0.0 111.183 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.71 -42.44 85.15 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 15.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.905 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.43 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -159.64 151.36 16.77 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.886 0.843 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.45 142.52 80.36 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.988 1.125 . . . . 0.0 111.59 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -86.56 125.17 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.354 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -72.06 -40.76 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.805 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.39 167.27 26.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.07 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -112.06 119.93 40.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.875 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.6 mt -92.18 113.07 26.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 51' ' ' LYS . 61.2 t -113.57 129.34 69.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.286 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -127.78 133.82 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -139.26 154.05 47.91 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.044 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.0 174.02 11.65 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.542 ' OG ' ' CE2' ' A' ' 71' ' ' TYR . 4.3 m -84.21 136.76 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.007 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.83 -35.36 78.01 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.879 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -63.11 -35.49 80.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -98.68 178.05 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.801 0.81 . . . . 0.0 111.432 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -160.05 -5.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.777 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -91.6 9.02 33.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -149.72 150.45 32.1 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.805 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.43 109.06 5.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.722 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.4 mt -72.61 159.91 33.11 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.506 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -121.72 151.72 40.2 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.09 0.472 . . . . 0.0 111.558 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.44 114.66 3.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -96.2 142.3 28.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.29 138.25 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.25 0.548 . . . . 0.0 111.038 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.499 ' C ' ' H ' ' A' ' 56' ' ' ASN . 48.9 tt0 -59.71 142.53 52.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.5 14.8 0.93 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.135 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 m120 -132.09 9.88 4.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 21.3 mttt -91.74 -46.3 7.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.663 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 49.69 39.13 16.88 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.64 0.588 . . . . 0.0 111.887 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -179.57 151.9 0.48 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.707 0.289 . . . . 0.0 110.798 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -151.61 146.58 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.383 0.611 . . . . 0.0 111.092 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -114.86 111.65 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.83 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -100.03 107.75 19.76 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 98.8 mt-10 -84.88 156.06 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.523 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 6.3 t-80 78.76 52.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.6 mm? -107.71 88.22 2.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -51.0 135.96 23.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.646 . . . . 0.0 111.335 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -64.39 -34.13 77.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.444 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.8 p -96.33 20.81 9.89 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.7 mtp -143.34 140.0 30.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.206 0.527 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.8 162.61 24.26 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.542 ' CE2' ' OG ' ' A' ' 41' ' ' SER . 43.3 m-85 -144.34 135.5 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.046 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -94.69 149.86 20.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.33 133.42 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -123.24 108.41 12.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.475 0.655 . . . . 0.0 109.705 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.87 131.21 44.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.923 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -135.47 119.47 17.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.98 126.21 35.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.07 116.05 31.3 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 112.46 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.543 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 4.1 p-10 -115.9 -166.55 1.15 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -51.78 -31.48 27.19 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.625 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.9 mm? -64.05 -42.54 97.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.488 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.82 -45.05 1.19 Allowed Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.488 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.1 m-85 -153.64 140.67 19.31 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -163.76 153.86 15.16 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.574 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' CD ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER 44.32 60.13 12.46 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.593 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 152.4 43.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.242 1.961 . . . . 0.0 110.965 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.0 m -131.23 118.44 20.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.65 0.738 . . . . 0.0 111.467 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.7 94.22 4.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.701 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -98.96 127.15 44.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.148 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.6 132.97 45.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.253 0.549 . . . . 0.0 110.967 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.581 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.1 p90 -166.49 140.07 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.334 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.9 156.49 19.33 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 85.8 mmm -85.88 147.4 45.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.48 162.76 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.343 2.029 . . . . 0.0 110.98 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.07 158.73 50.23 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.244 1.963 . . . . 0.0 111.121 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.91 129.89 0.95 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.447 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.453 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 37.1 Cg_endo -66.37 143.51 70.25 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.327 1.351 . . . . 0.0 112.425 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 100' ' ' ILE . 96.3 m-20 -148.72 99.36 2.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.632 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.4 pt 40.52 16.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.723 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -100.13 128.74 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.295 0.569 . . . . 0.0 109.85 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 102' ' ' ASP . 48.8 tttm -61.87 136.69 58.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.997 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 11.8 p30 . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.863 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -167.49 85.52 0.79 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -99.46 -164.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 123.65 2.9 . . . . 0.0 110.335 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.54 169.33 2.15 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.485 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' PRO . 79.0 Cg_exo -39.66 161.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.559 2.173 . . . . 0.0 111.913 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 22.3 Cg_exo -38.49 169.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.662 2.241 . . . . 0.0 114.93 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -156.56 46.19 0.43 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.347 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.27 127.11 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.331 0.586 . . . . 0.0 110.554 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -117.53 116.55 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.142 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.0 147.35 18.56 Favored Glycine 0 N--CA 1.464 0.517 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.3 130.43 8.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.94 81.97 1.59 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.43 1.42 . . . . 0.0 111.988 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.595 ' HG ' ' H ' ' A' ' 14' ' ' SER . 47.2 t -60.05 -159.73 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.595 ' H ' ' HG ' ' A' ' 13' ' ' SER . 33.4 t -63.33 134.52 55.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.246 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.53 -146.16 33.87 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.766 0.317 . . . . 0.0 110.62 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -64.97 148.89 50.76 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.775 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.3 121.17 33.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.693 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -83.97 98.51 9.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 90.21 7.25 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -69.72 117.55 11.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.754 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.6 mm -77.63 126.36 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -104.2 116.51 32.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 110.472 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -39.47 104.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.787 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.26 165.18 11.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 43.0 t0 -57.94 109.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.897 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -71.58 165.65 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.98 31.98 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.54 -0.28 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.1 151.58 75.54 Favored Pre-proline 0 N--CA 1.463 0.22 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.21 143.58 65.3 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.865 1.71 . . . . 0.0 111.278 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.1 mt -86.74 126.44 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.761 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.81 -41.38 64.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.138 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.02 165.67 35.76 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.375 0.607 . . . . 0.0 111.481 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -115.38 119.98 38.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.221 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.93 115.11 31.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 51' ' ' LYS . 38.7 t -118.89 131.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.072 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -125.56 139.76 53.33 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -143.6 156.25 44.52 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.278 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.48 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 34.5 ptt85 -149.54 174.8 12.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 m -82.23 143.04 31.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -63.64 -39.46 94.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 7.0 t0 -76.6 -46.13 27.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.102 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HZ2' ' HB3' ' A' ' 43' ' ' ASP . 1.4 mppt? -89.03 91.38 8.8 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -98.58 65.94 1.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.292 179.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -136.29 -5.87 2.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -146.59 155.87 42.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.991 0.424 . . . . 0.0 111.36 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -136.23 114.28 11.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.156 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.9 mt -77.55 160.31 28.69 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.908 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -111.04 155.62 22.5 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.788 0.328 . . . . 0.0 111.136 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -159.09 112.39 2.29 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -98.71 143.16 29.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.749 0.309 . . . . 0.0 111.289 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.66 156.54 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.42 0.629 . . . . 0.0 110.542 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 48.4 tt0 -82.09 144.35 30.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.307 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.6 81.42 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 32.8 m-20 -67.1 -39.3 86.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.295 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -55.27 -71.87 0.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.549 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 60.34 49.37 7.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.437 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -176.04 140.13 0.4 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -141.85 151.83 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.393 0.616 . . . . 0.0 112.329 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -122.47 101.49 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 9.1 mp -92.06 107.24 19.07 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 64' ' ' HIS . 6.5 tm-20 -96.57 148.76 22.51 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.236 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.489 ' N ' ' CD ' ' A' ' 63' ' ' GLU . 19.2 t-80 93.0 48.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' O ' ' SD ' ' A' ' 93' ' ' MET . 20.9 mt -112.95 94.0 4.69 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.528 ' O ' ' SD ' ' A' ' 93' ' ' MET . 47.1 tt0 -45.48 148.47 0.68 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 110.95 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.18 -8.65 56.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.767 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 p -113.44 19.13 17.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.3 mtp -144.22 133.86 23.56 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.806 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.7 157.37 27.46 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -137.56 133.31 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.794 0.33 . . . . 0.0 110.789 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.5 mt-10 -92.4 147.94 22.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.63 134.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.93 0.395 . . . . 0.0 109.96 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -124.2 108.27 12.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.267 0.556 . . . . 0.0 109.983 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.38 135.95 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.955 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -136.37 116.57 13.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.76 126.6 35.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.88 112.7 25.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.325 0.583 . . . . 0.0 112.541 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.679 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -114.53 -165.89 1.05 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -49.52 -33.12 13.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.834 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.5 mm? -64.7 -42.65 95.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.248 0.547 . . . . 0.0 109.635 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.35 -48.79 0.95 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.475 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.1 m-85 -154.01 137.71 16.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.2 m -160.22 164.24 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.348 0.594 . . . . 0.0 111.799 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 26' ' ' ASP . 16.9 pt-20 33.38 59.29 1.7 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.403 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 152.02 80.03 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.102 1.868 . . . . 0.0 109.963 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.57 111.24 15.42 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.0 110.714 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.47 95.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -102.28 136.31 42.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -138.3 134.95 34.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 7.0 p90 -162.05 152.83 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.728 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.9 170.85 8.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.974 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 65' ' ' LEU . 36.4 mtp -105.62 145.6 31.17 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.426 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.17 161.95 31.91 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.375 2.05 . . . . 0.0 110.751 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.32 155.39 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.12 1.88 . . . . 0.0 110.872 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -37.94 132.16 0.91 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.541 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.37 146.75 69.84 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.677 1.585 . . . . 0.0 112.796 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -144.31 -43.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 100' ' ' ILE . 34.0 pt -91.47 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.463 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 99' ' ' ILE . 48.1 pt 43.64 124.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.281 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -175.26 120.34 0.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.96 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 2.9 p30 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.564 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.461 ' NH2' ' OE2' ' A' ' 85' ' ' GLU . 35.9 ptt180 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 1' ' ' ARG . 4.4 tp10 -15.8 82.36 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.751 0.82 . . . . 0.0 112.78 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.433 ' N ' ' O ' ' A' ' 1' ' ' ARG . 16.5 Cg_endo -104.09 -163.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 124.302 3.334 . . . . 0.0 111.292 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -171.15 157.06 4.8 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.96 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' SER . 89.6 Cg_exo -39.14 171.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 123.45 2.766 . . . . 0.0 113.036 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.49 147.68 37.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.785 1.656 . . . . 0.0 114.449 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.5 34.88 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.201 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mm -107.51 122.49 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.999 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.66 117.14 28.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.9 147.34 18.56 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -159.83 115.82 1.51 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -50.98 94.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.202 1.268 . . . . 0.0 111.984 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -76.55 -48.7 18.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.63 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.439 ' H ' ' HG ' ' A' ' 17' ' ' SER . 69.2 p -144.49 166.77 24.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.037 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -35.99 128.67 0.89 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 39.78 48.37 1.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.167 0.508 . . . . 0.0 111.071 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.439 ' HG ' ' H ' ' A' ' 14' ' ' SER . 11.8 p -142.1 150.89 41.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.484 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.12 120.91 14.41 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -84.81 97.9 9.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.04 89.82 7.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 t -66.88 125.83 27.17 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.542 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mm -85.82 114.89 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.4 m -98.77 117.24 32.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.576 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.74 108.14 0.08 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.359 1.076 . . . . 0.0 110.518 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 26' ' ' ASP . 2.6 pt20 -115.63 101.54 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.152 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 25' ' ' GLN . 4.5 m-20 19.12 82.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.9 0.75 . . . . 0.0 111.779 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 29' ' ' GLY . 85.9 m-20 -50.67 131.47 25.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.046 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' ASP . . . -27.05 -35.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.961 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 163.93 0.08 0.05 OUTLIER Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.728 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.12 155.61 29.35 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 117.848 0.824 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -54.02 138.25 70.13 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 121.094 1.196 . . . . 0.0 111.767 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mt -81.66 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.384 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.91 -40.07 69.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -162.19 170.63 18.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.718 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -116.37 122.33 44.54 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.989 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.4 mt -96.93 114.17 33.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.0 t -115.09 130.41 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.604 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -140.77 152.55 45.31 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.637 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.523 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.2 ptt85 -145.64 172.9 12.59 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 44' ' ' LYS . 11.0 m -79.92 139.86 36.92 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -62.3 -36.27 81.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.249 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.97 -37.38 86.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.543 0.211 . . . . 0.0 110.718 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.3 mmtt -101.13 150.95 22.4 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.499 0.666 . . . . 0.0 110.502 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -138.27 19.82 2.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.186 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 20.8 p-10 -128.19 18.33 6.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 0.0 110.519 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -142.04 112.7 7.25 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.501 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -119.29 118.16 30.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.588 0.708 . . . . 0.0 110.917 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.3 mt -79.9 159.77 26.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.462 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 51.5 mp0 -117.93 151.91 36.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.97 113.1 2.68 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -97.64 146.4 25.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.469 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.35 158.4 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.223 0.535 . . . . 0.0 110.081 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.516 ' C ' ' H ' ' A' ' 56' ' ' ASN . 6.2 tp-100 -71.23 146.54 48.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.451 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.45 3.55 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.924 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 t-20 -133.2 0.77 3.44 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.647 -0.325 . . . . 0.0 111.446 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.6 tptp -64.07 -43.22 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 48.56 31.62 3.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.717 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 178.74 152.49 0.34 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.191 0.307 . . . . 0.0 110.744 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 pt -151.29 129.38 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.4 mm -99.38 103.26 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.3 mt -91.58 104.54 17.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 40.1 tt0 -95.77 151.18 19.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.254 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.479 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 3.9 t-160 89.11 60.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.253 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.95 91.84 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.91 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -39.15 143.58 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.422 0.63 . . . . 0.0 111.419 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -75.29 -9.07 58.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.039 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.8 p -114.34 19.7 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.604 0.24 . . . . 0.0 111.414 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -142.92 136.97 29.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.22 163.08 25.15 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -144.69 129.49 18.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.581 0.229 . . . . 0.0 111.603 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.9 mt-10 -88.6 153.62 20.98 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.77 135.55 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.71 108.59 11.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.217 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.54 134.58 33.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.081 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.3 m -136.09 124.26 23.08 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.38 124.94 43.33 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.83 114.06 26.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 112.558 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -122.22 -175.63 3.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.33 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -39.8 -33.01 0.17 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.409 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' N ' ' CD1' ' A' ' 81' ' ' LEU . 9.6 mp -63.53 -42.55 98.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.414 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 125.81 -49.94 0.89 Allowed Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 13.1 m-85 -153.73 122.07 6.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.7 p -88.15 176.89 7.07 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.143 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.461 ' OE2' ' NH2' ' A' ' 1' ' ' ARG . 11.3 mm-40 -49.11 112.96 2.76 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.45 159.43 49.2 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.049 1.166 . . . . 0.0 111.669 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.79 113.75 25.98 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.519 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.05 98.33 7.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.469 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 39.4 t80 -103.43 138.2 40.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -135.27 134.55 40.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.252 0.548 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.4 p90 -171.33 129.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.577 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -82.51 165.46 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.531 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.9 mmm -90.66 146.26 33.83 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.0 164.71 29.35 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.364 2.043 . . . . 0.0 111.22 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.45 160.04 41.32 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.35 2.033 . . . . 0.0 111.513 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -40.39 132.8 1.63 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.86 121.18 7.39 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.73 1.62 . . . . 0.0 112.757 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.33 -22.3 20.59 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.2 pt -142.36 -160.45 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 113.823 -1.535 . . . . 0.0 106.94 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.1 pt -146.98 137.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.501 0.667 . . . . 0.0 111.682 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -177.3 -45.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.598 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.0 t0 . . . . . 0 C--O 1.219 -0.545 0 CA-C-O 117.898 -1.049 . . . . 0.0 110.312 179.807 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 2' ' ' GLU . 79.2 mmt-85 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 1' ' ' ARG . 6.7 tp10 -29.68 97.69 0.09 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.937 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -99.61 -163.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 123.253 2.635 . . . . 0.0 109.547 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.88 167.39 7.86 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.134 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' PRO . 71.0 Cg_exo -47.94 157.71 1.02 Allowed 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.489 2.126 . . . . 0.0 112.571 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 Cg_exo -37.42 175.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.311 2.674 . . . . 0.0 115.441 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.43 46.83 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.646 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.94 123.48 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.24 0.543 . . . . 0.0 110.632 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -114.82 116.52 28.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.213 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.06 141.16 15.44 Favored Glycine 0 N--CA 1.464 0.51 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.952 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -139.71 134.46 16.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.02 88.25 1.34 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.655 1.57 . . . . 0.0 112.501 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 4.7 p -68.27 -179.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -55.82 118.22 4.38 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.516 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.1 -166.76 21.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HE3' ' H ' ' A' ' 66' ' ' GLN . 15.8 mtmt -77.13 -5.75 50.26 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 84.6 p -66.86 150.81 48.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.35 115.31 18.06 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -77.3 109.59 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.29 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.1 101.23 10.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -72.02 122.6 21.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.738 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 mm -87.34 113.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 m -86.09 127.2 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.543 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -44.26 105.38 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.808 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' OE1' ' OE1' ' A' ' 85' ' ' GLU . 74.2 mt-30 -80.68 159.38 25.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.47 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' ASP . 5.4 m-20 -78.35 78.61 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' ASP . 22.2 t70 -39.23 162.18 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.405 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.32 64.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.2 24.31 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.903 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.411 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -153.4 151.49 25.69 Favored Pre-proline 0 C--N 1.333 -0.152 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.96 143.61 55.33 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.687 1.591 . . . . 0.0 111.462 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -89.87 135.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.868 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.91 -48.98 10.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.706 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -146.48 162.04 39.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.282 0.563 . . . . 0.0 111.522 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -109.46 120.19 41.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.185 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.33 107.3 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' LYS . 24.2 t -109.05 127.08 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.01 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -125.22 129.22 49.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.133 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -133.05 148.56 52.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.965 0.412 . . . . 0.0 110.876 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' NH1' ' CB ' ' A' ' 45' ' ' GLU . 4.8 ptt180 -144.71 167.34 22.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.74 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 43' ' ' ASP . 5.1 m -76.16 143.58 41.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.1 0.41 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 41' ' ' SER . 71.7 m-20 -122.01 -9.74 8.7 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.361 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -122.76 110.49 15.54 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.744 0.307 . . . . 0.0 110.307 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.46 ' CB ' ' NH1' ' A' ' 40' ' ' ARG . 25.4 pt-20 -115.1 -8.4 12.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.8 -7.72 23.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.535 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -161.08 128.67 4.23 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -107.61 128.56 54.65 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 70.8 mt -77.16 158.21 30.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 3.4 pm0 -121.59 148.54 44.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.205 0.526 . . . . 0.0 111.882 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -150.74 113.53 4.74 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.885 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.48 142.52 27.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.91 158.71 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.281 0.562 . . . . 0.0 110.391 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.522 ' C ' ' H ' ' A' ' 56' ' ' ASN . 57.9 tt0 -74.17 130.9 40.67 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.474 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.58 0.17 0.3 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.822 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 54' ' ' GLN . 23.5 m120 -116.18 -26.19 7.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.729 0.264 . . . . 0.0 110.814 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 20.5 mttm -50.35 -68.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER 79.46 35.04 0.17 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.83 149.17 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.137 -0.352 . . . . 0.0 110.485 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.5 pt -147.58 144.85 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.98 115.99 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.1 mt -104.95 108.92 20.69 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.137 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.33 162.15 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.762 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.9 m80 60.6 67.68 0.81 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.852 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -107.91 -9.42 15.71 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.828 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.433 ' H ' ' HE3' ' A' ' 16' ' ' LYS . 49.9 tp60 60.13 152.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.969 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -96.81 -7.2 34.23 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 77.3 p -119.41 19.96 12.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.6 mmm -143.96 127.86 17.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.58 157.59 32.98 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.96 153.97 36.23 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.8 156.14 19.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.866 0.365 . . . . 0.0 110.278 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.7 130.08 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -122.63 107.28 11.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 110.329 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.27 134.97 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.796 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -136.27 123.77 22.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.17 120.48 36.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.486 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.31 105.06 16.56 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.598 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -108.53 -175.94 2.91 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -41.22 -31.5 0.22 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.2 mm? -65.54 -41.66 92.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.959 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.51 -48.61 0.96 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.485 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.2 m-85 -157.31 131.68 8.46 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.49 160.3 17.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.938 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 3.3 mm-40 53.2 50.43 7.59 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.292 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 84.8 Cg_endo -72.61 149.65 49.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.149 1.9 . . . . 0.0 111.147 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.63 109.31 13.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.157 0.503 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.21 95.97 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 31.2 t80 -102.95 131.5 49.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.496 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.18 134.45 42.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.074 0.464 . . . . 0.0 111.129 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.1 p90 -168.82 133.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.336 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.42 ' H ' ' HG ' ' A' ' 92' ' ' SER . 10.5 p -80.25 164.92 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.156 0.503 . . . . 0.0 111.473 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 95.6 mmm -93.23 141.67 24.3 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.474 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.84 162.62 29.44 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.414 2.076 . . . . 0.0 111.205 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.39 152.7 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.487 2.125 . . . . 0.0 111.638 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -43.74 132.56 3.94 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.632 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.5 158.99 36.2 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.885 1.723 . . . . 0.0 110.974 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.434 ' CG ' ' N ' ' A' ' 99' ' ' ILE . 18.8 p-10 -148.57 -51.73 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.751 0.31 . . . . 0.0 110.652 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.434 ' N ' ' CG ' ' A' ' 98' ' ' ASN . 13.5 tt -114.1 -51.04 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.047 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 101' ' ' LYS . 9.3 tt -56.52 156.15 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.673 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 100' ' ' ILE . 57.7 mttp -53.12 -115.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.557 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.531 -179.539 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -154.38 118.33 2.61 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.709 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -100.2 -163.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 122.954 2.436 . . . . 0.0 109.254 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.545 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -169.57 174.54 1.88 Allowed Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.047 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' PRO . 52.5 Cg_exo -55.1 159.22 10.16 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.115 1.877 . . . . 0.0 112.844 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 5' ' ' PRO . 30.0 Cg_exo -39.33 175.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.309 2.672 . . . . 0.0 114.849 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.8 53.43 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.082 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -129.51 127.99 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.226 0.536 . . . . 0.0 110.549 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -118.9 116.4 26.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.032 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.72 141.89 15.86 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.472 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -143.6 140.5 17.5 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.45 91.13 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.692 1.595 . . . . 0.0 112.216 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.453 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 60.6 p -72.16 162.93 28.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m -38.44 120.66 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.346 0.594 . . . . 0.0 111.516 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.05 -155.48 23.68 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -80.0 -8.8 59.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.107 0.48 . . . . 0.0 110.075 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.453 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 10.9 p -60.54 136.37 58.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.136 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.57 117.42 28.94 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.87 111.27 18.61 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.457 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -103.42 91.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -66.09 123.78 20.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.171 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 mm -86.27 112.51 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -81.42 143.43 32.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.949 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -66.43 105.5 1.49 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.349 0.595 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -88.3 174.66 8.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.767 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 96.2 m-20 -62.6 -3.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.205 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 29' ' ' GLY . 2.8 p30 46.27 -172.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -9.81 59.19 Favored Glycine 0 N--CA 1.465 0.625 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.037 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.506 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . 128.54 2.78 5.75 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.88 142.36 33.46 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.82 142.65 83.43 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.319 1.346 . . . . 0.0 111.677 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.4 mt -87.95 134.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.368 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 2.6 mm? -91.81 -42.11 10.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.211 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -142.68 152.32 42.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -109.47 126.15 53.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.613 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.46 110.51 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.2 t -107.57 124.86 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -125.16 121.43 34.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -126.57 154.65 43.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 31.3 ptt85 -146.47 169.45 18.88 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.255 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 p -79.66 141.21 36.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.773 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.91 -32.5 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.673 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.59 -6.65 42.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.679 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -139.66 174.4 10.55 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.217 0.532 . . . . 0.0 110.516 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -165.08 27.46 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.01 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -107.01 -2.85 20.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.866 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -144.52 145.5 31.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 111.218 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -133.74 117.97 17.56 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.05 160.39 27.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -118.2 155.01 31.25 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.158 0.504 . . . . 0.0 112.352 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 116.53 2.78 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.7 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -99.56 145.64 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.916 0.389 . . . . 0.0 111.34 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.49 152.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.716 HE21 HD21 ' A' ' 56' ' ' ASN . 31.7 tt0 -79.8 130.4 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.563 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.71 3.75 0.02 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.191 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.716 HD21 HE21 ' A' ' 54' ' ' GLN . 14.5 m-20 -112.03 -20.82 11.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.174 0.487 . . . . 0.0 110.004 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -63.66 -50.66 68.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.3 39.31 22.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.769 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.23 153.44 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.876 0.369 . . . . 0.0 111.117 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.17 145.19 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.128 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.5 mm -117.36 101.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.883 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -83.92 102.94 12.78 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.89 171.0 12.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.967 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.9 m80 51.96 66.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.18 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.3 -173.16 2.27 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -131.8 129.67 40.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -70.06 -7.21 39.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.515 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.2 p -122.65 12.93 10.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.9 ttm -142.65 124.56 15.18 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.763 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.5 162.43 34.69 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.01 143.55 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -94.14 153.19 18.23 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.81 132.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -122.74 104.11 9.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.765 0.793 . . . . 0.0 110.545 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -87.74 130.55 37.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.788 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -134.49 117.63 16.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.75 127.02 35.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.74 106.85 17.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -110.02 -168.94 1.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -48.06 -29.09 3.24 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.028 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.7 mm? -64.04 -41.79 97.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 123.59 -48.1 0.98 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.3 m-85 -157.22 132.98 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -169.34 163.86 10.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.545 ' OE2' ' N ' ' A' ' 4' ' ' SER . 5.8 tp10 52.43 52.16 10.61 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.506 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 93.1 Cg_endo -74.45 155.3 45.66 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 123.436 2.757 . . . . 0.0 112.083 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 m -136.59 117.95 14.66 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.929 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -97.25 97.54 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.613 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.55 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 33.4 t80 -102.0 135.81 42.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.637 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.63 134.59 37.5 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.4 p90 -169.18 133.35 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.18 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -79.44 168.64 19.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.5 mmm -95.66 138.51 21.78 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.529 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.39 164.93 32.93 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.62 2.213 . . . . 0.0 111.328 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.18 150.88 87.08 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.292 1.995 . . . . 0.0 111.642 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.82 133.91 1.72 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.154 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.43 158.72 44.12 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.264 1.976 . . . . 0.0 111.807 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.444 ' CG ' ' H ' ' A' ' 99' ' ' ILE . 2.5 t-20 -79.81 -126.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.444 ' H ' ' CG ' ' A' ' 98' ' ' ASN . 45.2 pt -109.74 -2.78 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.921 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.641 ' CG2' ' H ' ' A' ' 101' ' ' LYS . 5.3 tp -65.31 -93.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.843 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.641 ' H ' ' CG2' ' A' ' 100' ' ' ILE . 87.4 tttt -170.71 151.03 3.4 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.322 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.9 t0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.398 179.068 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' ASP . 50.3 mt-10 -132.08 82.54 58.75 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.861 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -105.18 -163.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 124.078 3.185 . . . . 0.0 111.473 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.8 163.13 3.77 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.232 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 74.2 Cg_exo -38.46 161.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.861 2.374 . . . . 0.0 112.418 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.9 Cg_exo -37.32 165.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.755 2.303 . . . . 0.0 113.769 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.528 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -148.4 47.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.617 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.9 mm -131.14 131.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 111.93 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -108.6 -173.13 2.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.79 118.19 0.65 Allowed Glycine 0 C--N 1.321 -0.256 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.359 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -135.39 144.13 48.24 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.65 85.41 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.396 1.397 . . . . 0.0 111.184 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -52.15 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.214 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.8 t -142.58 136.7 29.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.099 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.43 -134.81 33.44 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -93.58 -0.86 56.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.908 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.3 p -68.86 153.06 44.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.644 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 122.72 22.82 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -83.52 97.94 9.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.166 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mt -95.96 92.22 6.38 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 t -67.02 128.37 36.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.167 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.408 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 2.2 mm -88.2 112.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 7' ' ' SER . 18.9 m -83.18 129.09 34.99 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.079 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.583 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.1 102.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.745 -0.782 . . . . 0.0 108.932 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.64 148.56 24.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' GLU . 46.7 t0 -50.43 102.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.64 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 29' ' ' GLY . 5.7 m-20 -57.67 142.22 45.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.48 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 27' ' ' ASP . . . -32.43 -28.41 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 159.78 14.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.871 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.5 155.17 22.71 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 118.175 0.987 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.23 138.6 67.54 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.965 1.777 . . . . 0.0 111.062 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mt -86.13 135.76 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.14 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 55' ' ' GLY . 77.3 mt -85.79 -43.59 13.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.43 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -146.21 162.19 38.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.637 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -113.67 122.01 45.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.631 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 HD11 HG21 ' A' ' 36' ' ' ILE . 85.4 mt -99.52 112.15 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' LYS . 58.0 t -111.99 126.78 69.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.547 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -124.49 139.45 53.87 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 22.1 p90 -145.63 157.74 43.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.103 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.09 -176.62 5.43 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.312 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -91.99 138.18 31.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.154 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -66.68 -34.41 77.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.67 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 67.5 t0 -59.96 -34.64 73.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.787 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.1 mtmt -126.36 -172.01 2.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.508 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -173.78 63.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.682 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -131.06 -7.86 3.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.297 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -140.93 155.12 46.33 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -137.55 108.04 6.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.672 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.1 159.79 33.23 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.202 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.69 146.45 43.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.166 0.507 . . . . 0.0 111.866 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -146.68 112.82 5.82 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' HZ3' ' CG2' ' A' ' 36' ' ' ILE . 73.0 mmtt -100.34 142.57 31.64 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.07 160.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 110.315 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.543 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.5 tp60 -72.75 151.06 42.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.479 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.05 12.96 0.38 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 54' ' ' GLN . 65.4 t30 -145.19 2.6 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.007 0.403 . . . . 0.0 111.639 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -63.49 -47.47 81.62 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.593 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' OD2' ' NZ ' ' A' ' 24' ' ' LYS . 0.7 OUTLIER 59.37 31.03 20.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.976 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.26 151.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.01 147.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.867 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.8 mm -118.52 108.57 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 8.9 mp -94.41 106.58 18.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -85.31 147.55 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.977 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 71.02 77.83 0.18 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.944 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.5 ' O ' ' SD ' ' A' ' 93' ' ' MET . 91.3 mt -115.0 -3.98 12.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.534 ' O ' ' SD ' ' A' ' 93' ' ' MET . 80.4 mt-30 50.53 122.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.814 0.816 . . . . 0.0 112.792 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -61.28 -26.12 67.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.714 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -103.55 22.66 13.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.7 mmm -146.96 118.57 7.99 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.134 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.85 162.6 45.01 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -155.58 132.03 10.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.853 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.1 152.1 22.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.38 134.49 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -124.36 106.85 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.36 0.6 . . . . 0.0 109.722 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -91.68 132.45 36.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.47 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -134.31 121.39 21.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.51 124.15 38.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.26 108.83 21.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 5.7 p-10 -115.79 -164.94 0.99 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.24 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -53.17 -30.09 35.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 5.9 mp -62.53 -39.32 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 120.81 -47.91 0.99 Allowed Glycine 0 N--CA 1.463 0.466 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 9.8 m-85 -156.05 122.64 5.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.7 p -87.43 163.41 16.75 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -44.35 111.78 1.27 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 160.35 48.57 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.304 1.336 . . . . 0.0 112.823 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.41 HG21 ' H ' ' A' ' 7' ' ' SER . 26.3 m -107.24 116.75 32.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.641 0.734 . . . . 0.0 109.674 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.01 96.18 5.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.424 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.579 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -100.39 121.73 41.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.48 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -122.42 129.94 52.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 111.309 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 9.7 p90 -164.79 128.29 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.405 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -80.4 167.43 20.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.527 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.0 mtp -93.6 147.86 34.39 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.54 162.16 33.46 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.477 2.118 . . . . 0.0 110.384 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.47 154.29 72.51 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.207 1.938 . . . . 0.0 111.587 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -36.06 132.18 0.59 Allowed Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.31 141.39 51.58 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.599 1.532 . . . . 0.0 112.478 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.78 -36.07 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' ILE . 30.6 pt -130.05 17.88 2.27 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.493 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER 10.82 114.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 124.543 1.152 . . . . 0.0 112.887 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -129.5 -53.58 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.894 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.3 t0 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.152 179.363 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -120.25 89.3 43.17 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.51 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -99.77 -164.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 123.022 2.481 . . . . 0.0 110.608 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.19 160.26 7.73 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.63 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' PRO . 2.1 Cg_endo -44.77 170.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.818 2.345 . . . . 0.0 112.215 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -37.96 177.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.777 2.985 . . . . 0.0 116.173 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.28 37.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.953 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -125.02 136.56 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.537 0.684 . . . . 0.0 110.64 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -116.83 -172.87 2.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.837 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.28 143.0 8.03 Favored Glycine 0 N--CA 1.462 0.392 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.322 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -150.79 115.56 3.24 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -46.83 104.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.493 1.462 . . . . 0.0 112.689 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 17' ' ' SER . 28.7 p -80.7 172.21 14.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' SER . 58.8 m -40.56 107.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.798 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.89 -158.32 23.98 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -75.71 -11.6 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.871 0.367 . . . . 0.0 110.766 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 13' ' ' SER . 30.7 t -62.5 140.43 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.303 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.0 137.41 51.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.409 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -97.94 98.53 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mt -97.74 103.17 15.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 t -69.78 126.08 28.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.908 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.07 108.74 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -79.84 136.1 36.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.904 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.13 104.64 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.675 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 27' ' ' ASP . 28.3 mt-30 -89.51 137.63 32.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.552 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 27' ' ' ASP . 1.3 m-20 -54.64 93.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 24.7 t70 -44.54 171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.054 0.454 . . . . 0.0 110.881 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.56 -31.95 76.51 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.5 12.62 0.03 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.821 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -147.71 151.91 40.02 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 117.619 0.71 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.0 143.99 68.18 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.82 1.68 . . . . 0.0 111.783 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mt -93.8 133.06 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.262 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 2.3 mm? -95.43 -14.02 24.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.93 155.96 8.79 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -113.32 112.88 24.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.789 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 36' ' ' ILE . 98.5 mt -89.98 106.99 17.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 51' ' ' LYS . 21.6 t -109.35 129.78 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.415 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -123.84 142.86 50.73 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -143.92 158.46 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.891 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 41' ' ' SER . 1.1 ptm180 -151.3 -173.0 4.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.472 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 4.9 p -96.18 140.0 31.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -65.25 -17.9 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.639 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.61 -27.12 16.77 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -117.97 120.36 37.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.296 0.569 . . . . 0.0 110.811 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' NH1' ' A' ' 40' ' ' ARG . 83.9 tt0 -125.2 63.73 1.16 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.38 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.53 -14.71 8.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.953 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -159.64 161.87 35.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.403 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -128.35 136.39 50.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 68.7 mt -80.58 159.83 25.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -118.68 146.29 44.82 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.134 0.492 . . . . 0.0 111.447 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.9 110.27 5.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.5 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -95.65 126.63 41.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 54' ' ' GLN . 43.5 t -132.62 154.89 40.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.995 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.468 ' N ' HG12 ' A' ' 53' ' ' VAL . 71.3 tp60 -68.8 147.36 51.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.62 0.81 55.01 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.412 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -113.67 -14.13 12.64 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.044 0.422 . . . . 0.0 111.339 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.28 -45.14 94.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.723 0.297 . . . . 0.0 110.833 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 58.2 37.1 26.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.886 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.73 141.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -144.01 136.99 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.239 0.542 . . . . 0.0 111.988 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm -108.22 117.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.226 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.01 143.5 35.01 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.589 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 46.4 mt-10 -107.52 169.65 8.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 111.772 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 37.3 p-80 49.06 68.49 0.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.327 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.5 mm? -95.4 -12.3 26.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.296 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.522 ' O ' ' SD ' ' A' ' 93' ' ' MET . 13.0 mm-40 50.76 122.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.864 0.84 . . . . 0.0 112.058 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -61.52 -32.82 72.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.544 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -97.26 22.29 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.63 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.9 ttm -152.17 127.08 9.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.86 34.22 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -136.29 132.71 36.09 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.1 152.97 18.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.36 134.9 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 110.825 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -125.98 109.73 12.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.118 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.429 ' CG2' ' HG1' ' A' ' 87' ' ' THR . 1.7 mp -93.73 135.24 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m -134.83 121.66 20.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.18 123.5 34.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.06 107.8 19.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.28 0.562 . . . . 0.0 112.079 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 1.1 p-10 -110.29 -172.07 1.96 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -49.75 -27.71 5.24 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.789 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.8 mm? -65.64 -41.6 92.44 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.54 -50.3 0.89 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -155.81 134.45 11.79 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.7 t -162.83 157.24 21.13 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.867 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 44.48 61.99 10.55 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.088 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.48 155.51 45.48 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.599 2.199 . . . . 0.0 110.724 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.429 ' HG1' ' CG2' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -122.23 108.85 13.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.3 t -95.0 98.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -103.78 140.26 37.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.742 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -136.49 134.85 38.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.39 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 91' ' ' PHE . 35.3 p90 -165.95 125.36 1.65 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.509 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 p -82.44 171.13 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.575 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 14.8 mtp -99.4 152.59 37.85 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.89 163.53 25.91 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.638 2.225 . . . . 0.0 109.275 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.03 153.45 78.05 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 121.782 1.655 . . . . 0.0 111.533 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -41.47 133.88 2.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.58 148.7 54.13 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.986 1.791 . . . . 0.0 111.931 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -94.48 -83.52 0.34 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.4 pt -108.47 -16.54 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.147 0.499 . . . . 0.0 109.816 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.86 133.83 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.04 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.35 -95.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.224 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--N 1.325 -0.486 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.276 179.704 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 7.2 tpt180 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 1' ' ' ARG . 2.0 tm-20 81.91 81.28 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 120.708 0.29 . . . . 0.0 110.677 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -99.71 -164.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.733 2.955 . . . . 0.0 109.844 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.421 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -166.5 179.88 0.95 Allowed Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.765 179.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 6' ' ' PRO . 8.1 Cg_exo -67.01 176.33 4.64 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.239 1.959 . . . . 0.0 112.01 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 43.9 Cg_exo -42.53 176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 123.074 2.516 . . . . 0.0 114.109 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -173.41 54.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.743 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -131.25 130.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -121.3 115.37 22.84 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.49 145.37 17.66 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -146.96 111.49 4.12 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.38 98.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.382 1.388 . . . . 0.0 112.702 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -76.82 171.57 14.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -58.2 134.89 56.91 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.799 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.09 -154.54 26.57 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -99.14 46.46 0.98 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.414 ' HG ' ' C ' ' A' ' 62' ' ' LEU . 5.3 t -120.32 149.71 41.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.728 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.94 119.82 27.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.098 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -80.69 98.73 7.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.595 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.41 100.16 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -73.85 126.2 29.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.947 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mm -88.78 112.39 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -86.13 143.35 28.08 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.289 0.566 . . . . 0.0 110.203 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 112.69 10.22 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.519 ' H ' ' CD ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -112.13 170.28 8.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -50.8 112.34 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.608 ' C ' ' H ' ' A' ' 29' ' ' GLY . 69.1 m-20 -71.83 163.83 27.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 -178.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.07 14.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.075 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 101.78 8.81 44.75 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.96 149.42 25.11 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.47 140.06 61.7 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.803 1.669 . . . . 0.0 111.453 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mt -86.28 129.11 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -81.3 -39.69 24.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.37 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -148.78 170.13 18.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -123.23 122.15 37.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.457 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.4 mt -96.47 111.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 51' ' ' LYS . 55.6 t -112.1 128.09 68.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -121.54 134.58 55.04 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.603 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.86 154.84 46.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.59 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 41' ' ' SER . 2.8 ptm180 -144.41 -172.74 3.86 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.336 0.589 . . . . 0.0 110.972 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.521 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 5.9 p -101.58 135.15 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.42 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.12 -11.79 33.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.253 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -90.32 -35.06 15.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -118.58 129.55 55.39 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 110.351 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.3 2.98 11.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.969 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 38.0 p-10 -72.11 -3.57 23.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.389 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -152.77 155.86 37.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.165 0.507 . . . . 0.0 111.922 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -136.85 106.89 6.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.299 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.89 158.73 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.773 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.37 148.24 45.31 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -143.6 113.95 7.43 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.497 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -88.51 136.07 33.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -132.47 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 121.352 0.596 . . . . 0.0 111.951 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.0 144.78 29.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.573 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.01 -24.94 69.01 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -86.39 -22.12 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.621 -0.289 . . . . 0.0 111.515 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 25.7 mttm -60.53 -46.15 91.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.903 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.8 p30 46.52 37.25 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.048 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.55 0.72 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.827 0.346 . . . . 0.0 110.265 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -155.32 151.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.205 0.526 . . . . 0.0 110.564 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.06 112.67 37.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.091 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' C ' ' HG ' ' A' ' 17' ' ' SER . 54.0 mt -99.82 105.17 16.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.83 152.7 21.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 111.846 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 76.86 58.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.715 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 66' ' ' GLN . 80.6 mt -103.17 -4.84 23.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 65' ' ' LEU . 47.5 mt-30 55.24 159.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.477 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -99.11 -16.01 18.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.194 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.3 p -108.86 19.1 20.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.3 mtp -141.47 141.98 33.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.134 0.493 . . . . 0.0 110.541 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.82 153.4 19.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -138.83 138.02 37.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.95 164.54 12.86 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.63 146.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.142 0.496 . . . . 0.0 110.393 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -137.89 106.36 5.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.465 0.65 . . . . 0.0 109.672 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.82 134.96 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.6 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -137.25 120.69 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.77 125.26 36.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.52 110.82 22.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 9.6 p-10 -112.12 -163.33 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.298 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -32.19 55.37 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 81' ' ' LEU . 9.3 mp -64.55 -42.32 95.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.712 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.86 -46.61 1.07 Allowed Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -154.93 132.51 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -161.56 147.19 13.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.695 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 60.14 58.14 4.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.19 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.99 151.1 30.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.372 2.048 . . . . 0.0 111.223 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.5 m -131.16 118.62 20.73 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.457 0.646 . . . . 0.0 111.142 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 m -97.97 92.71 2.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.221 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -95.01 151.72 18.93 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -153.29 135.37 14.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.324 0.583 . . . . 0.0 111.571 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -164.92 156.9 15.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.903 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.51 163.98 12.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.633 0.254 . . . . 0.0 110.358 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.4 mmm -89.69 143.96 31.12 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.395 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.63 164.85 31.48 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.755 2.303 . . . . 0.0 110.981 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -65.99 154.91 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.987 1.792 . . . . 0.0 111.696 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -35.37 132.59 0.5 Allowed Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.191 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.37 155.17 55.9 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.867 1.711 . . . . 0.0 112.373 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -149.33 -48.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.257 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.1 tt -179.2 101.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.759 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.474 ' CG1' ' N ' ' A' ' 101' ' ' LYS . 6.3 tt -172.22 163.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.367 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' N ' ' CG1' ' A' ' 100' ' ' ILE . 85.6 tttt -71.27 136.2 47.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.809 -179.489 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -113.65 136.97 22.03 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.071 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -101.71 -163.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 122.589 2.193 . . . . 0.0 109.88 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.481 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -163.96 154.82 13.62 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.885 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -34.29 148.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.913 2.409 . . . . 0.0 112.596 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -39.4 164.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.408 2.072 . . . . 0.0 114.597 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -154.75 51.16 0.62 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.824 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -128.43 127.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.518 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -122.29 119.1 30.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.137 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.29 158.38 20.52 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -162.78 132.9 3.34 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 36.3 Cg_endo -67.85 98.47 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.357 1.371 . . . . 0.0 111.818 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 14' ' ' SER . 87.6 p -80.77 -116.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.659 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 13' ' ' SER . 91.5 p -80.99 112.66 18.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.971 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.03 -133.63 43.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -78.41 -11.28 59.94 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 m -60.8 135.18 57.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.317 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.08 140.42 48.49 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.538 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -99.38 94.85 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.7 90.7 7.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.2 t -66.65 124.46 22.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.217 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.47 113.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.2 m -97.01 114.03 25.61 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.412 0.625 . . . . 0.0 110.091 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -39.09 107.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.593 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.4 OUTLIER -97.79 151.17 20.47 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 85.8 m-20 -43.34 97.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.732 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' GLY . 19.3 m-20 -63.01 152.76 35.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.433 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -38.95 -21.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.773 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 135.42 -3.24 3.94 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.69 146.68 62.22 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.59 138.48 59.44 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.335 1.357 . . . . 0.0 111.133 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.46 126.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.514 0.673 . . . . 0.0 112.39 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -68.47 -41.06 80.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -161.18 168.05 24.94 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.794 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -114.3 119.4 36.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.219 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 HG23 HD13 ' A' ' 36' ' ' ILE . 80.9 mt -96.45 110.83 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.3 t -110.86 125.68 68.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.136 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -120.61 128.91 53.48 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -135.63 151.36 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.587 ' NE ' ' O ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -145.49 -177.87 5.79 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.705 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.587 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 25.4 m -90.72 146.43 24.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.874 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.36 -18.36 52.59 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.7 -49.66 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.535 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HB2' HH22 ' A' ' 40' ' ' ARG . 73.8 mmtt -110.53 -164.36 0.92 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -174.58 75.87 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -154.79 -8.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.075 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.0 129.23 21.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -116.18 131.14 57.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.144 0.497 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.73 160.32 18.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.45 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 54.5 mp0 -114.6 147.82 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.101 0.477 . . . . 0.0 111.44 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.16 113.99 5.39 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -99.32 146.59 26.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.911 0.386 . . . . 0.0 111.99 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.46 160.45 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.482 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' C ' ' H ' ' A' ' 56' ' ' ASN . 47.9 tp60 -83.07 148.46 27.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.857 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.13 5.72 3.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 54' ' ' GLN . 64.0 t30 -122.69 -14.45 7.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.027 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 21.3 mttp -67.47 -49.79 61.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.182 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 59.03 35.45 23.98 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.974 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -176.35 155.49 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.763 -0.585 . . . . 0.0 111.386 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -151.18 146.09 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.59 102.7 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.882 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp -87.67 105.62 17.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 79.4 mt-10 -86.77 139.16 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.346 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 2.0 t-160 83.92 79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.375 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.8 mt -131.86 77.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 42.4 tt0 -34.9 143.71 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.344 0.592 . . . . 0.0 111.151 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -70.08 -22.46 63.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.496 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 p -100.76 22.95 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.1 ttm -141.77 132.98 26.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.34 0.59 . . . . 0.0 110.981 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.26 153.4 20.5 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -148.61 133.36 17.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.571 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.94 151.75 23.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.753 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.07 133.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -125.98 108.9 11.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 0.0 109.872 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.35 135.86 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.285 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -134.82 117.73 16.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.85 126.06 35.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.233 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.33 107.88 18.89 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.7 p-10 -109.64 -174.09 2.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.897 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -45.64 -26.28 0.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.608 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.492 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -71.84 -40.27 69.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.935 0.397 . . . . 0.0 110.125 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.465 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 128.61 -49.22 0.93 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -153.66 131.74 11.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 t -167.78 162.97 14.09 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.836 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' OE2' ' N ' ' A' ' 4' ' ' SER . 8.3 tp10 50.27 53.89 14.8 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.188 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 92.3 Cg_endo -74.84 156.09 43.69 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.977 2.452 . . . . 0.0 110.943 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.01 110.42 11.64 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.03 0.443 . . . . 0.0 110.785 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 t -94.01 95.76 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.549 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -102.92 133.59 47.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.22 136.95 42.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.17 0.509 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.5 p90 -171.72 132.92 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.199 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.19 167.09 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.8 mmm -96.04 144.22 27.45 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.75 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.14 165.27 28.28 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.776 2.317 . . . . 0.0 110.903 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.98 162.89 33.28 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.992 1.795 . . . . 0.0 111.433 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -40.74 133.21 1.74 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.46 170.05 20.7 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.985 1.79 . . . . 0.0 111.085 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.473 ' CG ' ' H ' ' A' ' 99' ' ' ILE . 57.9 t30 -97.66 -121.28 0.13 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.473 ' H ' ' CG ' ' A' ' 98' ' ' ASN . 1.5 pp -102.31 3.83 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.229 0.538 . . . . 0.0 109.973 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.536 ' C ' ' H ' ' A' ' 102' ' ' ASP . 17.2 tt -51.33 140.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.115 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.14 19.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.22 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 100' ' ' ILE . 37.6 t0 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.299 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 28' ' ' GLY . 9.5 tpt180 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -144.67 104.61 4.57 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.397 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -98.11 -163.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 122.746 2.298 . . . . 0.0 109.558 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.8 165.8 4.1 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.961 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' PRO . 88.8 Cg_exo -39.29 157.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.965 2.443 . . . . 0.0 112.719 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' PRO . 15.7 Cg_exo -37.41 163.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.872 2.381 . . . . 0.0 113.707 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 m -151.38 52.2 0.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.444 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -130.18 128.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -122.46 117.11 25.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.1 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.02 161.53 21.75 Favored Glycine 0 N--CA 1.464 0.543 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.968 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -161.95 128.78 2.52 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.92 88.26 0.94 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.3 t -66.87 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -71.29 133.07 45.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.172 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 -160.11 49.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.864 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -79.82 -4.98 54.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.642 -0.279 . . . . 0.0 111.227 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.8 p -68.72 147.39 51.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.121 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.0 124.69 43.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -84.29 100.12 11.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.399 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.65 97.97 9.8 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -71.56 126.28 29.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.037 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mm -88.93 113.79 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 m -85.5 139.07 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.063 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -72.29 104.92 3.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.655 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 168.21 9.42 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.3 t70 -56.85 110.01 0.73 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.31 165.37 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.125 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 1' ' ' ARG . . . -55.37 -23.09 33.0 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.42 16.69 0.08 OUTLIER Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.247 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.91 152.48 20.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 117.169 0.485 . . . . 0.0 109.789 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.51 145.04 86.86 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.86 1.707 . . . . 0.0 111.112 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.4 mt -91.59 129.24 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.467 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.21 -44.56 14.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.24 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.6 161.64 39.34 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -113.88 122.19 46.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.98 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.4 mt -94.25 108.44 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 51' ' ' LYS . 58.1 t -113.77 130.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.113 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -127.95 147.23 50.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -148.55 155.69 41.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.074 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.741 HH21 ' H ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -152.49 -172.83 4.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.032 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -92.74 146.48 23.61 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.792 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.61 15.7 0.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -132.45 -45.92 0.9 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.739 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.561 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.79 37.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.684 0.278 . . . . 0.0 110.821 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 6.7 tm-20 -49.68 84.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 110.753 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 44' ' ' LYS . 73.0 m-20 -153.93 -16.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.966 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.741 ' H ' HH21 ' A' ' 40' ' ' ARG . 19.7 pt20 -156.74 155.68 32.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.063 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -124.39 136.01 53.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.084 0.469 . . . . 0.0 111.898 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.9 158.71 20.5 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -118.35 146.51 44.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.097 0.475 . . . . 0.0 111.319 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -147.45 117.78 7.38 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -100.94 143.53 30.97 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.95 161.38 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.357 0.598 . . . . 0.0 110.646 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' C ' ' H ' ' A' ' 56' ' ' ASN . 66.9 tp60 -79.14 147.71 32.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.606 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.62 0.29 5.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 54' ' ' GLN . 12.1 t-20 -118.62 -6.73 10.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.556 0.217 . . . . 0.0 110.891 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HZ2' ' CE1' ' A' ' 59' ' ' HIS . 10.2 tptp -63.6 -47.83 79.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.31 0.576 . . . . 0.0 109.638 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 53.02 30.17 9.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.686 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.546 ' CE1' ' HZ2' ' A' ' 57' ' ' LYS . 0.4 OUTLIER 178.69 153.39 0.36 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.968 0.414 . . . . 0.0 110.737 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -151.96 145.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.542 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.56 107.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 mt -92.7 133.06 36.38 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 83.4 tt0 -119.77 152.94 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.008 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 36.3 t-80 88.88 49.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.712 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.22 86.96 2.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -41.65 137.88 1.52 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.452 0.644 . . . . 0.0 111.122 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -65.0 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.755 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -98.32 21.42 11.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.384 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 8.8 ttm -145.17 128.64 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 110.145 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.76 161.9 46.48 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.61 129.61 23.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -90.55 154.39 19.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.875 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -135.1 136.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 67.2 tt0 -127.25 107.86 10.37 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -95.78 131.39 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.283 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -135.54 120.21 18.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.63 127.4 35.9 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.21 111.01 23.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.248 0.547 . . . . 0.0 112.248 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.5 p30 -112.08 -166.44 1.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.237 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -53.0 -30.91 38.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.027 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.494 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -66.37 -41.31 89.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.165 0.507 . . . . 0.0 109.736 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 129.93 -49.07 0.94 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -154.88 137.77 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.6 t -165.38 155.48 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.701 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 26' ' ' ASP . 18.5 tt0 50.06 56.94 17.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.232 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.81 154.37 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.68 2.253 . . . . 0.0 111.367 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -132.34 119.01 20.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 0.0 111.089 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.94 94.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.54 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 40.2 t80 -98.22 131.1 44.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.124 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -133.1 131.5 40.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.54 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 20.9 p90 -161.73 134.73 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.63 160.23 25.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.366 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 91.1 mmm -94.49 140.93 22.86 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.804 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.71 162.81 40.22 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.035 1.823 . . . . 0.0 110.861 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.33 151.99 83.46 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.499 2.133 . . . . 0.0 111.816 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -38.28 133.18 0.96 Allowed Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.97 153.74 76.92 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.477 1.452 . . . . 0.0 111.681 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -84.96 -102.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.5 pt -98.49 -3.93 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.959 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.33 131.58 68.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.942 0.401 . . . . 0.0 110.544 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -80.49 -163.21 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.607 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.691 179.725 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 2' ' ' GLU . 33.1 ptt-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 1' ' ' ARG . 34.5 mt-10 -25.05 88.59 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.003 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.441 ' N ' ' O ' ' A' ' 1' ' ' ARG . 15.5 Cg_endo -106.33 -163.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 124.116 3.211 . . . . 0.0 111.289 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.1 p -166.94 149.74 5.95 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.13 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' SER . 80.7 Cg_exo -37.61 164.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.974 2.449 . . . . 0.0 112.545 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.2 Cg_exo -38.75 163.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.331 2.021 . . . . 0.0 114.276 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.33 33.54 0.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.695 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.58 120.49 60.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.553 0.692 . . . . 0.0 110.788 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -116.26 116.86 28.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.039 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.24 150.44 19.68 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 13' ' ' SER . 21.6 mt-30 -153.62 113.46 2.59 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.41 85.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.171 1.248 . . . . 0.0 111.636 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 11' ' ' GLN . 10.8 t -53.92 -88.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.647 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.25 140.33 41.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.808 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.01 -127.9 39.11 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.499 ' CE ' ' O ' ' A' ' 65' ' ' LEU . 10.4 mtmm -99.39 -2.84 35.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 p -67.01 149.21 50.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.11 135.38 48.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.824 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -96.39 95.18 7.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -90.86 92.28 8.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -68.9 122.59 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.221 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mm -85.95 112.6 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -91.68 117.76 30.04 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.19 105.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.391 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -88.96 157.61 18.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -48.62 106.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -58.1 142.69 46.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.649 0.737 . . . . 0.0 111.965 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.99 -20.71 6.7 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.6 -1.65 0.73 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.75 25.78 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.87 133.33 38.41 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.86 1.707 . . . . 0.0 111.992 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -78.59 130.27 36.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.172 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 11.3 mp -80.99 -44.67 17.79 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -142.18 163.72 32.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.515 0.674 . . . . 0.0 111.434 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -116.71 113.88 23.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.166 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -87.83 109.94 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 51' ' ' LYS . 44.9 t -114.08 130.55 68.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -125.84 133.32 52.01 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.47 150.73 46.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.839 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.3 ptt85 -143.65 174.78 10.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.027 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 44' ' ' LYS . 16.5 m -84.99 142.57 29.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -63.31 -35.53 80.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.471 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.33 -10.52 59.53 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.564 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 41' ' ' SER . 28.4 mmtt -125.99 154.6 42.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.633 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.2 19.83 1.09 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.708 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.93 1.06 52.64 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -159.89 158.07 30.2 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.94 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -136.44 106.13 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.8 mt -67.59 145.77 54.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.81 151.86 25.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.22 0.533 . . . . 0.0 111.138 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' VAL . 11.2 tppt? -150.58 113.24 4.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.427 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -97.81 139.85 33.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.362 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.77 160.42 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.371 0.605 . . . . 0.0 110.997 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -78.67 142.55 37.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.362 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.68 -3.74 16.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -110.26 -21.36 12.27 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.723 -0.28 . . . . 0.0 110.622 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -61.55 -52.48 64.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.021 0.438 . . . . 0.0 110.687 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 56.57 41.67 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.809 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.81 150.44 0.8 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.525 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.05 140.7 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.2 mm -111.45 103.96 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.407 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 10.3 mp -92.57 107.57 19.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 171.11 10.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 m80 66.57 48.12 1.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.364 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.499 ' O ' ' CE ' ' A' ' 16' ' ' LYS . 23.8 mt -100.16 164.71 11.85 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -119.97 143.07 48.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.201 0.524 . . . . 0.0 110.625 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -68.87 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.1 p -102.44 17.93 22.37 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.6 mtp -143.41 134.12 25.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.41 166.44 31.88 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.147 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -142.82 131.73 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.54 . . . . 0.0 110.351 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.1 mt-10 -88.32 151.47 22.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.58 131.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.565 ' NE2' ' O ' ' A' ' 75' ' ' ILE . 10.0 tp60 -124.34 108.08 11.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.611 0.72 . . . . 0.0 110.371 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 1.6 mp -90.58 134.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.098 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.476 ' HG1' HE21 ' A' ' 74' ' ' GLN . 0.7 OUTLIER -134.46 120.36 19.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.25 127.03 37.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.58 107.24 18.07 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.019 0.438 . . . . 0.0 111.812 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.639 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.61 -170.58 1.8 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -44.09 -32.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.789 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -64.12 -41.52 97.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.64 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 123.52 -49.04 0.92 Allowed Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 7.0 m-85 -156.45 125.71 6.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.589 ' HG ' ' H ' ' A' ' 85' ' ' GLU . 11.7 t -160.64 169.68 22.37 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.651 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.589 ' H ' ' HG ' ' A' ' 84' ' ' SER . 60.3 mm-40 52.0 49.3 6.65 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.869 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 74.3 Cg_endo -71.35 152.37 60.85 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.068 1.845 . . . . 0.0 111.146 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.31 113.51 12.69 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 110.378 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.87 93.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -101.53 145.32 29.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.224 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.66 138.34 32.43 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 91' ' ' PHE . 16.7 p90 -164.39 127.61 2.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.0 p -83.76 143.06 30.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 94.6 mmm -74.29 140.32 76.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.144 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.05 164.76 34.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.92 152.7 80.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.431 2.087 . . . . 0.0 111.748 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -39.89 129.89 1.54 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.8 149.09 42.23 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 121.498 1.465 . . . . 0.0 112.254 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.53 -36.38 2.46 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.1 pt -107.46 3.43 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.485 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 100' ' ' ILE . 45.8 pt 42.87 44.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.84 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -69.35 -72.95 0.17 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.448 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.812 -1.089 . . . . 0.0 110.378 -179.364 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -124.38 82.21 58.34 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.494 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -99.74 -164.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 123.446 2.764 . . . . 0.0 110.832 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.436 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.6 OUTLIER -167.76 179.78 0.88 Allowed Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.469 179.284 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 14.3 Cg_exo -65.08 173.0 6.5 Favored 'Trans proline' 0 N--CA 1.503 2.066 0 C-N-CA 122.879 2.386 . . . . 0.0 112.204 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -35.89 166.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 123.6 2.867 . . . . 0.0 115.384 -179.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.51 43.15 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.518 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.02 132.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.323 0.582 . . . . 0.0 111.318 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -128.89 117.39 20.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.595 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.1 145.72 17.8 Favored Glycine 0 N--CA 1.464 0.562 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.031 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -148.03 118.18 4.29 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -48.96 109.15 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.097 1.198 . . . . 0.0 112.111 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 t -84.4 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.6 m -82.0 134.56 35.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.191 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.46 -135.05 41.76 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.7 ' HZ2' ' HE1' ' A' ' 67' ' ' TRP . 33.7 mttm -77.78 -8.64 58.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.838 0.351 . . . . 0.0 110.994 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.6 t -64.74 141.57 58.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.027 0.442 . . . . 0.0 111.946 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.3 124.3 44.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.898 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -87.57 104.49 16.55 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.251 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 mt -97.26 91.62 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.0 t -65.4 120.48 12.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.039 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.13 123.29 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -93.91 113.65 25.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.423 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -42.17 104.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.322 0.582 . . . . 0.0 110.841 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -85.82 171.34 11.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.093 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.46 108.66 0.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.18 142.4 56.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.444 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -40.88 -74.36 0.16 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.36 13.09 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.87 158.61 29.27 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -57.03 141.81 94.08 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.15 1.234 . . . . 0.0 111.069 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mt -83.95 122.13 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.104 0.478 . . . . 0.0 111.233 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.0 -41.97 85.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.278 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.6 163.17 24.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.255 0.55 . . . . 0.0 111.241 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -107.5 114.61 28.72 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.836 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -88.09 114.72 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.7 t -115.44 129.81 71.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.976 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -125.24 136.08 53.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -140.42 155.82 46.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.041 0.448 . . . . 0.0 110.514 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.554 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 11.1 ptt180 -149.9 178.99 8.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.377 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 p -91.1 140.64 29.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.223 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -68.67 -24.59 64.54 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -33.97 74.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.585 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -158.85 -175.48 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.854 0.835 . . . . 0.0 112.344 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 10.8 pt-20 -142.72 122.06 13.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.753 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 47' ' ' GLN . 63.7 m-20 -161.15 38.01 0.14 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 46' ' ' ASP . 26.1 mt-30 115.88 126.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.853 1.971 . . . . 0.0 110.927 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.554 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 21.6 m95 -87.89 135.78 33.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.842 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 76.3 mt -72.59 159.83 33.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.75 151.76 40.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.071 0.462 . . . . 0.0 111.567 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.15 113.44 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.506 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -92.8 144.17 25.55 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.01 150.47 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.474 ' C ' ' H ' ' A' ' 56' ' ' ASN . 52.2 tt0 -67.49 140.6 57.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.512 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.01 7.7 0.27 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.57 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 54' ' ' GLN . 8.3 t-20 -132.93 -8.92 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.364 0.582 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 14.7 mttp -64.65 -46.0 84.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.607 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.7 p30 50.04 39.5 19.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.799 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.45 151.95 0.63 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.7 140.87 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 0.0 110.707 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mm -111.87 98.4 6.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.119 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 mt -87.23 105.27 17.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 54.7 mp0 -86.58 175.31 8.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.3 m80 60.91 57.82 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -105.15 -171.68 1.96 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.09 129.57 22.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.579 0.704 . . . . 0.0 110.954 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.7 ' HE1' ' HZ2' ' A' ' 16' ' ' LYS . 68.0 m95 -63.81 -30.39 71.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.977 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 p -100.45 21.0 13.86 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.99 135.03 19.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.301 . . . . 0.0 110.458 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.77 166.17 42.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -144.97 135.0 23.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.501 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 7.5 mt-10 -98.11 151.77 20.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.43 136.95 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.938 0.399 . . . . 0.0 110.678 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -129.62 114.38 15.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.94 136.33 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.923 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -138.8 117.78 12.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.21 129.04 35.45 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.87 116.17 31.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.284 0.564 . . . . 0.0 112.454 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.9 p-10 -117.18 -169.57 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -50.89 -27.96 8.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.611 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -66.24 -37.6 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.529 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.467 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 121.52 -52.19 0.75 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.467 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.2 m-85 -151.67 138.22 18.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -161.71 171.68 17.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.407 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 32.03 64.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.408 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.66 151.91 32.72 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.297 1.998 . . . . 0.0 110.691 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.75 110.3 12.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.128 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -96.72 98.76 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -104.47 147.45 27.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.19 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.6 131.67 20.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.934 0.397 . . . . 0.0 111.182 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 38.1 p90 -165.81 142.34 5.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -90.01 161.05 16.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.375 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 92.3 mmm -87.77 137.62 31.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.552 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.38 165.43 31.79 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.306 2.004 . . . . 0.0 111.284 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.92 152.88 80.25 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.035 1.823 . . . . 0.0 110.888 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.615 ' CE ' ' NE1' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -44.49 130.93 4.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.35 121.97 9.35 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.71 1.606 . . . . 0.0 113.196 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -72.37 -31.65 65.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.4 tt -136.29 117.28 18.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.189 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 22.6 pt -72.81 -168.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.004 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 100' ' ' ILE . 82.6 tttt 100.04 118.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.438 1.086 . . . . 0.0 110.212 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.44 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 1' ' ' ARG . 1.3 tp10 94.39 74.92 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.619 0 O-C-N 123.854 0.721 . . . . 0.0 110.479 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -100.52 -164.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.594 2.863 . . . . 0.0 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -174.06 149.7 1.51 Allowed Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.005 178.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 6' ' ' PRO . 84.0 Cg_exo -39.93 163.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.072 2.515 . . . . 0.0 113.088 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.3 Cg_exo -38.71 163.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.693 2.262 . . . . 0.0 113.339 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.8 m -157.49 58.92 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.8 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.44 130.44 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.228 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -118.99 113.76 21.48 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.26 138.65 14.05 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -152.41 146.88 18.76 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.655 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.64 88.02 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.278 1.985 . . . . 0.0 111.792 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 t -67.98 -68.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.779 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' GLY . 20.0 m -136.88 156.66 48.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . . . 31.99 -116.22 0.1 OUTLIER Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.088 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -96.86 -8.32 31.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.962 0.41 . . . . 0.0 110.274 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.47 136.47 58.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.95 118.65 31.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.326 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.18 109.39 14.6 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.066 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.5 mt -100.93 89.7 3.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -70.3 121.85 18.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.38 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.2 mm -82.65 114.95 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 m -94.72 116.29 28.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.627 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.484 ' CD ' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.29 105.76 0.05 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.531 ' NE2' ' OE1' ' A' ' 85' ' ' GLU . 3.6 pt20 -117.87 101.21 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' GLN . 95.7 m-20 33.1 -154.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 29' ' ' GLY . 46.5 p-10 -165.11 161.61 19.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 1' ' ' ARG . . . -66.37 5.6 2.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 117.13 9.28 10.74 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.61 151.3 23.38 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 117.01 0.405 . . . . 0.0 110.156 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.32 141.69 76.08 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.926 1.751 . . . . 0.0 111.781 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mt -88.06 130.93 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.183 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.79 -41.82 14.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.283 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -146.67 162.12 39.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.299 0.571 . . . . 0.0 111.775 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -114.2 121.61 44.27 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.963 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.1 mt -95.45 110.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.26 130.88 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.563 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -128.56 133.06 48.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.413 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.8 153.3 49.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.446 . . . . 0.0 110.389 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -140.4 -174.1 3.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.459 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -100.68 137.36 39.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.029 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -66.77 -30.63 70.89 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.08 -33.43 73.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.569 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 41' ' ' SER . 12.1 ptpt -131.87 168.75 17.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 111.273 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.91 106.8 3.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.188 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 25.2 p-10 -164.74 -26.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -144.99 162.52 36.71 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -131.9 133.54 44.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.133 0.492 . . . . 0.0 110.939 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.8 mt -77.15 160.48 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.67 152.27 36.42 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.09 0.472 . . . . 0.0 111.8 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.72 113.71 2.27 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -98.83 145.98 26.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.598 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 157.4 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.115 0.483 . . . . 0.0 110.528 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.541 ' C ' ' H ' ' A' ' 56' ' ' ASN . 40.6 tt0 -77.05 137.08 38.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.488 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.95 0.02 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.522 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 54' ' ' GLN . 97.1 m-20 -121.09 -6.26 9.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.875 0.338 . . . . 0.0 110.615 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -64.63 -49.7 70.0 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.53 0.681 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 56.41 34.9 25.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.188 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.45 151.18 0.59 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.03 146.29 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.535 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 61' ' ' ILE . 32.5 mm -117.06 108.89 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.578 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -93.13 105.82 17.86 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 45.4 tt0 -91.63 152.04 20.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.805 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 12.3 t60 80.74 62.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.371 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' GLN . 66.8 mt -119.74 88.37 2.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.861 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' LEU . 86.4 mt-30 -36.91 152.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.151 0.501 . . . . 0.0 111.735 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -83.17 -5.9 59.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.404 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -115.04 15.13 17.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.689 0.28 . . . . 0.0 111.608 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 67.7 mtp -146.0 136.6 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 111.332 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.37 162.22 25.65 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.94 132.38 26.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.595 0.236 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -87.76 149.93 23.89 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.78 137.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -129.32 106.42 8.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.467 0.651 . . . . 0.0 109.423 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -92.51 134.97 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.968 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -138.79 116.01 11.07 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.26 128.16 34.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.189 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.26 107.27 18.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 1.2 p30 -110.7 -168.18 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -49.49 -31.65 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 4.0 mm? -63.07 -41.15 99.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 124.37 -44.2 1.31 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.47 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.8 m-85 -153.17 139.99 19.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.8 p -157.37 162.01 39.05 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.853 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.531 ' OE1' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 32.33 59.1 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.459 178.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.5 150.26 69.55 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 121.567 1.512 . . . . 0.0 110.548 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.8 m -128.21 116.51 20.0 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.492 0.663 . . . . 0.0 111.047 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.9 94.67 4.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.235 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -95.86 147.95 23.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.595 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -144.11 135.88 26.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.054 0.454 . . . . 0.0 110.83 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 18' ' ' PHE . 3.9 p90 -167.54 133.77 2.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -89.01 173.77 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.503 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.88 144.38 28.79 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.093 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.03 165.62 27.97 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.614 2.209 . . . . 0.0 110.41 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.59 152.45 81.74 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.749 1.633 . . . . 0.0 111.741 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -36.1 129.49 0.63 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.764 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.71 151.13 24.74 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.965 1.777 . . . . 0.0 110.939 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -105.99 -57.58 2.03 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.663 0.268 . . . . 0.0 110.844 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' ILE . 15.6 pt -72.82 -30.8 33.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.561 0.696 . . . . 0.0 109.5 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 99' ' ' ILE . 1.3 mt 51.1 132.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.509 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -173.63 -125.86 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.531 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.349 -179.527 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 3' ' ' PRO . 96.5 mtt-85 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 1' ' ' ARG . 6.2 tp10 -18.88 81.17 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 123.823 0.702 . . . . 0.0 112.381 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.526 ' N ' ' O ' ' A' ' 1' ' ' ARG . 91.3 Cg_endo -102.52 -163.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 124.476 3.451 . . . . 0.0 110.539 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -165.6 155.46 11.38 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.045 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 49.0 Cg_exo -49.49 -171.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.227 0 C-N-CA 122.408 2.072 . . . . 0.0 112.389 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 5' ' ' PRO . 86.6 Cg_exo -54.7 145.4 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.089 2.526 . . . . 0.0 114.237 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.403 ' HG ' ' CD ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER -138.03 50.44 1.91 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.541 -178.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.2 mm -126.21 128.5 71.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.241 0.543 . . . . 0.0 110.896 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -122.15 114.53 21.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.428 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.2 147.5 18.62 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.531 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -156.74 135.34 7.62 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 107.77 2.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.063 1.175 . . . . 0.0 111.51 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -78.18 -81.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.3 m -143.18 133.91 25.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.406 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.6 -145.68 35.97 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.689 ' NZ ' ' H ' ' A' ' 66' ' ' GLN . 2.6 mtmp? -87.76 -3.67 58.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.332 . . . . 0.0 110.71 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 82.6 p -71.72 145.66 48.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.749 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.79 125.75 48.36 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -85.77 104.01 15.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.808 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.89 97.49 8.37 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.4 t -72.39 120.16 17.61 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.689 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mm -80.11 119.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.6 m -85.32 128.26 34.63 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.906 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.98 110.93 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.209 1.004 . . . . 0.0 109.584 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.502 ' C ' ' H ' ' A' ' 27' ' ' ASP . 7.3 mm100 -92.79 169.05 10.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.076 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 17.1 t70 -53.75 -9.28 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.262 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 p30 47.92 34.97 4.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.848 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.2 -13.06 0.17 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 114.52 4.3 21.82 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.496 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . -131.44 152.5 80.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 122.633 -0.333 . . . . 0.0 110.358 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.79 144.08 58.02 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.213 1.942 . . . . 0.0 111.837 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -98.44 125.66 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.504 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 mt -72.92 -39.53 66.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.104 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -160.58 170.46 20.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.91 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.38 122.43 43.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.582 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -93.02 108.84 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.4 t -111.12 127.13 68.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.067 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.23 138.22 54.11 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.952 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -142.4 151.04 41.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.086 0.47 . . . . 0.0 111.436 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 37.2 ptt85 -143.94 174.27 10.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.864 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.403 ' HG ' ' H ' ' A' ' 44' ' ' LYS . 9.8 p -80.04 150.98 30.17 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.204 0.315 . . . . 0.0 110.261 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -75.12 12.15 0.97 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.425 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.69 -35.03 2.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.489 0.185 . . . . 0.0 110.776 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' H ' ' HG ' ' A' ' 41' ' ' SER . 33.7 mmtt -103.01 109.64 21.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.491 0.662 . . . . 0.0 110.741 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -105.07 15.95 26.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.695 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.91 3.39 53.62 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -161.38 136.26 7.36 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.214 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 43.0 m95 -119.59 123.56 44.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.76 160.24 23.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.017 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -120.18 154.68 34.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.428 0.632 . . . . 0.0 111.916 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.14 114.67 3.12 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.75 141.15 32.94 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.354 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.33 161.72 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.355 0.598 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -78.11 146.94 34.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.432 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.0 5.64 7.76 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.828 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -120.7 -15.82 8.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.737 0.304 . . . . 0.0 110.31 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -65.16 -52.06 57.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.238 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 55.9 38.45 30.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.283 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.35 150.96 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.528 0.204 . . . . 0.0 110.535 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.36 152.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.398 0.618 . . . . 0.0 111.667 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 mm -121.57 111.73 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.82 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 17' ' ' SER . 51.0 mt -97.61 112.88 24.57 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -84.93 153.54 22.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 0.0 112.47 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 70.3 t60 59.57 81.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.029 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 66' ' ' GLN . 75.1 mt -118.03 -4.15 11.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.689 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . 22.6 mt-30 57.13 149.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.405 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -90.64 -14.46 32.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.782 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 p -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.75 117.34 15.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.136 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.9 157.83 50.69 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.936 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -139.73 128.03 22.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.309 -0.445 . . . . 0.0 110.259 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -86.48 153.14 22.08 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.61 134.97 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -123.77 106.93 10.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.538 0.685 . . . . 0.0 109.414 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.11 133.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.489 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -139.9 116.2 10.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.37 127.75 35.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.28 110.62 22.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.29 0.567 . . . . 0.0 112.008 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.64 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -116.63 -176.45 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.839 178.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -42.52 -31.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 7.3 mp -64.75 -41.79 95.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.451 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 124.6 -45.38 1.18 Allowed Glycine 0 N--CA 1.465 0.573 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.484 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.7 m-85 -154.52 138.86 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.433 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 73.5 m -148.17 161.53 41.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.564 0.697 . . . . 0.0 111.87 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 85' ' ' GLU . 0.7 OUTLIER 22.75 60.94 0.34 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.417 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.8 150.27 86.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.154 1.236 . . . . 0.0 110.414 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.7 m -125.27 117.92 24.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.577 0.703 . . . . 0.0 111.712 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.92 93.6 4.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.584 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 36.7 t80 -95.81 132.67 40.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.704 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.83 136.46 46.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 111.221 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.1 p90 -172.24 133.44 0.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.165 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.4 p -80.52 162.76 24.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.343 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.6 mmm -89.29 143.31 30.72 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.285 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.93 164.98 34.06 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.684 2.256 . . . . 0.0 111.203 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.1 152.36 81.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.414 2.076 . . . . 0.0 111.507 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.75 131.22 1.83 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.64 179.05 6.82 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.208 1.939 . . . . 0.0 111.525 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -155.98 -93.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.099 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.591 ' H ' ' CD1' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -107.37 -1.68 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 122.298 -0.251 . . . . 0.0 111.336 179.482 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CG1' ' N ' ' A' ' 101' ' ' LYS . 15.5 tt -124.32 163.37 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.325 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.429 ' N ' ' CG1' ' A' ' 100' ' ' ILE . 60.9 tttp 61.84 127.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.063 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.561 179.469 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo . . . . . 0 N--CA 1.501 1.961 0 N-CA-C 111.884 -0.083 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -39.21 164.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.696 2.264 . . . . 0.0 114.732 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 m -163.74 48.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.635 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -126.12 127.4 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.621 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -113.35 113.98 26.0 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.06 141.54 15.59 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -150.37 148.63 24.65 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.767 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.75 88.29 1.39 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.167 1.911 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 14' ' ' SER . 79.7 p -58.12 -87.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.024 0.44 . . . . 0.0 109.971 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.463 ' N ' ' OG ' ' A' ' 13' ' ' SER . 37.9 m -139.29 127.97 23.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.58 -131.31 14.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -93.13 -10.67 35.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.634 0.254 . . . . 0.0 111.226 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -63.95 146.56 53.84 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.874 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 130.33 52.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.08 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -88.2 104.83 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.371 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.63 97.4 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 t -73.76 126.94 31.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 mm -87.49 110.44 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -88.89 115.61 26.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.49 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -36.98 105.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.297 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -91.92 170.5 9.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.614 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.94 109.21 1.2 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.12 142.81 58.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -46.38 -19.52 0.45 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.461 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.71 1.24 1.42 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.92 151.87 57.36 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.82 137.82 55.26 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.772 1.648 . . . . 0.0 111.385 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.617 HG21 ' CE1' ' A' ' 35' ' ' TYR . 3.5 mt -83.41 131.39 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.357 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.1 mm? -85.48 -42.71 14.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.32 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -146.66 161.06 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.266 0.555 . . . . 0.0 111.618 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.617 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.2 m-85 -114.98 125.01 53.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.101 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.628 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 80.6 mt -98.3 114.34 35.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.607 HG22 HG13 ' A' ' 75' ' ' ILE . 75.0 t -112.39 127.74 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.784 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -129.12 128.7 44.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CE2' HD12 ' A' ' 49' ' ' LEU . 36.3 p90 -136.64 153.19 50.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -142.36 172.93 12.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.753 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 15.4 m -84.25 137.96 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -63.13 -38.26 90.47 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.847 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.76 -43.04 97.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.529 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 41' ' ' SER . 36.8 mmtt -102.54 117.76 35.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.407 0.622 . . . . 0.0 110.961 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.77 54.91 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.63 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -142.37 5.66 1.65 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.258 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -144.31 152.85 41.34 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.014 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -141.57 110.6 6.23 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.232 0.539 . . . . 0.0 110.65 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.515 HD12 ' CE2' ' A' ' 39' ' ' TYR . 83.9 mt -73.13 160.08 32.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.72 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -121.71 148.02 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.07 0.462 . . . . 0.0 111.713 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.79 113.61 4.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.628 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 72.9 mmtt -97.3 146.16 25.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 160.95 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.436 0.636 . . . . 0.0 111.092 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 55.6 tt0 -82.86 136.11 34.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.51 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.06 -8.12 1.37 Allowed Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.263 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.489 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 30.3 m120 -107.12 -9.17 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.673 0.273 . . . . 0.0 110.32 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -64.62 -49.16 72.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.1 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 51.83 33.03 10.56 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.429 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 152.93 0.46 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.562 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.594 HD13 HG21 ' A' ' 37' ' ' VAL . 1.5 pt -150.33 141.39 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.145 0.498 . . . . 0.0 110.608 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -112.13 112.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.145 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.2 mt -98.38 136.31 38.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.09 159.52 20.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.999 0.428 . . . . 0.0 111.547 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 t60 71.04 62.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.781 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.657 HD13 ' OH ' ' A' ' 71' ' ' TYR . 54.0 mt -119.26 82.59 1.89 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.4 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' LEU . 49.8 mt-30 -36.35 152.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.134 0.493 . . . . 0.0 111.711 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -83.57 -9.65 58.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.81 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.4 p -113.64 13.36 18.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 61.8 mtp -139.25 136.44 34.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 111.492 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.85 161.29 19.42 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.131 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.657 ' OH ' HD13 ' A' ' 65' ' ' LEU . 3.8 p90 -150.66 139.37 20.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 109.992 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -87.5 148.9 24.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.1 t -125.47 132.72 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -123.39 112.58 17.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.186 0.517 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.607 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -95.97 135.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.13 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -138.5 116.03 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -87.01 125.47 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.333 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.34 111.73 24.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.4 p30 -111.6 -164.92 0.95 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -54.45 -30.98 54.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.599 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.4 mm? -65.02 -41.77 94.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.697 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.22 -48.16 0.98 Allowed Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.5 m-85 -153.75 137.76 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -161.55 170.49 19.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.237 0.541 . . . . 0.0 110.943 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 34.63 57.73 2.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.298 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.47 151.62 59.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.382 2.054 . . . . 0.0 110.898 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.33 110.57 12.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.5 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 m -95.02 95.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.555 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.6 t80 -102.46 138.64 39.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.603 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.5 136.0 34.08 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.744 0.306 . . . . 0.0 110.593 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.2 p90 -171.52 129.58 0.69 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -81.55 162.68 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 77.5 mmm -88.82 149.11 43.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.61 162.94 29.83 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.414 2.076 . . . . 0.0 110.338 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.1 154.8 72.64 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.092 1.861 . . . . 0.0 110.961 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.89 131.47 0.92 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.434 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 121.435 1.423 . . . . 0.0 112.427 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 49.8 Cg_exo . . . . . 0 N--CA 1.499 1.834 0 N-CA-C 112.973 0.336 . . . . 0.0 112.973 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.0 Cg_exo -39.79 175.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.286 2.657 . . . . 0.0 114.545 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -160.11 39.85 0.18 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.568 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 87' ' ' THR . 5.9 mm -126.02 128.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.326 0.584 . . . . 0.0 111.76 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -124.84 117.05 23.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.753 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.38 147.04 17.9 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-O 121.472 0.485 . . . . 0.0 112.568 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -145.48 132.29 9.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.47 100.22 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.475 1.45 . . . . 0.0 112.402 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 9.7 p -80.18 167.23 20.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.2 p -43.88 112.11 0.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.67 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.59 -171.72 20.44 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -75.15 -9.31 58.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.508 0.194 . . . . 0.0 111.284 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 7.4 p -66.23 142.56 57.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.713 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.07 125.87 50.33 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -86.64 100.24 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.262 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.7 mt -96.83 98.25 9.97 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.4 t -71.36 129.29 38.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.471 HG21 ' CD2' ' A' ' 35' ' ' TYR . 2.1 mm -92.36 111.34 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -77.4 128.16 33.79 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.211 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.655 ' HD3' ' H ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -34.57 105.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.878 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 85' ' ' GLU . 88.4 mt-30 -83.6 118.15 23.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.493 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.61 -10.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.358 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 25.8 t70 58.05 172.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.917 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.31 -48.14 72.54 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.22 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.82 25.7 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.419 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -152.17 151.87 28.48 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.72 146.5 60.63 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.88 1.72 . . . . 0.0 111.437 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.598 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -91.05 127.48 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.949 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.3 mm? -75.72 -45.14 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.25 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -151.99 167.07 29.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.536 ' CE1' HG21 ' A' ' 32' ' ' ILE . 10.4 m-85 -115.16 124.41 51.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.401 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.501 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 91.9 mt -95.65 109.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.603 HG22 HG13 ' A' ' 75' ' ' ILE . 48.9 t -111.51 128.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -125.81 137.93 53.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.421 ' CE2' HD12 ' A' ' 49' ' ' LEU . 47.1 p90 -140.99 155.74 46.16 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.935 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.77 175.32 11.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' LYS . 10.1 m -88.52 137.69 32.1 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.206 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -65.46 -34.19 77.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -10.88 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.615 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' SER . 40.5 mtmt -140.84 161.22 38.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 109.959 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -149.03 51.46 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.037 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -139.96 4.96 2.11 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.674 0.274 . . . . 0.0 111.001 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -138.56 144.11 39.72 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.494 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -141.38 112.18 7.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 110.546 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.421 HD12 ' CE2' ' A' ' 39' ' ' TYR . 96.1 mt -76.43 159.89 30.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.18 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -119.67 150.38 40.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.383 0.611 . . . . 0.0 112.026 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? -153.04 114.45 4.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.219 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.501 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 71.8 mmtt -95.29 144.36 25.93 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.09 159.08 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.185 0.517 . . . . 0.0 110.875 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 67.5 tp60 -78.43 143.78 36.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.893 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.06 -25.01 59.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.433 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 21.1 m120 -95.3 -12.25 26.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 16.9 mttm -64.06 -45.3 89.4 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.3 p30 47.78 38.61 9.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.819 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.04 154.0 0.65 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.785 0.326 . . . . 0.0 110.822 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -155.07 150.89 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 121.253 0.549 . . . . 0.0 110.758 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.34 109.51 27.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.035 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.75 106.23 18.2 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -84.67 149.26 25.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.685 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.5 t60 79.42 70.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.753 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -126.25 81.35 1.99 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' A' ' 68' ' ' THR . 16.5 tt0 -38.1 140.98 0.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 111.336 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -68.9 -29.53 67.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.797 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.429 ' H ' ' HG2' ' A' ' 66' ' ' GLN . 5.8 p -97.22 22.1 9.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 42.3 mtp -147.97 128.67 14.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.835 0.35 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.54 167.38 50.34 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.26 132.65 22.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.11 150.73 20.78 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.18 132.83 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -122.86 109.85 14.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.603 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -98.7 131.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.136 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -134.67 120.33 19.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.94 125.96 35.56 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.09 22.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.548 HD21 HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -115.98 -171.51 2.0 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.949 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -41.99 -35.11 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.406 . . . . 0.0 110.217 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.548 HD23 HD21 ' A' ' 79' ' ' ASN . 4.2 mm? -64.14 -40.49 96.26 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 120.86 -41.76 1.85 Allowed Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.0 m-85 -155.96 135.53 12.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -163.03 155.98 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.789 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.537 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 18.8 tt0 45.04 56.19 14.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.25 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.23 154.89 56.72 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.738 2.292 . . . . 0.0 111.119 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.46 HG21 HG12 ' A' ' 8' ' ' ILE . 35.4 m -130.46 121.15 25.3 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.62 0.724 . . . . 0.0 111.018 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.81 94.44 3.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 37.7 t80 -99.86 125.35 45.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.724 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.07 130.38 49.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.73 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.7 p90 -163.79 134.19 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.601 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -80.56 164.46 22.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.6 mmm -94.76 145.75 30.17 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.918 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.39 163.49 37.6 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.323 2.015 . . . . 0.0 110.937 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.22 154.95 72.14 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.455 2.103 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -40.37 132.77 1.63 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.801 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 N--CA 1.492 1.389 0 C-N-CA 121.805 1.67 . . . . 0.0 111.697 178.485 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' PRO . 76.4 Cg_exo . . . . . 0 N--CA 1.497 1.725 0 N-CA-C 112.793 0.267 . . . . 0.0 112.793 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.0 Cg_exo -37.38 164.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.768 2.312 . . . . 0.0 113.629 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.57 53.15 0.78 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.689 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 mm -130.04 128.4 64.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -119.09 114.71 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.47 145.64 17.75 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.659 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -148.38 116.46 3.99 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -50.02 104.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.248 1.299 . . . . 0.0 112.252 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -80.76 167.32 20.1 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.1 t -43.27 118.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.38 -150.21 21.15 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -82.18 -6.09 58.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 110.576 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -66.37 143.26 57.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.53 121.76 37.3 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -83.7 108.73 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.437 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 mt -101.81 108.83 20.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -83.4 121.96 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.004 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.3 mm -86.06 115.03 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -86.83 127.18 35.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.191 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -47.16 105.2 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.412 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 27' ' ' ASP . 78.7 mt-30 -81.44 158.35 24.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.858 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 35.1 t0 -51.16 -9.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.603 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER 64.83 131.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -40.05 -19.73 0.02 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 138.46 17.87 0.57 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -157.69 152.47 21.01 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.53 138.91 61.79 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.811 1.674 . . . . 0.0 111.732 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.565 HG21 ' CE1' ' A' ' 35' ' ' TYR . 6.4 mt -89.22 133.33 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.218 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.7 mp -89.51 -25.18 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.177 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -164.64 164.62 21.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.176 0.512 . . . . 0.0 111.436 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.565 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.4 m-85 -119.37 117.49 28.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.076 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.7 mt -91.54 116.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG13 ' A' ' 75' ' ' ILE . 75.2 t -115.36 130.0 70.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.542 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -129.22 129.07 44.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CE2' HD12 ' A' ' 49' ' ' LEU . 39.1 p90 -134.1 155.92 49.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.49 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 26.9 ptt85 -149.58 171.1 17.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.504 ' HG ' ' HE2' ' A' ' 71' ' ' TYR . 4.4 m -80.8 138.07 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -63.94 -32.17 73.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.702 0.287 . . . . 0.0 111.447 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.99 -29.36 69.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.646 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' SER . 38.5 mtmt -130.96 166.61 20.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.488 0.661 . . . . 0.0 110.996 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -144.74 16.21 1.6 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.558 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -90.14 -0.25 57.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.881 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -149.36 152.14 35.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 111.727 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.434 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 49.9 m95 -141.26 114.37 8.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.863 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 39' ' ' TYR . 91.5 mt -75.08 159.55 31.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.915 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -117.65 153.64 32.96 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.18 0.514 . . . . 0.0 111.508 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.47 113.59 2.88 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -95.89 143.73 26.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.567 0.223 . . . . 0.0 110.576 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.4 160.78 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 110.591 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 6.5 tt0 -79.1 148.68 32.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.026 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.21 2.31 14.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.46 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 9.4 t-20 -121.54 -15.66 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.67 0.271 . . . . 0.0 110.962 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.81 -47.98 81.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 110.233 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 54.89 34.8 22.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.333 0.587 . . . . 0.0 111.319 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.44 156.66 2.01 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.705 -0.622 . . . . 0.0 110.94 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -156.06 155.46 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.634 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.7 107.55 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 62' ' ' LEU . 2.0 mm? -92.5 107.47 19.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.06 157.44 18.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.592 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 73.23 68.6 0.11 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.712 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.5 mt -125.07 82.18 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.064 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 73.3 mt-30 -36.16 141.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.115 0.484 . . . . 0.0 111.555 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -74.75 -7.57 53.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.673 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -112.55 16.67 19.69 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtp -143.5 142.31 31.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.965 0.412 . . . . 0.0 110.188 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.17 164.19 25.83 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.504 ' HE2' ' HG ' ' A' ' 41' ' ' SER . 92.2 m-85 -146.49 137.19 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 111.277 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.4 mt-10 -97.96 149.86 21.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.87 133.83 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.48 106.96 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.592 0.71 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.596 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -93.03 132.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.539 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 m -134.79 121.74 21.12 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -94.55 126.54 39.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.3 112.58 24.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 112.181 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.9 p-10 -119.07 -165.71 1.17 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.986 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.42 -30.53 19.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD22 HD21 ' A' ' 79' ' ' ASN . 8.6 mp -63.46 -39.15 93.7 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 118.64 -46.65 1.11 Allowed Glycine 0 N--CA 1.463 0.474 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 5.2 m-85 -155.8 128.75 8.03 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.502 ' O ' ' C ' ' A' ' 85' ' ' GLU . 3.7 m -113.06 148.32 35.44 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 84' ' ' SER . 1.2 mp0 -12.6 98.03 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 124.225 0.953 . . . . 0.0 111.846 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.55 158.36 53.96 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.133 1.222 . . . . 0.0 111.325 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.8 m -105.71 114.19 28.21 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.534 0.683 . . . . 0.0 110.105 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -91.36 94.46 4.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.2 t80 -98.5 128.16 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.827 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.21 129.76 48.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 14.8 p90 -159.38 126.87 4.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.73 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.62 161.12 23.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.057 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.4 mmm -90.67 139.12 26.29 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.29 163.05 35.44 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.38 2.053 . . . . 0.0 111.103 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 152.12 82.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.071 1.847 . . . . 0.0 111.04 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -39.71 131.6 1.43 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.408 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 C-N-CA 121.501 1.467 . . . . 0.0 112.317 179.823 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo . . . . . 0 N--CA 1.5 1.902 0 N-CA-C 113.245 0.44 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.78 151.25 26.5 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.125 1.883 . . . . 0.0 114.275 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.02 30.29 3.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.955 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.36 120.06 54.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.283 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -115.73 116.23 27.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.302 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.55 156.29 21.52 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -157.68 133.41 5.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.29 82.73 1.06 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.322 1.348 . . . . 0.0 112.136 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -58.4 -173.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.5 p -56.48 122.36 11.76 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.272 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.06 -154.03 31.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HE2' ' H ' ' A' ' 66' ' ' GLN . 15.4 mtmm -78.1 -9.09 58.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.473 -0.363 . . . . 0.0 110.897 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 p -64.66 143.4 57.95 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.114 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.91 126.34 49.77 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -87.84 98.39 11.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mt -93.71 99.83 12.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -73.96 119.23 17.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.266 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.441 HG21 ' CD2' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -84.88 108.69 17.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.297 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -87.62 129.07 35.24 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -44.62 105.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -90.39 153.53 20.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.03 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -57.84 103.01 0.11 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 55.1 p-10 -57.52 145.39 33.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.103 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.63 -46.71 7.31 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.29 18.68 0.02 OUTLIER Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.397 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -158.78 156.43 26.89 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.41 0.605 . . . . 0.0 110.231 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.35 144.2 85.17 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.136 1.891 . . . . 0.0 110.967 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.583 HG21 ' CE1' ' A' ' 35' ' ' TYR . 5.7 mt -91.82 124.37 44.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.248 0.547 . . . . 0.0 111.454 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.78 -41.05 68.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.029 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.33 171.85 19.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.27 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -120.78 114.28 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.832 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -89.45 115.4 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG22 HG13 ' A' ' 75' ' ' ILE . 96.4 t -111.91 128.54 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -124.34 128.12 48.62 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' CE2' HD12 ' A' ' 49' ' ' LEU . 35.3 p90 -135.32 153.74 51.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.691 0.281 . . . . 0.0 110.875 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE1' ' A' ' 72' ' ' GLU . 29.3 ptt85 -147.23 171.72 14.95 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.4 m -81.4 137.77 35.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.494 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.36 -29.14 70.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.554 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.15 -31.05 72.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.244 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -119.82 171.73 8.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.769 0.795 . . . . 0.0 111.546 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -152.22 4.68 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.722 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -90.55 -1.33 57.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.426 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -140.62 138.45 34.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.239 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 44.9 m95 -134.62 108.45 8.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.907 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.486 HD12 ' CE2' ' A' ' 39' ' ' TYR . 84.6 mt -71.65 159.39 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.56 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 1.3 pm0 -124.42 147.19 48.44 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -145.45 111.89 5.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -84.79 142.35 29.85 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 35' ' ' TYR . 38.8 t -136.41 156.03 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.434 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 7.9 tp-100 -78.42 146.66 34.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.768 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.05 -6.4 45.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -111.47 -15.6 13.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.51 0.195 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HD2' ' H ' ' A' ' 54' ' ' GLN . 23.0 mttm -62.06 -49.1 77.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.285 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 53.34 36.07 21.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.412 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.98 154.07 0.67 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -154.68 146.13 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 110.587 179.145 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mm -114.82 115.52 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.26 105.59 16.26 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.6 154.19 25.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.7 t60 69.97 67.0 0.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.961 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' GLN . 57.4 mt -107.84 -7.92 16.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 65' ' ' LEU . 74.6 mt-30 55.72 147.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 111.646 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -91.94 -18.4 23.77 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.038 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.3 p -106.48 18.8 21.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 10.8 ttm -146.5 138.84 25.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 170.47 34.34 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -149.35 134.27 17.96 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 5.1 mt-10 -98.87 152.81 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.06 135.37 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.017 0.437 . . . . 0.0 110.767 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -128.22 108.27 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.983 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.612 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -92.18 137.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.543 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -137.19 117.86 13.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.11 126.64 35.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.68 112.23 25.24 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.315 0.578 . . . . 0.0 112.184 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.6 p-10 -114.73 -168.25 1.35 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.804 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -51.31 -30.48 18.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.621 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -63.18 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.11 -47.45 1.02 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -155.53 139.02 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' GLU . 1.3 t -131.84 135.46 46.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.75 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.6 mm-40 11.9 94.04 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 124.365 1.041 . . . . 0.0 112.091 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.38 154.26 55.91 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 120.995 1.13 . . . . 0.0 111.679 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.82 111.76 24.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 88' ' ' VAL . 28.6 m -94.64 96.62 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.165 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.481 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -101.8 130.43 48.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.264 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.52 130.68 44.44 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.167 0.508 . . . . 0.0 111.729 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 13.0 p90 -165.94 140.14 4.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.064 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -91.27 171.29 9.33 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.453 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.0 mmm -96.61 139.74 21.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.08 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.21 163.18 37.12 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.22 1.947 . . . . 0.0 110.955 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.95 147.61 91.89 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.39 2.06 . . . . 0.0 111.764 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -41.45 134.52 2.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 C-N-CA 121.61 1.54 . . . . 0.0 111.435 178.252 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' PRO . 54.4 Cg_exo . . . . . 0 N--CA 1.498 1.76 0 N-CA-C 112.73 0.242 . . . . 0.0 112.73 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -33.96 167.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 123.714 2.943 . . . . 0.0 116.155 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.425 ' H ' ' CG2' ' A' ' 87' ' ' THR . 0.2 OUTLIER -165.06 46.47 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.917 -177.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.99 129.28 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 111.579 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -119.26 116.91 27.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.184 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.55 155.95 19.4 Favored Glycine 0 N--CA 1.467 0.712 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.331 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -158.56 132.61 5.08 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 89.5 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.376 1.384 . . . . 0.0 110.923 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 t -60.73 -85.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.349 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 17' ' ' SER . 90.7 p -128.12 127.74 43.59 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.752 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.08 -128.67 31.48 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 65' ' ' LEU . 40.5 mttt -89.5 -5.6 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 14' ' ' SER . 85.7 p -61.75 144.87 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.425 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 120.78 27.26 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -88.03 101.18 13.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.272 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 mt -96.5 96.56 8.77 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 t -67.62 130.68 43.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.451 HD12 HG12 ' A' ' 75' ' ' ILE . 5.2 mm -91.74 117.16 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.3 m -84.17 128.33 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.762 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -63.05 105.23 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 18.2 mm100 -101.31 167.18 10.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.299 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.63 95.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 26.6 t70 -42.38 -64.55 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.657 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.62 -23.36 0.22 Allowed Glycine 0 C--N 1.318 -0.47 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.36 5.08 0.09 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.684 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.431 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -156.79 142.68 12.85 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 118.187 0.994 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.71 150.73 60.1 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.067 1.178 . . . . 0.0 111.927 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.588 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.4 mt -91.79 128.19 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.491 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.8 mt -72.95 -42.56 63.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -155.53 163.66 39.7 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.635 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.8 m-85 -110.98 127.12 55.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.058 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.51 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 85.9 mt -99.95 110.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.577 HG22 HG13 ' A' ' 75' ' ' ILE . 99.6 t -109.21 127.09 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.855 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -126.17 128.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 49' ' ' LEU . 41.7 p90 -132.9 151.51 52.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -142.34 172.82 12.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.397 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.9 p -84.17 147.24 27.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HZ2' ' N ' ' A' ' 92' ' ' SER . 95.4 mttt -75.24 4.64 6.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.74 -49.88 2.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 45' ' ' GLU . 11.2 mmpt? -60.92 -45.42 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.932 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 81.8 tt0 36.18 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.449 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 45' ' ' GLU . 1.9 m-20 167.15 -15.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.571 0.545 . . . . 0.0 110.493 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -137.24 117.74 13.81 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.56 0.219 . . . . 0.0 110.923 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -99.95 116.67 32.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.851 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.423 HD12 ' CE2' ' A' ' 39' ' ' TYR . 92.4 mt -73.45 160.07 32.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.182 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 25.0 mp0 -117.0 150.55 38.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.341 0.591 . . . . 0.0 112.47 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.24 115.33 4.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.51 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 73.0 mmtt -97.52 146.0 25.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.42 155.67 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.034 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.516 ' C ' ' H ' ' A' ' 56' ' ' ASN . 11.4 tt0 -78.08 137.24 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.208 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 7.07 0.16 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 54' ' ' GLN . 66.0 t30 -122.18 -13.97 8.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.793 0.297 . . . . 0.0 110.755 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -69.72 -53.08 20.16 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.811 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 58.28 40.06 24.98 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.648 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -178.05 153.15 0.78 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.564 HD13 HG21 ' A' ' 37' ' ' VAL . 1.4 pt -152.45 143.31 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.204 0.526 . . . . 0.0 111.428 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.6 mm -114.56 115.79 50.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.14 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.0 mt -103.73 105.52 15.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.5 152.2 23.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.225 0.536 . . . . 0.0 112.188 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t60 66.06 76.68 0.31 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.28 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.747 HD13 ' OH ' ' A' ' 71' ' ' TYR . 86.2 mt -111.52 -4.12 14.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' O ' ' SD ' ' A' ' 93' ' ' MET . 83.3 mt-30 52.49 120.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.877 0.846 . . . . 0.0 112.241 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -61.31 -32.04 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.093 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -94.52 22.87 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.3 tpt -144.46 114.73 7.51 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.395 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.78 155.59 32.09 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.747 ' OH ' HD13 ' A' ' 65' ' ' LEU . 48.5 p90 -151.29 138.29 19.1 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.54 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.96 156.21 19.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.642 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 132.71 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -126.12 110.82 13.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.373 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.577 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -91.76 137.24 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.768 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.82 117.24 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.59 124.38 34.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.26 113.43 26.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.268 0.556 . . . . 0.0 112.358 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -116.62 -163.38 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -52.75 -33.33 47.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 81' ' ' LEU . 8.5 mp -64.12 -40.98 97.37 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 126.09 -49.64 0.91 Allowed Glycine 0 N--CA 1.463 0.452 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.8 m-85 -154.46 133.96 12.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 t -159.85 170.28 21.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 25' ' ' GLN . 16.6 pt-20 39.91 51.41 3.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.392 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.76 148.37 82.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.941 1.76 . . . . 0.0 111.263 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.425 ' CG2' ' H ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -125.32 110.35 13.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 99.25 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.523 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -104.56 131.75 51.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.956 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -131.84 132.58 43.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 6.6 p90 -173.69 125.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.208 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.557 ' N ' ' HZ2' ' A' ' 42' ' ' LYS . 11.9 p -80.77 166.29 21.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.3 mtp -88.41 147.47 40.01 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.956 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.07 162.66 28.76 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.421 2.081 . . . . 0.0 110.211 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 96' ' ' LYS . 38.2 Cg_endo -65.6 153.64 77.29 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.912 1.741 . . . . 0.0 110.822 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 95' ' ' PRO . 4.1 tppp? -36.62 133.05 0.65 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.555 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.492 1.432 0 C-N-CA 121.465 1.443 . . . . 0.0 111.818 179.499 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.3 Cg_exo . . . . . 0 N--CA 1.495 1.604 0 N-CA-C 112.629 0.203 . . . . 0.0 112.629 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 32.8 Cg_exo -38.7 166.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.85 2.367 . . . . 0.0 113.322 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.25 41.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.683 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.08 124.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.578 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -116.14 118.96 34.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.462 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.64 140.91 15.06 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.474 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -143.73 146.51 35.21 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.2 80.46 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.828 1.685 . . . . 0.0 111.447 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.4 t -48.03 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -139.63 136.99 34.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.064 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.6 -130.76 37.34 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -95.17 -4.01 46.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -68.81 144.11 54.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.001 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.48 128.2 47.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 110.246 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -88.08 103.62 15.91 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mt -99.13 91.98 5.25 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -66.86 124.8 23.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.494 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.422 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.4 mm -86.97 115.72 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -95.13 119.3 33.4 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.488 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -38.28 105.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.49 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -95.0 148.87 21.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 97.9 m-20 -54.67 95.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.53 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 30' ' ' ALA . 28.3 t70 -48.02 169.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.609 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.43 84.08 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.67 22.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.811 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -159.05 151.66 17.96 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.58 140.62 57.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.435 1.423 . . . . 0.0 110.529 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.577 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.5 mt -83.48 127.71 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.82 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 33' ' ' LEU . 9.4 mp -75.18 -43.11 53.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.287 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -152.83 163.33 39.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.387 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.493 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -111.39 122.83 48.87 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.954 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.46 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 87.3 mt -96.47 107.93 20.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 75' ' ' ILE . 74.3 t -107.37 125.03 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.26 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -122.35 136.82 54.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 49' ' ' LEU . 33.0 p90 -143.18 152.15 41.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.679 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.474 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 35.6 ptt85 -148.39 173.43 13.09 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 111.634 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -79.08 147.83 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.266 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -69.36 -32.03 70.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.679 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -75.15 -47.31 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -57.51 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.856 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 58.18 76.66 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.762 0.791 . . . . 0.0 110.116 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 61.2 t0 -175.61 -21.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.3 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -138.47 158.13 44.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.2 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 63.4 m95 -136.12 134.29 38.17 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 112.209 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 39' ' ' TYR . 96.7 mt -84.79 160.38 20.25 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -118.07 149.1 41.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.26 0.552 . . . . 0.0 112.091 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.09 114.36 4.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 71.4 mmtt -98.92 144.7 27.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.668 0.27 . . . . 0.0 110.959 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.76 157.77 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.11 0.481 . . . . 0.0 110.648 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -70.6 149.53 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.448 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.89 -7.09 14.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.189 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -121.47 0.13 9.9 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.088 0.444 . . . . 0.0 111.346 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -61.83 -46.77 88.05 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.442 0.639 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 52.99 31.52 11.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.835 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.36 150.55 0.44 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.34 146.86 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.111 0.481 . . . . 0.0 111.243 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mm -113.9 117.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.35 105.65 15.79 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.612 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 65.5 mt-10 -96.93 119.7 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 28.9 m-70 122.65 54.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.997 1.436 . . . . 0.0 111.018 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.593 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 23.1 mt -111.89 105.24 13.64 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.485 ' O ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -59.06 135.85 57.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.237 0.542 . . . . 0.0 111.204 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -66.21 -23.81 66.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.075 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 p -104.82 18.23 22.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.9 mtp -149.79 129.97 13.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.027 0.442 . . . . 0.0 110.706 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.33 44.3 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.593 ' CZ ' HD13 ' A' ' 65' ' ' LEU . 9.3 p90 -157.46 132.11 8.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.286 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -87.27 154.29 20.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.007 0.432 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.53 134.0 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -124.62 110.46 14.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.496 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.572 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -95.82 132.4 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -136.76 118.29 14.84 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.577 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -90.13 126.24 35.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.61 108.41 19.68 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.661 HD21 HD23 ' A' ' 81' ' ' LEU . 1.1 p-10 -114.5 -175.11 2.61 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.303 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -40.3 -33.71 0.27 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.661 HD23 HD21 ' A' ' 79' ' ' ASN . 4.1 mm? -63.96 -42.8 97.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.496 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.93 -48.5 0.97 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -155.83 131.63 9.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.04 162.39 20.35 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER 52.88 51.87 9.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 98.0 Cg_endo -74.01 152.83 46.57 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.381 2.054 . . . . 0.0 111.258 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 m -133.93 117.74 17.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.368 0.604 . . . . 0.0 110.714 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -96.6 94.49 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.422 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 34.0 t80 -98.61 134.82 41.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.538 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -137.89 130.5 29.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 23.1 p90 -163.97 131.44 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.982 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -79.83 167.85 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 28.0 mtp -97.89 151.79 37.75 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.966 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.96 163.9 22.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.536 2.157 . . . . 0.0 110.012 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.35 156.38 63.59 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.774 1.649 . . . . 0.0 111.068 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -38.51 130.22 1.08 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.505 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.496 1.634 0 C-N-CA 121.726 1.617 . . . . 0.0 112.725 179.893 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.6 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 N-CA-C 112.601 0.193 . . . . 0.0 112.601 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.5 Cg_exo -37.3 167.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 123.305 2.67 . . . . 0.0 114.091 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.97 54.78 0.52 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.541 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.401 HG12 HG21 ' A' ' 87' ' ' THR . 6.0 mm -132.91 130.14 58.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.108 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -123.84 114.31 19.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.81 138.35 14.53 Favored Glycine 0 N--CA 1.46 0.297 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.45 116.95 8.6 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.556 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -52.03 103.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 120.945 1.096 . . . . 0.0 111.664 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.9 p -85.37 172.02 11.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 m -41.55 106.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.819 0.342 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.29 -154.01 21.28 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.005 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -77.23 -19.65 56.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.516 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.434 ' OG ' HG22 ' A' ' 61' ' ' ILE . 13.6 t -59.01 139.11 57.17 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.171 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.92 122.11 46.67 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -86.1 109.0 18.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.792 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.27 105.72 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 119.09 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.45 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.4 mm -84.08 112.47 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 5.9 m -79.35 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.034 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.516 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.84 104.89 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.513 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -100.59 158.85 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 27' ' ' ASP . 45.9 m-20 -61.88 95.38 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 32.4 t70 -43.41 168.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.135 0.493 . . . . 0.0 111.183 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.71 -42.44 85.15 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 15.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.905 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.43 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -159.64 151.36 16.77 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.886 0.843 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.45 142.52 80.36 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.988 1.125 . . . . 0.0 111.59 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.524 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.5 mt -86.56 125.17 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.354 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -72.06 -40.76 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.805 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.39 167.27 26.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.07 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 32' ' ' ILE . 14.6 m-85 -112.06 119.93 40.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.875 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.6 mt -92.18 113.07 26.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 75' ' ' ILE . 61.2 t -113.57 129.34 69.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.286 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -127.78 133.82 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CE2' HD12 ' A' ' 49' ' ' LEU . 29.7 p90 -139.26 154.05 47.91 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.044 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.0 174.02 11.65 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.533 ' OG ' ' CE2' ' A' ' 71' ' ' TYR . 4.3 m -84.21 136.76 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.007 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.83 -35.36 78.01 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.879 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -63.11 -35.49 80.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -98.68 178.05 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.801 0.81 . . . . 0.0 111.432 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -160.05 -5.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.777 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -91.6 9.02 33.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -149.72 150.45 32.1 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.805 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.43 109.06 5.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.722 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.492 HD12 ' CE2' ' A' ' 39' ' ' TYR . 56.4 mt -72.61 159.91 33.11 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.506 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -121.72 151.72 40.2 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.09 0.472 . . . . 0.0 111.558 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.44 114.66 3.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -96.2 142.3 28.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.29 138.25 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.25 0.548 . . . . 0.0 111.038 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.462 ' C ' ' H ' ' A' ' 56' ' ' ASN . 48.9 tt0 -59.71 142.53 52.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.5 14.8 0.93 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.135 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 m120 -132.09 9.88 4.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 21.3 mttt -91.74 -46.3 7.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.663 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 49.69 39.13 16.88 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.64 0.588 . . . . 0.0 111.887 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -179.57 151.9 0.48 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.707 0.289 . . . . 0.0 110.798 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -151.61 146.58 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.383 0.611 . . . . 0.0 111.092 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.434 HG22 ' OG ' ' A' ' 17' ' ' SER . 45.1 mm -114.86 111.65 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.83 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -100.03 107.75 19.76 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 98.8 mt-10 -84.88 156.06 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.523 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 6.3 t-80 78.76 52.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.6 mm? -107.71 88.22 2.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -51.0 135.96 23.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.646 . . . . 0.0 111.335 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -64.39 -34.13 77.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.444 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.8 p -96.33 20.81 9.89 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.7 mtp -143.34 140.0 30.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.206 0.527 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.8 162.61 24.26 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.533 ' CE2' ' OG ' ' A' ' 41' ' ' SER . 43.3 m-85 -144.34 135.5 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.046 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -94.69 149.86 20.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.33 133.42 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -123.24 108.41 12.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.475 0.655 . . . . 0.0 109.705 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -96.87 131.21 44.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.923 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -135.47 119.47 17.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.98 126.21 35.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.07 116.05 31.3 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 112.46 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.543 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 4.1 p-10 -115.9 -166.55 1.15 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -51.78 -31.48 27.19 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.625 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.9 mm? -64.05 -42.54 97.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.488 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.82 -45.05 1.19 Allowed Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.488 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.1 m-85 -153.64 140.67 19.31 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -163.76 153.86 15.16 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.574 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.4 ' CD ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER 44.32 60.13 12.46 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.593 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 152.4 43.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.242 1.961 . . . . 0.0 110.965 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.401 HG21 HG12 ' A' ' 8' ' ' ILE . 23.0 m -131.23 118.44 20.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.65 0.738 . . . . 0.0 111.467 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.7 94.22 4.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.701 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -98.96 127.15 44.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.148 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.6 132.97 45.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.253 0.549 . . . . 0.0 110.967 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.581 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.1 p90 -166.49 140.07 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.334 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.9 156.49 19.33 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 85.8 mmm -85.88 147.4 45.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.48 162.76 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.343 2.029 . . . . 0.0 110.98 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.07 158.73 50.23 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.244 1.963 . . . . 0.0 111.121 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.91 129.89 0.95 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.447 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 121.327 1.351 . . . . 0.0 112.425 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' PRO . 79.0 Cg_exo . . . . . 0 N--CA 1.492 1.433 0 N-CA-C 111.913 -0.072 . . . . 0.0 111.913 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 22.3 Cg_exo -38.49 169.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.662 2.241 . . . . 0.0 114.93 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.453 ' H ' HG21 ' A' ' 87' ' ' THR . 15.2 m -156.56 46.19 0.43 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.347 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.27 127.11 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.331 0.586 . . . . 0.0 110.554 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -117.53 116.55 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.142 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.0 147.35 18.56 Favored Glycine 0 N--CA 1.464 0.517 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.3 130.43 8.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.94 81.97 1.59 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.43 1.42 . . . . 0.0 111.988 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.452 ' OG ' ' N ' ' A' ' 14' ' ' SER . 47.2 t -60.05 -159.73 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.452 ' N ' ' OG ' ' A' ' 13' ' ' SER . 33.4 t -63.33 134.52 55.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.246 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.53 -146.16 33.87 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.766 0.317 . . . . 0.0 110.62 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -64.97 148.89 50.76 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.775 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.3 121.17 33.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.693 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -83.97 98.51 9.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 90.21 7.25 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -69.72 117.55 11.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.754 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.443 HG21 ' CE2' ' A' ' 35' ' ' TYR . 4.6 mm -77.63 126.36 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -104.2 116.51 32.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 110.472 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -39.47 104.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.787 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.26 165.18 11.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 43.0 t0 -57.94 109.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.897 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -71.58 165.65 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.98 31.98 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.54 -0.28 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.1 151.58 75.54 Favored Pre-proline 0 N--CA 1.463 0.22 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.21 143.58 65.3 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.865 1.71 . . . . 0.0 111.278 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.583 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.1 mt -86.74 126.44 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.761 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.9 mp -72.81 -41.38 64.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.138 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.02 165.67 35.76 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.375 0.607 . . . . 0.0 111.481 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.534 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -115.38 119.98 38.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.221 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.93 115.11 31.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 75' ' ' ILE . 38.7 t -118.89 131.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.072 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -125.56 139.76 53.33 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.465 ' CE2' HD12 ' A' ' 49' ' ' LEU . 37.2 p90 -143.6 156.25 44.52 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.278 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.48 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 34.5 ptt85 -149.54 174.8 12.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 m -82.23 143.04 31.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -63.64 -39.46 94.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.437 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 7.0 t0 -76.6 -46.13 27.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.102 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' CE ' ' HE1' ' A' ' 69' ' ' MET . 1.4 mppt? -89.03 91.38 8.8 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -98.58 65.94 1.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.292 179.037 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -136.29 -5.87 2.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -146.59 155.87 42.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.991 0.424 . . . . 0.0 111.36 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -136.23 114.28 11.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.156 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.465 HD12 ' CE2' ' A' ' 39' ' ' TYR . 79.9 mt -77.55 160.31 28.69 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.908 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -111.04 155.62 22.5 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.788 0.328 . . . . 0.0 111.136 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -159.09 112.39 2.29 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -98.71 143.16 29.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.749 0.309 . . . . 0.0 111.289 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.66 156.54 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.42 0.629 . . . . 0.0 110.542 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 48.4 tt0 -82.09 144.35 30.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.307 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.6 81.42 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.523 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 32.8 m-20 -67.1 -39.3 86.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.295 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 54' ' ' GLN . 74.0 mttt -55.27 -71.87 0.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.549 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 60.34 49.37 7.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.437 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -176.04 140.13 0.4 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -141.85 151.83 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.393 0.616 . . . . 0.0 112.329 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -122.47 101.49 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 62' ' ' LEU . 9.1 mp -92.06 107.24 19.07 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 64' ' ' HIS . 6.5 tm-20 -96.57 148.76 22.51 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.236 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.489 ' N ' ' CD ' ' A' ' 63' ' ' GLU . 19.2 t-80 93.0 48.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' O ' ' SD ' ' A' ' 93' ' ' MET . 20.9 mt -112.95 94.0 4.69 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.528 ' O ' ' SD ' ' A' ' 93' ' ' MET . 47.1 tt0 -45.48 148.47 0.68 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 110.95 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.18 -8.65 56.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.767 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 p -113.44 19.13 17.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.43 ' HE1' ' CE ' ' A' ' 44' ' ' LYS . 49.3 mtp -144.22 133.86 23.56 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.806 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.7 157.37 27.46 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -137.56 133.31 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.794 0.33 . . . . 0.0 110.789 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.48 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.5 mt-10 -92.4 147.94 22.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.63 134.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.93 0.395 . . . . 0.0 109.96 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -124.2 108.27 12.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.267 0.556 . . . . 0.0 109.983 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.513 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -93.38 135.95 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.955 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -136.37 116.57 13.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.76 126.6 35.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.88 112.7 25.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.325 0.583 . . . . 0.0 112.541 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 84' ' ' SER . 0.4 OUTLIER -114.53 -165.89 1.05 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -49.52 -33.12 13.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.834 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.5 mm? -64.7 -42.65 95.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.248 0.547 . . . . 0.0 109.635 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.35 -48.79 0.95 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.475 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.1 m-85 -154.01 137.71 16.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.44 ' HB2' HD22 ' A' ' 79' ' ' ASN . 74.2 m -160.22 164.24 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.348 0.594 . . . . 0.0 111.799 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 26' ' ' ASP . 16.9 pt-20 33.38 59.29 1.7 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.403 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 152.02 80.03 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.102 1.868 . . . . 0.0 109.963 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.453 HG21 ' H ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -124.57 111.24 15.42 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.0 110.714 -179.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.47 95.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -102.28 136.31 42.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -138.3 134.95 34.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 7.0 p90 -162.05 152.83 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.728 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.9 170.85 8.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.974 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 65' ' ' LEU . 36.4 mtp -105.62 145.6 31.17 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.426 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.17 161.95 31.91 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.375 2.05 . . . . 0.0 110.751 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.32 155.39 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.12 1.88 . . . . 0.0 110.872 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -37.94 132.16 0.91 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.541 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 121.677 1.585 . . . . 0.0 112.796 -179.779 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo . . . . . 0 N--CA 1.503 2.074 0 N-CA-C 113.036 0.36 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.49 147.68 37.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.785 1.656 . . . . 0.0 114.449 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.5 34.88 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.201 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mm -107.51 122.49 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.999 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.66 117.14 28.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.9 147.34 18.56 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -159.83 115.82 1.51 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -50.98 94.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.202 1.268 . . . . 0.0 111.984 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -76.55 -48.7 18.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.63 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.551 ' H ' ' HG ' ' A' ' 17' ' ' SER . 69.2 p -144.49 166.77 24.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.037 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -35.99 128.67 0.89 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 39.78 48.37 1.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.167 0.508 . . . . 0.0 111.071 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.551 ' HG ' ' H ' ' A' ' 14' ' ' SER . 11.8 p -142.1 150.89 41.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.484 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.12 120.91 14.41 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -84.81 97.9 9.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.04 89.82 7.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 t -66.88 125.83 27.17 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.542 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.438 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.2 mm -85.82 114.89 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.4 m -98.77 117.24 32.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.576 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.74 108.14 0.08 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.359 1.076 . . . . 0.0 110.518 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 26' ' ' ASP . 2.6 pt20 -115.63 101.54 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.152 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 25' ' ' GLN . 4.5 m-20 19.12 82.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.9 0.75 . . . . 0.0 111.779 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 29' ' ' GLY . 85.9 m-20 -50.67 131.47 25.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.046 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' ASP . . . -27.05 -35.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.961 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 163.93 0.08 0.05 OUTLIER Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.728 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.12 155.61 29.35 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 117.848 0.824 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -54.02 138.25 70.13 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 121.094 1.196 . . . . 0.0 111.767 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.567 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.2 mt -81.66 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.384 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.91 -40.07 69.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -162.19 170.63 18.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.718 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE2' HG21 ' A' ' 22' ' ' ILE . 21.3 m-85 -116.37 122.33 44.54 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.989 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.4 mt -96.93 114.17 33.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 75' ' ' ILE . 74.0 t -115.09 130.41 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.604 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CE2' HD12 ' A' ' 49' ' ' LEU . 23.8 p90 -140.77 152.55 45.31 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.637 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.523 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.2 ptt85 -145.64 172.9 12.59 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.521 ' HG ' ' HE1' ' A' ' 71' ' ' TYR . 11.0 m -79.92 139.86 36.92 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -62.3 -36.27 81.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.249 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.97 -37.38 86.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.543 0.211 . . . . 0.0 110.718 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.3 mmtt -101.13 150.95 22.4 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.499 0.666 . . . . 0.0 110.502 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -138.27 19.82 2.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.186 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 20.8 p-10 -128.19 18.33 6.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 0.0 110.519 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -142.04 112.7 7.25 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.501 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -119.29 118.16 30.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.588 0.708 . . . . 0.0 110.917 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.492 HD12 ' CE2' ' A' ' 39' ' ' TYR . 60.3 mt -79.9 159.77 26.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.462 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 51.5 mp0 -117.93 151.91 36.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.97 113.1 2.68 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -97.64 146.4 25.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.469 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.35 158.4 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.223 0.535 . . . . 0.0 110.081 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 56' ' ' ASN . 43.7 tp60 -71.23 146.54 48.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.451 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.45 3.55 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.924 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 t-20 -133.2 0.77 3.44 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.647 -0.325 . . . . 0.0 111.446 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.6 tptp -64.07 -43.22 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 48.56 31.62 3.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.717 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 178.74 152.49 0.34 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.191 0.307 . . . . 0.0 110.744 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 37' ' ' VAL . 2.7 pt -151.29 129.38 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.4 mm -99.38 103.26 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.3 mt -91.58 104.54 17.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 40.1 tt0 -95.77 151.18 19.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.254 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.479 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 3.9 t-160 89.11 60.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.253 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.95 91.84 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.91 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -39.15 143.58 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.422 0.63 . . . . 0.0 111.419 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -75.29 -9.07 58.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.039 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.8 p -114.34 19.7 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.604 0.24 . . . . 0.0 111.414 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -142.92 136.97 29.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.22 163.08 25.15 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.521 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 98.3 m-85 -144.69 129.49 18.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.581 0.229 . . . . 0.0 111.603 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.9 mt-10 -88.6 153.62 20.98 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.77 135.55 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.71 108.59 11.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.217 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -96.54 134.58 33.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.081 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.3 m -136.09 124.26 23.08 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.567 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -98.38 124.94 43.33 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.83 114.06 26.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 112.558 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -122.22 -175.63 3.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.33 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -39.8 -33.01 0.17 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.409 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 81' ' ' LEU . 9.6 mp -63.53 -42.55 98.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.414 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 125.81 -49.94 0.89 Allowed Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 13.1 m-85 -153.73 122.07 6.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 77' ' ' ALA . 82.7 p -88.15 176.89 7.07 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.143 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -49.11 112.96 2.76 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.45 159.43 49.2 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.049 1.166 . . . . 0.0 111.669 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.79 113.75 25.98 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.519 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.05 98.33 7.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.469 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 39.4 t80 -103.43 138.2 40.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -135.27 134.55 40.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.252 0.548 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.4 p90 -171.33 129.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.577 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -82.51 165.46 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.531 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.9 mmm -90.66 146.26 33.83 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.0 164.71 29.35 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.364 2.043 . . . . 0.0 111.22 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.45 160.04 41.32 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.35 2.033 . . . . 0.0 111.513 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -40.39 132.8 1.63 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.494 1.524 0 C-N-CA 121.73 1.62 . . . . 0.0 112.757 179.166 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' PRO . 71.0 Cg_exo . . . . . 0 N--CA 1.501 1.952 0 N-CA-C 112.571 0.181 . . . . 0.0 112.571 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 Cg_exo -37.42 175.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.311 2.674 . . . . 0.0 115.441 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.43 46.83 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.646 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.94 123.48 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.24 0.543 . . . . 0.0 110.632 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -114.82 116.52 28.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.213 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.06 141.16 15.44 Favored Glycine 0 N--CA 1.464 0.51 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.952 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -139.71 134.46 16.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.02 88.25 1.34 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.655 1.57 . . . . 0.0 112.501 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 4.7 p -68.27 -179.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -55.82 118.22 4.38 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.516 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.1 -166.76 21.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.5 ' HE3' ' H ' ' A' ' 66' ' ' GLN . 15.8 mtmt -77.13 -5.75 50.26 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 84.6 p -66.86 150.81 48.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.35 115.31 18.06 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -77.3 109.59 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.29 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.1 101.23 10.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -72.02 122.6 21.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.738 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.427 HD12 HG12 ' A' ' 75' ' ' ILE . 2.7 mm -87.34 113.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 m -86.09 127.2 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.543 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' H ' ' HE2' ' A' ' 24' ' ' LYS . 1.9 mppt? -44.26 105.38 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.808 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.576 ' NE2' ' OE1' ' A' ' 85' ' ' GLU . 35.5 mt-30 -80.68 159.38 25.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.47 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' ASP . 5.4 m-20 -78.35 78.61 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' ASP . 22.2 t70 -39.23 162.18 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.405 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.32 64.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.2 24.31 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.903 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.411 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -153.4 151.49 25.69 Favored Pre-proline 0 C--N 1.333 -0.152 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.96 143.61 55.33 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.687 1.591 . . . . 0.0 111.462 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.592 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.5 mt -89.87 135.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.868 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.91 -48.98 10.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.706 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -146.48 162.04 39.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.282 0.563 . . . . 0.0 111.522 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -109.46 120.19 41.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.185 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.33 107.3 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' LYS . 24.2 t -109.05 127.08 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.01 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -125.22 129.22 49.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.133 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.56 ' CE2' HD12 ' A' ' 49' ' ' LEU . 38.9 p90 -133.05 148.56 52.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.965 0.412 . . . . 0.0 110.876 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.46 ' NH1' ' CB ' ' A' ' 45' ' ' GLU . 4.8 ptt180 -144.71 167.34 22.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.74 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 43' ' ' ASP . 5.1 m -76.16 143.58 41.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.1 0.41 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 41' ' ' SER . 71.7 m-20 -122.01 -9.74 8.7 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.361 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -122.76 110.49 15.54 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.744 0.307 . . . . 0.0 110.307 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.46 ' CB ' ' NH1' ' A' ' 40' ' ' ARG . 25.4 pt-20 -115.1 -8.4 12.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.8 -7.72 23.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.535 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -161.08 128.67 4.23 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -107.61 128.56 54.65 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.56 HD12 ' CE2' ' A' ' 39' ' ' TYR . 70.8 mt -77.16 158.21 30.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 3.4 pm0 -121.59 148.54 44.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.205 0.526 . . . . 0.0 111.882 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -150.74 113.53 4.74 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.885 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.48 142.52 27.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.91 158.71 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.281 0.562 . . . . 0.0 110.391 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 56' ' ' ASN . 57.9 tt0 -74.17 130.9 40.67 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.474 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.58 0.17 0.3 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.822 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 54' ' ' GLN . 23.5 m120 -116.18 -26.19 7.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.729 0.264 . . . . 0.0 110.814 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 20.5 mttm -50.35 -68.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER 79.46 35.04 0.17 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.83 149.17 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.137 -0.352 . . . . 0.0 110.485 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.5 pt -147.58 144.85 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.98 115.99 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.1 mt -104.95 108.92 20.69 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.137 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.33 162.15 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.762 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.9 m80 60.6 67.68 0.81 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.852 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -107.91 -9.42 15.71 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.828 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.5 ' H ' ' HE3' ' A' ' 16' ' ' LYS . 49.9 tp60 60.13 152.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.969 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -96.81 -7.2 34.23 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.411 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 77.3 p -119.41 19.96 12.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.6 mmm -143.96 127.86 17.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.58 157.59 32.98 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.96 153.97 36.23 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.8 156.14 19.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.866 0.365 . . . . 0.0 110.278 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.7 130.08 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -122.63 107.28 11.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 110.329 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.427 HG12 HD12 ' A' ' 22' ' ' ILE . 1.7 mp -90.27 134.97 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.796 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -136.27 123.77 22.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -96.17 120.48 36.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.486 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.31 105.06 16.56 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.731 HD21 HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -108.53 -175.94 2.91 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -41.22 -31.5 0.22 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.731 HD23 HD21 ' A' ' 79' ' ' ASN . 3.2 mm? -65.54 -41.66 92.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.959 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.51 -48.61 0.96 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.485 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.2 m-85 -157.31 131.68 8.46 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.49 160.3 17.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.938 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.576 ' OE1' ' NE2' ' A' ' 25' ' ' GLN . 3.3 mm-40 53.2 50.43 7.59 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.292 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 84.8 Cg_endo -72.61 149.65 49.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.149 1.9 . . . . 0.0 111.147 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.63 109.31 13.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.157 0.503 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.21 95.97 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 31.2 t80 -102.95 131.5 49.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.496 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.18 134.45 42.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.074 0.464 . . . . 0.0 111.129 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.1 p90 -168.82 133.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.336 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.5 p -80.25 164.92 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.156 0.503 . . . . 0.0 111.473 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 95.6 mmm -93.23 141.67 24.3 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.474 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.84 162.62 29.44 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.414 2.076 . . . . 0.0 111.205 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.39 152.7 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.487 2.125 . . . . 0.0 111.638 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -43.74 132.56 3.94 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.632 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.49 1.29 0 C-N-CA 121.885 1.723 . . . . 0.0 110.974 177.857 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' PRO . 52.5 Cg_exo . . . . . 0 N--CA 1.497 1.7 0 N-CA-C 112.844 0.286 . . . . 0.0 112.844 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 5' ' ' PRO . 30.0 Cg_exo -39.33 175.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.309 2.672 . . . . 0.0 114.849 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.8 53.43 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.082 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -129.51 127.99 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.226 0.536 . . . . 0.0 110.549 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -118.9 116.4 26.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.032 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.72 141.89 15.86 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.472 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -143.6 140.5 17.5 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.45 91.13 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.692 1.595 . . . . 0.0 112.216 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 p -72.16 162.93 28.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m -38.44 120.66 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.346 0.594 . . . . 0.0 111.516 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.05 -155.48 23.68 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' O ' HD12 ' A' ' 65' ' ' LEU . 32.0 mttp -80.0 -8.8 59.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.107 0.48 . . . . 0.0 110.075 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 p -60.54 136.37 58.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.136 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.57 117.42 28.94 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.87 111.27 18.61 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.457 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -103.42 91.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -66.09 123.78 20.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.171 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.417 HG21 ' CD2' ' A' ' 35' ' ' TYR . 2.4 mm -86.27 112.51 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -81.42 143.43 32.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.949 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -66.43 105.5 1.49 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.349 0.595 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -88.3 174.66 8.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.767 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 96.2 m-20 -62.6 -3.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.205 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 29' ' ' GLY . 2.8 p30 46.27 -172.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -9.81 59.19 Favored Glycine 0 N--CA 1.465 0.625 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.037 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . 128.54 2.78 5.75 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.88 142.36 33.46 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.82 142.65 83.43 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.319 1.346 . . . . 0.0 111.677 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.598 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.4 mt -87.95 134.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.368 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 2.6 mm? -91.81 -42.11 10.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.211 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -142.68 152.32 42.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.2 m-85 -109.47 126.15 53.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.613 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.46 110.51 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.534 HG21 ' CD1' ' A' ' 60' ' ' ILE . 69.2 t -107.57 124.86 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -125.16 121.43 34.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -126.57 154.65 43.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 31.3 ptt85 -146.47 169.45 18.88 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.255 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 p -79.66 141.21 36.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.773 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.91 -32.5 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.673 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.59 -6.65 42.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.679 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -139.66 174.4 10.55 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.217 0.532 . . . . 0.0 110.516 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -165.08 27.46 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.01 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -107.01 -2.85 20.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.866 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -144.52 145.5 31.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 111.218 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -133.74 117.97 17.56 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.05 160.39 27.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -118.2 155.01 31.25 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.158 0.504 . . . . 0.0 112.352 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 116.53 2.78 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.7 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -99.56 145.64 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.916 0.389 . . . . 0.0 111.34 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.49 152.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.529 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 4.5 tt0 -79.8 130.4 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.563 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.71 3.75 0.02 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.191 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.529 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 14.5 m-20 -112.03 -20.82 11.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.174 0.487 . . . . 0.0 110.004 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -63.66 -50.66 68.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.3 39.31 22.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.769 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.23 153.44 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.876 0.369 . . . . 0.0 111.117 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 37' ' ' VAL . 1.5 pt -150.17 145.19 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.128 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.5 mm -117.36 101.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.883 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' H ' HD22 ' A' ' 62' ' ' LEU . 1.8 mm? -83.92 102.94 12.78 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.89 171.0 12.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.967 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.9 m80 51.96 66.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.18 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 16' ' ' LYS . 24.3 mt -102.3 -173.16 2.27 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -131.8 129.67 40.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -70.06 -7.21 39.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.515 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.2 p -122.65 12.93 10.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.9 ttm -142.65 124.56 15.18 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.763 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.5 162.43 34.69 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.01 143.55 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -94.14 153.19 18.23 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.81 132.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -122.74 104.11 9.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.765 0.793 . . . . 0.0 110.545 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.486 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -87.74 130.55 37.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.788 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -134.49 117.63 16.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.75 127.02 35.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.74 106.85 17.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -110.02 -168.94 1.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -48.06 -29.09 3.24 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.028 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.7 mm? -64.04 -41.79 97.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 123.59 -48.1 0.98 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.3 m-85 -157.22 132.98 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -169.34 163.86 10.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 5.8 tp10 52.43 52.16 10.61 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.506 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 93.1 Cg_endo -74.45 155.3 45.66 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 123.436 2.757 . . . . 0.0 112.083 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 m -136.59 117.95 14.66 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.929 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -97.25 97.54 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.613 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.55 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 33.4 t80 -102.0 135.81 42.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.637 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.63 134.59 37.5 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.4 p90 -169.18 133.35 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.18 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -79.44 168.64 19.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.5 mmm -95.66 138.51 21.78 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.529 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.39 164.93 32.93 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.62 2.213 . . . . 0.0 111.328 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.18 150.88 87.08 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.292 1.995 . . . . 0.0 111.642 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.82 133.91 1.72 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.154 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.493 1.482 0 C-N-CA 122.264 1.976 . . . . 0.0 111.807 177.769 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 74.2 Cg_exo . . . . . 0 N--CA 1.498 1.75 0 N-CA-C 112.418 0.122 . . . . 0.0 112.418 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.9 Cg_exo -37.32 165.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.755 2.303 . . . . 0.0 113.769 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.528 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -148.4 47.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.617 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.4 HG12 HG21 ' A' ' 87' ' ' THR . 5.9 mm -131.14 131.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 111.93 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -108.6 -173.13 2.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.79 118.19 0.65 Allowed Glycine 0 C--N 1.321 -0.256 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.359 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -135.39 144.13 48.24 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.65 85.41 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.396 1.397 . . . . 0.0 111.184 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -52.15 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.214 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.8 t -142.58 136.7 29.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.099 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.43 -134.81 33.44 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HE2' ' H ' ' A' ' 66' ' ' GLN . 17.9 mtmm -93.58 -0.86 56.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.908 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.3 p -68.86 153.06 44.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.644 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 122.72 22.82 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -83.52 97.94 9.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.166 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mt -95.96 92.22 6.38 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 t -67.02 128.37 36.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.167 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.439 HG21 ' CE2' ' A' ' 35' ' ' TYR . 2.2 mm -88.2 112.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -83.18 129.09 34.99 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.079 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.659 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.1 102.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.745 -0.782 . . . . 0.0 108.932 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.64 148.56 24.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -50.43 102.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.64 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 29' ' ' GLY . 5.7 m-20 -57.67 142.22 45.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.48 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 27' ' ' ASP . . . -32.43 -28.41 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 159.78 14.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.871 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -159.5 155.17 22.71 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 118.175 0.987 . . . . 0.0 110.796 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.23 138.6 67.54 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.965 1.777 . . . . 0.0 111.062 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.606 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.0 mt -86.13 135.76 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.14 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 55' ' ' GLY . 77.3 mt -85.79 -43.59 13.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.43 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -146.21 162.19 38.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.637 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 22' ' ' ILE . 22.0 m-85 -113.67 122.01 45.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.631 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.57 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 85.4 mt -99.52 112.15 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 75' ' ' ILE . 58.0 t -111.99 126.78 69.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.547 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -124.49 139.45 53.87 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 22.1 p90 -145.63 157.74 43.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.103 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.09 -176.62 5.43 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.312 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -91.99 138.18 31.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.154 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -66.68 -34.41 77.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.67 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 67.5 t0 -59.96 -34.64 73.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.787 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.1 mtmt -126.36 -172.01 2.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.508 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -173.78 63.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.682 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -131.06 -7.86 3.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.297 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -140.93 155.12 46.33 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -137.55 108.04 6.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.672 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.1 159.79 33.23 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.202 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.69 146.45 43.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.166 0.507 . . . . 0.0 111.866 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -146.68 112.82 5.82 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.59 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.57 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 73.0 mmtt -100.34 142.57 31.64 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.07 160.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 110.315 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.5 tp60 -72.75 151.06 42.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.479 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.05 12.96 0.38 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 54' ' ' GLN . 65.4 t30 -145.19 2.6 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.007 0.403 . . . . 0.0 111.639 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -63.49 -47.47 81.62 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.593 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER 59.37 31.03 20.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.976 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.26 151.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.01 147.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.867 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.8 mm -118.52 108.57 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.9 mp -94.41 106.58 18.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -85.31 147.55 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.977 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 71.02 77.83 0.18 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.944 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.538 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 91.3 mt -115.0 -3.98 12.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.534 ' O ' ' SD ' ' A' ' 93' ' ' MET . 80.4 mt-30 50.53 122.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.814 0.816 . . . . 0.0 112.792 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -61.28 -26.12 67.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.714 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -103.55 22.66 13.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.7 mmm -146.96 118.57 7.99 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.134 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.85 162.6 45.01 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.538 ' CZ ' HD13 ' A' ' 65' ' ' LEU . 8.8 p90 -155.58 132.03 10.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.853 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.1 152.1 22.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.38 134.49 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -124.36 106.85 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.36 0.6 . . . . 0.0 109.722 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -91.68 132.45 36.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.47 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -134.31 121.39 21.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -94.51 124.15 38.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.26 108.83 21.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 5.7 p-10 -115.79 -164.94 0.99 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.24 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -53.17 -30.09 35.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 5.9 mp -62.53 -39.32 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 120.81 -47.91 0.99 Allowed Glycine 0 N--CA 1.463 0.466 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 9.8 m-85 -156.05 122.64 5.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 77' ' ' ALA . 96.7 p -87.43 163.41 16.75 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -44.35 111.78 1.27 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 160.35 48.57 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.304 1.336 . . . . 0.0 112.823 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.4 HG21 HG12 ' A' ' 8' ' ' ILE . 26.3 m -107.24 116.75 32.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.641 0.734 . . . . 0.0 109.674 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.01 96.18 5.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.424 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.579 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -100.39 121.73 41.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.48 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -122.42 129.94 52.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 111.309 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.579 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 9.7 p90 -164.79 128.29 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.405 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -80.4 167.43 20.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.527 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.0 mtp -93.6 147.86 34.39 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.54 162.16 33.46 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.477 2.118 . . . . 0.0 110.384 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.47 154.29 72.51 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.207 1.938 . . . . 0.0 111.587 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -36.06 132.18 0.59 Allowed Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.492 1.396 0 C-N-CA 121.599 1.532 . . . . 0.0 112.478 179.645 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' PRO . 2.1 Cg_endo . . . . . 0 N--CA 1.495 1.614 0 CA-C-O 120.375 0.073 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -37.96 177.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.777 2.985 . . . . 0.0 116.173 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.28 37.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.953 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -125.02 136.56 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.537 0.684 . . . . 0.0 110.64 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -116.83 -172.87 2.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.837 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.28 143.0 8.03 Favored Glycine 0 N--CA 1.462 0.392 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.322 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -150.79 115.56 3.24 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -46.83 104.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.493 1.462 . . . . 0.0 112.689 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 14' ' ' SER . 28.7 p -80.7 172.21 14.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' SER . 58.8 m -40.56 107.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.798 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.89 -158.32 23.98 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HE3' ' H ' ' A' ' 66' ' ' GLN . 18.8 mtmt -75.71 -11.6 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.871 0.367 . . . . 0.0 110.766 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 t -62.5 140.43 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.303 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.0 137.41 51.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.409 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -97.94 98.53 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mt -97.74 103.17 15.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 t -69.78 126.08 28.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.908 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.07 108.74 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -79.84 136.1 36.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.904 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.13 104.64 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.675 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 27' ' ' ASP . 11.8 mt-30 -89.51 137.63 32.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.552 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 27' ' ' ASP . 1.3 m-20 -54.64 93.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 24.7 t70 -44.54 171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.054 0.454 . . . . 0.0 110.881 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.56 -31.95 76.51 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.5 12.62 0.03 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.821 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -147.71 151.91 40.02 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 117.619 0.71 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.0 143.99 68.18 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.82 1.68 . . . . 0.0 111.783 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.586 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.0 mt -93.8 133.06 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.262 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.747 HD22 ' N ' ' A' ' 33' ' ' LEU . 2.3 mm? -95.43 -14.02 24.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.93 155.96 8.79 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -113.32 112.88 24.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.789 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.422 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 98.5 mt -89.98 106.99 17.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG22 HG13 ' A' ' 75' ' ' ILE . 21.6 t -109.35 129.78 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.415 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -123.84 142.86 50.73 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -143.92 158.46 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.891 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 41' ' ' SER . 1.1 ptm180 -151.3 -173.0 4.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.472 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 4.9 p -96.18 140.0 31.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -65.25 -17.9 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.639 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.61 -27.12 16.77 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -117.97 120.36 37.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.296 0.569 . . . . 0.0 110.811 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' NH1' ' A' ' 40' ' ' ARG . 83.9 tt0 -125.2 63.73 1.16 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.38 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.53 -14.71 8.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.953 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -159.64 161.87 35.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.403 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -128.35 136.39 50.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 68.7 mt -80.58 159.83 25.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -118.68 146.29 44.82 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.134 0.492 . . . . 0.0 111.447 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.9 110.27 5.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.5 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 72.7 mmtt -95.65 126.63 41.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.585 HG21 ' CG2' ' A' ' 60' ' ' ILE . 43.5 t -132.62 154.89 40.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.995 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 11.7 tp-100 -68.8 147.36 51.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.62 0.81 55.01 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.412 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.431 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 93.0 m-20 -113.67 -14.13 12.64 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.044 0.422 . . . . 0.0 111.339 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.28 -45.14 94.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.723 0.297 . . . . 0.0 110.833 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 58.2 37.1 26.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.886 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.73 141.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.585 ' CG2' HG21 ' A' ' 53' ' ' VAL . 6.5 pt -144.01 136.99 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.239 0.542 . . . . 0.0 111.988 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' C ' HD12 ' A' ' 62' ' ' LEU . 34.7 mm -108.22 117.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.226 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 62' ' ' LEU . 10.8 mp -107.01 143.5 35.01 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.589 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 46.4 mt-10 -107.52 169.65 8.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 111.772 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 37.3 p-80 49.06 68.49 0.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.327 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.5 mm? -95.4 -12.3 26.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.296 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.522 ' O ' ' SD ' ' A' ' 93' ' ' MET . 3.1 mm100 50.76 122.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.864 0.84 . . . . 0.0 112.058 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -61.52 -32.82 72.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.544 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -97.26 22.29 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.63 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.9 ttm -152.17 127.08 9.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.86 34.22 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -136.29 132.71 36.09 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.1 152.97 18.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.36 134.9 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 110.825 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -125.98 109.73 12.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.118 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.51 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -93.73 135.24 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m -134.83 121.66 20.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -91.18 123.5 34.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.06 107.8 19.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.28 0.562 . . . . 0.0 112.079 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 1.1 p-10 -110.29 -172.07 1.96 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -49.75 -27.71 5.24 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.789 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.8 mm? -65.64 -41.6 92.44 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.54 -50.3 0.89 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -155.81 134.45 11.79 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.7 t -162.83 157.24 21.13 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.867 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 44.48 61.99 10.55 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.088 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.48 155.51 45.48 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.599 2.199 . . . . 0.0 110.724 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.23 108.85 13.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.3 t -95.0 98.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -103.78 140.26 37.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.742 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -136.49 134.85 38.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.39 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 91' ' ' PHE . 35.3 p90 -165.95 125.36 1.65 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.509 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 p -82.44 171.13 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.575 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 14.8 mtp -99.4 152.59 37.85 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.89 163.53 25.91 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.638 2.225 . . . . 0.0 109.275 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.03 153.45 78.05 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 121.782 1.655 . . . . 0.0 111.533 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -41.47 133.88 2.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.496 1.652 0 C-N-CA 121.986 1.791 . . . . 0.0 111.931 179.116 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 6' ' ' PRO . 8.1 Cg_exo . . . . . 0 N--CA 1.494 1.546 0 CA-C-O 120.679 0.2 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 43.9 Cg_exo -42.53 176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 123.074 2.516 . . . . 0.0 114.109 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -173.41 54.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.743 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -131.25 130.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -121.3 115.37 22.84 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.49 145.37 17.66 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -146.96 111.49 4.12 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.38 98.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.382 1.388 . . . . 0.0 112.702 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -76.82 171.57 14.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -58.2 134.89 56.91 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.799 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.09 -154.54 26.57 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -99.14 46.46 0.98 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 61' ' ' ILE . 5.3 t -120.32 149.71 41.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.728 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.94 119.82 27.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.098 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -80.69 98.73 7.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.595 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.41 100.16 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -73.85 126.2 29.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.947 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.471 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -88.78 112.39 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -86.13 143.35 28.08 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.289 0.566 . . . . 0.0 110.203 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 112.69 10.22 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -112.13 170.28 8.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -50.8 112.34 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.581 ' C ' ' H ' ' A' ' 29' ' ' GLY . 69.1 m-20 -71.83 163.83 27.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 -178.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.07 14.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.075 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 101.78 8.81 44.75 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.96 149.42 25.11 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.47 140.06 61.7 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.803 1.669 . . . . 0.0 111.453 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.585 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.2 mt -86.28 129.11 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -81.3 -39.69 24.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.37 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -148.78 170.13 18.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.545 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.1 m-85 -123.23 122.15 37.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.457 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.4 mt -96.47 111.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.593 HG22 HG13 ' A' ' 75' ' ' ILE . 55.6 t -112.1 128.09 68.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -121.54 134.58 55.04 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.603 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.86 154.84 46.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.59 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 41' ' ' SER . 2.8 ptm180 -144.41 -172.74 3.86 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.336 0.589 . . . . 0.0 110.972 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.521 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 5.9 p -101.58 135.15 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.42 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.12 -11.79 33.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.253 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -90.32 -35.06 15.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -118.58 129.55 55.39 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 110.351 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.3 2.98 11.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.969 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 38.0 p-10 -72.11 -3.57 23.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.389 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -152.77 155.86 37.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.165 0.507 . . . . 0.0 111.922 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -136.85 106.89 6.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.299 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.89 158.73 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.773 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.37 148.24 45.31 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -143.6 113.95 7.43 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.497 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -88.51 136.07 33.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 54' ' ' GLN . 45.6 t -132.47 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 121.352 0.596 . . . . 0.0 111.951 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 53' ' ' VAL . 6.7 tp60 -83.0 144.78 29.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.573 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.01 -24.94 69.01 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -86.39 -22.12 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.621 -0.289 . . . . 0.0 111.515 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 25.7 mttm -60.53 -46.15 91.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.903 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.8 p30 46.52 37.25 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.048 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.55 0.72 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.827 0.346 . . . . 0.0 110.265 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -155.32 151.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.205 0.526 . . . . 0.0 110.564 178.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.42 HG22 ' OG ' ' A' ' 17' ' ' SER . 45.2 mm -120.06 112.67 37.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.091 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.82 105.17 16.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.83 152.7 21.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 111.846 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 76.86 58.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.715 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 66' ' ' GLN . 80.6 mt -103.17 -4.84 23.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 65' ' ' LEU . 47.5 mt-30 55.24 159.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.477 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -99.11 -16.01 18.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.194 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.3 p -108.86 19.1 20.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.3 mtp -141.47 141.98 33.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.134 0.493 . . . . 0.0 110.541 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.82 153.4 19.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -138.83 138.02 37.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.95 164.54 12.86 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.63 146.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.142 0.496 . . . . 0.0 110.393 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -137.89 106.36 5.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.465 0.65 . . . . 0.0 109.672 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.593 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -93.82 134.96 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.6 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -137.25 120.69 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -91.77 125.26 36.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.52 110.82 22.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 9.6 p-10 -112.12 -163.33 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.298 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -32.19 55.37 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 81' ' ' LEU . 9.3 mp -64.55 -42.32 95.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.712 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.86 -46.61 1.07 Allowed Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -154.93 132.51 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -161.56 147.19 13.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.695 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.14 58.14 4.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.19 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.99 151.1 30.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.372 2.048 . . . . 0.0 111.223 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.5 m -131.16 118.62 20.73 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.457 0.646 . . . . 0.0 111.142 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 m -97.97 92.71 2.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.221 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -95.01 151.72 18.93 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -153.29 135.37 14.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.324 0.583 . . . . 0.0 111.571 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -164.92 156.9 15.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.903 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.51 163.98 12.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.633 0.254 . . . . 0.0 110.358 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.4 mmm -89.69 143.96 31.12 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.395 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.63 164.85 31.48 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.755 2.303 . . . . 0.0 110.981 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -65.99 154.91 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.987 1.792 . . . . 0.0 111.696 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -35.37 132.59 0.5 Allowed Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.191 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 121.867 1.711 . . . . 0.0 112.373 178.784 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo . . . . . 0 N--CA 1.494 1.539 0 N-CA-C 112.596 0.191 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -39.4 164.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.408 2.072 . . . . 0.0 114.597 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -154.75 51.16 0.62 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.824 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -128.43 127.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.518 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -122.29 119.1 30.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.137 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.29 158.38 20.52 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -162.78 132.9 3.34 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.85 98.47 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.357 1.371 . . . . 0.0 111.818 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 14' ' ' SER . 87.6 p -80.77 -116.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.659 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 13' ' ' SER . 91.5 p -80.99 112.66 18.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.971 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.03 -133.63 43.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -78.41 -11.28 59.94 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 m -60.8 135.18 57.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.317 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.08 140.42 48.49 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.538 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -99.38 94.85 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.7 90.7 7.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.2 t -66.65 124.46 22.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.217 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.459 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -87.47 113.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.2 m -97.01 114.03 25.61 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.412 0.625 . . . . 0.0 110.091 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -39.09 107.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.593 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -97.79 151.17 20.47 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 85.8 m-20 -43.34 97.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.732 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' GLY . 19.3 m-20 -63.01 152.76 35.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.433 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -38.95 -21.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.773 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 135.42 -3.24 3.94 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.69 146.68 62.22 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.59 138.48 59.44 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.335 1.357 . . . . 0.0 111.133 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.606 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.5 mt -80.46 126.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.514 0.673 . . . . 0.0 112.39 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -68.47 -41.06 80.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -161.18 168.05 24.94 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.794 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.459 ' CD2' HG21 ' A' ' 22' ' ' ILE . 9.7 m-85 -114.3 119.4 36.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.219 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.47 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 80.9 mt -96.45 110.83 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.536 HG22 HG13 ' A' ' 75' ' ' ILE . 47.3 t -110.86 125.68 68.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.136 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -120.61 128.91 53.48 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -135.63 151.36 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.587 ' NE ' ' O ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -145.49 -177.87 5.79 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.705 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.587 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 25.4 m -90.72 146.43 24.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.874 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.36 -18.36 52.59 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.7 -49.66 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.535 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HB2' HH22 ' A' ' 40' ' ' ARG . 73.8 mmtt -110.53 -164.36 0.92 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -174.58 75.87 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -154.79 -8.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.075 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.0 129.23 21.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -116.18 131.14 57.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.144 0.497 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.73 160.32 18.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.45 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 54.5 mp0 -114.6 147.82 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.101 0.477 . . . . 0.0 111.44 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.16 113.99 5.39 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 72.0 mmtt -99.32 146.59 26.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.911 0.386 . . . . 0.0 111.99 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.46 160.45 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.482 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' A' ' 56' ' ' ASN . 47.9 tp60 -83.07 148.46 27.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.857 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.13 5.72 3.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 54' ' ' GLN . 64.0 t30 -122.69 -14.45 7.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.027 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 21.3 mttp -67.47 -49.79 61.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.182 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 59.03 35.45 23.98 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.974 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -176.35 155.49 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.763 -0.585 . . . . 0.0 111.386 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -151.18 146.09 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.59 102.7 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.882 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.9 mp -87.67 105.62 17.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 79.4 mt-10 -86.77 139.16 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.346 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 2.0 t-160 83.92 79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.375 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.8 mt -131.86 77.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 7.3 tt0 -34.9 143.71 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.344 0.592 . . . . 0.0 111.151 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -70.08 -22.46 63.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.496 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 p -100.76 22.95 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.1 ttm -141.77 132.98 26.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.34 0.59 . . . . 0.0 110.981 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.26 153.4 20.5 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -148.61 133.36 17.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.571 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.94 151.75 23.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.753 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.07 133.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -125.98 108.9 11.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 0.0 109.872 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.536 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -91.35 135.86 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.285 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -134.82 117.73 16.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -90.85 126.06 35.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.233 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.33 107.88 18.89 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.7 p-10 -109.64 -174.09 2.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.897 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -45.64 -26.28 0.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.608 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.647 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -71.84 -40.27 69.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.935 0.397 . . . . 0.0 110.125 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.465 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 128.61 -49.22 0.93 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -153.66 131.74 11.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 t -167.78 162.97 14.09 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.836 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 26' ' ' ASP . 8.3 tp10 50.27 53.89 14.8 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.188 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 92.3 Cg_endo -74.84 156.09 43.69 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.977 2.452 . . . . 0.0 110.943 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.01 110.42 11.64 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.03 0.443 . . . . 0.0 110.785 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 t -94.01 95.76 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.549 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -102.92 133.59 47.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.22 136.95 42.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.17 0.509 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.5 p90 -171.72 132.92 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.199 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.19 167.09 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.8 mmm -96.04 144.22 27.45 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.75 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.14 165.27 28.28 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.776 2.317 . . . . 0.0 110.903 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.98 162.89 33.28 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.992 1.795 . . . . 0.0 111.433 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -40.74 133.21 1.74 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 C-N-CA 121.985 1.79 . . . . 0.0 111.085 177.759 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' PRO . 88.8 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 N-CA-C 112.719 0.238 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' PRO . 15.7 Cg_exo -37.41 163.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.872 2.381 . . . . 0.0 113.707 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 m -151.38 52.2 0.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.444 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -130.18 128.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -122.46 117.11 25.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.1 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.02 161.53 21.75 Favored Glycine 0 N--CA 1.464 0.543 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.968 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -161.95 128.78 2.52 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.92 88.26 0.94 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.3 t -66.87 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -71.29 133.07 45.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.172 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 -160.11 49.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.864 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -79.82 -4.98 54.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.642 -0.279 . . . . 0.0 111.227 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.8 p -68.72 147.39 51.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.121 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.0 124.69 43.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -84.29 100.12 11.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.399 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.65 97.97 9.8 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -71.56 126.28 29.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.037 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.44 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -88.93 113.79 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 m -85.5 139.07 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.063 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -72.29 104.92 3.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.655 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 168.21 9.42 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.3 t70 -56.85 110.01 0.73 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.31 165.37 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.125 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.37 -23.09 33.0 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.42 16.69 0.08 OUTLIER Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.247 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.91 152.48 20.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 117.169 0.485 . . . . 0.0 109.789 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.51 145.04 86.86 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.86 1.707 . . . . 0.0 111.112 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.613 HG21 ' CE1' ' A' ' 35' ' ' TYR . 4.4 mt -91.59 129.24 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.467 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.21 -44.56 14.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.24 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.6 161.64 39.34 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 32' ' ' ILE . 10.4 m-85 -113.88 122.19 46.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.98 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.4 mt -94.25 108.44 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.549 HG22 HG13 ' A' ' 75' ' ' ILE . 58.1 t -113.77 130.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.113 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -127.95 147.23 50.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.473 ' CE2' HD12 ' A' ' 49' ' ' LEU . 42.8 p90 -148.55 155.69 41.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.074 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.793 HH21 ' H ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -152.49 -172.83 4.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.032 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -92.74 146.48 23.61 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.792 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.61 15.7 0.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -132.45 -45.92 0.9 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.739 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.561 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.79 37.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.684 0.278 . . . . 0.0 110.821 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 6.7 tm-20 -49.68 84.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 110.753 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 44' ' ' LYS . 73.0 m-20 -153.93 -16.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.966 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.793 ' H ' HH21 ' A' ' 40' ' ' ARG . 19.7 pt20 -156.74 155.68 32.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.063 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -124.39 136.01 53.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.084 0.469 . . . . 0.0 111.898 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.473 HD12 ' CE2' ' A' ' 39' ' ' TYR . 97.7 mt -84.9 158.71 20.5 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -118.35 146.51 44.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.097 0.475 . . . . 0.0 111.319 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -147.45 117.78 7.38 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -100.94 143.53 30.97 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.95 161.38 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.357 0.598 . . . . 0.0 110.646 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -79.14 147.71 32.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.606 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.62 0.29 5.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -118.62 -6.73 10.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.556 0.217 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -63.6 -47.83 79.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.31 0.576 . . . . 0.0 109.638 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 53.02 30.17 9.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.686 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.69 153.39 0.36 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.968 0.414 . . . . 0.0 110.737 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -151.96 145.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.542 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.56 107.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 mt -92.7 133.06 36.38 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 83.4 tt0 -119.77 152.94 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.008 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 36.3 t-80 88.88 49.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.712 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.22 86.96 2.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -41.65 137.88 1.52 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.452 0.644 . . . . 0.0 111.122 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -65.0 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.755 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -98.32 21.42 11.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.384 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 8.8 ttm -145.17 128.64 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 110.145 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.76 161.9 46.48 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.61 129.61 23.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -90.55 154.39 19.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.875 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -135.1 136.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 67.2 tt0 -127.25 107.86 10.37 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.549 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -95.78 131.39 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.283 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -135.54 120.21 18.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.63 127.4 35.9 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.21 111.01 23.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.248 0.547 . . . . 0.0 112.248 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.5 p30 -112.08 -166.44 1.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.237 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -53.0 -30.91 38.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.027 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -66.37 -41.31 89.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.165 0.507 . . . . 0.0 109.736 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 129.93 -49.07 0.94 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -154.88 137.77 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.6 t -165.38 155.48 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.701 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 26' ' ' ASP . 18.5 tt0 50.06 56.94 17.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.232 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.81 154.37 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.68 2.253 . . . . 0.0 111.367 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -132.34 119.01 20.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 0.0 111.089 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.94 94.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.54 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 40.2 t80 -98.22 131.1 44.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.124 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -133.1 131.5 40.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.54 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 20.9 p90 -161.73 134.73 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.63 160.23 25.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.366 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 91.1 mmm -94.49 140.93 22.86 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.804 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.71 162.81 40.22 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.035 1.823 . . . . 0.0 110.861 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.33 151.99 83.46 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.499 2.133 . . . . 0.0 111.816 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -38.28 133.18 0.96 Allowed Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 N--CA 1.494 1.519 0 C-N-CA 121.477 1.452 . . . . 0.0 111.681 179.118 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 6' ' ' PRO . 80.7 Cg_exo . . . . . 0 N--CA 1.502 1.977 0 N-CA-C 112.545 0.171 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.2 Cg_exo -38.75 163.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.331 2.021 . . . . 0.0 114.276 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.33 33.54 0.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.695 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.58 120.49 60.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.553 0.692 . . . . 0.0 110.788 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -116.26 116.86 28.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.039 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.24 150.44 19.68 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 13' ' ' SER . 71.2 mt-30 -153.62 113.46 2.59 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.41 85.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.171 1.248 . . . . 0.0 111.636 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 11' ' ' GLN . 10.8 t -53.92 -88.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.647 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.25 140.33 41.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.808 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.01 -127.9 39.11 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.499 ' CE ' ' O ' ' A' ' 65' ' ' LEU . 10.4 mtmm -99.39 -2.84 35.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 p -67.01 149.21 50.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.11 135.38 48.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.824 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -96.39 95.18 7.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -90.86 92.28 8.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -68.9 122.59 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.221 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.438 HG21 ' CE2' ' A' ' 35' ' ' TYR . 2.2 mm -85.95 112.6 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -91.68 117.76 30.04 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.19 105.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.391 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -88.96 157.61 18.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -48.62 106.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -58.1 142.69 46.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.649 0.737 . . . . 0.0 111.965 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.99 -20.71 6.7 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.6 -1.65 0.73 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.75 25.78 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.87 133.33 38.41 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.86 1.707 . . . . 0.0 111.992 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.563 HG21 ' CE1' ' A' ' 35' ' ' TYR . 4.5 mt -78.59 130.27 36.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.172 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 33' ' ' LEU . 11.3 mp -80.99 -44.67 17.79 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -142.18 163.72 32.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.515 0.674 . . . . 0.0 111.434 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.563 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.2 m-85 -116.71 113.88 23.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.166 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.578 HG23 ' HZ3' ' A' ' 52' ' ' LYS . 95.0 mt -87.83 109.94 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.538 HG22 HG13 ' A' ' 75' ' ' ILE . 44.9 t -114.08 130.55 68.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -125.84 133.32 52.01 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.457 ' CE2' HD12 ' A' ' 49' ' ' LEU . 54.4 p90 -138.47 150.73 46.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.839 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.3 ptt85 -143.65 174.78 10.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.027 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 44' ' ' LYS . 16.5 m -84.99 142.57 29.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -63.31 -35.53 80.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.471 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.33 -10.52 59.53 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.564 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 41' ' ' SER . 28.4 mmtt -125.99 154.6 42.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.633 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.2 19.83 1.09 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.708 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.93 1.06 52.64 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -159.89 158.07 30.2 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.94 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -136.44 106.13 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 39' ' ' TYR . 50.8 mt -67.59 145.77 54.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.81 151.86 25.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.22 0.533 . . . . 0.0 111.138 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' VAL . 11.2 tppt? -150.58 113.24 4.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.427 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.578 ' HZ3' HG23 ' A' ' 36' ' ' ILE . 72.2 mmtt -97.81 139.85 33.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.362 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.77 160.42 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.371 0.605 . . . . 0.0 110.997 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 65.2 tp60 -78.67 142.55 37.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.362 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.68 -3.74 16.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.417 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 91.7 m-20 -110.26 -21.36 12.27 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.723 -0.28 . . . . 0.0 110.622 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -61.55 -52.48 64.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.021 0.438 . . . . 0.0 110.687 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 56.57 41.67 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.809 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.81 150.44 0.8 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.525 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -149.05 140.7 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.2 mm -111.45 103.96 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.407 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 62' ' ' LEU . 10.3 mp -92.57 107.57 19.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 171.11 10.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 m80 66.57 48.12 1.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.364 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.499 ' O ' ' CE ' ' A' ' 16' ' ' LYS . 23.8 mt -100.16 164.71 11.85 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 68' ' ' THR . 50.6 tt0 -119.97 143.07 48.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.201 0.524 . . . . 0.0 110.625 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -68.87 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.432 ' H ' ' HG2' ' A' ' 66' ' ' GLN . 43.1 p -102.44 17.93 22.37 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.6 mtp -143.41 134.12 25.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.41 166.44 31.88 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.147 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -142.82 131.73 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.54 . . . . 0.0 110.351 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.1 mt-10 -88.32 151.47 22.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.58 131.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.574 ' OE1' HG22 ' A' ' 88' ' ' VAL . 10.0 tp60 -124.34 108.08 11.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.611 0.72 . . . . 0.0 110.371 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 1.6 mp -90.58 134.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.098 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.46 120.36 19.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -92.25 127.03 37.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.58 107.24 18.07 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.019 0.438 . . . . 0.0 111.812 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -115.61 -170.58 1.8 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -44.09 -32.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.789 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -64.12 -41.52 97.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.64 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 123.52 -49.04 0.92 Allowed Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 7.0 m-85 -156.45 125.71 6.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.7 t -160.64 169.68 22.37 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.651 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 60.3 mm-40 52.0 49.3 6.65 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.869 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 74.3 Cg_endo -71.35 152.37 60.85 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.068 1.845 . . . . 0.0 111.146 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.31 113.51 12.69 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 110.378 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.574 HG22 ' OE1' ' A' ' 74' ' ' GLN . 61.6 t -95.87 93.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -101.53 145.32 29.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.224 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.66 138.34 32.43 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 91' ' ' PHE . 16.7 p90 -164.39 127.61 2.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.0 p -83.76 143.06 30.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 94.6 mmm -74.29 140.32 76.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.144 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.05 164.76 34.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.92 152.7 80.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.431 2.087 . . . . 0.0 111.748 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -39.89 129.89 1.54 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.487 1.119 0 C-N-CA 121.498 1.465 . . . . 0.0 112.254 178.778 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' PRO . 14.3 Cg_exo . . . . . 0 N--CA 1.503 2.066 0 CA-C-O 120.581 0.159 . . . . 0.0 112.204 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -35.89 166.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 123.6 2.867 . . . . 0.0 115.384 -179.304 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.51 43.15 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.518 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.02 132.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.323 0.582 . . . . 0.0 111.318 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -128.89 117.39 20.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.595 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.1 145.72 17.8 Favored Glycine 0 N--CA 1.464 0.562 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.031 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -148.03 118.18 4.29 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -48.96 109.15 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.097 1.198 . . . . 0.0 112.111 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 t -84.4 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.6 m -82.0 134.56 35.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.191 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.46 -135.05 41.76 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.763 ' HZ2' ' HE1' ' A' ' 67' ' ' TRP . 33.7 mttm -77.78 -8.64 58.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.838 0.351 . . . . 0.0 110.994 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.509 ' OG ' HG22 ' A' ' 61' ' ' ILE . 4.6 t -64.74 141.57 58.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.027 0.442 . . . . 0.0 111.946 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.3 124.3 44.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.898 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -87.57 104.49 16.55 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.251 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 mt -97.26 91.62 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.0 t -65.4 120.48 12.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.039 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.13 123.29 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -93.91 113.65 25.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.423 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -42.17 104.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.322 0.582 . . . . 0.0 110.841 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -85.82 171.34 11.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.093 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.46 108.66 0.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.18 142.4 56.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.444 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -40.88 -74.36 0.16 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.36 13.09 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.87 158.61 29.27 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -57.03 141.81 94.08 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.15 1.234 . . . . 0.0 111.069 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.659 HG21 ' CE1' ' A' ' 35' ' ' TYR . 3.6 mt -83.95 122.13 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.104 0.478 . . . . 0.0 111.233 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.0 -41.97 85.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.278 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.6 163.17 24.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.255 0.55 . . . . 0.0 111.241 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.659 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.5 m-85 -107.5 114.61 28.72 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.836 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -88.09 114.72 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.581 HG22 HG13 ' A' ' 75' ' ' ILE . 63.7 t -115.44 129.81 71.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.976 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -125.24 136.08 53.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.552 ' CE2' HD12 ' A' ' 49' ' ' LEU . 27.8 p90 -140.42 155.82 46.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.041 0.448 . . . . 0.0 110.514 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.554 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 11.1 ptt180 -149.9 178.99 8.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.377 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 p -91.1 140.64 29.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.223 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -68.67 -24.59 64.54 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -33.97 74.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.585 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -158.85 -175.48 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.854 0.835 . . . . 0.0 112.344 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 10.8 pt-20 -142.72 122.06 13.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.753 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.7 m-20 -161.15 38.01 0.14 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 89.5 mt-30 115.88 126.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.853 1.971 . . . . 0.0 110.927 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.554 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 21.6 m95 -87.89 135.78 33.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.842 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.552 HD12 ' CE2' ' A' ' 39' ' ' TYR . 76.3 mt -72.59 159.83 33.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.75 151.76 40.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.071 0.462 . . . . 0.0 111.567 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.15 113.44 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.506 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -92.8 144.17 25.55 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.01 150.47 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.446 ' C ' ' H ' ' A' ' 56' ' ' ASN . 52.2 tt0 -67.49 140.6 57.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.512 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.01 7.7 0.27 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.57 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 54' ' ' GLN . 8.3 t-20 -132.93 -8.92 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.364 0.582 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 14.7 mttp -64.65 -46.0 84.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.607 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.7 p30 50.04 39.5 19.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.799 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.45 151.95 0.63 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.7 140.87 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 0.0 110.707 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.509 HG22 ' OG ' ' A' ' 17' ' ' SER . 33.1 mm -111.87 98.4 6.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.119 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 mt -87.23 105.27 17.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 54.7 mp0 -86.58 175.31 8.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.3 m80 60.91 57.82 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -105.15 -171.68 1.96 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.09 129.57 22.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.579 0.704 . . . . 0.0 110.954 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.763 ' HE1' ' HZ2' ' A' ' 16' ' ' LYS . 68.0 m95 -63.81 -30.39 71.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.977 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 p -100.45 21.0 13.86 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.99 135.03 19.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.301 . . . . 0.0 110.458 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.77 166.17 42.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -144.97 135.0 23.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.501 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 7.5 mt-10 -98.11 151.77 20.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.43 136.95 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.938 0.399 . . . . 0.0 110.678 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -129.62 114.38 15.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -98.94 136.33 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.923 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -138.8 117.78 12.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.519 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.21 129.04 35.45 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.87 116.17 31.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.284 0.564 . . . . 0.0 112.454 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.9 p-10 -117.18 -169.57 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -50.89 -27.96 8.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.611 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -66.24 -37.6 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.529 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 121.52 -52.19 0.75 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.467 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.2 m-85 -151.67 138.22 18.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -161.71 171.68 17.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.407 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 32.03 64.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.408 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.66 151.91 32.72 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.297 1.998 . . . . 0.0 110.691 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -128.75 110.3 12.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.128 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -96.72 98.76 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -104.47 147.45 27.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.19 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.6 131.67 20.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.934 0.397 . . . . 0.0 111.182 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 38.1 p90 -165.81 142.34 5.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -90.01 161.05 16.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.375 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 92.3 mmm -87.77 137.62 31.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.552 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.38 165.43 31.79 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.306 2.004 . . . . 0.0 111.284 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.92 152.88 80.25 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.035 1.823 . . . . 0.0 110.888 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.615 ' CE ' ' NE1' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -44.49 130.93 4.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.526 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.496 1.665 0 C-N-CA 121.71 1.606 . . . . 0.0 113.196 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 6' ' ' PRO . 84.0 Cg_exo . . . . . 0 N--CA 1.501 1.927 0 N-CA-C 113.088 0.38 . . . . 0.0 113.088 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.3 Cg_exo -38.71 163.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.693 2.262 . . . . 0.0 113.339 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.8 m -157.49 58.92 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.8 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.44 130.44 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.228 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -118.99 113.76 21.48 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA2' HD23 ' A' ' 20' ' ' LEU . . . -96.26 138.65 14.05 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -152.41 146.88 18.76 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.655 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.64 88.02 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.278 1.985 . . . . 0.0 111.792 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 t -67.98 -68.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.779 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' GLY . 20.0 m -136.88 156.66 48.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . . . 31.99 -116.22 0.1 OUTLIER Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.088 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HE2' ' HE1' ' A' ' 67' ' ' TRP . 61.1 mttt -96.86 -8.32 31.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.962 0.41 . . . . 0.0 110.274 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.47 136.47 58.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.95 118.65 31.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.326 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.18 109.39 14.6 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.066 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD23 ' HA2' ' A' ' 10' ' ' GLY . 11.5 mt -100.93 89.7 3.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -70.3 121.85 18.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.38 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.415 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.2 mm -82.65 114.95 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 m -94.72 116.29 28.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.627 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.552 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.29 105.76 0.05 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.531 ' NE2' ' OE1' ' A' ' 85' ' ' GLU . 3.6 pt20 -117.87 101.21 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' GLN . 95.7 m-20 33.1 -154.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 29' ' ' GLY . 46.5 p-10 -165.11 161.61 19.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.37 5.6 2.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 117.13 9.28 10.74 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.61 151.3 23.38 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 117.01 0.405 . . . . 0.0 110.156 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.32 141.69 76.08 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.926 1.751 . . . . 0.0 111.781 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.568 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -88.06 130.93 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.183 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.9 mp -85.79 -41.82 14.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.283 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -146.67 162.12 39.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.299 0.571 . . . . 0.0 111.775 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.534 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.3 m-85 -114.2 121.61 44.27 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.963 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.1 mt -95.45 110.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.528 HG22 HG13 ' A' ' 75' ' ' ILE . 60.8 t -112.26 130.88 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.563 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -128.56 133.06 48.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.413 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.533 ' CE2' HD12 ' A' ' 49' ' ' LEU . 37.7 p90 -137.8 153.3 49.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.446 . . . . 0.0 110.389 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -140.4 -174.1 3.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.459 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -100.68 137.36 39.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.029 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -66.77 -30.63 70.89 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.08 -33.43 73.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.569 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 41' ' ' SER . 12.1 ptpt -131.87 168.75 17.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 111.273 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.91 106.8 3.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.188 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 25.2 p-10 -164.74 -26.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -144.99 162.52 36.71 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -131.9 133.54 44.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.133 0.492 . . . . 0.0 110.939 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.533 HD12 ' CE2' ' A' ' 39' ' ' TYR . 90.8 mt -77.15 160.48 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.67 152.27 36.42 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.09 0.472 . . . . 0.0 111.8 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.72 113.71 2.27 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -98.83 145.98 26.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.598 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 157.4 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.115 0.483 . . . . 0.0 110.528 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 56' ' ' ASN . 40.6 tt0 -77.05 137.08 38.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.488 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.95 0.02 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.522 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 54' ' ' GLN . 97.1 m-20 -121.09 -6.26 9.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.875 0.338 . . . . 0.0 110.615 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -64.63 -49.7 70.0 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.53 0.681 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 56.41 34.9 25.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.188 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.45 151.18 0.59 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.03 146.29 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.535 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.5 mm -117.06 108.89 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.578 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 62' ' ' LEU . 1.9 mm? -93.13 105.82 17.86 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 45.4 tt0 -91.63 152.04 20.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.805 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 12.3 t60 80.74 62.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.371 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' GLN . 66.8 mt -119.74 88.37 2.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.861 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' LEU . 86.4 mt-30 -36.91 152.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.151 0.501 . . . . 0.0 111.735 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.409 ' HE1' ' HE2' ' A' ' 16' ' ' LYS . 85.2 m95 -83.17 -5.9 59.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.404 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -115.04 15.13 17.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.689 0.28 . . . . 0.0 111.608 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 67.7 mtp -146.0 136.6 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 111.332 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.37 162.22 25.65 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.94 132.38 26.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.595 0.236 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -87.76 149.93 23.89 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.78 137.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -129.32 106.42 8.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.467 0.651 . . . . 0.0 109.423 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.528 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -92.51 134.97 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.968 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -138.79 116.01 11.07 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -86.26 128.16 34.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.189 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.26 107.27 18.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 1.2 p30 -110.7 -168.18 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -49.49 -31.65 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.0 mm? -63.07 -41.15 99.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 124.37 -44.2 1.31 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.47 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.8 m-85 -153.17 139.99 19.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.8 p -157.37 162.01 39.05 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.853 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.531 ' OE1' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 32.33 59.1 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.459 178.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.5 150.26 69.55 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 121.567 1.512 . . . . 0.0 110.548 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.8 m -128.21 116.51 20.0 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.492 0.663 . . . . 0.0 111.047 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.9 94.67 4.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.235 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -95.86 147.95 23.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.595 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -144.11 135.88 26.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.054 0.454 . . . . 0.0 110.83 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 18' ' ' PHE . 3.9 p90 -167.54 133.77 2.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -89.01 173.77 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.503 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.88 144.38 28.79 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.093 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.03 165.62 27.97 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.614 2.209 . . . . 0.0 110.41 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.59 152.45 81.74 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.749 1.633 . . . . 0.0 111.741 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -36.1 129.49 0.63 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.764 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 N--CA 1.49 1.277 0 C-N-CA 121.965 1.777 . . . . 0.0 110.939 177.391 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.438 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 49.0 Cg_exo . . . . . 0 N--CA 1.506 2.227 0 N-CA-C 112.389 0.111 . . . . 0.0 112.389 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 5' ' ' PRO . 86.6 Cg_exo -54.7 145.4 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.089 2.526 . . . . 0.0 114.237 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.03 50.44 1.91 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.541 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.2 mm -126.21 128.5 71.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.241 0.543 . . . . 0.0 110.896 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -122.15 114.53 21.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.428 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.2 147.5 18.62 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.531 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -156.74 135.34 7.62 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 107.77 2.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.063 1.175 . . . . 0.0 111.51 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -78.18 -81.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.3 m -143.18 133.91 25.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.406 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.6 -145.68 35.97 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.765 ' NZ ' ' H ' ' A' ' 66' ' ' GLN . 2.6 mtmp? -87.76 -3.67 58.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.332 . . . . 0.0 110.71 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 82.6 p -71.72 145.66 48.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.749 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.79 125.75 48.36 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -85.77 104.01 15.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.808 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.89 97.49 8.37 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.4 t -72.39 120.16 17.61 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.689 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.494 HG21 ' CE2' ' A' ' 35' ' ' TYR . 3.1 mm -80.11 119.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.6 m -85.32 128.26 34.63 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.906 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.461 ' H ' ' HE2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.98 110.93 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.209 1.004 . . . . 0.0 109.584 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 27' ' ' ASP . 7.3 mm100 -92.79 169.05 10.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.076 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 17.1 t70 -53.75 -9.28 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.262 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 p30 47.92 34.97 4.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.848 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.2 -13.06 0.17 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 114.52 4.3 21.82 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . -131.44 152.5 80.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 122.633 -0.333 . . . . 0.0 110.358 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.79 144.08 58.02 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.213 1.942 . . . . 0.0 111.837 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.507 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.6 mt -98.44 125.66 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.504 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 mt -72.92 -39.53 66.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.104 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -160.58 170.46 20.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.91 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.505 ' CE1' HG21 ' A' ' 32' ' ' ILE . 11.7 m-85 -117.38 122.43 43.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.582 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -93.02 108.84 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 75' ' ' ILE . 61.4 t -111.12 127.13 68.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.067 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.23 138.22 54.11 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.952 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.527 ' CE2' HD12 ' A' ' 49' ' ' LEU . 28.8 p90 -142.4 151.04 41.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.086 0.47 . . . . 0.0 111.436 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 37.2 ptt85 -143.94 174.27 10.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.864 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.8 p -80.04 150.98 30.17 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.204 0.315 . . . . 0.0 110.261 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -75.12 12.15 0.97 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.425 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.69 -35.03 2.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.489 0.185 . . . . 0.0 110.776 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -103.01 109.64 21.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.491 0.662 . . . . 0.0 110.741 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -105.07 15.95 26.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.695 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.91 3.39 53.62 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -161.38 136.26 7.36 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.214 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 43.0 m95 -119.59 123.56 44.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.527 HD12 ' CE2' ' A' ' 39' ' ' TYR . 82.6 mt -81.76 160.24 23.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.017 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -120.18 154.68 34.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.428 0.632 . . . . 0.0 111.916 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.14 114.67 3.12 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.75 141.15 32.94 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.354 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.33 161.72 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.355 0.598 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 7.3 tp-100 -78.11 146.94 34.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.432 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.0 5.64 7.76 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.828 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.429 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 64.4 t30 -120.7 -15.82 8.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.737 0.304 . . . . 0.0 110.31 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -65.16 -52.06 57.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.238 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 55.9 38.45 30.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.283 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.35 150.96 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.528 0.204 . . . . 0.0 110.535 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.36 152.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.398 0.618 . . . . 0.0 111.667 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 mm -121.57 111.73 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.82 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 17' ' ' SER . 51.0 mt -97.61 112.88 24.57 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -84.93 153.54 22.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 0.0 112.47 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.718 ' HA ' ' HZ1' ' A' ' 16' ' ' LYS . 70.3 t60 59.57 81.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.029 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 66' ' ' GLN . 75.1 mt -118.03 -4.15 11.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.765 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . 22.6 mt-30 57.13 149.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.405 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -90.64 -14.46 32.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.782 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 p -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.75 117.34 15.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.136 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.9 157.83 50.69 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.936 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -139.73 128.03 22.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.309 -0.445 . . . . 0.0 110.259 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -86.48 153.14 22.08 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.61 134.97 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -123.77 106.93 10.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.538 0.685 . . . . 0.0 109.414 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.565 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -94.11 133.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.489 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -139.9 116.2 10.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.659 ' HB3' ' OE2' ' A' ' 85' ' ' GLU . . . -89.37 127.75 35.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.28 110.62 22.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.29 0.567 . . . . 0.0 112.008 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.654 HD22 ' HB2' ' A' ' 84' ' ' SER . 0.1 OUTLIER -116.63 -176.45 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.839 178.594 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -42.52 -31.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.3 mp -64.75 -41.79 95.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.451 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 124.6 -45.38 1.18 Allowed Glycine 0 N--CA 1.465 0.573 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.484 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.7 m-85 -154.52 138.86 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.654 ' HB2' HD22 ' A' ' 79' ' ' ASN . 73.5 m -148.17 161.53 41.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.564 0.697 . . . . 0.0 111.87 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.659 ' OE2' ' HB3' ' A' ' 77' ' ' ALA . 0.7 OUTLIER 22.75 60.94 0.34 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.417 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.8 150.27 86.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.154 1.236 . . . . 0.0 110.414 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.7 m -125.27 117.92 24.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.577 0.703 . . . . 0.0 111.712 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -93.92 93.6 4.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.584 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 36.7 t80 -95.81 132.67 40.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.704 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.83 136.46 46.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 111.221 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.1 p90 -172.24 133.44 0.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.165 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.4 p -80.52 162.76 24.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.343 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.6 mmm -89.29 143.31 30.72 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.285 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.93 164.98 34.06 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.684 2.256 . . . . 0.0 111.203 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.1 152.36 81.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.414 2.076 . . . . 0.0 111.507 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.75 131.22 1.83 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.208 1.939 . . . . 0.0 111.525 178.19 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' H ' ' HA2' ' A' ' 28' ' ' GLY . 38.0 mt-10 -135.06 81.87 43.95 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -101.2 -164.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 124.008 3.139 . . . . 0.0 110.057 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.441 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -167.83 -179.79 0.81 Allowed Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.149 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 30.1 Cg_exo -59.96 171.01 3.22 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.592 2.195 . . . . 0.0 111.884 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -39.21 164.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.696 2.264 . . . . 0.0 114.732 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 m -163.74 48.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.635 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -126.12 127.4 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.621 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -113.35 113.98 26.0 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.06 141.54 15.59 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -150.37 148.63 24.65 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.767 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.75 88.29 1.39 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.167 1.911 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 14' ' ' SER . 79.7 p -58.12 -87.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.024 0.44 . . . . 0.0 109.971 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.463 ' N ' ' OG ' ' A' ' 13' ' ' SER . 37.9 m -139.29 127.97 23.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.58 -131.31 14.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -93.13 -10.67 35.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.634 0.254 . . . . 0.0 111.226 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -63.95 146.56 53.84 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.874 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 130.33 52.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.08 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -88.2 104.83 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.371 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.63 97.4 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 t -73.76 126.94 31.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 mm -87.49 110.44 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -88.89 115.61 26.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.49 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -36.98 105.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.297 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -91.92 170.5 9.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.614 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.94 109.21 1.2 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.12 142.81 58.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.417 ' HA2' ' H ' ' A' ' 2' ' ' GLU . . . -46.38 -19.52 0.45 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.461 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.71 1.24 1.42 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.92 151.87 57.36 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.82 137.82 55.26 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.772 1.648 . . . . 0.0 111.385 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.617 HG21 ' CE1' ' A' ' 35' ' ' TYR . 3.5 mt -83.41 131.39 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.357 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.1 mm? -85.48 -42.71 14.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.32 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -146.66 161.06 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.266 0.555 . . . . 0.0 111.618 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.617 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.2 m-85 -114.98 125.01 53.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.101 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.628 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 80.6 mt -98.3 114.34 35.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.607 HG22 HG13 ' A' ' 75' ' ' ILE . 75.0 t -112.39 127.74 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.784 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -129.12 128.7 44.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CE2' HD12 ' A' ' 49' ' ' LEU . 36.3 p90 -136.64 153.19 50.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -142.36 172.93 12.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.753 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 15.4 m -84.25 137.96 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -63.13 -38.26 90.47 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.847 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.76 -43.04 97.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.529 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 41' ' ' SER . 36.8 mmtt -102.54 117.76 35.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.407 0.622 . . . . 0.0 110.961 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.77 54.91 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.63 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -142.37 5.66 1.65 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.258 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -144.31 152.85 41.34 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.014 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -141.57 110.6 6.23 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.232 0.539 . . . . 0.0 110.65 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.515 HD12 ' CE2' ' A' ' 39' ' ' TYR . 83.9 mt -73.13 160.08 32.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.72 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -121.71 148.02 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.07 0.462 . . . . 0.0 111.713 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.79 113.61 4.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.628 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 72.9 mmtt -97.3 146.16 25.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 160.95 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.436 0.636 . . . . 0.0 111.092 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 55.6 tt0 -82.86 136.11 34.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.51 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.06 -8.12 1.37 Allowed Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.263 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.489 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 30.3 m120 -107.12 -9.17 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.673 0.273 . . . . 0.0 110.32 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -64.62 -49.16 72.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.1 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 51.83 33.03 10.56 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.429 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 152.93 0.46 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.562 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.594 HD13 HG21 ' A' ' 37' ' ' VAL . 1.5 pt -150.33 141.39 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.145 0.498 . . . . 0.0 110.608 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -112.13 112.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.145 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.2 mt -98.38 136.31 38.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.09 159.52 20.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.999 0.428 . . . . 0.0 111.547 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 t60 71.04 62.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.781 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.657 HD13 ' OH ' ' A' ' 71' ' ' TYR . 54.0 mt -119.26 82.59 1.89 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.4 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' LEU . 49.8 mt-30 -36.35 152.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.134 0.493 . . . . 0.0 111.711 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -83.57 -9.65 58.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.81 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.4 p -113.64 13.36 18.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 61.8 mtp -139.25 136.44 34.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 111.492 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.85 161.29 19.42 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.131 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.657 ' OH ' HD13 ' A' ' 65' ' ' LEU . 3.8 p90 -150.66 139.37 20.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 109.992 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -87.5 148.9 24.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.1 t -125.47 132.72 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -123.39 112.58 17.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.186 0.517 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.607 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -95.97 135.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.13 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -138.5 116.03 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -87.01 125.47 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.333 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.34 111.73 24.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.4 p30 -111.6 -164.92 0.95 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -54.45 -30.98 54.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.599 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.4 mm? -65.02 -41.77 94.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.697 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.22 -48.16 0.98 Allowed Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.5 m-85 -153.75 137.76 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -161.55 170.49 19.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.237 0.541 . . . . 0.0 110.943 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 34.63 57.73 2.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.298 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.47 151.62 59.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.382 2.054 . . . . 0.0 110.898 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.33 110.57 12.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.5 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 m -95.02 95.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.555 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.6 t80 -102.46 138.64 39.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.603 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.5 136.0 34.08 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.744 0.306 . . . . 0.0 110.593 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.2 p90 -171.52 129.58 0.69 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -81.55 162.68 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 77.5 mmm -88.82 149.11 43.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.61 162.94 29.83 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.414 2.076 . . . . 0.0 110.338 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.1 154.8 72.64 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.092 1.861 . . . . 0.0 110.961 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.89 131.47 0.92 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.434 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.32 141.18 55.6 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.435 1.423 . . . . 0.0 112.427 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.26 -12.65 17.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 101' ' ' LYS . 38.9 pt -105.26 -7.92 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.686 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.6 pt 39.36 16.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.343 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 99' ' ' ILE . 88.4 tttt -86.99 -72.81 0.49 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.22 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.567 179.8 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 34.84 84.84 0.17 Allowed Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.757 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.41 -163.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.252 2.635 . . . . 0.0 109.28 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.42 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -168.86 179.55 0.83 Allowed Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 119.609 -0.837 . . . . 0.0 110.852 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 49.8 Cg_exo -55.25 161.05 7.51 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.647 2.231 . . . . 0.0 112.973 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.0 Cg_exo -39.79 175.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.286 2.657 . . . . 0.0 114.545 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -160.11 39.85 0.18 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.568 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 87' ' ' THR . 5.9 mm -126.02 128.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.326 0.584 . . . . 0.0 111.76 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -124.84 117.05 23.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.753 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.38 147.04 17.9 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-O 121.472 0.485 . . . . 0.0 112.568 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -145.48 132.29 9.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.47 100.22 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.475 1.45 . . . . 0.0 112.402 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 9.7 p -80.18 167.23 20.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.2 p -43.88 112.11 0.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.67 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.59 -171.72 20.44 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -75.15 -9.31 58.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.508 0.194 . . . . 0.0 111.284 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 7.4 p -66.23 142.56 57.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.713 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.07 125.87 50.33 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -86.64 100.24 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.262 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.7 mt -96.83 98.25 9.97 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.4 t -71.36 129.29 38.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.471 HG21 ' CD2' ' A' ' 35' ' ' TYR . 2.1 mm -92.36 111.34 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -77.4 128.16 33.79 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.211 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.655 ' HD3' ' H ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -34.57 105.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.878 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 85' ' ' GLU . 88.4 mt-30 -83.6 118.15 23.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.493 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.61 -10.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.358 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 25.8 t70 58.05 172.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.917 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.31 -48.14 72.54 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.22 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.82 25.7 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -152.17 151.87 28.48 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.72 146.5 60.63 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.88 1.72 . . . . 0.0 111.437 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.598 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -91.05 127.48 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.949 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.3 mm? -75.72 -45.14 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.25 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -151.99 167.07 29.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.536 ' CE1' HG21 ' A' ' 32' ' ' ILE . 10.4 m-85 -115.16 124.41 51.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.401 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.501 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 91.9 mt -95.65 109.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.603 HG22 HG13 ' A' ' 75' ' ' ILE . 48.9 t -111.51 128.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -125.81 137.93 53.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.421 ' CE2' HD12 ' A' ' 49' ' ' LEU . 47.1 p90 -140.99 155.74 46.16 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.935 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.77 175.32 11.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' LYS . 10.1 m -88.52 137.69 32.1 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.206 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -65.46 -34.19 77.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -10.88 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.615 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' SER . 40.5 mtmt -140.84 161.22 38.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 109.959 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -149.03 51.46 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.037 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -139.96 4.96 2.11 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.674 0.274 . . . . 0.0 111.001 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -138.56 144.11 39.72 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.494 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -141.38 112.18 7.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 110.546 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.421 HD12 ' CE2' ' A' ' 39' ' ' TYR . 96.1 mt -76.43 159.89 30.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.18 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -119.67 150.38 40.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.383 0.611 . . . . 0.0 112.026 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? -153.04 114.45 4.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.219 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.501 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 71.8 mmtt -95.29 144.36 25.93 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.09 159.08 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.185 0.517 . . . . 0.0 110.875 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 67.5 tp60 -78.43 143.78 36.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.893 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.06 -25.01 59.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.433 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 21.1 m120 -95.3 -12.25 26.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 16.9 mttm -64.06 -45.3 89.4 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.3 p30 47.78 38.61 9.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.819 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.04 154.0 0.65 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.785 0.326 . . . . 0.0 110.822 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -155.07 150.89 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 121.253 0.549 . . . . 0.0 110.758 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.34 109.51 27.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.035 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.75 106.23 18.2 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -84.67 149.26 25.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.685 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.5 t60 79.42 70.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.753 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -126.25 81.35 1.99 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' A' ' 68' ' ' THR . 16.5 tt0 -38.1 140.98 0.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 111.336 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -68.9 -29.53 67.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.797 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.429 ' H ' ' HG2' ' A' ' 66' ' ' GLN . 5.8 p -97.22 22.1 9.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 42.3 mtp -147.97 128.67 14.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.835 0.35 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.54 167.38 50.34 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.26 132.65 22.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.11 150.73 20.78 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.18 132.83 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -122.86 109.85 14.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.603 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -98.7 131.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.136 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -134.67 120.33 19.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.94 125.96 35.56 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.09 22.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.548 HD21 HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -115.98 -171.51 2.0 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.949 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -41.99 -35.11 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.406 . . . . 0.0 110.217 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.548 HD23 HD21 ' A' ' 79' ' ' ASN . 4.2 mm? -64.14 -40.49 96.26 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 120.86 -41.76 1.85 Allowed Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.0 m-85 -155.96 135.53 12.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -163.03 155.98 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.789 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.537 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 18.8 tt0 45.04 56.19 14.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.25 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.23 154.89 56.72 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.738 2.292 . . . . 0.0 111.119 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.46 HG21 HG12 ' A' ' 8' ' ' ILE . 35.4 m -130.46 121.15 25.3 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.62 0.724 . . . . 0.0 111.018 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.81 94.44 3.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 37.7 t80 -99.86 125.35 45.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.724 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.07 130.38 49.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.73 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.7 p90 -163.79 134.19 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.601 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -80.56 164.46 22.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.6 mmm -94.76 145.75 30.17 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.918 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.39 163.49 37.6 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.323 2.015 . . . . 0.0 110.937 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.22 154.95 72.14 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.455 2.103 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -40.37 132.77 1.63 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.801 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.85 155.04 48.74 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.805 1.67 . . . . 0.0 111.697 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -80.73 -75.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.988 0.423 . . . . 0.0 110.123 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 100' ' ' ILE . 6.2 tt -151.7 -48.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.417 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.434 ' N ' HG23 ' A' ' 99' ' ' ILE . 11.5 tt -44.88 152.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.558 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 102' ' ' ASP . 63.6 mmtt -51.15 175.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.068 0.461 . . . . 0.0 111.008 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 101' ' ' LYS . 67.5 t0 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.777 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.549 ' HD2' ' H1 ' ' A' ' 1' ' ' ARG . 10.8 mpt_? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 1' ' ' ARG . 5.3 pt-20 -25.41 86.75 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.684 0 O-C-N 123.879 0.737 . . . . 0.0 112.283 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' N ' ' O ' ' A' ' 1' ' ' ARG . 48.2 Cg_endo -101.93 -164.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.679 2.919 . . . . 0.0 110.517 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -169.29 154.12 5.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.486 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' SER . 76.4 Cg_exo -36.1 162.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.261 2.641 . . . . 0.0 112.793 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.0 Cg_exo -37.38 164.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.768 2.312 . . . . 0.0 113.629 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.57 53.15 0.78 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.689 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 mm -130.04 128.4 64.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -119.09 114.71 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.47 145.64 17.75 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.659 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -148.38 116.46 3.99 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -50.02 104.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.248 1.299 . . . . 0.0 112.252 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -80.76 167.32 20.1 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.1 t -43.27 118.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.38 -150.21 21.15 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -82.18 -6.09 58.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 110.576 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -66.37 143.26 57.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.53 121.76 37.3 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -83.7 108.73 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.437 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 mt -101.81 108.83 20.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -83.4 121.96 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.004 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.3 mm -86.06 115.03 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -86.83 127.18 35.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.191 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -47.16 105.2 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.412 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 27' ' ' ASP . 78.7 mt-30 -81.44 158.35 24.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.858 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 35.1 t0 -51.16 -9.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.603 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER 64.83 131.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 1' ' ' ARG . . . -40.05 -19.73 0.02 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 138.46 17.87 0.57 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -157.69 152.47 21.01 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.53 138.91 61.79 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.811 1.674 . . . . 0.0 111.732 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.565 HG21 ' CE1' ' A' ' 35' ' ' TYR . 6.4 mt -89.22 133.33 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.218 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.7 mp -89.51 -25.18 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.177 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -164.64 164.62 21.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.176 0.512 . . . . 0.0 111.436 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.565 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.4 m-85 -119.37 117.49 28.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.076 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.7 mt -91.54 116.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG13 ' A' ' 75' ' ' ILE . 75.2 t -115.36 130.0 70.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.542 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -129.22 129.07 44.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CE2' HD12 ' A' ' 49' ' ' LEU . 39.1 p90 -134.1 155.92 49.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.49 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 26.9 ptt85 -149.58 171.1 17.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.504 ' HG ' ' HE2' ' A' ' 71' ' ' TYR . 4.4 m -80.8 138.07 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -63.94 -32.17 73.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.702 0.287 . . . . 0.0 111.447 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.99 -29.36 69.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.646 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' SER . 38.5 mtmt -130.96 166.61 20.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.488 0.661 . . . . 0.0 110.996 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -144.74 16.21 1.6 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.558 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -90.14 -0.25 57.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.881 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -149.36 152.14 35.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 111.727 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.434 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 49.9 m95 -141.26 114.37 8.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.863 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 39' ' ' TYR . 91.5 mt -75.08 159.55 31.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.915 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -117.65 153.64 32.96 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.18 0.514 . . . . 0.0 111.508 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.47 113.59 2.88 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -95.89 143.73 26.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.567 0.223 . . . . 0.0 110.576 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.4 160.78 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 110.591 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 6.5 tt0 -79.1 148.68 32.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.026 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.21 2.31 14.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.46 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 9.4 t-20 -121.54 -15.66 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.67 0.271 . . . . 0.0 110.962 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.81 -47.98 81.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 110.233 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 54.89 34.8 22.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.333 0.587 . . . . 0.0 111.319 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.44 156.66 2.01 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.705 -0.622 . . . . 0.0 110.94 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -156.06 155.46 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.634 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.7 107.55 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 62' ' ' LEU . 2.0 mm? -92.5 107.47 19.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.06 157.44 18.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.592 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 73.23 68.6 0.11 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.712 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.5 mt -125.07 82.18 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.064 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 73.3 mt-30 -36.16 141.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.115 0.484 . . . . 0.0 111.555 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -74.75 -7.57 53.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.673 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -112.55 16.67 19.69 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtp -143.5 142.31 31.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.965 0.412 . . . . 0.0 110.188 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.17 164.19 25.83 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.504 ' HE2' ' HG ' ' A' ' 41' ' ' SER . 92.2 m-85 -146.49 137.19 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 111.277 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.4 mt-10 -97.96 149.86 21.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.87 133.83 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.48 106.96 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.592 0.71 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.596 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -93.03 132.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.539 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 m -134.79 121.74 21.12 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -94.55 126.54 39.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.3 112.58 24.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 112.181 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.9 p-10 -119.07 -165.71 1.17 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.986 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.42 -30.53 19.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD22 HD21 ' A' ' 79' ' ' ASN . 8.6 mp -63.46 -39.15 93.7 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 118.64 -46.65 1.11 Allowed Glycine 0 N--CA 1.463 0.474 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 5.2 m-85 -155.8 128.75 8.03 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.502 ' O ' ' C ' ' A' ' 85' ' ' GLU . 3.7 m -113.06 148.32 35.44 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 84' ' ' SER . 1.2 mp0 -12.6 98.03 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 124.225 0.953 . . . . 0.0 111.846 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.55 158.36 53.96 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.133 1.222 . . . . 0.0 111.325 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.8 m -105.71 114.19 28.21 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.534 0.683 . . . . 0.0 110.105 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -91.36 94.46 4.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.2 t80 -98.5 128.16 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.827 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.21 129.76 48.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 14.8 p90 -159.38 126.87 4.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.73 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.62 161.12 23.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.057 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.4 mmm -90.67 139.12 26.29 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.29 163.05 35.44 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.38 2.053 . . . . 0.0 111.103 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 152.12 82.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.071 1.847 . . . . 0.0 111.04 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -39.71 131.6 1.43 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.408 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.08 144.4 63.41 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.501 1.467 . . . . 0.0 112.317 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -117.88 -77.99 0.58 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.828 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.8 pt -126.19 -1.42 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.424 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 101' ' ' LYS . 20.9 tt -65.72 -41.35 90.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.495 ' N ' HG23 ' A' ' 100' ' ' ILE . 24.1 ttpt 73.9 167.81 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.601 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.511 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.442 ' NH2' HD12 ' A' ' 81' ' ' LEU . 2.9 ttm180 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 1' ' ' ARG . 15.8 mt-10 -27.9 92.13 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.809 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -101.36 -164.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 123.902 3.068 . . . . 0.0 109.959 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -168.36 155.32 7.3 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.634 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' SER . 81.7 Cg_exo -38.5 170.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.402 2.735 . . . . 0.0 113.245 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.78 151.25 26.5 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.125 1.883 . . . . 0.0 114.275 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.02 30.29 3.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.955 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.36 120.06 54.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.283 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -115.73 116.23 27.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.302 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.55 156.29 21.52 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -157.68 133.41 5.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.29 82.73 1.06 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.322 1.348 . . . . 0.0 112.136 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -58.4 -173.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.5 p -56.48 122.36 11.76 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.272 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.06 -154.03 31.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HE2' ' H ' ' A' ' 66' ' ' GLN . 15.4 mtmm -78.1 -9.09 58.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.473 -0.363 . . . . 0.0 110.897 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 p -64.66 143.4 57.95 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.114 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.91 126.34 49.77 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -87.84 98.39 11.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mt -93.71 99.83 12.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -73.96 119.23 17.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.266 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.441 HG21 ' CD2' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -84.88 108.69 17.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.297 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -87.62 129.07 35.24 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -44.62 105.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -90.39 153.53 20.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.03 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -57.84 103.01 0.11 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 55.1 p-10 -57.52 145.39 33.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.103 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.63 -46.71 7.31 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.29 18.68 0.02 OUTLIER Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.397 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -158.78 156.43 26.89 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.41 0.605 . . . . 0.0 110.231 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.35 144.2 85.17 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.136 1.891 . . . . 0.0 110.967 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.583 HG21 ' CE1' ' A' ' 35' ' ' TYR . 5.7 mt -91.82 124.37 44.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.248 0.547 . . . . 0.0 111.454 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.78 -41.05 68.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.029 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.33 171.85 19.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.27 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -120.78 114.28 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.832 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -89.45 115.4 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG22 HG13 ' A' ' 75' ' ' ILE . 96.4 t -111.91 128.54 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -124.34 128.12 48.62 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' CE2' HD12 ' A' ' 49' ' ' LEU . 35.3 p90 -135.32 153.74 51.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.691 0.281 . . . . 0.0 110.875 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE1' ' A' ' 72' ' ' GLU . 29.3 ptt85 -147.23 171.72 14.95 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.4 m -81.4 137.77 35.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.494 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.36 -29.14 70.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.554 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.15 -31.05 72.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.244 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -119.82 171.73 8.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.769 0.795 . . . . 0.0 111.546 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -152.22 4.68 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.722 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -90.55 -1.33 57.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.426 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -140.62 138.45 34.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.239 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 44.9 m95 -134.62 108.45 8.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.907 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.486 HD12 ' CE2' ' A' ' 39' ' ' TYR . 84.6 mt -71.65 159.39 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.56 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 1.3 pm0 -124.42 147.19 48.44 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -145.45 111.89 5.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -84.79 142.35 29.85 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 35' ' ' TYR . 38.8 t -136.41 156.03 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.434 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 7.9 tp-100 -78.42 146.66 34.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.768 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.05 -6.4 45.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -111.47 -15.6 13.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.51 0.195 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HD2' ' H ' ' A' ' 54' ' ' GLN . 23.0 mttm -62.06 -49.1 77.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.285 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 53.34 36.07 21.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.412 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.98 154.07 0.67 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -154.68 146.13 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 110.587 179.145 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mm -114.82 115.52 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.26 105.59 16.26 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.6 154.19 25.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.7 t60 69.97 67.0 0.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.961 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' GLN . 57.4 mt -107.84 -7.92 16.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 65' ' ' LEU . 74.6 mt-30 55.72 147.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 111.646 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -91.94 -18.4 23.77 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.038 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.3 p -106.48 18.8 21.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 10.8 ttm -146.5 138.84 25.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 170.47 34.34 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -149.35 134.27 17.96 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 5.1 mt-10 -98.87 152.81 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.06 135.37 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.017 0.437 . . . . 0.0 110.767 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -128.22 108.27 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.983 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.612 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -92.18 137.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.543 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -137.19 117.86 13.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.11 126.64 35.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.68 112.23 25.24 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.315 0.578 . . . . 0.0 112.184 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.6 p-10 -114.73 -168.25 1.35 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.804 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -51.31 -30.48 18.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.621 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -63.18 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.11 -47.45 1.02 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -155.53 139.02 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' GLU . 1.3 t -131.84 135.46 46.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.75 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.6 mm-40 11.9 94.04 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 124.365 1.041 . . . . 0.0 112.091 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.38 154.26 55.91 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 120.995 1.13 . . . . 0.0 111.679 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.82 111.76 24.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 88' ' ' VAL . 28.6 m -94.64 96.62 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.165 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.481 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -101.8 130.43 48.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.264 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.52 130.68 44.44 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.167 0.508 . . . . 0.0 111.729 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 13.0 p90 -165.94 140.14 4.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.064 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -91.27 171.29 9.33 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.453 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.0 mmm -96.61 139.74 21.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.08 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.21 163.18 37.12 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.22 1.947 . . . . 0.0 110.955 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.95 147.61 91.89 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.39 2.06 . . . . 0.0 111.764 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -41.45 134.52 2.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.02 158.19 46.11 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 121.61 1.54 . . . . 0.0 111.435 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -66.81 0.77 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 99' ' ' ILE . 9.0 tt -177.86 92.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.209 0.528 . . . . 0.0 110.711 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.453 ' CG1' ' N ' ' A' ' 101' ' ' LYS . 6.4 tt -177.77 161.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.824 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 21.2 tptm -51.19 113.86 1.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.086 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.7 m-20 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.936 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 26' ' ' ASP . 1.2 mm-40 -152.33 93.06 3.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.663 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -97.42 -163.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 123.449 2.766 . . . . 0.0 109.142 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 1.9 p -177.26 156.5 1.22 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.542 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' PRO . 54.4 Cg_exo -36.21 161.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.96 2.44 . . . . 0.0 112.73 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -33.96 167.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 123.714 2.943 . . . . 0.0 116.155 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.425 ' H ' ' CG2' ' A' ' 87' ' ' THR . 0.2 OUTLIER -165.06 46.47 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.917 -177.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.99 129.28 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 111.579 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -119.26 116.91 27.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.184 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.55 155.95 19.4 Favored Glycine 0 N--CA 1.467 0.712 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.331 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -158.56 132.61 5.08 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 89.5 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.376 1.384 . . . . 0.0 110.923 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 t -60.73 -85.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.349 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 17' ' ' SER . 90.7 p -128.12 127.74 43.59 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.752 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.08 -128.67 31.48 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 65' ' ' LEU . 40.5 mttt -89.5 -5.6 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 14' ' ' SER . 85.7 p -61.75 144.87 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.425 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 120.78 27.26 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -88.03 101.18 13.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.272 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 mt -96.5 96.56 8.77 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 t -67.62 130.68 43.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.451 HD12 HG12 ' A' ' 75' ' ' ILE . 5.2 mm -91.74 117.16 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.3 m -84.17 128.33 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.762 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -63.05 105.23 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 18.2 mm100 -101.31 167.18 10.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.299 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' GLU . 99.3 m-20 -59.63 95.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 26.6 t70 -42.38 -64.55 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.657 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.62 -23.36 0.22 Allowed Glycine 0 C--N 1.318 -0.47 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.36 5.08 0.09 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.684 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.431 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -156.79 142.68 12.85 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 118.187 0.994 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.71 150.73 60.1 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.067 1.178 . . . . 0.0 111.927 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.588 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.4 mt -91.79 128.19 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.491 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.8 mt -72.95 -42.56 63.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -155.53 163.66 39.7 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.635 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.8 m-85 -110.98 127.12 55.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.058 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.51 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 85.9 mt -99.95 110.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.577 HG22 HG13 ' A' ' 75' ' ' ILE . 99.6 t -109.21 127.09 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.855 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -126.17 128.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 49' ' ' LEU . 41.7 p90 -132.9 151.51 52.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -142.34 172.82 12.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.397 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.9 p -84.17 147.24 27.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HZ2' ' N ' ' A' ' 92' ' ' SER . 95.4 mttt -75.24 4.64 6.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.74 -49.88 2.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 45' ' ' GLU . 11.2 mmpt? -60.92 -45.42 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.932 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 81.8 tt0 36.18 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.449 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 45' ' ' GLU . 1.9 m-20 167.15 -15.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.571 0.545 . . . . 0.0 110.493 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -137.24 117.74 13.81 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.56 0.219 . . . . 0.0 110.923 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -99.95 116.67 32.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.851 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.423 HD12 ' CE2' ' A' ' 39' ' ' TYR . 92.4 mt -73.45 160.07 32.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.182 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 25.0 mp0 -117.0 150.55 38.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.341 0.591 . . . . 0.0 112.47 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.24 115.33 4.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.51 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 73.0 mmtt -97.52 146.0 25.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.42 155.67 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.034 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.516 ' C ' ' H ' ' A' ' 56' ' ' ASN . 11.4 tt0 -78.08 137.24 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.208 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 7.07 0.16 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 54' ' ' GLN . 66.0 t30 -122.18 -13.97 8.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.793 0.297 . . . . 0.0 110.755 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -69.72 -53.08 20.16 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.811 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 58.28 40.06 24.98 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.648 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -178.05 153.15 0.78 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.564 HD13 HG21 ' A' ' 37' ' ' VAL . 1.4 pt -152.45 143.31 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.204 0.526 . . . . 0.0 111.428 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.6 mm -114.56 115.79 50.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.14 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.0 mt -103.73 105.52 15.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.5 152.2 23.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.225 0.536 . . . . 0.0 112.188 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t60 66.06 76.68 0.31 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.28 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.747 HD13 ' OH ' ' A' ' 71' ' ' TYR . 86.2 mt -111.52 -4.12 14.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' O ' ' SD ' ' A' ' 93' ' ' MET . 83.3 mt-30 52.49 120.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.877 0.846 . . . . 0.0 112.241 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -61.31 -32.04 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.093 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -94.52 22.87 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.3 tpt -144.46 114.73 7.51 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.395 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.78 155.59 32.09 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.747 ' OH ' HD13 ' A' ' 65' ' ' LEU . 48.5 p90 -151.29 138.29 19.1 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.54 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.96 156.21 19.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.642 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 132.71 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -126.12 110.82 13.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.373 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.577 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -91.76 137.24 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.768 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.82 117.24 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.59 124.38 34.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.26 113.43 26.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.268 0.556 . . . . 0.0 112.358 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -116.62 -163.38 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -52.75 -33.33 47.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 81' ' ' LEU . 8.5 mp -64.12 -40.98 97.37 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 126.09 -49.64 0.91 Allowed Glycine 0 N--CA 1.463 0.452 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.8 m-85 -154.46 133.96 12.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 t -159.85 170.28 21.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 25' ' ' GLN . 16.6 pt-20 39.91 51.41 3.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.392 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.76 148.37 82.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.941 1.76 . . . . 0.0 111.263 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.425 ' CG2' ' H ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -125.32 110.35 13.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 99.25 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.523 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -104.56 131.75 51.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.956 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -131.84 132.58 43.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 6.6 p90 -173.69 125.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.208 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.557 ' N ' ' HZ2' ' A' ' 42' ' ' LYS . 11.9 p -80.77 166.29 21.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.3 mtp -88.41 147.47 40.01 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.956 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.07 162.66 28.76 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.421 2.081 . . . . 0.0 110.211 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 96' ' ' LYS . 38.2 Cg_endo -65.6 153.64 77.29 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.912 1.741 . . . . 0.0 110.822 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 95' ' ' PRO . 4.1 tppp? -36.62 133.05 0.65 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.555 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.47 144.48 50.39 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.465 1.443 . . . . 0.0 111.818 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -98.13 -17.4 19.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.011 0.434 . . . . 0.0 110.135 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' LYS . 26.7 pt -104.98 -8.26 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.097 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.4 pt 39.23 16.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.327 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' ILE . 88.6 tttt -82.32 -68.84 0.67 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.387 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.1 t0 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.092 -179.3 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 2' ' ' GLU . 83.7 mtt85 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 1' ' ' ARG . 1.5 pm0 6.26 76.32 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 124.204 0.94 . . . . 0.0 112.936 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -100.13 -165.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.608 2.872 . . . . 0.0 110.82 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -169.76 151.56 4.26 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.637 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.3 Cg_exo -39.8 162.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.508 2.139 . . . . 0.0 112.629 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 32.8 Cg_exo -38.7 166.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.85 2.367 . . . . 0.0 113.322 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.25 41.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.683 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.08 124.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.578 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -116.14 118.96 34.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.462 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.64 140.91 15.06 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.474 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -143.73 146.51 35.21 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.2 80.46 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.828 1.685 . . . . 0.0 111.447 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.4 t -48.03 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -139.63 136.99 34.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.064 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.6 -130.76 37.34 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -95.17 -4.01 46.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -68.81 144.11 54.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.001 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.48 128.2 47.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 110.246 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -88.08 103.62 15.91 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mt -99.13 91.98 5.25 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -66.86 124.8 23.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.494 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.422 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.4 mm -86.97 115.72 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -95.13 119.3 33.4 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.488 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -38.28 105.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.49 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -95.0 148.87 21.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 97.9 m-20 -54.67 95.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.53 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 30' ' ' ALA . 28.3 t70 -48.02 169.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.609 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.43 84.08 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.67 22.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.811 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -159.05 151.66 17.96 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.58 140.62 57.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.435 1.423 . . . . 0.0 110.529 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.577 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.5 mt -83.48 127.71 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.82 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 33' ' ' LEU . 9.4 mp -75.18 -43.11 53.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.287 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -152.83 163.33 39.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.387 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.493 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -111.39 122.83 48.87 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.954 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.46 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 87.3 mt -96.47 107.93 20.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 75' ' ' ILE . 74.3 t -107.37 125.03 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.26 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -122.35 136.82 54.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 49' ' ' LEU . 33.0 p90 -143.18 152.15 41.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.679 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.474 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 35.6 ptt85 -148.39 173.43 13.09 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 111.634 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -79.08 147.83 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.266 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -69.36 -32.03 70.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.679 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -75.15 -47.31 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -57.51 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.856 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 58.18 76.66 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.762 0.791 . . . . 0.0 110.116 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 61.2 t0 -175.61 -21.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.3 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -138.47 158.13 44.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.2 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 63.4 m95 -136.12 134.29 38.17 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 112.209 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 39' ' ' TYR . 96.7 mt -84.79 160.38 20.25 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -118.07 149.1 41.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.26 0.552 . . . . 0.0 112.091 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.09 114.36 4.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 71.4 mmtt -98.92 144.7 27.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.668 0.27 . . . . 0.0 110.959 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.76 157.77 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.11 0.481 . . . . 0.0 110.648 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -70.6 149.53 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.448 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.89 -7.09 14.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.189 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -121.47 0.13 9.9 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.088 0.444 . . . . 0.0 111.346 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -61.83 -46.77 88.05 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.442 0.639 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 52.99 31.52 11.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.835 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.36 150.55 0.44 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.34 146.86 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.111 0.481 . . . . 0.0 111.243 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mm -113.9 117.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.35 105.65 15.79 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.612 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 65.5 mt-10 -96.93 119.7 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 28.9 m-70 122.65 54.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.997 1.436 . . . . 0.0 111.018 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.593 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 23.1 mt -111.89 105.24 13.64 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.485 ' O ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -59.06 135.85 57.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.237 0.542 . . . . 0.0 111.204 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -66.21 -23.81 66.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.075 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 p -104.82 18.23 22.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.9 mtp -149.79 129.97 13.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.027 0.442 . . . . 0.0 110.706 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.33 44.3 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.593 ' CZ ' HD13 ' A' ' 65' ' ' LEU . 9.3 p90 -157.46 132.11 8.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.286 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -87.27 154.29 20.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.007 0.432 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.53 134.0 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -124.62 110.46 14.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.496 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.572 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -95.82 132.4 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -136.76 118.29 14.84 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.577 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -90.13 126.24 35.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.61 108.41 19.68 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.661 HD21 HD23 ' A' ' 81' ' ' LEU . 1.1 p-10 -114.5 -175.11 2.61 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.303 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -40.3 -33.71 0.27 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.661 HD23 HD21 ' A' ' 79' ' ' ASN . 4.1 mm? -63.96 -42.8 97.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.496 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.93 -48.5 0.97 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -155.83 131.63 9.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.04 162.39 20.35 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER 52.88 51.87 9.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 98.0 Cg_endo -74.01 152.83 46.57 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.381 2.054 . . . . 0.0 111.258 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 m -133.93 117.74 17.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.368 0.604 . . . . 0.0 110.714 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -96.6 94.49 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.422 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 34.0 t80 -98.61 134.82 41.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.538 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -137.89 130.5 29.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 23.1 p90 -163.97 131.44 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.982 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -79.83 167.85 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 28.0 mtp -97.89 151.79 37.75 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.966 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.96 163.9 22.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.536 2.157 . . . . 0.0 110.012 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.35 156.38 63.59 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.774 1.649 . . . . 0.0 111.068 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -38.51 130.22 1.08 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.505 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.7 142.82 49.23 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.726 1.617 . . . . 0.0 112.725 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -95.52 -80.64 0.42 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.5 pt -73.57 -22.37 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.759 0.79 . . . . 0.0 109.066 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.7 mt 72.22 136.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 113.844 -1.526 . . . . 0.0 111.035 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -139.2 152.58 47.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.399 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.642 -179.752 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 26' ' ' ASP . 31.7 mt-10 -151.85 73.89 7.87 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -102.03 -165.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.677 2.918 . . . . 0.0 111.636 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.4 166.2 2.9 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.474 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.6 Cg_exo -39.94 161.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.977 2.451 . . . . 0.0 112.601 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.5 Cg_exo -37.3 167.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 123.305 2.67 . . . . 0.0 114.091 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.97 54.78 0.52 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.541 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.401 HG12 HG21 ' A' ' 87' ' ' THR . 6.0 mm -132.91 130.14 58.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.108 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -123.84 114.31 19.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.81 138.35 14.53 Favored Glycine 0 N--CA 1.46 0.297 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.45 116.95 8.6 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.556 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -52.03 103.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 120.945 1.096 . . . . 0.0 111.664 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.9 p -85.37 172.02 11.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 m -41.55 106.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.819 0.342 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.29 -154.01 21.28 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.005 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -77.23 -19.65 56.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.516 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.434 ' OG ' HG22 ' A' ' 61' ' ' ILE . 13.6 t -59.01 139.11 57.17 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.171 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.92 122.11 46.67 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -86.1 109.0 18.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.792 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.27 105.72 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 119.09 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.45 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.4 mm -84.08 112.47 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 5.9 m -79.35 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.034 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.516 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.84 104.89 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.513 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -100.59 158.85 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 2' ' ' GLU . 45.9 m-20 -61.88 95.38 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 32.4 t70 -43.41 168.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.135 0.493 . . . . 0.0 111.183 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' HA2' ' H ' ' A' ' 2' ' ' GLU . . . -55.71 -42.44 85.15 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 15.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.905 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.43 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -159.64 151.36 16.77 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.886 0.843 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.45 142.52 80.36 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.988 1.125 . . . . 0.0 111.59 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.524 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.5 mt -86.56 125.17 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.354 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -72.06 -40.76 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.805 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.39 167.27 26.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.07 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 32' ' ' ILE . 14.6 m-85 -112.06 119.93 40.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.875 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.6 mt -92.18 113.07 26.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 75' ' ' ILE . 61.2 t -113.57 129.34 69.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.286 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -127.78 133.82 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CE2' HD12 ' A' ' 49' ' ' LEU . 29.7 p90 -139.26 154.05 47.91 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.044 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.0 174.02 11.65 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.533 ' OG ' ' CE2' ' A' ' 71' ' ' TYR . 4.3 m -84.21 136.76 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.007 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.83 -35.36 78.01 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.879 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -63.11 -35.49 80.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -98.68 178.05 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.801 0.81 . . . . 0.0 111.432 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -160.05 -5.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.777 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -91.6 9.02 33.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -149.72 150.45 32.1 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.805 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.43 109.06 5.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.722 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.492 HD12 ' CE2' ' A' ' 39' ' ' TYR . 56.4 mt -72.61 159.91 33.11 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.506 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -121.72 151.72 40.2 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.09 0.472 . . . . 0.0 111.558 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.44 114.66 3.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -96.2 142.3 28.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.29 138.25 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.25 0.548 . . . . 0.0 111.038 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' C ' ' H ' ' A' ' 56' ' ' ASN . 48.9 tt0 -59.71 142.53 52.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.5 14.8 0.93 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.135 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 m120 -132.09 9.88 4.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 21.3 mttt -91.74 -46.3 7.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.663 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 49.69 39.13 16.88 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.64 0.588 . . . . 0.0 111.887 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -179.57 151.9 0.48 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.707 0.289 . . . . 0.0 110.798 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -151.61 146.58 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.383 0.611 . . . . 0.0 111.092 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.434 HG22 ' OG ' ' A' ' 17' ' ' SER . 45.1 mm -114.86 111.65 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.83 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -100.03 107.75 19.76 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 98.8 mt-10 -84.88 156.06 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.523 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 6.3 t-80 78.76 52.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.6 mm? -107.71 88.22 2.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -51.0 135.96 23.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.646 . . . . 0.0 111.335 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -64.39 -34.13 77.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.444 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.8 p -96.33 20.81 9.89 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.7 mtp -143.34 140.0 30.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.206 0.527 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.8 162.61 24.26 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.533 ' CE2' ' OG ' ' A' ' 41' ' ' SER . 43.3 m-85 -144.34 135.5 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.046 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -94.69 149.86 20.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.33 133.42 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -123.24 108.41 12.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.475 0.655 . . . . 0.0 109.705 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -96.87 131.21 44.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.923 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -135.47 119.47 17.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.98 126.21 35.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.07 116.05 31.3 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 112.46 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.543 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 4.1 p-10 -115.9 -166.55 1.15 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -51.78 -31.48 27.19 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.625 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.9 mm? -64.05 -42.54 97.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.488 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.82 -45.05 1.19 Allowed Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.488 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.1 m-85 -153.64 140.67 19.31 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -163.76 153.86 15.16 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.574 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' CD ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER 44.32 60.13 12.46 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.593 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 152.4 43.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.242 1.961 . . . . 0.0 110.965 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.401 HG21 HG12 ' A' ' 8' ' ' ILE . 23.0 m -131.23 118.44 20.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.65 0.738 . . . . 0.0 111.467 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.7 94.22 4.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.701 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -98.96 127.15 44.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.148 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.6 132.97 45.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.253 0.549 . . . . 0.0 110.967 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.581 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.1 p90 -166.49 140.07 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.334 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.9 156.49 19.33 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 85.8 mmm -85.88 147.4 45.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.48 162.76 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.343 2.029 . . . . 0.0 110.98 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.07 158.73 50.23 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.244 1.963 . . . . 0.0 111.121 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.91 129.89 0.95 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.447 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.453 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 37.1 Cg_endo -66.37 143.51 70.25 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.327 1.351 . . . . 0.0 112.425 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 100' ' ' ILE . 96.3 m-20 -148.72 99.36 2.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.632 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.4 pt 40.52 16.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.723 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.73 HD13 ' N ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -100.13 128.74 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.295 0.569 . . . . 0.0 109.85 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.73 ' N ' HD13 ' A' ' 100' ' ' ILE . 48.8 tttm -61.87 136.69 58.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.997 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 11.8 p30 . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.863 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -167.49 85.52 0.79 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -99.46 -164.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 123.65 2.9 . . . . 0.0 110.335 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.54 169.33 2.15 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.485 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' PRO . 79.0 Cg_exo -39.66 161.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.559 2.173 . . . . 0.0 111.913 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 22.3 Cg_exo -38.49 169.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.662 2.241 . . . . 0.0 114.93 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.453 ' H ' HG21 ' A' ' 87' ' ' THR . 15.2 m -156.56 46.19 0.43 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.347 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.27 127.11 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.331 0.586 . . . . 0.0 110.554 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -117.53 116.55 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.142 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.0 147.35 18.56 Favored Glycine 0 N--CA 1.464 0.517 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.3 130.43 8.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.94 81.97 1.59 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.43 1.42 . . . . 0.0 111.988 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.452 ' OG ' ' N ' ' A' ' 14' ' ' SER . 47.2 t -60.05 -159.73 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.452 ' N ' ' OG ' ' A' ' 13' ' ' SER . 33.4 t -63.33 134.52 55.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.246 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.53 -146.16 33.87 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.766 0.317 . . . . 0.0 110.62 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -64.97 148.89 50.76 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.775 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.3 121.17 33.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.693 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -83.97 98.51 9.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 90.21 7.25 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -69.72 117.55 11.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.754 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.443 HG21 ' CE2' ' A' ' 35' ' ' TYR . 4.6 mm -77.63 126.36 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -104.2 116.51 32.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 110.472 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -39.47 104.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.787 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.26 165.18 11.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 43.0 t0 -57.94 109.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.897 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -71.58 165.65 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.98 31.98 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.54 -0.28 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.1 151.58 75.54 Favored Pre-proline 0 N--CA 1.463 0.22 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.21 143.58 65.3 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.865 1.71 . . . . 0.0 111.278 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.583 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.1 mt -86.74 126.44 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.761 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.9 mp -72.81 -41.38 64.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.138 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.02 165.67 35.76 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.375 0.607 . . . . 0.0 111.481 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.534 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -115.38 119.98 38.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.221 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.93 115.11 31.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 75' ' ' ILE . 38.7 t -118.89 131.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.072 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -125.56 139.76 53.33 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.465 ' CE2' HD12 ' A' ' 49' ' ' LEU . 37.2 p90 -143.6 156.25 44.52 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.278 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.48 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 34.5 ptt85 -149.54 174.8 12.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 m -82.23 143.04 31.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -63.64 -39.46 94.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 7.0 t0 -76.6 -46.13 27.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.102 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' CE ' ' HE1' ' A' ' 69' ' ' MET . 1.4 mppt? -89.03 91.38 8.8 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -98.58 65.94 1.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.292 179.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -136.29 -5.87 2.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -146.59 155.87 42.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.991 0.424 . . . . 0.0 111.36 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -136.23 114.28 11.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.156 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.465 HD12 ' CE2' ' A' ' 39' ' ' TYR . 79.9 mt -77.55 160.31 28.69 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.908 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -111.04 155.62 22.5 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.788 0.328 . . . . 0.0 111.136 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -159.09 112.39 2.29 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -98.71 143.16 29.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.749 0.309 . . . . 0.0 111.289 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.66 156.54 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.42 0.629 . . . . 0.0 110.542 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 48.4 tt0 -82.09 144.35 30.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.307 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.6 81.42 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.523 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 32.8 m-20 -67.1 -39.3 86.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.295 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 54' ' ' GLN . 74.0 mttt -55.27 -71.87 0.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.549 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 60.34 49.37 7.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.437 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -176.04 140.13 0.4 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -141.85 151.83 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.393 0.616 . . . . 0.0 112.329 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -122.47 101.49 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 62' ' ' LEU . 9.1 mp -92.06 107.24 19.07 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 64' ' ' HIS . 6.5 tm-20 -96.57 148.76 22.51 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.236 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.489 ' N ' ' CD ' ' A' ' 63' ' ' GLU . 19.2 t-80 93.0 48.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' O ' ' SD ' ' A' ' 93' ' ' MET . 20.9 mt -112.95 94.0 4.69 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.528 ' O ' ' SD ' ' A' ' 93' ' ' MET . 47.1 tt0 -45.48 148.47 0.68 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 110.95 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.18 -8.65 56.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.767 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 p -113.44 19.13 17.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.43 ' HE1' ' CE ' ' A' ' 44' ' ' LYS . 49.3 mtp -144.22 133.86 23.56 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.806 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.7 157.37 27.46 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -137.56 133.31 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.794 0.33 . . . . 0.0 110.789 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.5 mt-10 -92.4 147.94 22.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.63 134.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.93 0.395 . . . . 0.0 109.96 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -124.2 108.27 12.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.267 0.556 . . . . 0.0 109.983 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.513 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -93.38 135.95 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.955 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -136.37 116.57 13.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.76 126.6 35.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.88 112.7 25.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.325 0.583 . . . . 0.0 112.541 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 84' ' ' SER . 0.4 OUTLIER -114.53 -165.89 1.05 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -49.52 -33.12 13.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.834 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.5 mm? -64.7 -42.65 95.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.248 0.547 . . . . 0.0 109.635 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.35 -48.79 0.95 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.475 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.1 m-85 -154.01 137.71 16.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.44 ' HB2' HD22 ' A' ' 79' ' ' ASN . 74.2 m -160.22 164.24 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.348 0.594 . . . . 0.0 111.799 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 26' ' ' ASP . 16.9 pt-20 33.38 59.29 1.7 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.403 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 152.02 80.03 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.102 1.868 . . . . 0.0 109.963 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.453 HG21 ' H ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -124.57 111.24 15.42 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.0 110.714 -179.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.47 95.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -102.28 136.31 42.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -138.3 134.95 34.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 7.0 p90 -162.05 152.83 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.728 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.9 170.85 8.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.974 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 65' ' ' LEU . 36.4 mtp -105.62 145.6 31.17 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.426 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.17 161.95 31.91 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.375 2.05 . . . . 0.0 110.751 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.32 155.39 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.12 1.88 . . . . 0.0 110.872 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -37.94 132.16 0.91 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.541 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.37 146.75 69.84 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.677 1.585 . . . . 0.0 112.796 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -144.31 -43.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 100' ' ' ILE . 34.0 pt -91.47 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.463 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 99' ' ' ILE . 48.1 pt 43.64 124.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.281 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -175.26 120.34 0.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.96 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 2.9 p30 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.564 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.461 ' NH2' ' OE2' ' A' ' 85' ' ' GLU . 35.9 ptt180 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 1' ' ' ARG . 4.4 tp10 -15.8 82.36 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.751 0.82 . . . . 0.0 112.78 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.433 ' N ' ' O ' ' A' ' 1' ' ' ARG . 16.5 Cg_endo -104.09 -163.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 124.302 3.334 . . . . 0.0 111.292 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -171.15 157.06 4.8 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.96 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' SER . 89.6 Cg_exo -39.14 171.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 123.45 2.766 . . . . 0.0 113.036 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.49 147.68 37.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.785 1.656 . . . . 0.0 114.449 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.5 34.88 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.201 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mm -107.51 122.49 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.999 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.66 117.14 28.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.9 147.34 18.56 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -159.83 115.82 1.51 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -50.98 94.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.202 1.268 . . . . 0.0 111.984 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -76.55 -48.7 18.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.63 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.551 ' H ' ' HG ' ' A' ' 17' ' ' SER . 69.2 p -144.49 166.77 24.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.037 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -35.99 128.67 0.89 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 39.78 48.37 1.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.167 0.508 . . . . 0.0 111.071 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.551 ' HG ' ' H ' ' A' ' 14' ' ' SER . 11.8 p -142.1 150.89 41.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.484 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.12 120.91 14.41 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -84.81 97.9 9.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.04 89.82 7.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 t -66.88 125.83 27.17 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.542 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.438 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.2 mm -85.82 114.89 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.4 m -98.77 117.24 32.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.576 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.74 108.14 0.08 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.359 1.076 . . . . 0.0 110.518 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 26' ' ' ASP . 2.6 pt20 -115.63 101.54 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.152 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 25' ' ' GLN . 4.5 m-20 19.12 82.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.9 0.75 . . . . 0.0 111.779 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 29' ' ' GLY . 85.9 m-20 -50.67 131.47 25.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.046 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' ASP . . . -27.05 -35.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.961 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 163.93 0.08 0.05 OUTLIER Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.728 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.12 155.61 29.35 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 117.848 0.824 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -54.02 138.25 70.13 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 121.094 1.196 . . . . 0.0 111.767 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.567 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.2 mt -81.66 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.384 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.91 -40.07 69.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -162.19 170.63 18.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.718 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE2' HG21 ' A' ' 22' ' ' ILE . 21.3 m-85 -116.37 122.33 44.54 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.989 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.4 mt -96.93 114.17 33.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 75' ' ' ILE . 74.0 t -115.09 130.41 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.604 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CE2' HD12 ' A' ' 49' ' ' LEU . 23.8 p90 -140.77 152.55 45.31 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.637 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.523 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.2 ptt85 -145.64 172.9 12.59 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.521 ' HG ' ' HE1' ' A' ' 71' ' ' TYR . 11.0 m -79.92 139.86 36.92 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -62.3 -36.27 81.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.249 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.97 -37.38 86.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.543 0.211 . . . . 0.0 110.718 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.3 mmtt -101.13 150.95 22.4 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.499 0.666 . . . . 0.0 110.502 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -138.27 19.82 2.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.186 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 20.8 p-10 -128.19 18.33 6.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 0.0 110.519 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -142.04 112.7 7.25 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.501 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -119.29 118.16 30.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.588 0.708 . . . . 0.0 110.917 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.492 HD12 ' CE2' ' A' ' 39' ' ' TYR . 60.3 mt -79.9 159.77 26.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.462 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 51.5 mp0 -117.93 151.91 36.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.97 113.1 2.68 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -97.64 146.4 25.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.469 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.35 158.4 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.223 0.535 . . . . 0.0 110.081 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 56' ' ' ASN . 43.7 tp60 -71.23 146.54 48.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.451 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.45 3.55 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.924 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 t-20 -133.2 0.77 3.44 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.647 -0.325 . . . . 0.0 111.446 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.6 tptp -64.07 -43.22 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 48.56 31.62 3.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.717 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 178.74 152.49 0.34 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.191 0.307 . . . . 0.0 110.744 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 37' ' ' VAL . 2.7 pt -151.29 129.38 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.4 mm -99.38 103.26 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.3 mt -91.58 104.54 17.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 40.1 tt0 -95.77 151.18 19.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.254 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.479 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 3.9 t-160 89.11 60.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.253 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.95 91.84 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.91 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -39.15 143.58 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.422 0.63 . . . . 0.0 111.419 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -75.29 -9.07 58.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.039 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.8 p -114.34 19.7 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.604 0.24 . . . . 0.0 111.414 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -142.92 136.97 29.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.22 163.08 25.15 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.521 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 98.3 m-85 -144.69 129.49 18.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.581 0.229 . . . . 0.0 111.603 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.9 mt-10 -88.6 153.62 20.98 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.77 135.55 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.71 108.59 11.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.217 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -96.54 134.58 33.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.081 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.3 m -136.09 124.26 23.08 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.567 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -98.38 124.94 43.33 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.83 114.06 26.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 112.558 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -122.22 -175.63 3.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.33 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -39.8 -33.01 0.17 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.409 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 81' ' ' LEU . 9.6 mp -63.53 -42.55 98.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.414 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 125.81 -49.94 0.89 Allowed Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 13.1 m-85 -153.73 122.07 6.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 77' ' ' ALA . 82.7 p -88.15 176.89 7.07 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.143 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.461 ' OE2' ' NH2' ' A' ' 1' ' ' ARG . 11.3 mm-40 -49.11 112.96 2.76 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.45 159.43 49.2 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.049 1.166 . . . . 0.0 111.669 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.79 113.75 25.98 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.519 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.05 98.33 7.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.469 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 39.4 t80 -103.43 138.2 40.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -135.27 134.55 40.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.252 0.548 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.4 p90 -171.33 129.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.577 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -82.51 165.46 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.531 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.9 mmm -90.66 146.26 33.83 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.0 164.71 29.35 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.364 2.043 . . . . 0.0 111.22 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.45 160.04 41.32 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.35 2.033 . . . . 0.0 111.513 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -40.39 132.8 1.63 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.86 121.18 7.39 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.73 1.62 . . . . 0.0 112.757 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -91.33 -22.3 20.59 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.2 pt -142.36 -160.45 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 113.823 -1.535 . . . . 0.0 106.94 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.1 pt -146.98 137.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.501 0.667 . . . . 0.0 111.682 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -177.3 -45.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.598 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.0 t0 . . . . . 0 C--O 1.219 -0.545 0 CA-C-O 117.898 -1.049 . . . . 0.0 110.312 179.807 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 2' ' ' GLU . 79.2 mmt-85 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 1' ' ' ARG . 6.7 tp10 -29.68 97.69 0.09 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.937 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -99.61 -163.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 123.253 2.635 . . . . 0.0 109.547 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.88 167.39 7.86 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.134 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' PRO . 71.0 Cg_exo -47.94 157.71 1.02 Allowed 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.489 2.126 . . . . 0.0 112.571 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 Cg_exo -37.42 175.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.311 2.674 . . . . 0.0 115.441 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.43 46.83 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.646 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.94 123.48 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.24 0.543 . . . . 0.0 110.632 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -114.82 116.52 28.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.213 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.06 141.16 15.44 Favored Glycine 0 N--CA 1.464 0.51 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.952 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -139.71 134.46 16.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.02 88.25 1.34 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.655 1.57 . . . . 0.0 112.501 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 4.7 p -68.27 -179.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -55.82 118.22 4.38 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.516 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.1 -166.76 21.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.5 ' HE3' ' H ' ' A' ' 66' ' ' GLN . 15.8 mtmt -77.13 -5.75 50.26 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 84.6 p -66.86 150.81 48.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.35 115.31 18.06 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -77.3 109.59 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.29 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.1 101.23 10.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -72.02 122.6 21.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.738 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.427 HD12 HG12 ' A' ' 75' ' ' ILE . 2.7 mm -87.34 113.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 m -86.09 127.2 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.543 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' H ' ' HE2' ' A' ' 24' ' ' LYS . 1.9 mppt? -44.26 105.38 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.808 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.576 ' NE2' ' OE1' ' A' ' 85' ' ' GLU . 35.5 mt-30 -80.68 159.38 25.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.47 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' ASP . 5.4 m-20 -78.35 78.61 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' ASP . 22.2 t70 -39.23 162.18 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.405 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.32 64.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.2 24.31 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.903 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.411 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -153.4 151.49 25.69 Favored Pre-proline 0 C--N 1.333 -0.152 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.96 143.61 55.33 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.687 1.591 . . . . 0.0 111.462 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.592 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.5 mt -89.87 135.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.868 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.91 -48.98 10.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.706 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -146.48 162.04 39.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.282 0.563 . . . . 0.0 111.522 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -109.46 120.19 41.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.185 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.33 107.3 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' LYS . 24.2 t -109.05 127.08 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.01 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -125.22 129.22 49.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.133 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.56 ' CE2' HD12 ' A' ' 49' ' ' LEU . 38.9 p90 -133.05 148.56 52.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.965 0.412 . . . . 0.0 110.876 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' NH1' ' CB ' ' A' ' 45' ' ' GLU . 4.8 ptt180 -144.71 167.34 22.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.74 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 43' ' ' ASP . 5.1 m -76.16 143.58 41.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.1 0.41 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 41' ' ' SER . 71.7 m-20 -122.01 -9.74 8.7 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.361 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -122.76 110.49 15.54 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.744 0.307 . . . . 0.0 110.307 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.46 ' CB ' ' NH1' ' A' ' 40' ' ' ARG . 25.4 pt-20 -115.1 -8.4 12.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.8 -7.72 23.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.535 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -161.08 128.67 4.23 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -107.61 128.56 54.65 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.56 HD12 ' CE2' ' A' ' 39' ' ' TYR . 70.8 mt -77.16 158.21 30.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 3.4 pm0 -121.59 148.54 44.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.205 0.526 . . . . 0.0 111.882 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -150.74 113.53 4.74 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.885 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.48 142.52 27.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.91 158.71 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.281 0.562 . . . . 0.0 110.391 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 56' ' ' ASN . 57.9 tt0 -74.17 130.9 40.67 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.474 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.58 0.17 0.3 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.822 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 54' ' ' GLN . 23.5 m120 -116.18 -26.19 7.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.729 0.264 . . . . 0.0 110.814 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 20.5 mttm -50.35 -68.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER 79.46 35.04 0.17 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.83 149.17 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.137 -0.352 . . . . 0.0 110.485 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.5 pt -147.58 144.85 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.98 115.99 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.1 mt -104.95 108.92 20.69 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.137 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.33 162.15 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.762 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.9 m80 60.6 67.68 0.81 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.852 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -107.91 -9.42 15.71 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.828 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.5 ' H ' ' HE3' ' A' ' 16' ' ' LYS . 49.9 tp60 60.13 152.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.969 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -96.81 -7.2 34.23 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.411 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 77.3 p -119.41 19.96 12.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.6 mmm -143.96 127.86 17.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.58 157.59 32.98 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.96 153.97 36.23 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.8 156.14 19.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.866 0.365 . . . . 0.0 110.278 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.7 130.08 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -122.63 107.28 11.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 110.329 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.427 HG12 HD12 ' A' ' 22' ' ' ILE . 1.7 mp -90.27 134.97 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.796 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -136.27 123.77 22.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -96.17 120.48 36.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.486 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.31 105.06 16.56 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.731 HD21 HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -108.53 -175.94 2.91 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -41.22 -31.5 0.22 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.731 HD23 HD21 ' A' ' 79' ' ' ASN . 3.2 mm? -65.54 -41.66 92.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.959 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.51 -48.61 0.96 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.485 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.2 m-85 -157.31 131.68 8.46 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.49 160.3 17.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.938 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.576 ' OE1' ' NE2' ' A' ' 25' ' ' GLN . 3.3 mm-40 53.2 50.43 7.59 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.292 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 84.8 Cg_endo -72.61 149.65 49.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.149 1.9 . . . . 0.0 111.147 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.63 109.31 13.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.157 0.503 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.21 95.97 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 31.2 t80 -102.95 131.5 49.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.496 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.18 134.45 42.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.074 0.464 . . . . 0.0 111.129 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.1 p90 -168.82 133.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.336 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.5 p -80.25 164.92 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.156 0.503 . . . . 0.0 111.473 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 95.6 mmm -93.23 141.67 24.3 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.474 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.84 162.62 29.44 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.414 2.076 . . . . 0.0 111.205 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.39 152.7 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.487 2.125 . . . . 0.0 111.638 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -43.74 132.56 3.94 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.632 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.5 158.99 36.2 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.885 1.723 . . . . 0.0 110.974 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.434 ' CG ' ' N ' ' A' ' 99' ' ' ILE . 18.8 p-10 -148.57 -51.73 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.751 0.31 . . . . 0.0 110.652 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.583 HG23 ' N ' ' A' ' 100' ' ' ILE . 13.5 tt -114.1 -51.04 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.047 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.583 ' N ' HG23 ' A' ' 99' ' ' ILE . 9.3 tt -56.52 156.15 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.673 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 100' ' ' ILE . 57.7 mttp -53.12 -115.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.557 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.531 -179.539 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -154.38 118.33 2.61 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.709 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -100.2 -163.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 122.954 2.436 . . . . 0.0 109.254 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.545 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -169.57 174.54 1.88 Allowed Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.047 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' PRO . 52.5 Cg_exo -55.1 159.22 10.16 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.115 1.877 . . . . 0.0 112.844 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 5' ' ' PRO . 30.0 Cg_exo -39.33 175.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.309 2.672 . . . . 0.0 114.849 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.8 53.43 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.082 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -129.51 127.99 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.226 0.536 . . . . 0.0 110.549 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -118.9 116.4 26.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.032 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.72 141.89 15.86 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.472 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -143.6 140.5 17.5 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.45 91.13 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.692 1.595 . . . . 0.0 112.216 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 p -72.16 162.93 28.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m -38.44 120.66 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.346 0.594 . . . . 0.0 111.516 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.05 -155.48 23.68 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' O ' HD12 ' A' ' 65' ' ' LEU . 32.0 mttp -80.0 -8.8 59.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.107 0.48 . . . . 0.0 110.075 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 p -60.54 136.37 58.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.136 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.57 117.42 28.94 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.87 111.27 18.61 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.457 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -103.42 91.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -66.09 123.78 20.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.171 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG21 ' CD2' ' A' ' 35' ' ' TYR . 2.4 mm -86.27 112.51 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -81.42 143.43 32.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.949 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -66.43 105.5 1.49 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.349 0.595 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -88.3 174.66 8.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.767 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 96.2 m-20 -62.6 -3.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.205 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 29' ' ' GLY . 2.8 p30 46.27 -172.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -9.81 59.19 Favored Glycine 0 N--CA 1.465 0.625 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.037 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . 128.54 2.78 5.75 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.88 142.36 33.46 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.82 142.65 83.43 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.319 1.346 . . . . 0.0 111.677 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.598 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.4 mt -87.95 134.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.368 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 2.6 mm? -91.81 -42.11 10.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.211 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -142.68 152.32 42.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.2 m-85 -109.47 126.15 53.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.613 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.46 110.51 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.534 HG21 ' CD1' ' A' ' 60' ' ' ILE . 69.2 t -107.57 124.86 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -125.16 121.43 34.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -126.57 154.65 43.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 31.3 ptt85 -146.47 169.45 18.88 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.255 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 p -79.66 141.21 36.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.773 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.91 -32.5 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.673 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.59 -6.65 42.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.679 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -139.66 174.4 10.55 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.217 0.532 . . . . 0.0 110.516 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -165.08 27.46 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.01 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -107.01 -2.85 20.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.866 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -144.52 145.5 31.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 111.218 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -133.74 117.97 17.56 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.05 160.39 27.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -118.2 155.01 31.25 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.158 0.504 . . . . 0.0 112.352 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 116.53 2.78 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.7 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -99.56 145.64 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.916 0.389 . . . . 0.0 111.34 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.49 152.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.529 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 4.5 tt0 -79.8 130.4 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.563 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.71 3.75 0.02 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.191 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 14.5 m-20 -112.03 -20.82 11.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.174 0.487 . . . . 0.0 110.004 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -63.66 -50.66 68.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.3 39.31 22.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.769 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.23 153.44 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.876 0.369 . . . . 0.0 111.117 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 37' ' ' VAL . 1.5 pt -150.17 145.19 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.128 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.5 mm -117.36 101.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.883 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' H ' HD22 ' A' ' 62' ' ' LEU . 1.8 mm? -83.92 102.94 12.78 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.89 171.0 12.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.967 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.9 m80 51.96 66.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.18 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 16' ' ' LYS . 24.3 mt -102.3 -173.16 2.27 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -131.8 129.67 40.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -70.06 -7.21 39.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.515 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.2 p -122.65 12.93 10.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.9 ttm -142.65 124.56 15.18 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.763 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.5 162.43 34.69 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.01 143.55 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -94.14 153.19 18.23 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.81 132.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -122.74 104.11 9.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.765 0.793 . . . . 0.0 110.545 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.486 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -87.74 130.55 37.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.788 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -134.49 117.63 16.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.75 127.02 35.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.74 106.85 17.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -110.02 -168.94 1.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -48.06 -29.09 3.24 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.028 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.7 mm? -64.04 -41.79 97.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 123.59 -48.1 0.98 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.3 m-85 -157.22 132.98 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -169.34 163.86 10.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.545 ' OE2' ' N ' ' A' ' 4' ' ' SER . 5.8 tp10 52.43 52.16 10.61 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.506 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 93.1 Cg_endo -74.45 155.3 45.66 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 123.436 2.757 . . . . 0.0 112.083 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 m -136.59 117.95 14.66 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.929 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -97.25 97.54 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.613 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.55 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 33.4 t80 -102.0 135.81 42.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.637 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.63 134.59 37.5 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.4 p90 -169.18 133.35 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.18 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -79.44 168.64 19.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.5 mmm -95.66 138.51 21.78 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.529 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.39 164.93 32.93 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.62 2.213 . . . . 0.0 111.328 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.18 150.88 87.08 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.292 1.995 . . . . 0.0 111.642 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.82 133.91 1.72 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.154 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.43 158.72 44.12 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.264 1.976 . . . . 0.0 111.807 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 99' ' ' ILE . 65.2 t30 -79.81 -126.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.41 ' H ' ' CG ' ' A' ' 98' ' ' ASN . 45.2 pt -109.74 -2.78 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.921 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.939 HG23 ' H ' ' A' ' 101' ' ' LYS . 5.3 tp -65.31 -93.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.843 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.939 ' H ' HG23 ' A' ' 100' ' ' ILE . 87.4 tttt -170.71 151.03 3.4 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.322 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.9 t0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.398 179.068 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' GLY . 50.3 mt-10 -132.08 82.54 58.75 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.861 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -105.18 -163.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 124.078 3.185 . . . . 0.0 111.473 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.8 163.13 3.77 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.232 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 74.2 Cg_exo -38.46 161.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.861 2.374 . . . . 0.0 112.418 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.9 Cg_exo -37.32 165.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.755 2.303 . . . . 0.0 113.769 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.528 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -148.4 47.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.617 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.4 HG12 HG21 ' A' ' 87' ' ' THR . 5.9 mm -131.14 131.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 111.93 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -108.6 -173.13 2.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.79 118.19 0.65 Allowed Glycine 0 C--N 1.321 -0.256 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.359 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -135.39 144.13 48.24 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.65 85.41 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.396 1.397 . . . . 0.0 111.184 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -52.15 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.214 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.8 t -142.58 136.7 29.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.099 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.43 -134.81 33.44 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HE2' ' H ' ' A' ' 66' ' ' GLN . 17.9 mtmm -93.58 -0.86 56.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.908 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.3 p -68.86 153.06 44.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.644 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 122.72 22.82 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -83.52 97.94 9.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.166 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mt -95.96 92.22 6.38 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 t -67.02 128.37 36.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.167 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.439 HG21 ' CE2' ' A' ' 35' ' ' TYR . 2.2 mm -88.2 112.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -83.18 129.09 34.99 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.079 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.659 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.1 102.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.745 -0.782 . . . . 0.0 108.932 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.64 148.56 24.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' GLU . 46.7 t0 -50.43 102.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.64 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 29' ' ' GLY . 5.7 m-20 -57.67 142.22 45.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.48 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 2' ' ' GLU . . . -32.43 -28.41 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 159.78 14.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.871 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -159.5 155.17 22.71 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 118.175 0.987 . . . . 0.0 110.796 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.23 138.6 67.54 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.965 1.777 . . . . 0.0 111.062 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.606 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.0 mt -86.13 135.76 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.14 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 55' ' ' GLY . 77.3 mt -85.79 -43.59 13.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.43 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -146.21 162.19 38.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.637 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 22' ' ' ILE . 22.0 m-85 -113.67 122.01 45.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.631 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.57 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 85.4 mt -99.52 112.15 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 75' ' ' ILE . 58.0 t -111.99 126.78 69.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.547 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -124.49 139.45 53.87 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 22.1 p90 -145.63 157.74 43.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.103 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.09 -176.62 5.43 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.312 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -91.99 138.18 31.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.154 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -66.68 -34.41 77.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.67 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 67.5 t0 -59.96 -34.64 73.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.787 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.1 mtmt -126.36 -172.01 2.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.508 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -173.78 63.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.682 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -131.06 -7.86 3.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.297 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -140.93 155.12 46.33 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -137.55 108.04 6.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.672 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.1 159.79 33.23 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.202 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.69 146.45 43.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.166 0.507 . . . . 0.0 111.866 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -146.68 112.82 5.82 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.59 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.57 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 73.0 mmtt -100.34 142.57 31.64 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.07 160.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 110.315 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.5 tp60 -72.75 151.06 42.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.479 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.05 12.96 0.38 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 54' ' ' GLN . 65.4 t30 -145.19 2.6 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.007 0.403 . . . . 0.0 111.639 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -63.49 -47.47 81.62 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.593 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER 59.37 31.03 20.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.976 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.26 151.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.01 147.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.867 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.8 mm -118.52 108.57 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.9 mp -94.41 106.58 18.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -85.31 147.55 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.977 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 71.02 77.83 0.18 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.944 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.538 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 91.3 mt -115.0 -3.98 12.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.534 ' O ' ' SD ' ' A' ' 93' ' ' MET . 80.4 mt-30 50.53 122.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.814 0.816 . . . . 0.0 112.792 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -61.28 -26.12 67.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.714 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -103.55 22.66 13.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.7 mmm -146.96 118.57 7.99 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.134 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.85 162.6 45.01 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.538 ' CZ ' HD13 ' A' ' 65' ' ' LEU . 8.8 p90 -155.58 132.03 10.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.853 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.1 152.1 22.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.38 134.49 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -124.36 106.85 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.36 0.6 . . . . 0.0 109.722 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -91.68 132.45 36.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.47 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -134.31 121.39 21.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -94.51 124.15 38.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.26 108.83 21.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 5.7 p-10 -115.79 -164.94 0.99 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.24 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -53.17 -30.09 35.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 5.9 mp -62.53 -39.32 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 120.81 -47.91 0.99 Allowed Glycine 0 N--CA 1.463 0.466 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 9.8 m-85 -156.05 122.64 5.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 77' ' ' ALA . 96.7 p -87.43 163.41 16.75 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -44.35 111.78 1.27 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 160.35 48.57 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.304 1.336 . . . . 0.0 112.823 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.4 HG21 HG12 ' A' ' 8' ' ' ILE . 26.3 m -107.24 116.75 32.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.641 0.734 . . . . 0.0 109.674 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.01 96.18 5.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.424 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.579 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -100.39 121.73 41.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.48 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -122.42 129.94 52.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 111.309 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 9.7 p90 -164.79 128.29 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.405 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -80.4 167.43 20.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.527 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.0 mtp -93.6 147.86 34.39 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.54 162.16 33.46 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.477 2.118 . . . . 0.0 110.384 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.47 154.29 72.51 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.207 1.938 . . . . 0.0 111.587 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -36.06 132.18 0.59 Allowed Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.31 141.39 51.58 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.599 1.532 . . . . 0.0 112.478 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -123.78 -36.07 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' ILE . 30.6 pt -130.05 17.88 2.27 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.493 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER 10.82 114.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 124.543 1.152 . . . . 0.0 112.887 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -129.5 -53.58 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.894 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.3 t0 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.152 179.363 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -120.25 89.3 43.17 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.51 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -99.77 -164.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 123.022 2.481 . . . . 0.0 110.608 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.19 160.26 7.73 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.63 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' PRO . 2.1 Cg_endo -44.77 170.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.818 2.345 . . . . 0.0 112.215 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -37.96 177.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.777 2.985 . . . . 0.0 116.173 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.28 37.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.953 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -125.02 136.56 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.537 0.684 . . . . 0.0 110.64 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -116.83 -172.87 2.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.837 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.28 143.0 8.03 Favored Glycine 0 N--CA 1.462 0.392 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.322 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -150.79 115.56 3.24 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -46.83 104.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.493 1.462 . . . . 0.0 112.689 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 14' ' ' SER . 28.7 p -80.7 172.21 14.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' SER . 58.8 m -40.56 107.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.798 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.89 -158.32 23.98 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HE3' ' H ' ' A' ' 66' ' ' GLN . 18.8 mtmt -75.71 -11.6 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.871 0.367 . . . . 0.0 110.766 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 t -62.5 140.43 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.303 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.0 137.41 51.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.409 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -97.94 98.53 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mt -97.74 103.17 15.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 t -69.78 126.08 28.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.908 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.07 108.74 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -79.84 136.1 36.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.904 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.13 104.64 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.675 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 27' ' ' ASP . 11.8 mt-30 -89.51 137.63 32.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.552 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 27' ' ' ASP . 1.3 m-20 -54.64 93.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 24.7 t70 -44.54 171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.054 0.454 . . . . 0.0 110.881 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.56 -31.95 76.51 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.5 12.62 0.03 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.821 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -147.71 151.91 40.02 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 117.619 0.71 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.0 143.99 68.18 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.82 1.68 . . . . 0.0 111.783 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.586 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.0 mt -93.8 133.06 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.262 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.747 HD22 ' N ' ' A' ' 33' ' ' LEU . 2.3 mm? -95.43 -14.02 24.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.93 155.96 8.79 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -113.32 112.88 24.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.789 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.422 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 98.5 mt -89.98 106.99 17.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG22 HG13 ' A' ' 75' ' ' ILE . 21.6 t -109.35 129.78 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.415 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -123.84 142.86 50.73 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -143.92 158.46 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.891 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 41' ' ' SER . 1.1 ptm180 -151.3 -173.0 4.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.472 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 4.9 p -96.18 140.0 31.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -65.25 -17.9 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.639 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.61 -27.12 16.77 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -117.97 120.36 37.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.296 0.569 . . . . 0.0 110.811 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' NH1' ' A' ' 40' ' ' ARG . 83.9 tt0 -125.2 63.73 1.16 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.38 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.53 -14.71 8.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.953 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -159.64 161.87 35.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.403 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -128.35 136.39 50.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 68.7 mt -80.58 159.83 25.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -118.68 146.29 44.82 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.134 0.492 . . . . 0.0 111.447 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.9 110.27 5.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.5 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 72.7 mmtt -95.65 126.63 41.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.585 HG21 ' CG2' ' A' ' 60' ' ' ILE . 43.5 t -132.62 154.89 40.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.995 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 11.7 tp-100 -68.8 147.36 51.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.62 0.81 55.01 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.412 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 93.0 m-20 -113.67 -14.13 12.64 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.044 0.422 . . . . 0.0 111.339 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.28 -45.14 94.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.723 0.297 . . . . 0.0 110.833 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 58.2 37.1 26.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.886 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.73 141.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.585 ' CG2' HG21 ' A' ' 53' ' ' VAL . 6.5 pt -144.01 136.99 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.239 0.542 . . . . 0.0 111.988 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' C ' HD12 ' A' ' 62' ' ' LEU . 34.7 mm -108.22 117.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.226 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 62' ' ' LEU . 10.8 mp -107.01 143.5 35.01 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.589 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 46.4 mt-10 -107.52 169.65 8.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 111.772 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 37.3 p-80 49.06 68.49 0.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.327 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.5 mm? -95.4 -12.3 26.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.296 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.522 ' O ' ' SD ' ' A' ' 93' ' ' MET . 3.1 mm100 50.76 122.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.864 0.84 . . . . 0.0 112.058 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -61.52 -32.82 72.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.544 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -97.26 22.29 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.63 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.9 ttm -152.17 127.08 9.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.86 34.22 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -136.29 132.71 36.09 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.1 152.97 18.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.36 134.9 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 110.825 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -125.98 109.73 12.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.118 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.51 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -93.73 135.24 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m -134.83 121.66 20.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -91.18 123.5 34.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.06 107.8 19.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.28 0.562 . . . . 0.0 112.079 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 1.1 p-10 -110.29 -172.07 1.96 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -49.75 -27.71 5.24 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.789 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.8 mm? -65.64 -41.6 92.44 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.54 -50.3 0.89 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -155.81 134.45 11.79 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.7 t -162.83 157.24 21.13 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.867 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 44.48 61.99 10.55 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.088 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.48 155.51 45.48 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.599 2.199 . . . . 0.0 110.724 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.23 108.85 13.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.3 t -95.0 98.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -103.78 140.26 37.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.742 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -136.49 134.85 38.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.39 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 91' ' ' PHE . 35.3 p90 -165.95 125.36 1.65 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.509 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 p -82.44 171.13 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.575 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 14.8 mtp -99.4 152.59 37.85 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.89 163.53 25.91 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.638 2.225 . . . . 0.0 109.275 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.03 153.45 78.05 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 121.782 1.655 . . . . 0.0 111.533 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -41.47 133.88 2.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.58 148.7 54.13 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.986 1.791 . . . . 0.0 111.931 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -94.48 -83.52 0.34 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.4 pt -108.47 -16.54 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.147 0.499 . . . . 0.0 109.816 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.86 133.83 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.04 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.35 -95.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.224 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--N 1.325 -0.486 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.276 179.704 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 7.2 tpt180 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 1' ' ' ARG . 2.0 tm-20 81.91 81.28 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 120.708 0.29 . . . . 0.0 110.677 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -99.71 -164.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.733 2.955 . . . . 0.0 109.844 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.421 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -166.5 179.88 0.95 Allowed Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.765 179.399 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 6' ' ' PRO . 8.1 Cg_exo -67.01 176.33 4.64 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.239 1.959 . . . . 0.0 112.01 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 43.9 Cg_exo -42.53 176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 123.074 2.516 . . . . 0.0 114.109 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -173.41 54.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.743 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -131.25 130.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -121.3 115.37 22.84 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.49 145.37 17.66 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -146.96 111.49 4.12 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.38 98.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.382 1.388 . . . . 0.0 112.702 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -76.82 171.57 14.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -58.2 134.89 56.91 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.799 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.09 -154.54 26.57 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -99.14 46.46 0.98 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 61' ' ' ILE . 5.3 t -120.32 149.71 41.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.728 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.94 119.82 27.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.098 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -80.69 98.73 7.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.595 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.41 100.16 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -73.85 126.2 29.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.947 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.471 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -88.78 112.39 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -86.13 143.35 28.08 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.289 0.566 . . . . 0.0 110.203 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 112.69 10.22 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -112.13 170.28 8.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -50.8 112.34 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.581 ' C ' ' H ' ' A' ' 29' ' ' GLY . 69.1 m-20 -71.83 163.83 27.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 -178.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.07 14.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.075 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 101.78 8.81 44.75 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.96 149.42 25.11 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.47 140.06 61.7 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.803 1.669 . . . . 0.0 111.453 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.585 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.2 mt -86.28 129.11 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -81.3 -39.69 24.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.37 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -148.78 170.13 18.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.545 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.1 m-85 -123.23 122.15 37.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.457 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.4 mt -96.47 111.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.593 HG22 HG13 ' A' ' 75' ' ' ILE . 55.6 t -112.1 128.09 68.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -121.54 134.58 55.04 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.603 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.86 154.84 46.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.59 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 41' ' ' SER . 2.8 ptm180 -144.41 -172.74 3.86 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.336 0.589 . . . . 0.0 110.972 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.521 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 5.9 p -101.58 135.15 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.42 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.12 -11.79 33.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.253 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -90.32 -35.06 15.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -118.58 129.55 55.39 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 110.351 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.3 2.98 11.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.969 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 38.0 p-10 -72.11 -3.57 23.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.389 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -152.77 155.86 37.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.165 0.507 . . . . 0.0 111.922 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -136.85 106.89 6.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.299 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.89 158.73 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.773 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.37 148.24 45.31 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -143.6 113.95 7.43 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.497 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -88.51 136.07 33.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 54' ' ' GLN . 45.6 t -132.47 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 121.352 0.596 . . . . 0.0 111.951 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 53' ' ' VAL . 6.7 tp60 -83.0 144.78 29.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.573 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.01 -24.94 69.01 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -86.39 -22.12 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.621 -0.289 . . . . 0.0 111.515 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 25.7 mttm -60.53 -46.15 91.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.903 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.8 p30 46.52 37.25 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.048 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.55 0.72 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.827 0.346 . . . . 0.0 110.265 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -155.32 151.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.205 0.526 . . . . 0.0 110.564 178.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.42 HG22 ' OG ' ' A' ' 17' ' ' SER . 45.2 mm -120.06 112.67 37.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.091 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.82 105.17 16.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.83 152.7 21.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 111.846 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 76.86 58.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.715 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 66' ' ' GLN . 80.6 mt -103.17 -4.84 23.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 65' ' ' LEU . 47.5 mt-30 55.24 159.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.477 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -99.11 -16.01 18.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.194 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.3 p -108.86 19.1 20.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.3 mtp -141.47 141.98 33.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.134 0.493 . . . . 0.0 110.541 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.82 153.4 19.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -138.83 138.02 37.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.95 164.54 12.86 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.63 146.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.142 0.496 . . . . 0.0 110.393 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -137.89 106.36 5.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.465 0.65 . . . . 0.0 109.672 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.593 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -93.82 134.96 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.6 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -137.25 120.69 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -91.77 125.26 36.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.52 110.82 22.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 9.6 p-10 -112.12 -163.33 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.298 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -32.19 55.37 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 81' ' ' LEU . 9.3 mp -64.55 -42.32 95.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.712 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.86 -46.61 1.07 Allowed Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -154.93 132.51 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -161.56 147.19 13.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.695 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 60.14 58.14 4.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.19 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.99 151.1 30.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.372 2.048 . . . . 0.0 111.223 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.5 m -131.16 118.62 20.73 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.457 0.646 . . . . 0.0 111.142 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 m -97.97 92.71 2.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.221 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -95.01 151.72 18.93 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -153.29 135.37 14.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.324 0.583 . . . . 0.0 111.571 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -164.92 156.9 15.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.903 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.51 163.98 12.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.633 0.254 . . . . 0.0 110.358 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.4 mmm -89.69 143.96 31.12 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.395 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.63 164.85 31.48 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.755 2.303 . . . . 0.0 110.981 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -65.99 154.91 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.987 1.792 . . . . 0.0 111.696 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -35.37 132.59 0.5 Allowed Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.191 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.37 155.17 55.9 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.867 1.711 . . . . 0.0 112.373 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -149.33 -48.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.257 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 99' ' ' ILE . 12.1 tt -179.2 101.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.759 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.474 ' CG1' ' N ' ' A' ' 101' ' ' LYS . 6.3 tt -172.22 163.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.367 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' N ' ' CG1' ' A' ' 100' ' ' ILE . 85.6 tttt -71.27 136.2 47.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.809 -179.489 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -113.65 136.97 22.03 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.071 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -101.71 -163.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 122.589 2.193 . . . . 0.0 109.88 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.481 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -163.96 154.82 13.62 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.885 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -34.29 148.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.913 2.409 . . . . 0.0 112.596 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -39.4 164.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.408 2.072 . . . . 0.0 114.597 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -154.75 51.16 0.62 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.824 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -128.43 127.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.518 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -122.29 119.1 30.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.137 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.29 158.38 20.52 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -162.78 132.9 3.34 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 36.3 Cg_endo -67.85 98.47 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.357 1.371 . . . . 0.0 111.818 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 14' ' ' SER . 87.6 p -80.77 -116.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.659 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 13' ' ' SER . 91.5 p -80.99 112.66 18.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.971 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.03 -133.63 43.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -78.41 -11.28 59.94 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 m -60.8 135.18 57.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.317 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.08 140.42 48.49 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.538 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -99.38 94.85 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.7 90.7 7.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.2 t -66.65 124.46 22.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.217 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.459 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -87.47 113.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.2 m -97.01 114.03 25.61 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.412 0.625 . . . . 0.0 110.091 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -39.09 107.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.593 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -97.79 151.17 20.47 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 85.8 m-20 -43.34 97.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.732 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' GLY . 19.3 m-20 -63.01 152.76 35.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.433 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -38.95 -21.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.773 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 135.42 -3.24 3.94 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.69 146.68 62.22 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.59 138.48 59.44 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.335 1.357 . . . . 0.0 111.133 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.606 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.5 mt -80.46 126.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.514 0.673 . . . . 0.0 112.39 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -68.47 -41.06 80.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -161.18 168.05 24.94 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.794 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.459 ' CD2' HG21 ' A' ' 22' ' ' ILE . 9.7 m-85 -114.3 119.4 36.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.219 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.47 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 80.9 mt -96.45 110.83 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.536 HG22 HG13 ' A' ' 75' ' ' ILE . 47.3 t -110.86 125.68 68.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.136 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -120.61 128.91 53.48 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -135.63 151.36 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.587 ' NE ' ' O ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -145.49 -177.87 5.79 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.705 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.587 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 25.4 m -90.72 146.43 24.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.874 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.36 -18.36 52.59 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.7 -49.66 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.535 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HB2' HH22 ' A' ' 40' ' ' ARG . 73.8 mmtt -110.53 -164.36 0.92 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -174.58 75.87 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -154.79 -8.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.075 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.0 129.23 21.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -116.18 131.14 57.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.144 0.497 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.73 160.32 18.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.45 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 54.5 mp0 -114.6 147.82 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.101 0.477 . . . . 0.0 111.44 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.16 113.99 5.39 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 72.0 mmtt -99.32 146.59 26.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.911 0.386 . . . . 0.0 111.99 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.46 160.45 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.482 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' A' ' 56' ' ' ASN . 47.9 tp60 -83.07 148.46 27.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.857 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.13 5.72 3.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 54' ' ' GLN . 64.0 t30 -122.69 -14.45 7.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.027 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 21.3 mttp -67.47 -49.79 61.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.182 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 59.03 35.45 23.98 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.974 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -176.35 155.49 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.763 -0.585 . . . . 0.0 111.386 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -151.18 146.09 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.59 102.7 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.882 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.9 mp -87.67 105.62 17.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 79.4 mt-10 -86.77 139.16 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.346 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 2.0 t-160 83.92 79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.375 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.8 mt -131.86 77.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 7.3 tt0 -34.9 143.71 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.344 0.592 . . . . 0.0 111.151 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -70.08 -22.46 63.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.496 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 p -100.76 22.95 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.1 ttm -141.77 132.98 26.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.34 0.59 . . . . 0.0 110.981 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.26 153.4 20.5 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -148.61 133.36 17.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.571 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.94 151.75 23.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.753 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.07 133.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -125.98 108.9 11.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 0.0 109.872 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.536 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -91.35 135.86 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.285 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -134.82 117.73 16.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -90.85 126.06 35.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.233 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.33 107.88 18.89 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.7 p-10 -109.64 -174.09 2.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.897 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -45.64 -26.28 0.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.608 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.647 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -71.84 -40.27 69.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.935 0.397 . . . . 0.0 110.125 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.465 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 128.61 -49.22 0.93 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -153.66 131.74 11.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 t -167.78 162.97 14.09 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.836 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' OE2' ' N ' ' A' ' 4' ' ' SER . 8.3 tp10 50.27 53.89 14.8 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.188 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 92.3 Cg_endo -74.84 156.09 43.69 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.977 2.452 . . . . 0.0 110.943 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.01 110.42 11.64 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.03 0.443 . . . . 0.0 110.785 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 t -94.01 95.76 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.549 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -102.92 133.59 47.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.22 136.95 42.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.17 0.509 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.5 p90 -171.72 132.92 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.199 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.19 167.09 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.8 mmm -96.04 144.22 27.45 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.75 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.14 165.27 28.28 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.776 2.317 . . . . 0.0 110.903 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.98 162.89 33.28 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.992 1.795 . . . . 0.0 111.433 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -40.74 133.21 1.74 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.46 170.05 20.7 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.985 1.79 . . . . 0.0 111.085 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.441 ' CG ' ' H ' ' A' ' 99' ' ' ILE . 57.9 t30 -97.66 -121.28 0.13 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.441 ' H ' ' CG ' ' A' ' 98' ' ' ASN . 1.5 pp -102.31 3.83 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.229 0.538 . . . . 0.0 109.973 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 102' ' ' ASP . 17.2 tt -51.33 140.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.115 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.14 19.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.22 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 100' ' ' ILE . 37.6 t0 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.299 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 28' ' ' GLY . 9.5 tpt180 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -144.67 104.61 4.57 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.397 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -98.11 -163.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 122.746 2.298 . . . . 0.0 109.558 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.8 165.8 4.1 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.961 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' PRO . 88.8 Cg_exo -39.29 157.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.965 2.443 . . . . 0.0 112.719 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' PRO . 15.7 Cg_exo -37.41 163.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.872 2.381 . . . . 0.0 113.707 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 m -151.38 52.2 0.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.444 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -130.18 128.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -122.46 117.11 25.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.1 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.02 161.53 21.75 Favored Glycine 0 N--CA 1.464 0.543 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.968 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -161.95 128.78 2.52 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.92 88.26 0.94 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.3 t -66.87 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -71.29 133.07 45.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.172 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 -160.11 49.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.864 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -79.82 -4.98 54.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.642 -0.279 . . . . 0.0 111.227 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.8 p -68.72 147.39 51.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.121 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.0 124.69 43.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -84.29 100.12 11.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.399 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.65 97.97 9.8 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -71.56 126.28 29.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.037 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.44 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -88.93 113.79 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 m -85.5 139.07 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.063 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -72.29 104.92 3.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.655 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 168.21 9.42 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.3 t70 -56.85 110.01 0.73 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.31 165.37 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.125 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 1' ' ' ARG . . . -55.37 -23.09 33.0 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.42 16.69 0.08 OUTLIER Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.247 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.91 152.48 20.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 117.169 0.485 . . . . 0.0 109.789 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.51 145.04 86.86 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.86 1.707 . . . . 0.0 111.112 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.613 HG21 ' CE1' ' A' ' 35' ' ' TYR . 4.4 mt -91.59 129.24 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.467 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.21 -44.56 14.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.24 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.6 161.64 39.34 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 32' ' ' ILE . 10.4 m-85 -113.88 122.19 46.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.98 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.4 mt -94.25 108.44 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG22 HG13 ' A' ' 75' ' ' ILE . 58.1 t -113.77 130.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.113 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -127.95 147.23 50.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.473 ' CE2' HD12 ' A' ' 49' ' ' LEU . 42.8 p90 -148.55 155.69 41.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.074 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.793 HH21 ' H ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -152.49 -172.83 4.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.032 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -92.74 146.48 23.61 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.792 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.61 15.7 0.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -132.45 -45.92 0.9 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.739 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.561 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.79 37.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.684 0.278 . . . . 0.0 110.821 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 6.7 tm-20 -49.68 84.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 110.753 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 44' ' ' LYS . 73.0 m-20 -153.93 -16.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.966 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.793 ' H ' HH21 ' A' ' 40' ' ' ARG . 19.7 pt20 -156.74 155.68 32.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.063 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -124.39 136.01 53.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.084 0.469 . . . . 0.0 111.898 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.473 HD12 ' CE2' ' A' ' 39' ' ' TYR . 97.7 mt -84.9 158.71 20.5 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -118.35 146.51 44.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.097 0.475 . . . . 0.0 111.319 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -147.45 117.78 7.38 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -100.94 143.53 30.97 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.95 161.38 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.357 0.598 . . . . 0.0 110.646 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -79.14 147.71 32.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.606 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.62 0.29 5.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -118.62 -6.73 10.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.556 0.217 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -63.6 -47.83 79.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.31 0.576 . . . . 0.0 109.638 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 53.02 30.17 9.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.686 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.69 153.39 0.36 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.968 0.414 . . . . 0.0 110.737 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -151.96 145.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.542 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.56 107.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 mt -92.7 133.06 36.38 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 83.4 tt0 -119.77 152.94 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.008 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 36.3 t-80 88.88 49.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.712 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.22 86.96 2.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -41.65 137.88 1.52 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.452 0.644 . . . . 0.0 111.122 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -65.0 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.755 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -98.32 21.42 11.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.384 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 8.8 ttm -145.17 128.64 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 110.145 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.76 161.9 46.48 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.61 129.61 23.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -90.55 154.39 19.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.875 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -135.1 136.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 67.2 tt0 -127.25 107.86 10.37 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.549 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -95.78 131.39 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.283 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -135.54 120.21 18.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.63 127.4 35.9 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.21 111.01 23.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.248 0.547 . . . . 0.0 112.248 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.5 p30 -112.08 -166.44 1.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.237 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -53.0 -30.91 38.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.027 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -66.37 -41.31 89.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.165 0.507 . . . . 0.0 109.736 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 129.93 -49.07 0.94 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -154.88 137.77 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.6 t -165.38 155.48 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.701 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 26' ' ' ASP . 18.5 tt0 50.06 56.94 17.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.232 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.81 154.37 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.68 2.253 . . . . 0.0 111.367 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -132.34 119.01 20.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 0.0 111.089 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.94 94.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.54 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 40.2 t80 -98.22 131.1 44.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.124 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -133.1 131.5 40.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.54 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 20.9 p90 -161.73 134.73 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.63 160.23 25.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.366 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 91.1 mmm -94.49 140.93 22.86 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.804 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.71 162.81 40.22 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.035 1.823 . . . . 0.0 110.861 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.33 151.99 83.46 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.499 2.133 . . . . 0.0 111.816 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -38.28 133.18 0.96 Allowed Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.97 153.74 76.92 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.477 1.452 . . . . 0.0 111.681 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -84.96 -102.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.5 pt -98.49 -3.93 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.959 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.33 131.58 68.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.942 0.401 . . . . 0.0 110.544 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -80.49 -163.21 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.607 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.691 179.725 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 2' ' ' GLU . 33.1 ptt-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 1' ' ' ARG . 34.5 mt-10 -25.05 88.59 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.003 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.441 ' N ' ' O ' ' A' ' 1' ' ' ARG . 15.5 Cg_endo -106.33 -163.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 124.116 3.211 . . . . 0.0 111.289 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.1 p -166.94 149.74 5.95 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.13 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' SER . 80.7 Cg_exo -37.61 164.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.974 2.449 . . . . 0.0 112.545 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.2 Cg_exo -38.75 163.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.331 2.021 . . . . 0.0 114.276 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.33 33.54 0.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.695 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.58 120.49 60.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.553 0.692 . . . . 0.0 110.788 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -116.26 116.86 28.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.039 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.24 150.44 19.68 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 13' ' ' SER . 71.2 mt-30 -153.62 113.46 2.59 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.41 85.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.171 1.248 . . . . 0.0 111.636 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 11' ' ' GLN . 10.8 t -53.92 -88.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.647 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.25 140.33 41.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.808 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.01 -127.9 39.11 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.499 ' CE ' ' O ' ' A' ' 65' ' ' LEU . 10.4 mtmm -99.39 -2.84 35.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 p -67.01 149.21 50.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.11 135.38 48.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.824 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -96.39 95.18 7.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -90.86 92.28 8.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -68.9 122.59 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.221 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.438 HG21 ' CE2' ' A' ' 35' ' ' TYR . 2.2 mm -85.95 112.6 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -91.68 117.76 30.04 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.19 105.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.391 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 4' ' ' SER . 35.7 mt-30 -88.96 157.61 18.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -48.62 106.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -58.1 142.69 46.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.649 0.737 . . . . 0.0 111.965 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.99 -20.71 6.7 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.6 -1.65 0.73 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.75 25.78 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.87 133.33 38.41 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.86 1.707 . . . . 0.0 111.992 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.563 HG21 ' CE1' ' A' ' 35' ' ' TYR . 4.5 mt -78.59 130.27 36.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.172 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 33' ' ' LEU . 11.3 mp -80.99 -44.67 17.79 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -142.18 163.72 32.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.515 0.674 . . . . 0.0 111.434 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.563 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.2 m-85 -116.71 113.88 23.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.166 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.578 HG23 ' HZ3' ' A' ' 52' ' ' LYS . 95.0 mt -87.83 109.94 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.538 HG22 HG13 ' A' ' 75' ' ' ILE . 44.9 t -114.08 130.55 68.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -125.84 133.32 52.01 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.457 ' CE2' HD12 ' A' ' 49' ' ' LEU . 54.4 p90 -138.47 150.73 46.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.839 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.3 ptt85 -143.65 174.78 10.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.027 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 44' ' ' LYS . 16.5 m -84.99 142.57 29.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -63.31 -35.53 80.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.471 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.33 -10.52 59.53 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.564 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 41' ' ' SER . 28.4 mmtt -125.99 154.6 42.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.633 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.2 19.83 1.09 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.708 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.93 1.06 52.64 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -159.89 158.07 30.2 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.94 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -136.44 106.13 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 39' ' ' TYR . 50.8 mt -67.59 145.77 54.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.81 151.86 25.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.22 0.533 . . . . 0.0 111.138 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' VAL . 11.2 tppt? -150.58 113.24 4.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.427 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.578 ' HZ3' HG23 ' A' ' 36' ' ' ILE . 72.2 mmtt -97.81 139.85 33.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.362 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.77 160.42 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.371 0.605 . . . . 0.0 110.997 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 65.2 tp60 -78.67 142.55 37.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.362 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.68 -3.74 16.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.417 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 91.7 m-20 -110.26 -21.36 12.27 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.723 -0.28 . . . . 0.0 110.622 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -61.55 -52.48 64.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.021 0.438 . . . . 0.0 110.687 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 56.57 41.67 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.809 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.81 150.44 0.8 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.525 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -149.05 140.7 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.2 mm -111.45 103.96 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.407 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 62' ' ' LEU . 10.3 mp -92.57 107.57 19.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 171.11 10.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 m80 66.57 48.12 1.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.364 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.499 ' O ' ' CE ' ' A' ' 16' ' ' LYS . 23.8 mt -100.16 164.71 11.85 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 68' ' ' THR . 50.6 tt0 -119.97 143.07 48.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.201 0.524 . . . . 0.0 110.625 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -68.87 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.432 ' H ' ' HG2' ' A' ' 66' ' ' GLN . 43.1 p -102.44 17.93 22.37 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.6 mtp -143.41 134.12 25.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.41 166.44 31.88 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.147 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -142.82 131.73 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.54 . . . . 0.0 110.351 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.1 mt-10 -88.32 151.47 22.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.58 131.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.574 ' OE1' HG22 ' A' ' 88' ' ' VAL . 10.0 tp60 -124.34 108.08 11.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.611 0.72 . . . . 0.0 110.371 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 1.6 mp -90.58 134.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.098 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.46 120.36 19.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -92.25 127.03 37.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.58 107.24 18.07 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.019 0.438 . . . . 0.0 111.812 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' O ' ' N ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -115.61 -170.58 1.8 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -44.09 -32.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.789 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -64.12 -41.52 97.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.64 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 123.52 -49.04 0.92 Allowed Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 7.0 m-85 -156.45 125.71 6.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.7 t -160.64 169.68 22.37 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.651 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 60.3 mm-40 52.0 49.3 6.65 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.869 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 74.3 Cg_endo -71.35 152.37 60.85 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.068 1.845 . . . . 0.0 111.146 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.31 113.51 12.69 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 110.378 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.574 HG22 ' OE1' ' A' ' 74' ' ' GLN . 61.6 t -95.87 93.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -101.53 145.32 29.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.224 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.66 138.34 32.43 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 91' ' ' PHE . 16.7 p90 -164.39 127.61 2.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.0 p -83.76 143.06 30.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 94.6 mmm -74.29 140.32 76.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.144 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.05 164.76 34.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.92 152.7 80.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.431 2.087 . . . . 0.0 111.748 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -39.89 129.89 1.54 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.8 149.09 42.23 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 121.498 1.465 . . . . 0.0 112.254 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.53 -36.38 2.46 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.1 pt -107.46 3.43 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.485 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.8 pt 42.87 44.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.84 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -69.35 -72.95 0.17 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.448 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.812 -1.089 . . . . 0.0 110.378 -179.364 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' H ' ' HA2' ' A' ' 28' ' ' GLY . 58.3 mm-40 -124.38 82.21 58.34 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.494 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.429 ' HB3' ' H ' ' A' ' 85' ' ' GLU . 68.3 Cg_endo -99.74 -164.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 123.446 2.764 . . . . 0.0 110.832 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.436 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.6 OUTLIER -167.76 179.78 0.88 Allowed Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.469 179.284 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 14.3 Cg_exo -65.08 173.0 6.5 Favored 'Trans proline' 0 N--CA 1.503 2.066 0 C-N-CA 122.879 2.386 . . . . 0.0 112.204 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -35.89 166.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 123.6 2.867 . . . . 0.0 115.384 -179.304 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.51 43.15 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.518 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.02 132.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.323 0.582 . . . . 0.0 111.318 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -128.89 117.39 20.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.595 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.1 145.72 17.8 Favored Glycine 0 N--CA 1.464 0.562 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.031 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -148.03 118.18 4.29 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -48.96 109.15 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.097 1.198 . . . . 0.0 112.111 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 t -84.4 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.6 m -82.0 134.56 35.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.191 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.46 -135.05 41.76 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.763 ' HZ2' ' HE1' ' A' ' 67' ' ' TRP . 33.7 mttm -77.78 -8.64 58.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.838 0.351 . . . . 0.0 110.994 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.509 ' OG ' HG22 ' A' ' 61' ' ' ILE . 4.6 t -64.74 141.57 58.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.027 0.442 . . . . 0.0 111.946 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.3 124.3 44.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.898 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -87.57 104.49 16.55 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.251 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 mt -97.26 91.62 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.0 t -65.4 120.48 12.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.039 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.13 123.29 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -93.91 113.65 25.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.423 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -42.17 104.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.322 0.582 . . . . 0.0 110.841 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -85.82 171.34 11.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.093 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.46 108.66 0.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.18 142.4 56.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.444 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' HA2' ' H ' ' A' ' 2' ' ' GLU . . . -40.88 -74.36 0.16 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.36 13.09 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.87 158.61 29.27 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -57.03 141.81 94.08 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.15 1.234 . . . . 0.0 111.069 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.659 HG21 ' CE1' ' A' ' 35' ' ' TYR . 3.6 mt -83.95 122.13 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.104 0.478 . . . . 0.0 111.233 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.0 -41.97 85.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.278 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.6 163.17 24.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.255 0.55 . . . . 0.0 111.241 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.659 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.5 m-85 -107.5 114.61 28.72 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.836 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -88.09 114.72 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.581 HG22 HG13 ' A' ' 75' ' ' ILE . 63.7 t -115.44 129.81 71.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.976 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -125.24 136.08 53.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.552 ' CE2' HD12 ' A' ' 49' ' ' LEU . 27.8 p90 -140.42 155.82 46.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.041 0.448 . . . . 0.0 110.514 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.554 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 11.1 ptt180 -149.9 178.99 8.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.377 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 p -91.1 140.64 29.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.223 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -68.67 -24.59 64.54 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -33.97 74.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.585 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -158.85 -175.48 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.854 0.835 . . . . 0.0 112.344 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 10.8 pt-20 -142.72 122.06 13.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.753 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.7 m-20 -161.15 38.01 0.14 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 89.5 mt-30 115.88 126.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.853 1.971 . . . . 0.0 110.927 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.554 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 21.6 m95 -87.89 135.78 33.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.842 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.552 HD12 ' CE2' ' A' ' 39' ' ' TYR . 76.3 mt -72.59 159.83 33.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.75 151.76 40.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.071 0.462 . . . . 0.0 111.567 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.15 113.44 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.506 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -92.8 144.17 25.55 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.01 150.47 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.446 ' C ' ' H ' ' A' ' 56' ' ' ASN . 52.2 tt0 -67.49 140.6 57.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.512 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.01 7.7 0.27 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.57 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 54' ' ' GLN . 8.3 t-20 -132.93 -8.92 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.364 0.582 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 14.7 mttp -64.65 -46.0 84.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.607 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.7 p30 50.04 39.5 19.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.799 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.45 151.95 0.63 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.7 140.87 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 0.0 110.707 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.509 HG22 ' OG ' ' A' ' 17' ' ' SER . 33.1 mm -111.87 98.4 6.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.119 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 mt -87.23 105.27 17.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 54.7 mp0 -86.58 175.31 8.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.3 m80 60.91 57.82 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -105.15 -171.68 1.96 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.09 129.57 22.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.579 0.704 . . . . 0.0 110.954 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.763 ' HE1' ' HZ2' ' A' ' 16' ' ' LYS . 68.0 m95 -63.81 -30.39 71.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.977 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 p -100.45 21.0 13.86 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.99 135.03 19.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.301 . . . . 0.0 110.458 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.77 166.17 42.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -144.97 135.0 23.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.501 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 7.5 mt-10 -98.11 151.77 20.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.43 136.95 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.938 0.399 . . . . 0.0 110.678 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -129.62 114.38 15.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -98.94 136.33 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.923 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -138.8 117.78 12.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.519 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.21 129.04 35.45 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.87 116.17 31.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.284 0.564 . . . . 0.0 112.454 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.9 p-10 -117.18 -169.57 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -50.89 -27.96 8.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.611 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -66.24 -37.6 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.529 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.467 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 121.52 -52.19 0.75 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.467 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.2 m-85 -151.67 138.22 18.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -161.71 171.68 17.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.407 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' H ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 pm0 32.03 64.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.408 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.66 151.91 32.72 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.297 1.998 . . . . 0.0 110.691 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -128.75 110.3 12.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.128 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -96.72 98.76 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -104.47 147.45 27.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.19 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.6 131.67 20.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.934 0.397 . . . . 0.0 111.182 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 38.1 p90 -165.81 142.34 5.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -90.01 161.05 16.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.375 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 92.3 mmm -87.77 137.62 31.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.552 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.38 165.43 31.79 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.306 2.004 . . . . 0.0 111.284 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.92 152.88 80.25 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.035 1.823 . . . . 0.0 110.888 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.615 ' CE ' ' NE1' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -44.49 130.93 4.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.526 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.35 121.97 9.35 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.71 1.606 . . . . 0.0 113.196 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -72.37 -31.65 65.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 99' ' ' ILE . 18.4 tt -136.29 117.28 18.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.189 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 22.6 pt -72.81 -168.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.004 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 100' ' ' ILE . 82.6 tttt 100.04 118.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.438 1.086 . . . . 0.0 110.212 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.44 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.632 ' HD2' ' H3 ' ' A' ' 1' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 1' ' ' ARG . 1.3 tp10 94.39 74.92 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.619 0 O-C-N 123.854 0.721 . . . . 0.0 110.479 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -100.52 -164.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.594 2.863 . . . . 0.0 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.405 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -174.06 149.7 1.51 Allowed Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.005 178.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 6' ' ' PRO . 84.0 Cg_exo -39.93 163.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.072 2.515 . . . . 0.0 113.088 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.3 Cg_exo -38.71 163.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.693 2.262 . . . . 0.0 113.339 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.8 m -157.49 58.92 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.8 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.44 130.44 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.228 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -118.99 113.76 21.48 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA2' HD23 ' A' ' 20' ' ' LEU . . . -96.26 138.65 14.05 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -152.41 146.88 18.76 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.655 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.64 88.02 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.278 1.985 . . . . 0.0 111.792 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 t -67.98 -68.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.779 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' GLY . 20.0 m -136.88 156.66 48.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . . . 31.99 -116.22 0.1 OUTLIER Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.088 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HE2' ' HE1' ' A' ' 67' ' ' TRP . 61.1 mttt -96.86 -8.32 31.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.962 0.41 . . . . 0.0 110.274 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.47 136.47 58.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.95 118.65 31.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.326 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.18 109.39 14.6 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.066 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD23 ' HA2' ' A' ' 10' ' ' GLY . 11.5 mt -100.93 89.7 3.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -70.3 121.85 18.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.38 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.415 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.2 mm -82.65 114.95 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 m -94.72 116.29 28.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.627 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.552 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.29 105.76 0.05 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.531 ' NE2' ' OE1' ' A' ' 85' ' ' GLU . 3.6 pt20 -117.87 101.21 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' GLN . 95.7 m-20 33.1 -154.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 29' ' ' GLY . 46.5 p-10 -165.11 161.61 19.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 1' ' ' ARG . . . -66.37 5.6 2.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 117.13 9.28 10.74 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.61 151.3 23.38 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 117.01 0.405 . . . . 0.0 110.156 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.32 141.69 76.08 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.926 1.751 . . . . 0.0 111.781 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.568 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -88.06 130.93 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.183 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.9 mp -85.79 -41.82 14.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.283 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -146.67 162.12 39.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.299 0.571 . . . . 0.0 111.775 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.534 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.3 m-85 -114.2 121.61 44.27 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.963 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.1 mt -95.45 110.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.528 HG22 HG13 ' A' ' 75' ' ' ILE . 60.8 t -112.26 130.88 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.563 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -128.56 133.06 48.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.413 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.533 ' CE2' HD12 ' A' ' 49' ' ' LEU . 37.7 p90 -137.8 153.3 49.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.446 . . . . 0.0 110.389 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -140.4 -174.1 3.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.459 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -100.68 137.36 39.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.029 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -66.77 -30.63 70.89 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.08 -33.43 73.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.569 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 41' ' ' SER . 12.1 ptpt -131.87 168.75 17.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 111.273 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.91 106.8 3.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.188 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 25.2 p-10 -164.74 -26.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -144.99 162.52 36.71 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -131.9 133.54 44.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.133 0.492 . . . . 0.0 110.939 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.533 HD12 ' CE2' ' A' ' 39' ' ' TYR . 90.8 mt -77.15 160.48 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.67 152.27 36.42 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.09 0.472 . . . . 0.0 111.8 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.72 113.71 2.27 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -98.83 145.98 26.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.598 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 157.4 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.115 0.483 . . . . 0.0 110.528 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 56' ' ' ASN . 40.6 tt0 -77.05 137.08 38.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.488 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.95 0.02 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.522 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 54' ' ' GLN . 97.1 m-20 -121.09 -6.26 9.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.875 0.338 . . . . 0.0 110.615 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -64.63 -49.7 70.0 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.53 0.681 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 56.41 34.9 25.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.188 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.45 151.18 0.59 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.03 146.29 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.535 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.5 mm -117.06 108.89 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.578 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 62' ' ' LEU . 1.9 mm? -93.13 105.82 17.86 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 45.4 tt0 -91.63 152.04 20.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.805 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 12.3 t60 80.74 62.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.371 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' GLN . 66.8 mt -119.74 88.37 2.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.861 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' LEU . 86.4 mt-30 -36.91 152.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.151 0.501 . . . . 0.0 111.735 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.409 ' HE1' ' HE2' ' A' ' 16' ' ' LYS . 85.2 m95 -83.17 -5.9 59.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.404 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -115.04 15.13 17.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.689 0.28 . . . . 0.0 111.608 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 67.7 mtp -146.0 136.6 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 111.332 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.37 162.22 25.65 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.94 132.38 26.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.595 0.236 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -87.76 149.93 23.89 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.78 137.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -129.32 106.42 8.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.467 0.651 . . . . 0.0 109.423 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.528 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -92.51 134.97 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.968 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -138.79 116.01 11.07 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -86.26 128.16 34.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.189 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.26 107.27 18.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 1.2 p30 -110.7 -168.18 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -49.49 -31.65 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.0 mm? -63.07 -41.15 99.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 124.37 -44.2 1.31 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.47 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.8 m-85 -153.17 139.99 19.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.8 p -157.37 162.01 39.05 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.853 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.531 ' OE1' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 32.33 59.1 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.459 178.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.5 150.26 69.55 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 121.567 1.512 . . . . 0.0 110.548 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.8 m -128.21 116.51 20.0 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.492 0.663 . . . . 0.0 111.047 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.9 94.67 4.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.235 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -95.86 147.95 23.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.595 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -144.11 135.88 26.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.054 0.454 . . . . 0.0 110.83 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 18' ' ' PHE . 3.9 p90 -167.54 133.77 2.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -89.01 173.77 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.503 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.88 144.38 28.79 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.093 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.03 165.62 27.97 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.614 2.209 . . . . 0.0 110.41 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.59 152.45 81.74 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.749 1.633 . . . . 0.0 111.741 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -36.1 129.49 0.63 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.764 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.71 151.13 24.74 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.965 1.777 . . . . 0.0 110.939 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -105.99 -57.58 2.03 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.663 0.268 . . . . 0.0 110.844 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' ILE . 15.6 pt -72.82 -30.8 33.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.561 0.696 . . . . 0.0 109.5 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 99' ' ' ILE . 1.3 mt 51.1 132.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.509 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -173.63 -125.86 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.531 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.349 -179.527 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 3' ' ' PRO . 96.5 mtt-85 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 1' ' ' ARG . 6.2 tp10 -18.88 81.17 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 123.823 0.702 . . . . 0.0 112.381 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.526 ' N ' ' O ' ' A' ' 1' ' ' ARG . 91.3 Cg_endo -102.52 -163.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 124.476 3.451 . . . . 0.0 110.539 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -165.6 155.46 11.38 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.045 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 49.0 Cg_exo -49.49 -171.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.227 0 C-N-CA 122.408 2.072 . . . . 0.0 112.389 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 5' ' ' PRO . 86.6 Cg_exo -54.7 145.4 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.089 2.526 . . . . 0.0 114.237 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.03 50.44 1.91 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.541 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.2 mm -126.21 128.5 71.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.241 0.543 . . . . 0.0 110.896 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -122.15 114.53 21.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.428 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.2 147.5 18.62 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.531 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -156.74 135.34 7.62 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 107.77 2.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.063 1.175 . . . . 0.0 111.51 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -78.18 -81.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.3 m -143.18 133.91 25.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.406 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.6 -145.68 35.97 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.765 ' NZ ' ' H ' ' A' ' 66' ' ' GLN . 2.6 mtmp? -87.76 -3.67 58.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.332 . . . . 0.0 110.71 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 82.6 p -71.72 145.66 48.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.749 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.79 125.75 48.36 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -85.77 104.01 15.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.808 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.89 97.49 8.37 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.4 t -72.39 120.16 17.61 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.689 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.494 HG21 ' CE2' ' A' ' 35' ' ' TYR . 3.1 mm -80.11 119.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.6 m -85.32 128.26 34.63 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.906 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.461 ' H ' ' HE2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.98 110.93 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.209 1.004 . . . . 0.0 109.584 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 27' ' ' ASP . 8.8 mm-40 -92.79 169.05 10.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.076 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 17.1 t70 -53.75 -9.28 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.262 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 p30 47.92 34.97 4.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.848 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.2 -13.06 0.17 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 114.52 4.3 21.82 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.496 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . -131.44 152.5 80.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 122.633 -0.333 . . . . 0.0 110.358 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.79 144.08 58.02 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.213 1.942 . . . . 0.0 111.837 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.507 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.6 mt -98.44 125.66 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.504 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 mt -72.92 -39.53 66.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.104 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -160.58 170.46 20.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.91 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.505 ' CE1' HG21 ' A' ' 32' ' ' ILE . 11.7 m-85 -117.38 122.43 43.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.582 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -93.02 108.84 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 75' ' ' ILE . 61.4 t -111.12 127.13 68.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.067 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.23 138.22 54.11 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.952 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.527 ' CE2' HD12 ' A' ' 49' ' ' LEU . 28.8 p90 -142.4 151.04 41.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.086 0.47 . . . . 0.0 111.436 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 37.2 ptt85 -143.94 174.27 10.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.864 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.8 p -80.04 150.98 30.17 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.204 0.315 . . . . 0.0 110.261 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -75.12 12.15 0.97 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.425 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.69 -35.03 2.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.489 0.185 . . . . 0.0 110.776 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -103.01 109.64 21.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.491 0.662 . . . . 0.0 110.741 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -105.07 15.95 26.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.695 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.91 3.39 53.62 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -161.38 136.26 7.36 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.214 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 43.0 m95 -119.59 123.56 44.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.527 HD12 ' CE2' ' A' ' 39' ' ' TYR . 82.6 mt -81.76 160.24 23.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.017 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -120.18 154.68 34.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.428 0.632 . . . . 0.0 111.916 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.14 114.67 3.12 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.75 141.15 32.94 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.354 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.33 161.72 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.355 0.598 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 7.3 tp-100 -78.11 146.94 34.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.432 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.0 5.64 7.76 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.828 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.429 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 64.4 t30 -120.7 -15.82 8.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.737 0.304 . . . . 0.0 110.31 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -65.16 -52.06 57.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.238 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 55.9 38.45 30.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.283 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.35 150.96 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.528 0.204 . . . . 0.0 110.535 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.36 152.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.398 0.618 . . . . 0.0 111.667 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 mm -121.57 111.73 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.82 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 17' ' ' SER . 51.0 mt -97.61 112.88 24.57 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -84.93 153.54 22.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 0.0 112.47 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.718 ' HA ' ' HZ1' ' A' ' 16' ' ' LYS . 70.3 t60 59.57 81.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.029 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 66' ' ' GLN . 75.1 mt -118.03 -4.15 11.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.765 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . 22.6 mt-30 57.13 149.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.405 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -90.64 -14.46 32.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.782 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 p -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.75 117.34 15.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.136 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.9 157.83 50.69 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.936 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -139.73 128.03 22.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.309 -0.445 . . . . 0.0 110.259 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -86.48 153.14 22.08 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.61 134.97 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -123.77 106.93 10.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.538 0.685 . . . . 0.0 109.414 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.565 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -94.11 133.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.489 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -139.9 116.2 10.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.659 ' HB3' ' OE2' ' A' ' 85' ' ' GLU . . . -89.37 127.75 35.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.28 110.62 22.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.29 0.567 . . . . 0.0 112.008 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.654 HD22 ' HB2' ' A' ' 84' ' ' SER . 0.1 OUTLIER -116.63 -176.45 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.839 178.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -42.52 -31.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.3 mp -64.75 -41.79 95.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.451 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 124.6 -45.38 1.18 Allowed Glycine 0 N--CA 1.465 0.573 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.484 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.7 m-85 -154.52 138.86 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.654 ' HB2' HD22 ' A' ' 79' ' ' ASN . 73.5 m -148.17 161.53 41.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.564 0.697 . . . . 0.0 111.87 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.659 ' OE2' ' HB3' ' A' ' 77' ' ' ALA . 0.7 OUTLIER 22.75 60.94 0.34 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.417 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.8 150.27 86.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.154 1.236 . . . . 0.0 110.414 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.7 m -125.27 117.92 24.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.577 0.703 . . . . 0.0 111.712 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -93.92 93.6 4.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.584 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 36.7 t80 -95.81 132.67 40.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.704 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.83 136.46 46.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 111.221 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.1 p90 -172.24 133.44 0.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.165 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.4 p -80.52 162.76 24.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.343 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.6 mmm -89.29 143.31 30.72 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.285 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.93 164.98 34.06 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.684 2.256 . . . . 0.0 111.203 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.1 152.36 81.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.414 2.076 . . . . 0.0 111.507 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.75 131.22 1.83 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.64 179.05 6.82 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.208 1.939 . . . . 0.0 111.525 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -155.98 -93.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.099 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.739 ' H ' HD13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -107.37 -1.68 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 122.298 -0.251 . . . . 0.0 111.336 179.482 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CG1' ' N ' ' A' ' 101' ' ' LYS . 15.5 tt -124.32 163.37 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.325 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.429 ' N ' ' CG1' ' A' ' 100' ' ' ILE . 60.9 tttp 61.84 127.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.063 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.561 179.469 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo . . . . . 0 N--CA 1.501 1.961 0 N-CA-C 111.884 -0.083 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -39.21 164.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.696 2.264 . . . . 0.0 114.732 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 m -163.74 48.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.635 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -126.12 127.4 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.621 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -113.35 113.98 26.0 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.06 141.54 15.59 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -150.37 148.63 24.65 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.767 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.75 88.29 1.39 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.167 1.911 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 14' ' ' SER . 79.7 p -58.12 -87.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.024 0.44 . . . . 0.0 109.971 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.463 ' N ' ' OG ' ' A' ' 13' ' ' SER . 37.9 m -139.29 127.97 23.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.58 -131.31 14.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -93.13 -10.67 35.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.634 0.254 . . . . 0.0 111.226 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -63.95 146.56 53.84 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.874 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 130.33 52.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.08 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -88.2 104.83 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.371 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.63 97.4 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 t -73.76 126.94 31.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 mm -87.49 110.44 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -88.89 115.61 26.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.49 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -36.98 105.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.297 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.607 HE22 HG23 ' A' ' 87' ' ' THR . 66.1 mt-30 -91.92 170.5 9.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.614 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.94 109.21 1.2 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.12 142.81 58.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -46.38 -19.52 0.45 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.461 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.71 1.24 1.42 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.92 151.87 57.36 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.82 137.82 55.26 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.772 1.648 . . . . 0.0 111.385 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.617 HG21 ' CE1' ' A' ' 35' ' ' TYR . 3.5 mt -83.41 131.39 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.357 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.1 mm? -85.48 -42.71 14.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.32 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -146.66 161.06 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.266 0.555 . . . . 0.0 111.618 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.617 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.2 m-85 -114.98 125.01 53.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.101 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.628 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 80.6 mt -98.3 114.34 35.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.607 HG22 HG13 ' A' ' 75' ' ' ILE . 75.0 t -112.39 127.74 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.784 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -129.12 128.7 44.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CE2' HD12 ' A' ' 49' ' ' LEU . 36.3 p90 -136.64 153.19 50.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -142.36 172.93 12.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.753 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 15.4 m -84.25 137.96 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -63.13 -38.26 90.47 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.847 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.76 -43.04 97.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.529 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 41' ' ' SER . 36.8 mmtt -102.54 117.76 35.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.407 0.622 . . . . 0.0 110.961 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.77 54.91 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.63 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -142.37 5.66 1.65 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.258 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -144.31 152.85 41.34 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.014 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -141.57 110.6 6.23 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.232 0.539 . . . . 0.0 110.65 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.515 HD12 ' CE2' ' A' ' 39' ' ' TYR . 83.9 mt -73.13 160.08 32.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.72 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -121.71 148.02 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.07 0.462 . . . . 0.0 111.713 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.79 113.61 4.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.628 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 72.9 mmtt -97.3 146.16 25.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 160.95 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.436 0.636 . . . . 0.0 111.092 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 55.6 tt0 -82.86 136.11 34.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.51 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.06 -8.12 1.37 Allowed Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.263 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.489 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 81.8 m-20 -107.12 -9.17 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.673 0.273 . . . . 0.0 110.32 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -64.62 -49.16 72.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.1 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 51.83 33.03 10.56 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.429 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.8 152.93 0.46 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.562 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.594 HD13 HG21 ' A' ' 37' ' ' VAL . 1.5 pt -150.33 141.39 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.145 0.498 . . . . 0.0 110.608 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -112.13 112.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.145 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.2 mt -98.38 136.31 38.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.09 159.52 20.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.999 0.428 . . . . 0.0 111.547 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 t60 71.04 62.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.781 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.657 HD13 ' OH ' ' A' ' 71' ' ' TYR . 54.0 mt -119.26 82.59 1.89 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.4 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' LEU . 49.8 mt-30 -36.35 152.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.134 0.493 . . . . 0.0 111.711 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -83.57 -9.65 58.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.81 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.4 p -113.64 13.36 18.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 61.8 mtp -139.25 136.44 34.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 111.492 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.85 161.29 19.42 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.131 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.657 ' OH ' HD13 ' A' ' 65' ' ' LEU . 3.8 p90 -150.66 139.37 20.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 109.992 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -87.5 148.9 24.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.1 t -125.47 132.72 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -123.39 112.58 17.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.186 0.517 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.607 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -95.97 135.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.13 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -138.5 116.03 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -87.01 125.47 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.333 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.34 111.73 24.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.4 p30 -111.6 -164.92 0.95 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -54.45 -30.98 54.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.599 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.4 mm? -65.02 -41.77 94.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.697 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.22 -48.16 0.98 Allowed Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.5 m-85 -153.75 137.76 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -161.55 170.49 19.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.237 0.541 . . . . 0.0 110.943 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 34.63 57.73 2.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.298 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.47 151.62 59.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.382 2.054 . . . . 0.0 110.898 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.607 HG23 HE22 ' A' ' 25' ' ' GLN . 0.1 OUTLIER -127.33 110.57 12.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.5 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 m -95.02 95.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.555 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.6 t80 -102.46 138.64 39.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.603 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.5 136.0 34.08 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.744 0.306 . . . . 0.0 110.593 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.2 p90 -171.52 129.58 0.69 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -81.55 162.68 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 77.5 mmm -88.82 149.11 43.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.61 162.94 29.83 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.414 2.076 . . . . 0.0 110.338 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.1 154.8 72.64 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.092 1.861 . . . . 0.0 110.961 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.89 131.47 0.92 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.434 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 121.435 1.423 . . . . 0.0 112.427 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 49.8 Cg_exo . . . . . 0 N--CA 1.499 1.834 0 N-CA-C 112.973 0.336 . . . . 0.0 112.973 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.0 Cg_exo -39.79 175.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.286 2.657 . . . . 0.0 114.545 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -160.11 39.85 0.18 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.568 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 87' ' ' THR . 5.9 mm -126.02 128.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.326 0.584 . . . . 0.0 111.76 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -124.84 117.05 23.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.753 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.38 147.04 17.9 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-O 121.472 0.485 . . . . 0.0 112.568 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -145.48 132.29 9.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.47 100.22 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.475 1.45 . . . . 0.0 112.402 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 9.7 p -80.18 167.23 20.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.2 p -43.88 112.11 0.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.67 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.59 -171.72 20.44 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -75.15 -9.31 58.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.508 0.194 . . . . 0.0 111.284 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 7.4 p -66.23 142.56 57.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.713 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.07 125.87 50.33 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -86.64 100.24 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.262 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.7 mt -96.83 98.25 9.97 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.4 t -71.36 129.29 38.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.471 HG21 ' CD2' ' A' ' 35' ' ' TYR . 2.1 mm -92.36 111.34 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -77.4 128.16 33.79 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.211 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.655 ' HD3' ' H ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -34.57 105.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.878 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 85' ' ' GLU . 88.4 mt-30 -83.6 118.15 23.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.493 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.61 -10.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.358 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.529 ' OD1' ' ND2' ' A' ' 79' ' ' ASN . 25.8 t70 58.05 172.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.917 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.31 -48.14 72.54 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.22 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.82 25.7 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.419 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -152.17 151.87 28.48 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.72 146.5 60.63 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.88 1.72 . . . . 0.0 111.437 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.598 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -91.05 127.48 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.949 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.3 mm? -75.72 -45.14 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.25 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -151.99 167.07 29.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.536 ' CE1' HG21 ' A' ' 32' ' ' ILE . 10.4 m-85 -115.16 124.41 51.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.401 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.501 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 91.9 mt -95.65 109.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.603 HG22 HG13 ' A' ' 75' ' ' ILE . 48.9 t -111.51 128.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -125.81 137.93 53.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.421 ' CE2' HD12 ' A' ' 49' ' ' LEU . 47.1 p90 -140.99 155.74 46.16 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.935 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.77 175.32 11.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' LYS . 10.1 m -88.52 137.69 32.1 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.206 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -65.46 -34.19 77.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -10.88 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.615 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' SER . 40.5 mtmt -140.84 161.22 38.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 109.959 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -149.03 51.46 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.037 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -139.96 4.96 2.11 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.674 0.274 . . . . 0.0 111.001 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -138.56 144.11 39.72 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.494 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -141.38 112.18 7.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 110.546 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.421 HD12 ' CE2' ' A' ' 39' ' ' TYR . 96.1 mt -76.43 159.89 30.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.18 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -119.67 150.38 40.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.383 0.611 . . . . 0.0 112.026 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? -153.04 114.45 4.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.219 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.501 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 71.8 mmtt -95.29 144.36 25.93 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.09 159.08 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.185 0.517 . . . . 0.0 110.875 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 67.5 tp60 -78.43 143.78 36.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.893 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.06 -25.01 59.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.433 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 21.1 m120 -95.3 -12.25 26.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 16.9 mttm -64.06 -45.3 89.4 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.3 p30 47.78 38.61 9.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.819 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.04 154.0 0.65 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.785 0.326 . . . . 0.0 110.822 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -155.07 150.89 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 121.253 0.549 . . . . 0.0 110.758 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.34 109.51 27.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.035 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.75 106.23 18.2 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -84.67 149.26 25.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.685 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.5 t60 79.42 70.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.753 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -126.25 81.35 1.99 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' A' ' 68' ' ' THR . 16.5 tt0 -38.1 140.98 0.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 111.336 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -68.9 -29.53 67.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.797 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.429 ' H ' ' HG2' ' A' ' 66' ' ' GLN . 5.8 p -97.22 22.1 9.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 42.3 mtp -147.97 128.67 14.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.835 0.35 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.54 167.38 50.34 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.26 132.65 22.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.11 150.73 20.78 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.18 132.83 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -122.86 109.85 14.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.603 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -98.7 131.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.136 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -134.67 120.33 19.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.94 125.96 35.56 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.09 22.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.643 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.98 -171.51 2.0 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.949 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -41.99 -35.11 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.406 . . . . 0.0 110.217 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.2 mm? -64.14 -40.49 96.26 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 120.86 -41.76 1.85 Allowed Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.0 m-85 -155.96 135.53 12.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -163.03 155.98 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.789 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.537 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 18.8 tt0 45.04 56.19 14.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.25 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.23 154.89 56.72 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.738 2.292 . . . . 0.0 111.119 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.46 HG21 HG12 ' A' ' 8' ' ' ILE . 35.4 m -130.46 121.15 25.3 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.62 0.724 . . . . 0.0 111.018 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.81 94.44 3.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 37.7 t80 -99.86 125.35 45.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.724 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.07 130.38 49.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.73 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.7 p90 -163.79 134.19 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.601 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -80.56 164.46 22.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.6 mmm -94.76 145.75 30.17 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.918 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.39 163.49 37.6 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.323 2.015 . . . . 0.0 110.937 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.22 154.95 72.14 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.455 2.103 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -40.37 132.77 1.63 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.801 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 N--CA 1.492 1.389 0 C-N-CA 121.805 1.67 . . . . 0.0 111.697 178.485 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' PRO . 76.4 Cg_exo . . . . . 0 N--CA 1.497 1.725 0 N-CA-C 112.793 0.267 . . . . 0.0 112.793 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.0 Cg_exo -37.38 164.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.768 2.312 . . . . 0.0 113.629 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.57 53.15 0.78 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.689 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 mm -130.04 128.4 64.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -119.09 114.71 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.47 145.64 17.75 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.659 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.38 116.46 3.99 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -50.02 104.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.248 1.299 . . . . 0.0 112.252 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -80.76 167.32 20.1 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.1 t -43.27 118.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.38 -150.21 21.15 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -82.18 -6.09 58.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 110.576 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -66.37 143.26 57.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.53 121.76 37.3 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -83.7 108.73 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.437 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 mt -101.81 108.83 20.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -83.4 121.96 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.004 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.3 mm -86.06 115.03 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -86.83 127.18 35.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.191 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -47.16 105.2 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.412 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 27' ' ' ASP . 78.7 mt-30 -81.44 158.35 24.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.858 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 35.1 t0 -51.16 -9.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.603 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER 64.83 131.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -40.05 -19.73 0.02 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 138.46 17.87 0.57 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -157.69 152.47 21.01 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.53 138.91 61.79 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.811 1.674 . . . . 0.0 111.732 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.565 HG21 ' CE1' ' A' ' 35' ' ' TYR . 6.4 mt -89.22 133.33 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.218 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.7 mp -89.51 -25.18 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.177 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -164.64 164.62 21.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.176 0.512 . . . . 0.0 111.436 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.565 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.4 m-85 -119.37 117.49 28.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.076 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.7 mt -91.54 116.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG13 ' A' ' 75' ' ' ILE . 75.2 t -115.36 130.0 70.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.542 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -129.22 129.07 44.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CE2' HD12 ' A' ' 49' ' ' LEU . 39.1 p90 -134.1 155.92 49.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.49 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 26.9 ptt85 -149.58 171.1 17.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.504 ' HG ' ' HE2' ' A' ' 71' ' ' TYR . 4.4 m -80.8 138.07 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -63.94 -32.17 73.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.702 0.287 . . . . 0.0 111.447 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.99 -29.36 69.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.646 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' SER . 38.5 mtmt -130.96 166.61 20.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.488 0.661 . . . . 0.0 110.996 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -144.74 16.21 1.6 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.558 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -90.14 -0.25 57.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.881 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -149.36 152.14 35.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 111.727 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.434 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 49.9 m95 -141.26 114.37 8.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.863 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 39' ' ' TYR . 91.5 mt -75.08 159.55 31.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.915 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -117.65 153.64 32.96 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.18 0.514 . . . . 0.0 111.508 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.47 113.59 2.88 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -95.89 143.73 26.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.567 0.223 . . . . 0.0 110.576 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.4 160.78 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 110.591 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 6.5 tt0 -79.1 148.68 32.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.026 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.21 2.31 14.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.46 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 9.4 t-20 -121.54 -15.66 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.67 0.271 . . . . 0.0 110.962 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.81 -47.98 81.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 110.233 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 54.89 34.8 22.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.333 0.587 . . . . 0.0 111.319 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.44 156.66 2.01 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.705 -0.622 . . . . 0.0 110.94 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -156.06 155.46 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.634 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.7 107.55 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 62' ' ' LEU . 2.0 mm? -92.5 107.47 19.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.06 157.44 18.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.592 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 m170 73.23 68.6 0.11 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.712 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.5 mt -125.07 82.18 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.064 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 73.3 mt-30 -36.16 141.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.115 0.484 . . . . 0.0 111.555 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -74.75 -7.57 53.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.673 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -112.55 16.67 19.69 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtp -143.5 142.31 31.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.965 0.412 . . . . 0.0 110.188 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.17 164.19 25.83 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.504 ' HE2' ' HG ' ' A' ' 41' ' ' SER . 92.2 m-85 -146.49 137.19 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 111.277 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.4 mt-10 -97.96 149.86 21.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.87 133.83 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.48 106.96 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.592 0.71 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.596 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -93.03 132.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.539 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 m -134.79 121.74 21.12 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -94.55 126.54 39.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.3 112.58 24.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 112.181 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.9 p-10 -119.07 -165.71 1.17 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.986 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.42 -30.53 19.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD22 HD21 ' A' ' 79' ' ' ASN . 8.6 mp -63.46 -39.15 93.7 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 118.64 -46.65 1.11 Allowed Glycine 0 N--CA 1.463 0.474 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 5.2 m-85 -155.8 128.75 8.03 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.502 ' O ' ' C ' ' A' ' 85' ' ' GLU . 3.7 m -113.06 148.32 35.44 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 84' ' ' SER . 1.2 mp0 -12.6 98.03 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 124.225 0.953 . . . . 0.0 111.846 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.55 158.36 53.96 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.133 1.222 . . . . 0.0 111.325 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.8 m -105.71 114.19 28.21 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.534 0.683 . . . . 0.0 110.105 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -91.36 94.46 4.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.2 t80 -98.5 128.16 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.827 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.21 129.76 48.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 14.8 p90 -159.38 126.87 4.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.73 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.62 161.12 23.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.057 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.4 mmm -90.67 139.12 26.29 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.29 163.05 35.44 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.38 2.053 . . . . 0.0 111.103 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 152.12 82.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.071 1.847 . . . . 0.0 111.04 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -39.71 131.6 1.43 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.408 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 C-N-CA 121.501 1.467 . . . . 0.0 112.317 179.823 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo . . . . . 0 N--CA 1.5 1.902 0 N-CA-C 113.245 0.44 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.78 151.25 26.5 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.125 1.883 . . . . 0.0 114.275 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.02 30.29 3.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.955 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.36 120.06 54.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.283 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -115.73 116.23 27.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.302 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.55 156.29 21.52 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -157.68 133.41 5.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.29 82.73 1.06 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.322 1.348 . . . . 0.0 112.136 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -58.4 -173.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.5 p -56.48 122.36 11.76 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.272 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.06 -154.03 31.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HE2' ' H ' ' A' ' 66' ' ' GLN . 15.4 mtmm -78.1 -9.09 58.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.473 -0.363 . . . . 0.0 110.897 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 p -64.66 143.4 57.95 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.114 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.91 126.34 49.77 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -87.84 98.39 11.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mt -93.71 99.83 12.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -73.96 119.23 17.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.266 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.441 HG21 ' CD2' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -84.88 108.69 17.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -87.62 129.07 35.24 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -44.62 105.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.39 153.53 20.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.03 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -57.84 103.01 0.11 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 55.1 p-10 -57.52 145.39 33.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.103 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.63 -46.71 7.31 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.29 18.68 0.02 OUTLIER Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.397 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -158.78 156.43 26.89 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.41 0.605 . . . . 0.0 110.231 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.35 144.2 85.17 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.136 1.891 . . . . 0.0 110.967 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.583 HG21 ' CE1' ' A' ' 35' ' ' TYR . 5.7 mt -91.82 124.37 44.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.248 0.547 . . . . 0.0 111.454 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.78 -41.05 68.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.029 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.33 171.85 19.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.27 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -120.78 114.28 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.832 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -89.45 115.4 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG22 HG13 ' A' ' 75' ' ' ILE . 96.4 t -111.91 128.54 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -124.34 128.12 48.62 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' CE2' HD12 ' A' ' 49' ' ' LEU . 35.3 p90 -135.32 153.74 51.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.691 0.281 . . . . 0.0 110.875 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE1' ' A' ' 72' ' ' GLU . 29.3 ptt85 -147.23 171.72 14.95 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.4 m -81.4 137.77 35.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.494 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.36 -29.14 70.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.554 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.15 -31.05 72.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.244 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -119.82 171.73 8.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.769 0.795 . . . . 0.0 111.546 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -152.22 4.68 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.722 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -90.55 -1.33 57.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.426 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -140.62 138.45 34.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.239 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 44.9 m95 -134.62 108.45 8.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.907 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.486 HD12 ' CE2' ' A' ' 39' ' ' TYR . 84.6 mt -71.65 159.39 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.56 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 1.3 pm0 -124.42 147.19 48.44 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -145.45 111.89 5.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -84.79 142.35 29.85 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 35' ' ' TYR . 38.8 t -136.41 156.03 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.434 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 7.9 tp-100 -78.42 146.66 34.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.768 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.05 -6.4 45.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -111.47 -15.6 13.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.51 0.195 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HD2' ' H ' ' A' ' 54' ' ' GLN . 23.0 mttm -62.06 -49.1 77.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.285 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 53.34 36.07 21.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.412 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.98 154.07 0.67 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -154.68 146.13 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 110.587 179.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mm -114.82 115.52 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.26 105.59 16.26 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.6 154.19 25.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.7 t60 69.97 67.0 0.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.961 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' GLN . 57.4 mt -107.84 -7.92 16.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 65' ' ' LEU . 74.6 mt-30 55.72 147.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 111.646 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -91.94 -18.4 23.77 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.038 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.3 p -106.48 18.8 21.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 10.8 ttm -146.5 138.84 25.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 170.47 34.34 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -149.35 134.27 17.96 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 5.1 mt-10 -98.87 152.81 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.06 135.37 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.017 0.437 . . . . 0.0 110.767 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -128.22 108.27 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.983 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.612 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -92.18 137.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.543 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -137.19 117.86 13.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.11 126.64 35.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.68 112.23 25.24 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.315 0.578 . . . . 0.0 112.184 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.6 p-10 -114.73 -168.25 1.35 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.804 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -51.31 -30.48 18.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.621 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -63.18 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.11 -47.45 1.02 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -155.53 139.02 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' GLU . 1.3 t -131.84 135.46 46.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.75 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.6 mm-40 11.9 94.04 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 124.365 1.041 . . . . 0.0 112.091 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.38 154.26 55.91 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 120.995 1.13 . . . . 0.0 111.679 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.82 111.76 24.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 88' ' ' VAL . 28.6 m -94.64 96.62 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.165 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.481 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -101.8 130.43 48.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.264 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.52 130.68 44.44 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.167 0.508 . . . . 0.0 111.729 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 13.0 p90 -165.94 140.14 4.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.064 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -91.27 171.29 9.33 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.453 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.0 mmm -96.61 139.74 21.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.08 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.21 163.18 37.12 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.22 1.947 . . . . 0.0 110.955 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.95 147.61 91.89 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.39 2.06 . . . . 0.0 111.764 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -41.45 134.52 2.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 C-N-CA 121.61 1.54 . . . . 0.0 111.435 178.252 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' PRO . 54.4 Cg_exo . . . . . 0 N--CA 1.498 1.76 0 N-CA-C 112.73 0.242 . . . . 0.0 112.73 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -33.96 167.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 123.714 2.943 . . . . 0.0 116.155 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.491 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -165.06 46.47 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.917 -177.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.99 129.28 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 111.579 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -119.26 116.91 27.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.184 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.55 155.95 19.4 Favored Glycine 0 N--CA 1.467 0.712 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.331 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -158.56 132.61 5.08 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 89.5 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.376 1.384 . . . . 0.0 110.923 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 t -60.73 -85.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.349 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 17' ' ' SER . 90.7 p -128.12 127.74 43.59 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.752 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.08 -128.67 31.48 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 65' ' ' LEU . 40.5 mttt -89.5 -5.6 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 14' ' ' SER . 85.7 p -61.75 144.87 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.425 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 120.78 27.26 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -88.03 101.18 13.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.272 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 mt -96.5 96.56 8.77 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 t -67.62 130.68 43.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.451 HD12 HG12 ' A' ' 75' ' ' ILE . 5.2 mm -91.74 117.16 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.3 m -84.17 128.33 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.762 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -63.05 105.23 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' NE2' ' OG ' ' A' ' 7' ' ' SER . 76.0 mm-40 -101.31 167.18 10.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.299 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -59.63 95.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 26.6 t70 -42.38 -64.55 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.657 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.62 -23.36 0.22 Allowed Glycine 0 C--N 1.318 -0.47 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.36 5.08 0.09 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.684 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.431 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -156.79 142.68 12.85 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 118.187 0.994 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.71 150.73 60.1 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.067 1.178 . . . . 0.0 111.927 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.588 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.4 mt -91.79 128.19 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.491 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.8 mt -72.95 -42.56 63.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -155.53 163.66 39.7 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.635 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.8 m-85 -110.98 127.12 55.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.058 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.51 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 85.9 mt -99.95 110.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.577 HG22 HG13 ' A' ' 75' ' ' ILE . 99.6 t -109.21 127.09 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.855 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -126.17 128.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 49' ' ' LEU . 41.7 p90 -132.9 151.51 52.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -142.34 172.82 12.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.397 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.9 p -84.17 147.24 27.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HZ2' ' N ' ' A' ' 92' ' ' SER . 95.4 mttt -75.24 4.64 6.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.74 -49.88 2.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 45' ' ' GLU . 11.2 mmpt? -60.92 -45.42 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.932 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 81.8 tt0 36.18 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.449 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' O ' ' NE2' ' A' ' 47' ' ' GLN . 1.9 m-20 167.15 -15.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.571 0.545 . . . . 0.0 110.493 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 46' ' ' ASP . 96.0 mm-40 -137.24 117.74 13.81 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.56 0.219 . . . . 0.0 110.923 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -99.95 116.67 32.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.851 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.423 HD12 ' CE2' ' A' ' 39' ' ' TYR . 92.4 mt -73.45 160.07 32.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.182 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 25.0 mp0 -117.0 150.55 38.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.341 0.591 . . . . 0.0 112.47 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.24 115.33 4.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.51 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 73.0 mmtt -97.52 146.0 25.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.42 155.67 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.034 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.516 ' C ' ' H ' ' A' ' 56' ' ' ASN . 33.3 tt0 -78.08 137.24 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.208 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 7.07 0.16 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 54' ' ' GLN . 66.0 t30 -122.18 -13.97 8.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.793 0.297 . . . . 0.0 110.755 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -69.72 -53.08 20.16 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.811 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 58.28 40.06 24.98 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.648 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -178.05 153.15 0.78 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.564 HD13 HG21 ' A' ' 37' ' ' VAL . 1.4 pt -152.45 143.31 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.204 0.526 . . . . 0.0 111.428 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.6 mm -114.56 115.79 50.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.14 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.0 mt -103.73 105.52 15.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.5 152.2 23.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.225 0.536 . . . . 0.0 112.188 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 66.06 76.68 0.31 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.28 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.747 HD13 ' OH ' ' A' ' 71' ' ' TYR . 86.2 mt -111.52 -4.12 14.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' O ' ' SD ' ' A' ' 93' ' ' MET . 83.3 mt-30 52.49 120.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.877 0.846 . . . . 0.0 112.241 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -61.31 -32.04 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.093 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -94.52 22.87 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.3 tpt -144.46 114.73 7.51 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.395 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.78 155.59 32.09 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.747 ' OH ' HD13 ' A' ' 65' ' ' LEU . 48.5 p90 -151.29 138.29 19.1 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.54 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.96 156.21 19.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.642 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 132.71 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -126.12 110.82 13.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.373 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.577 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -91.76 137.24 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.768 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.82 117.24 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.59 124.38 34.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.26 113.43 26.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.268 0.556 . . . . 0.0 112.358 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -116.62 -163.38 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -52.75 -33.33 47.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 81' ' ' LEU . 8.5 mp -64.12 -40.98 97.37 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 126.09 -49.64 0.91 Allowed Glycine 0 N--CA 1.463 0.452 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.8 m-85 -154.46 133.96 12.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 t -159.85 170.28 21.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 25' ' ' GLN . 16.6 pt-20 39.91 51.41 3.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.392 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.76 148.37 82.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.941 1.76 . . . . 0.0 111.263 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.425 ' CG2' ' H ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -125.32 110.35 13.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 99.25 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.523 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -104.56 131.75 51.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.956 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -131.84 132.58 43.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 6.6 p90 -173.69 125.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.208 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.557 ' N ' ' HZ2' ' A' ' 42' ' ' LYS . 11.9 p -80.77 166.29 21.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.3 mtp -88.41 147.47 40.01 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.956 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.07 162.66 28.76 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.421 2.081 . . . . 0.0 110.211 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 96' ' ' LYS . 38.2 Cg_endo -65.6 153.64 77.29 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.912 1.741 . . . . 0.0 110.822 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 95' ' ' PRO . 4.1 tppp? -36.62 133.05 0.65 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.555 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.492 1.432 0 C-N-CA 121.465 1.443 . . . . 0.0 111.818 179.499 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.3 Cg_exo . . . . . 0 N--CA 1.495 1.604 0 N-CA-C 112.629 0.203 . . . . 0.0 112.629 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 32.8 Cg_exo -38.7 166.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.85 2.367 . . . . 0.0 113.322 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.25 41.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.683 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.08 124.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.578 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -116.14 118.96 34.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.462 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.64 140.91 15.06 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.474 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -143.73 146.51 35.21 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.2 80.46 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.828 1.685 . . . . 0.0 111.447 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.4 t -48.03 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -139.63 136.99 34.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.064 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.6 -130.76 37.34 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -95.17 -4.01 46.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -68.81 144.11 54.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.001 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.48 128.2 47.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 110.246 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -88.08 103.62 15.91 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mt -99.13 91.98 5.25 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -66.86 124.8 23.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.494 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.422 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.4 mm -86.97 115.72 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -95.13 119.3 33.4 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.488 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -38.28 105.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.49 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -95.0 148.87 21.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 97.9 m-20 -54.67 95.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.53 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 30' ' ' ALA . 28.3 t70 -48.02 169.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.609 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.43 84.08 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.67 22.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.811 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -159.05 151.66 17.96 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.58 140.62 57.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.435 1.423 . . . . 0.0 110.529 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.577 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.5 mt -83.48 127.71 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.82 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 33' ' ' LEU . 9.4 mp -75.18 -43.11 53.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.287 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -152.83 163.33 39.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.387 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.493 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -111.39 122.83 48.87 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.954 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.46 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 87.3 mt -96.47 107.93 20.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 75' ' ' ILE . 74.3 t -107.37 125.03 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.26 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -122.35 136.82 54.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 49' ' ' LEU . 33.0 p90 -143.18 152.15 41.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.679 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.474 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 35.6 ptt85 -148.39 173.43 13.09 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 111.634 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -79.08 147.83 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.266 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -69.36 -32.03 70.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.679 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -75.15 -47.31 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -57.51 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.856 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 58.18 76.66 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.762 0.791 . . . . 0.0 110.116 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 61.2 t0 -175.61 -21.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.3 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -138.47 158.13 44.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.2 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 63.4 m95 -136.12 134.29 38.17 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 112.209 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 39' ' ' TYR . 96.7 mt -84.79 160.38 20.25 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -118.07 149.1 41.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.26 0.552 . . . . 0.0 112.091 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.09 114.36 4.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 71.4 mmtt -98.92 144.7 27.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.668 0.27 . . . . 0.0 110.959 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.76 157.77 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.11 0.481 . . . . 0.0 110.648 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -70.6 149.53 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.448 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.89 -7.09 14.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.189 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -121.47 0.13 9.9 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.088 0.444 . . . . 0.0 111.346 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -61.83 -46.77 88.05 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.442 0.639 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 52.99 31.52 11.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.835 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.36 150.55 0.44 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.34 146.86 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.111 0.481 . . . . 0.0 111.243 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mm -113.9 117.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.35 105.65 15.79 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.612 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 65.5 mt-10 -96.93 119.7 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 28.9 m-70 122.65 54.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.997 1.436 . . . . 0.0 111.018 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.593 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 23.1 mt -111.89 105.24 13.64 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.488 ' N ' HE21 ' A' ' 66' ' ' GLN . 0.0 OUTLIER -59.06 135.85 57.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.237 0.542 . . . . 0.0 111.204 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -66.21 -23.81 66.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.075 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 p -104.82 18.23 22.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.9 mtp -149.79 129.97 13.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.027 0.442 . . . . 0.0 110.706 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.33 44.3 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.593 ' CZ ' HD13 ' A' ' 65' ' ' LEU . 9.3 p90 -157.46 132.11 8.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.286 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -87.27 154.29 20.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.007 0.432 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.53 134.0 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -124.62 110.46 14.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.496 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.572 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -95.82 132.4 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -136.76 118.29 14.84 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.577 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -90.13 126.24 35.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.61 108.41 19.68 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.603 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -114.5 -175.11 2.61 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.303 178.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -40.3 -33.71 0.27 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -63.96 -42.8 97.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.496 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.93 -48.5 0.97 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -155.83 131.63 9.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.04 162.39 20.35 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER 52.88 51.87 9.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 98.0 Cg_endo -74.01 152.83 46.57 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.381 2.054 . . . . 0.0 111.258 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 m -133.93 117.74 17.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.368 0.604 . . . . 0.0 110.714 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -96.6 94.49 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.422 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 34.0 t80 -98.61 134.82 41.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.538 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -137.89 130.5 29.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 23.1 p90 -163.97 131.44 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.982 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -79.83 167.85 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 28.0 mtp -97.89 151.79 37.75 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.966 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.96 163.9 22.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.536 2.157 . . . . 0.0 110.012 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.35 156.38 63.59 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.774 1.649 . . . . 0.0 111.068 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -38.51 130.22 1.08 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.505 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.496 1.634 0 C-N-CA 121.726 1.617 . . . . 0.0 112.725 179.893 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.6 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 N-CA-C 112.601 0.193 . . . . 0.0 112.601 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.5 Cg_exo -37.3 167.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 123.305 2.67 . . . . 0.0 114.091 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.97 54.78 0.52 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.541 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.401 HG12 HG21 ' A' ' 87' ' ' THR . 6.0 mm -132.91 130.14 58.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.108 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -123.84 114.31 19.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.81 138.35 14.53 Favored Glycine 0 N--CA 1.46 0.297 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.45 116.95 8.6 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.556 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -52.03 103.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 120.945 1.096 . . . . 0.0 111.664 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.9 p -85.37 172.02 11.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 m -41.55 106.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.819 0.342 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.29 -154.01 21.28 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.005 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -77.23 -19.65 56.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.516 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.434 ' OG ' HG22 ' A' ' 61' ' ' ILE . 13.6 t -59.01 139.11 57.17 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.171 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.92 122.11 46.67 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -86.1 109.0 18.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.792 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.27 105.72 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 119.09 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.45 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.4 mm -84.08 112.47 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 5.9 m -79.35 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.034 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.516 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.84 104.89 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.513 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -100.59 158.85 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 27' ' ' ASP . 45.9 m-20 -61.88 95.38 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 32.4 t70 -43.41 168.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.135 0.493 . . . . 0.0 111.183 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.71 -42.44 85.15 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 15.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.905 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.43 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -159.64 151.36 16.77 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.886 0.843 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.45 142.52 80.36 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.988 1.125 . . . . 0.0 111.59 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.524 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.5 mt -86.56 125.17 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.354 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -72.06 -40.76 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.805 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.39 167.27 26.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.07 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 32' ' ' ILE . 14.6 m-85 -112.06 119.93 40.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.875 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.6 mt -92.18 113.07 26.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 75' ' ' ILE . 61.2 t -113.57 129.34 69.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.286 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -127.78 133.82 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CE2' HD12 ' A' ' 49' ' ' LEU . 29.7 p90 -139.26 154.05 47.91 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.044 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.0 174.02 11.65 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.533 ' OG ' ' CE2' ' A' ' 71' ' ' TYR . 4.3 m -84.21 136.76 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.007 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.83 -35.36 78.01 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.879 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -63.11 -35.49 80.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -98.68 178.05 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.801 0.81 . . . . 0.0 111.432 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -160.05 -5.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.777 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -91.6 9.02 33.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -149.72 150.45 32.1 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.805 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.43 109.06 5.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.722 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.492 HD12 ' CE2' ' A' ' 39' ' ' TYR . 56.4 mt -72.61 159.91 33.11 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.506 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -121.72 151.72 40.2 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.09 0.472 . . . . 0.0 111.558 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.44 114.66 3.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -96.2 142.3 28.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.29 138.25 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.25 0.548 . . . . 0.0 111.038 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.462 ' C ' ' H ' ' A' ' 56' ' ' ASN . 48.9 tt0 -59.71 142.53 52.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.5 14.8 0.93 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.135 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 m120 -132.09 9.88 4.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 21.3 mttt -91.74 -46.3 7.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.663 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 49.69 39.13 16.88 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.64 0.588 . . . . 0.0 111.887 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -179.57 151.9 0.48 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.707 0.289 . . . . 0.0 110.798 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -151.61 146.58 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.383 0.611 . . . . 0.0 111.092 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.434 HG22 ' OG ' ' A' ' 17' ' ' SER . 45.1 mm -114.86 111.65 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.83 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -100.03 107.75 19.76 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 98.8 mt-10 -84.88 156.06 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.523 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 6.3 t-80 78.76 52.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.6 mm? -107.71 88.22 2.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -51.0 135.96 23.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.646 . . . . 0.0 111.335 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -64.39 -34.13 77.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.444 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.8 p -96.33 20.81 9.89 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.7 mtp -143.34 140.0 30.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.206 0.527 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.8 162.61 24.26 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.533 ' CE2' ' OG ' ' A' ' 41' ' ' SER . 43.3 m-85 -144.34 135.5 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.046 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -94.69 149.86 20.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.33 133.42 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -123.24 108.41 12.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.475 0.655 . . . . 0.0 109.705 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -96.87 131.21 44.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.923 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -135.47 119.47 17.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.98 126.21 35.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.07 116.05 31.3 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 112.46 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.543 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 4.1 p-10 -115.9 -166.55 1.15 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -51.78 -31.48 27.19 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.625 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.9 mm? -64.05 -42.54 97.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.488 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.82 -45.05 1.19 Allowed Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.488 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.1 m-85 -153.64 140.67 19.31 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -163.76 153.86 15.16 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.574 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.4 ' CD ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER 44.32 60.13 12.46 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.593 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 152.4 43.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.242 1.961 . . . . 0.0 110.965 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.401 HG21 HG12 ' A' ' 8' ' ' ILE . 23.0 m -131.23 118.44 20.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.65 0.738 . . . . 0.0 111.467 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.7 94.22 4.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.701 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -98.96 127.15 44.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.148 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.6 132.97 45.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.253 0.549 . . . . 0.0 110.967 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.581 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.1 p90 -166.49 140.07 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.334 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.9 156.49 19.33 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 85.8 mmm -85.88 147.4 45.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.48 162.76 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.343 2.029 . . . . 0.0 110.98 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.07 158.73 50.23 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.244 1.963 . . . . 0.0 111.121 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.91 129.89 0.95 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.447 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 121.327 1.351 . . . . 0.0 112.425 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' PRO . 79.0 Cg_exo . . . . . 0 N--CA 1.492 1.433 0 N-CA-C 111.913 -0.072 . . . . 0.0 111.913 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 22.3 Cg_exo -38.49 169.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.662 2.241 . . . . 0.0 114.93 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.453 ' H ' HG21 ' A' ' 87' ' ' THR . 15.2 m -156.56 46.19 0.43 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.347 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.27 127.11 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.331 0.586 . . . . 0.0 110.554 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -117.53 116.55 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.142 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.0 147.35 18.56 Favored Glycine 0 N--CA 1.464 0.517 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.3 130.43 8.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.94 81.97 1.59 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.43 1.42 . . . . 0.0 111.988 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.452 ' OG ' ' N ' ' A' ' 14' ' ' SER . 47.2 t -60.05 -159.73 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.452 ' N ' ' OG ' ' A' ' 13' ' ' SER . 33.4 t -63.33 134.52 55.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.246 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.53 -146.16 33.87 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.766 0.317 . . . . 0.0 110.62 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -64.97 148.89 50.76 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.775 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.3 121.17 33.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.693 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -83.97 98.51 9.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 90.21 7.25 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -69.72 117.55 11.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.754 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.443 HG21 ' CE2' ' A' ' 35' ' ' TYR . 4.6 mm -77.63 126.36 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -104.2 116.51 32.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 110.472 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -39.47 104.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.787 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.26 165.18 11.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 43.0 t0 -57.94 109.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.897 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -71.58 165.65 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.98 31.98 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.54 -0.28 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.1 151.58 75.54 Favored Pre-proline 0 N--CA 1.463 0.22 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.21 143.58 65.3 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.865 1.71 . . . . 0.0 111.278 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.583 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.1 mt -86.74 126.44 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.761 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.9 mp -72.81 -41.38 64.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.138 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.02 165.67 35.76 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.375 0.607 . . . . 0.0 111.481 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.534 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -115.38 119.98 38.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.221 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.93 115.11 31.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 75' ' ' ILE . 38.7 t -118.89 131.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.072 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -125.56 139.76 53.33 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.465 ' CE2' HD12 ' A' ' 49' ' ' LEU . 37.2 p90 -143.6 156.25 44.52 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.278 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.48 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 34.5 ptt85 -149.54 174.8 12.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 m -82.23 143.04 31.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -63.64 -39.46 94.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.437 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 7.0 t0 -76.6 -46.13 27.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.102 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' CE ' ' HE1' ' A' ' 69' ' ' MET . 1.4 mppt? -89.03 91.38 8.8 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -98.58 65.94 1.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.292 179.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -136.29 -5.87 2.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -146.59 155.87 42.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.991 0.424 . . . . 0.0 111.36 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -136.23 114.28 11.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.156 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.465 HD12 ' CE2' ' A' ' 39' ' ' TYR . 79.9 mt -77.55 160.31 28.69 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.908 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -111.04 155.62 22.5 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.788 0.328 . . . . 0.0 111.136 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -159.09 112.39 2.29 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -98.71 143.16 29.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.749 0.309 . . . . 0.0 111.289 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.66 156.54 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.42 0.629 . . . . 0.0 110.542 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 48.4 tt0 -82.09 144.35 30.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.307 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.6 81.42 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.523 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 32.8 m-20 -67.1 -39.3 86.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.295 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 54' ' ' GLN . 74.0 mttt -55.27 -71.87 0.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.549 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 60.34 49.37 7.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.437 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -176.04 140.13 0.4 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -141.85 151.83 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.393 0.616 . . . . 0.0 112.329 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -122.47 101.49 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 62' ' ' LEU . 9.1 mp -92.06 107.24 19.07 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 64' ' ' HIS . 6.5 tm-20 -96.57 148.76 22.51 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.236 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.489 ' N ' ' CD ' ' A' ' 63' ' ' GLU . 19.2 t-80 93.0 48.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' O ' ' SD ' ' A' ' 93' ' ' MET . 20.9 mt -112.95 94.0 4.69 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.528 ' O ' ' SD ' ' A' ' 93' ' ' MET . 47.1 tt0 -45.48 148.47 0.68 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 110.95 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.18 -8.65 56.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.767 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 p -113.44 19.13 17.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.43 ' HE1' ' CE ' ' A' ' 44' ' ' LYS . 49.3 mtp -144.22 133.86 23.56 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.806 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.7 157.37 27.46 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -137.56 133.31 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.794 0.33 . . . . 0.0 110.789 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.48 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.5 mt-10 -92.4 147.94 22.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.63 134.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.93 0.395 . . . . 0.0 109.96 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -124.2 108.27 12.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.267 0.556 . . . . 0.0 109.983 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.513 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -93.38 135.95 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.955 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -136.37 116.57 13.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.76 126.6 35.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.88 112.7 25.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.325 0.583 . . . . 0.0 112.541 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.75 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -114.53 -165.89 1.05 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -49.52 -33.12 13.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.834 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.5 mm? -64.7 -42.65 95.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.248 0.547 . . . . 0.0 109.635 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.35 -48.79 0.95 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.475 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.1 m-85 -154.01 137.71 16.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.2 m -160.22 164.24 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.348 0.594 . . . . 0.0 111.799 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 26' ' ' ASP . 16.9 pt-20 33.38 59.29 1.7 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.403 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 152.02 80.03 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.102 1.868 . . . . 0.0 109.963 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.453 HG21 ' H ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -124.57 111.24 15.42 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.0 110.714 -179.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.47 95.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -102.28 136.31 42.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -138.3 134.95 34.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 7.0 p90 -162.05 152.83 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.728 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.9 170.85 8.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.974 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 65' ' ' LEU . 36.4 mtp -105.62 145.6 31.17 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.426 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.17 161.95 31.91 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.375 2.05 . . . . 0.0 110.751 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.32 155.39 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.12 1.88 . . . . 0.0 110.872 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -37.94 132.16 0.91 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.541 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 121.677 1.585 . . . . 0.0 112.796 -179.779 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo . . . . . 0 N--CA 1.503 2.074 0 N-CA-C 113.036 0.36 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.49 147.68 37.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.785 1.656 . . . . 0.0 114.449 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.5 34.88 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.201 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mm -107.51 122.49 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.999 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.66 117.14 28.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.9 147.34 18.56 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -159.83 115.82 1.51 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -50.98 94.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.202 1.268 . . . . 0.0 111.984 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -76.55 -48.7 18.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.63 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.551 ' H ' ' HG ' ' A' ' 17' ' ' SER . 69.2 p -144.49 166.77 24.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.037 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -35.99 128.67 0.89 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 39.78 48.37 1.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.167 0.508 . . . . 0.0 111.071 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.551 ' HG ' ' H ' ' A' ' 14' ' ' SER . 11.8 p -142.1 150.89 41.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.484 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.12 120.91 14.41 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -84.81 97.9 9.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.04 89.82 7.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 t -66.88 125.83 27.17 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.542 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.438 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.2 mm -85.82 114.89 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.4 m -98.77 117.24 32.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.576 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.74 108.14 0.08 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.359 1.076 . . . . 0.0 110.518 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 26' ' ' ASP . 2.6 pt20 -115.63 101.54 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.152 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 25' ' ' GLN . 4.5 m-20 19.12 82.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.9 0.75 . . . . 0.0 111.779 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 29' ' ' GLY . 85.9 m-20 -50.67 131.47 25.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.046 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' ASP . . . -27.05 -35.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.961 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 163.93 0.08 0.05 OUTLIER Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.728 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.12 155.61 29.35 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 117.848 0.824 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -54.02 138.25 70.13 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 121.094 1.196 . . . . 0.0 111.767 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.567 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.2 mt -81.66 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.384 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.91 -40.07 69.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -162.19 170.63 18.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.718 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE2' HG21 ' A' ' 22' ' ' ILE . 21.3 m-85 -116.37 122.33 44.54 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.989 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.4 mt -96.93 114.17 33.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 75' ' ' ILE . 74.0 t -115.09 130.41 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.604 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CE2' HD12 ' A' ' 49' ' ' LEU . 23.8 p90 -140.77 152.55 45.31 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.637 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.523 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.2 ptt85 -145.64 172.9 12.59 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.521 ' HG ' ' HE1' ' A' ' 71' ' ' TYR . 11.0 m -79.92 139.86 36.92 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -62.3 -36.27 81.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.249 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.97 -37.38 86.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.543 0.211 . . . . 0.0 110.718 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.3 mmtt -101.13 150.95 22.4 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.499 0.666 . . . . 0.0 110.502 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -138.27 19.82 2.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.186 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 20.8 p-10 -128.19 18.33 6.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 0.0 110.519 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -142.04 112.7 7.25 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.501 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -119.29 118.16 30.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.588 0.708 . . . . 0.0 110.917 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.492 HD12 ' CE2' ' A' ' 39' ' ' TYR . 60.3 mt -79.9 159.77 26.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.462 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 51.5 mp0 -117.93 151.91 36.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.97 113.1 2.68 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -97.64 146.4 25.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.469 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.35 158.4 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.223 0.535 . . . . 0.0 110.081 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 56' ' ' ASN . 6.2 tp-100 -71.23 146.54 48.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.451 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.45 3.55 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.924 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 t-20 -133.2 0.77 3.44 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.647 -0.325 . . . . 0.0 111.446 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.6 tptp -64.07 -43.22 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 48.56 31.62 3.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.717 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 178.74 152.49 0.34 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.191 0.307 . . . . 0.0 110.744 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 37' ' ' VAL . 2.7 pt -151.29 129.38 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.4 mm -99.38 103.26 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.3 mt -91.58 104.54 17.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 40.1 tt0 -95.77 151.18 19.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.254 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.479 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 3.9 t-160 89.11 60.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.253 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.95 91.84 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.91 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -39.15 143.58 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.422 0.63 . . . . 0.0 111.419 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -75.29 -9.07 58.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.039 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.8 p -114.34 19.7 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.604 0.24 . . . . 0.0 111.414 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -142.92 136.97 29.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.22 163.08 25.15 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.521 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 98.3 m-85 -144.69 129.49 18.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.581 0.229 . . . . 0.0 111.603 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.9 mt-10 -88.6 153.62 20.98 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.77 135.55 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.71 108.59 11.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.217 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -96.54 134.58 33.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.081 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.3 m -136.09 124.26 23.08 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.567 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -98.38 124.94 43.33 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.83 114.06 26.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 112.558 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -122.22 -175.63 3.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.33 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -39.8 -33.01 0.17 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.409 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 81' ' ' LEU . 9.6 mp -63.53 -42.55 98.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.414 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 125.81 -49.94 0.89 Allowed Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 13.1 m-85 -153.73 122.07 6.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 77' ' ' ALA . 82.7 p -88.15 176.89 7.07 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.143 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -49.11 112.96 2.76 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.45 159.43 49.2 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.049 1.166 . . . . 0.0 111.669 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.79 113.75 25.98 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.519 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.05 98.33 7.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.469 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 39.4 t80 -103.43 138.2 40.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -135.27 134.55 40.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.252 0.548 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.4 p90 -171.33 129.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.577 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -82.51 165.46 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.531 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.9 mmm -90.66 146.26 33.83 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.0 164.71 29.35 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.364 2.043 . . . . 0.0 111.22 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.45 160.04 41.32 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.35 2.033 . . . . 0.0 111.513 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -40.39 132.8 1.63 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.494 1.524 0 C-N-CA 121.73 1.62 . . . . 0.0 112.757 179.166 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' PRO . 71.0 Cg_exo . . . . . 0 N--CA 1.501 1.952 0 N-CA-C 112.571 0.181 . . . . 0.0 112.571 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 Cg_exo -37.42 175.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.311 2.674 . . . . 0.0 115.441 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.43 46.83 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.646 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.94 123.48 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.24 0.543 . . . . 0.0 110.632 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -114.82 116.52 28.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.213 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.06 141.16 15.44 Favored Glycine 0 N--CA 1.464 0.51 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.952 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -139.71 134.46 16.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.02 88.25 1.34 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.655 1.57 . . . . 0.0 112.501 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 4.7 p -68.27 -179.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -55.82 118.22 4.38 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.516 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.1 -166.76 21.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.5 ' HE3' ' H ' ' A' ' 66' ' ' GLN . 15.8 mtmt -77.13 -5.75 50.26 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 84.6 p -66.86 150.81 48.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.35 115.31 18.06 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -77.3 109.59 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.29 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.1 101.23 10.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -72.02 122.6 21.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.738 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.427 HD12 HG12 ' A' ' 75' ' ' ILE . 2.7 mm -87.34 113.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 m -86.09 127.2 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.543 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' H ' ' HE2' ' A' ' 24' ' ' LYS . 1.9 mppt? -44.26 105.38 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.808 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' OE1' ' OE1' ' A' ' 85' ' ' GLU . 74.2 mt-30 -80.68 159.38 25.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.47 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' ASP . 5.4 m-20 -78.35 78.61 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' ASP . 22.2 t70 -39.23 162.18 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.405 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.32 64.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.2 24.31 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.903 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.411 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -153.4 151.49 25.69 Favored Pre-proline 0 C--N 1.333 -0.152 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.96 143.61 55.33 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.687 1.591 . . . . 0.0 111.462 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.592 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.5 mt -89.87 135.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.868 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.91 -48.98 10.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.706 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -146.48 162.04 39.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.282 0.563 . . . . 0.0 111.522 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -109.46 120.19 41.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.185 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.33 107.3 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' LYS . 24.2 t -109.05 127.08 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.01 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -125.22 129.22 49.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.133 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.56 ' CE2' HD12 ' A' ' 49' ' ' LEU . 38.9 p90 -133.05 148.56 52.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.965 0.412 . . . . 0.0 110.876 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.46 ' NH1' ' CB ' ' A' ' 45' ' ' GLU . 4.8 ptt180 -144.71 167.34 22.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.74 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 43' ' ' ASP . 5.1 m -76.16 143.58 41.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.1 0.41 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 41' ' ' SER . 71.7 m-20 -122.01 -9.74 8.7 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.361 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -122.76 110.49 15.54 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.744 0.307 . . . . 0.0 110.307 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.46 ' CB ' ' NH1' ' A' ' 40' ' ' ARG . 25.4 pt-20 -115.1 -8.4 12.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.8 -7.72 23.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.535 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -161.08 128.67 4.23 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -107.61 128.56 54.65 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.56 HD12 ' CE2' ' A' ' 39' ' ' TYR . 70.8 mt -77.16 158.21 30.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 3.4 pm0 -121.59 148.54 44.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.205 0.526 . . . . 0.0 111.882 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -150.74 113.53 4.74 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.885 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.48 142.52 27.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.91 158.71 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.281 0.562 . . . . 0.0 110.391 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 56' ' ' ASN . 57.9 tt0 -74.17 130.9 40.67 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.474 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.58 0.17 0.3 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.822 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 54' ' ' GLN . 23.5 m120 -116.18 -26.19 7.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.729 0.264 . . . . 0.0 110.814 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 20.5 mttm -50.35 -68.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER 79.46 35.04 0.17 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.83 149.17 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.137 -0.352 . . . . 0.0 110.485 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.5 pt -147.58 144.85 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.98 115.99 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.1 mt -104.95 108.92 20.69 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.137 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.33 162.15 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.762 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.9 m80 60.6 67.68 0.81 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.852 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -107.91 -9.42 15.71 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.828 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.5 ' H ' ' HE3' ' A' ' 16' ' ' LYS . 49.9 tp60 60.13 152.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.969 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -96.81 -7.2 34.23 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.411 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 77.3 p -119.41 19.96 12.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.6 mmm -143.96 127.86 17.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.58 157.59 32.98 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.96 153.97 36.23 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.8 156.14 19.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.866 0.365 . . . . 0.0 110.278 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.7 130.08 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -122.63 107.28 11.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 110.329 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.427 HG12 HD12 ' A' ' 22' ' ' ILE . 1.7 mp -90.27 134.97 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.796 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -136.27 123.77 22.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -96.17 120.48 36.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.486 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.31 105.06 16.56 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.6 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -108.53 -175.94 2.91 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -41.22 -31.5 0.22 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.2 mm? -65.54 -41.66 92.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.959 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.51 -48.61 0.96 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.485 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.2 m-85 -157.31 131.68 8.46 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.49 160.3 17.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.938 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 3.3 mm-40 53.2 50.43 7.59 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.292 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 84.8 Cg_endo -72.61 149.65 49.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.149 1.9 . . . . 0.0 111.147 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.63 109.31 13.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.157 0.503 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.21 95.97 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 31.2 t80 -102.95 131.5 49.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.496 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.18 134.45 42.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.074 0.464 . . . . 0.0 111.129 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.1 p90 -168.82 133.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.336 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.5 p -80.25 164.92 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.156 0.503 . . . . 0.0 111.473 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 95.6 mmm -93.23 141.67 24.3 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.474 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.84 162.62 29.44 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.414 2.076 . . . . 0.0 111.205 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.39 152.7 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.487 2.125 . . . . 0.0 111.638 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -43.74 132.56 3.94 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.632 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.49 1.29 0 C-N-CA 121.885 1.723 . . . . 0.0 110.974 177.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' PRO . 52.5 Cg_exo . . . . . 0 N--CA 1.497 1.7 0 N-CA-C 112.844 0.286 . . . . 0.0 112.844 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 5' ' ' PRO . 30.0 Cg_exo -39.33 175.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.309 2.672 . . . . 0.0 114.849 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.8 53.43 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.082 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -129.51 127.99 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.226 0.536 . . . . 0.0 110.549 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -118.9 116.4 26.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.032 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.72 141.89 15.86 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.472 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -143.6 140.5 17.5 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.45 91.13 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.692 1.595 . . . . 0.0 112.216 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 p -72.16 162.93 28.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m -38.44 120.66 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.346 0.594 . . . . 0.0 111.516 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.05 -155.48 23.68 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' O ' HD12 ' A' ' 65' ' ' LEU . 32.0 mttp -80.0 -8.8 59.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.107 0.48 . . . . 0.0 110.075 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 p -60.54 136.37 58.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.136 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.57 117.42 28.94 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.87 111.27 18.61 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.457 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -103.42 91.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -66.09 123.78 20.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.171 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.417 HG21 ' CD2' ' A' ' 35' ' ' TYR . 2.4 mm -86.27 112.51 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -81.42 143.43 32.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.949 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -66.43 105.5 1.49 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.349 0.595 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -88.3 174.66 8.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.767 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 96.2 m-20 -62.6 -3.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.205 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 29' ' ' GLY . 2.8 p30 46.27 -172.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -9.81 59.19 Favored Glycine 0 N--CA 1.465 0.625 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.037 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . 128.54 2.78 5.75 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.88 142.36 33.46 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.82 142.65 83.43 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.319 1.346 . . . . 0.0 111.677 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.598 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.4 mt -87.95 134.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.368 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 2.6 mm? -91.81 -42.11 10.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.211 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -142.68 152.32 42.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.2 m-85 -109.47 126.15 53.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.613 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.46 110.51 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.534 HG21 ' CD1' ' A' ' 60' ' ' ILE . 69.2 t -107.57 124.86 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -125.16 121.43 34.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -126.57 154.65 43.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 31.3 ptt85 -146.47 169.45 18.88 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.255 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 p -79.66 141.21 36.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.773 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.91 -32.5 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.673 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.59 -6.65 42.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.679 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -139.66 174.4 10.55 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.217 0.532 . . . . 0.0 110.516 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -165.08 27.46 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.01 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -107.01 -2.85 20.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.866 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -144.52 145.5 31.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 111.218 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -133.74 117.97 17.56 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.05 160.39 27.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -118.2 155.01 31.25 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.158 0.504 . . . . 0.0 112.352 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 116.53 2.78 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.7 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -99.56 145.64 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.916 0.389 . . . . 0.0 111.34 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.49 152.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.748 HE21 HD22 ' A' ' 56' ' ' ASN . 31.7 tt0 -79.8 130.4 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.563 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.71 3.75 0.02 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.191 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.748 HD22 HE21 ' A' ' 54' ' ' GLN . 14.5 m-20 -112.03 -20.82 11.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.174 0.487 . . . . 0.0 110.004 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -63.66 -50.66 68.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.3 39.31 22.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.769 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.23 153.44 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.876 0.369 . . . . 0.0 111.117 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 37' ' ' VAL . 1.5 pt -150.17 145.19 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.128 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.5 mm -117.36 101.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.883 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' H ' HD22 ' A' ' 62' ' ' LEU . 1.8 mm? -83.92 102.94 12.78 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.89 171.0 12.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.967 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.9 m80 51.96 66.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.18 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 16' ' ' LYS . 24.3 mt -102.3 -173.16 2.27 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -131.8 129.67 40.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -70.06 -7.21 39.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.515 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.2 p -122.65 12.93 10.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.9 ttm -142.65 124.56 15.18 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.763 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.5 162.43 34.69 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.01 143.55 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -94.14 153.19 18.23 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.81 132.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -122.74 104.11 9.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.765 0.793 . . . . 0.0 110.545 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.486 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -87.74 130.55 37.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.788 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -134.49 117.63 16.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.75 127.02 35.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.74 106.85 17.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -110.02 -168.94 1.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -48.06 -29.09 3.24 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.028 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.7 mm? -64.04 -41.79 97.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 123.59 -48.1 0.98 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.3 m-85 -157.22 132.98 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -169.34 163.86 10.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.469 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 5.8 tp10 52.43 52.16 10.61 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.506 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 93.1 Cg_endo -74.45 155.3 45.66 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 123.436 2.757 . . . . 0.0 112.083 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 m -136.59 117.95 14.66 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.929 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -97.25 97.54 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.613 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.55 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 33.4 t80 -102.0 135.81 42.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.637 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.63 134.59 37.5 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.4 p90 -169.18 133.35 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.18 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -79.44 168.64 19.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.5 mmm -95.66 138.51 21.78 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.529 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.39 164.93 32.93 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.62 2.213 . . . . 0.0 111.328 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.18 150.88 87.08 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.292 1.995 . . . . 0.0 111.642 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.82 133.91 1.72 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.154 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.493 1.482 0 C-N-CA 122.264 1.976 . . . . 0.0 111.807 177.769 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 74.2 Cg_exo . . . . . 0 N--CA 1.498 1.75 0 N-CA-C 112.418 0.122 . . . . 0.0 112.418 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.9 Cg_exo -37.32 165.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.755 2.303 . . . . 0.0 113.769 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.528 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -148.4 47.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.617 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.4 HG12 HG21 ' A' ' 87' ' ' THR . 5.9 mm -131.14 131.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 111.93 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -108.6 -173.13 2.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.79 118.19 0.65 Allowed Glycine 0 C--N 1.321 -0.256 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.359 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -135.39 144.13 48.24 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.65 85.41 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.396 1.397 . . . . 0.0 111.184 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -52.15 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.214 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.8 t -142.58 136.7 29.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.099 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.43 -134.81 33.44 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HE2' ' H ' ' A' ' 66' ' ' GLN . 17.9 mtmm -93.58 -0.86 56.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.908 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.3 p -68.86 153.06 44.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.644 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 122.72 22.82 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -83.52 97.94 9.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.166 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mt -95.96 92.22 6.38 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 t -67.02 128.37 36.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.167 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.439 HG21 ' CE2' ' A' ' 35' ' ' TYR . 2.2 mm -88.2 112.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -83.18 129.09 34.99 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.079 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.659 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.1 102.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.745 -0.782 . . . . 0.0 108.932 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.64 148.56 24.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -50.43 102.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.64 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 29' ' ' GLY . 5.7 m-20 -57.67 142.22 45.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.48 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 27' ' ' ASP . . . -32.43 -28.41 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 159.78 14.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.871 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -159.5 155.17 22.71 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 118.175 0.987 . . . . 0.0 110.796 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.23 138.6 67.54 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.965 1.777 . . . . 0.0 111.062 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.606 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.0 mt -86.13 135.76 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.14 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 55' ' ' GLY . 77.3 mt -85.79 -43.59 13.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.43 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -146.21 162.19 38.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.637 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 22' ' ' ILE . 22.0 m-85 -113.67 122.01 45.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.631 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.57 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 85.4 mt -99.52 112.15 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 75' ' ' ILE . 58.0 t -111.99 126.78 69.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.547 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -124.49 139.45 53.87 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 22.1 p90 -145.63 157.74 43.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.103 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.09 -176.62 5.43 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.312 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -91.99 138.18 31.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.154 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -66.68 -34.41 77.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.67 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 67.5 t0 -59.96 -34.64 73.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.787 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.1 mtmt -126.36 -172.01 2.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.508 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -173.78 63.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.682 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -131.06 -7.86 3.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.297 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -140.93 155.12 46.33 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -137.55 108.04 6.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.672 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.1 159.79 33.23 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.202 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.69 146.45 43.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.166 0.507 . . . . 0.0 111.866 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -146.68 112.82 5.82 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.57 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 73.0 mmtt -100.34 142.57 31.64 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.07 160.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 110.315 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.5 tp60 -72.75 151.06 42.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.479 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.05 12.96 0.38 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 54' ' ' GLN . 65.4 t30 -145.19 2.6 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.007 0.403 . . . . 0.0 111.639 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -63.49 -47.47 81.62 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.593 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER 59.37 31.03 20.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.976 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.26 151.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.01 147.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.867 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.8 mm -118.52 108.57 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.9 mp -94.41 106.58 18.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -85.31 147.55 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.977 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 71.02 77.83 0.18 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.944 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.538 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 91.3 mt -115.0 -3.98 12.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.534 ' O ' ' SD ' ' A' ' 93' ' ' MET . 80.4 mt-30 50.53 122.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.814 0.816 . . . . 0.0 112.792 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -61.28 -26.12 67.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.714 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -103.55 22.66 13.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.7 mmm -146.96 118.57 7.99 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.134 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.85 162.6 45.01 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.538 ' CZ ' HD13 ' A' ' 65' ' ' LEU . 8.8 p90 -155.58 132.03 10.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.853 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.1 152.1 22.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.38 134.49 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -124.36 106.85 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.36 0.6 . . . . 0.0 109.722 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -91.68 132.45 36.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.47 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -134.31 121.39 21.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -94.51 124.15 38.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.26 108.83 21.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 5.7 p-10 -115.79 -164.94 0.99 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.24 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -53.17 -30.09 35.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 5.9 mp -62.53 -39.32 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 120.81 -47.91 0.99 Allowed Glycine 0 N--CA 1.463 0.466 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 9.8 m-85 -156.05 122.64 5.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 77' ' ' ALA . 96.7 p -87.43 163.41 16.75 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -44.35 111.78 1.27 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 160.35 48.57 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.304 1.336 . . . . 0.0 112.823 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.4 HG21 HG12 ' A' ' 8' ' ' ILE . 26.3 m -107.24 116.75 32.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.641 0.734 . . . . 0.0 109.674 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.01 96.18 5.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.424 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.579 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -100.39 121.73 41.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.48 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -122.42 129.94 52.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 111.309 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.579 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 9.7 p90 -164.79 128.29 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.405 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -80.4 167.43 20.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.527 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.0 mtp -93.6 147.86 34.39 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.54 162.16 33.46 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.477 2.118 . . . . 0.0 110.384 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.47 154.29 72.51 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.207 1.938 . . . . 0.0 111.587 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -36.06 132.18 0.59 Allowed Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.492 1.396 0 C-N-CA 121.599 1.532 . . . . 0.0 112.478 179.645 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' PRO . 2.1 Cg_endo . . . . . 0 N--CA 1.495 1.614 0 CA-C-O 120.375 0.073 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -37.96 177.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.777 2.985 . . . . 0.0 116.173 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.28 37.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.953 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -125.02 136.56 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.537 0.684 . . . . 0.0 110.64 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -116.83 -172.87 2.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.837 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.28 143.0 8.03 Favored Glycine 0 N--CA 1.462 0.392 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.322 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -150.79 115.56 3.24 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -46.83 104.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.493 1.462 . . . . 0.0 112.689 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 14' ' ' SER . 28.7 p -80.7 172.21 14.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' SER . 58.8 m -40.56 107.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.798 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.89 -158.32 23.98 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HE3' ' H ' ' A' ' 66' ' ' GLN . 18.8 mtmt -75.71 -11.6 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.871 0.367 . . . . 0.0 110.766 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 t -62.5 140.43 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.303 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.0 137.41 51.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.409 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -97.94 98.53 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mt -97.74 103.17 15.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 t -69.78 126.08 28.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.908 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.07 108.74 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -79.84 136.1 36.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.904 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.13 104.64 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.675 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 27' ' ' ASP . 28.3 mt-30 -89.51 137.63 32.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.552 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 27' ' ' ASP . 1.3 m-20 -54.64 93.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 24.7 t70 -44.54 171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.054 0.454 . . . . 0.0 110.881 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.56 -31.95 76.51 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.5 12.62 0.03 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.821 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -147.71 151.91 40.02 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 117.619 0.71 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.0 143.99 68.18 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.82 1.68 . . . . 0.0 111.783 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.586 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.0 mt -93.8 133.06 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.262 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.747 HD22 ' N ' ' A' ' 33' ' ' LEU . 2.3 mm? -95.43 -14.02 24.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.93 155.96 8.79 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -113.32 112.88 24.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.789 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.422 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 98.5 mt -89.98 106.99 17.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG22 HG13 ' A' ' 75' ' ' ILE . 21.6 t -109.35 129.78 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.415 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -123.84 142.86 50.73 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -143.92 158.46 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.891 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 41' ' ' SER . 1.1 ptm180 -151.3 -173.0 4.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.472 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 4.9 p -96.18 140.0 31.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -65.25 -17.9 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.639 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.61 -27.12 16.77 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -117.97 120.36 37.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.296 0.569 . . . . 0.0 110.811 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' NH1' ' A' ' 40' ' ' ARG . 83.9 tt0 -125.2 63.73 1.16 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.38 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.53 -14.71 8.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.953 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -159.64 161.87 35.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.403 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -128.35 136.39 50.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 68.7 mt -80.58 159.83 25.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -118.68 146.29 44.82 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.134 0.492 . . . . 0.0 111.447 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.9 110.27 5.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 72.7 mmtt -95.65 126.63 41.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.585 HG21 ' CG2' ' A' ' 60' ' ' ILE . 43.5 t -132.62 154.89 40.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.995 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 71.3 tp60 -68.8 147.36 51.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.62 0.81 55.01 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.412 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.431 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 15.2 m120 -113.67 -14.13 12.64 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.044 0.422 . . . . 0.0 111.339 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.28 -45.14 94.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.723 0.297 . . . . 0.0 110.833 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 58.2 37.1 26.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.886 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.73 141.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.585 ' CG2' HG21 ' A' ' 53' ' ' VAL . 6.5 pt -144.01 136.99 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.239 0.542 . . . . 0.0 111.988 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' C ' HD12 ' A' ' 62' ' ' LEU . 34.7 mm -108.22 117.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.226 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 62' ' ' LEU . 10.8 mp -107.01 143.5 35.01 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.589 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 46.4 mt-10 -107.52 169.65 8.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 111.772 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 37.3 p-80 49.06 68.49 0.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.327 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.5 mm? -95.4 -12.3 26.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.296 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.522 ' O ' ' SD ' ' A' ' 93' ' ' MET . 13.0 mm-40 50.76 122.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.864 0.84 . . . . 0.0 112.058 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -61.52 -32.82 72.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.544 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -97.26 22.29 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.63 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.9 ttm -152.17 127.08 9.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.86 34.22 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -136.29 132.71 36.09 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.1 152.97 18.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.36 134.9 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 110.825 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -125.98 109.73 12.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.118 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.51 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -93.73 135.24 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m -134.83 121.66 20.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -91.18 123.5 34.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.06 107.8 19.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.28 0.562 . . . . 0.0 112.079 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 1.1 p-10 -110.29 -172.07 1.96 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -49.75 -27.71 5.24 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.789 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.8 mm? -65.64 -41.6 92.44 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.54 -50.3 0.89 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -155.81 134.45 11.79 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.7 t -162.83 157.24 21.13 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.867 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 44.48 61.99 10.55 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.088 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.48 155.51 45.48 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.599 2.199 . . . . 0.0 110.724 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.23 108.85 13.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.3 t -95.0 98.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -103.78 140.26 37.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.742 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -136.49 134.85 38.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.39 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 91' ' ' PHE . 35.3 p90 -165.95 125.36 1.65 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.509 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 p -82.44 171.13 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.575 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 14.8 mtp -99.4 152.59 37.85 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.89 163.53 25.91 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.638 2.225 . . . . 0.0 109.275 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.03 153.45 78.05 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 121.782 1.655 . . . . 0.0 111.533 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -41.47 133.88 2.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.496 1.652 0 C-N-CA 121.986 1.791 . . . . 0.0 111.931 179.116 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 6' ' ' PRO . 8.1 Cg_exo . . . . . 0 N--CA 1.494 1.546 0 CA-C-O 120.679 0.2 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 43.9 Cg_exo -42.53 176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 123.074 2.516 . . . . 0.0 114.109 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -173.41 54.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.743 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -131.25 130.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -121.3 115.37 22.84 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.49 145.37 17.66 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -146.96 111.49 4.12 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.38 98.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.382 1.388 . . . . 0.0 112.702 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -76.82 171.57 14.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -58.2 134.89 56.91 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.799 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.09 -154.54 26.57 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -99.14 46.46 0.98 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 61' ' ' ILE . 5.3 t -120.32 149.71 41.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.728 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.94 119.82 27.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.098 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -80.69 98.73 7.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.595 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.41 100.16 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -73.85 126.2 29.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.947 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.471 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -88.78 112.39 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -86.13 143.35 28.08 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.289 0.566 . . . . 0.0 110.203 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 112.69 10.22 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -112.13 170.28 8.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -50.8 112.34 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.581 ' C ' ' H ' ' A' ' 29' ' ' GLY . 69.1 m-20 -71.83 163.83 27.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 -178.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.07 14.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.075 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 101.78 8.81 44.75 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.96 149.42 25.11 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.47 140.06 61.7 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.803 1.669 . . . . 0.0 111.453 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.585 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.2 mt -86.28 129.11 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -81.3 -39.69 24.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.37 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -148.78 170.13 18.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.545 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.1 m-85 -123.23 122.15 37.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.457 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.4 mt -96.47 111.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.593 HG22 HG13 ' A' ' 75' ' ' ILE . 55.6 t -112.1 128.09 68.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -121.54 134.58 55.04 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.603 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.86 154.84 46.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.59 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 41' ' ' SER . 2.8 ptm180 -144.41 -172.74 3.86 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.336 0.589 . . . . 0.0 110.972 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.521 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 5.9 p -101.58 135.15 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.42 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.12 -11.79 33.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.253 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -90.32 -35.06 15.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -118.58 129.55 55.39 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 110.351 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.3 2.98 11.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.969 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 38.0 p-10 -72.11 -3.57 23.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.389 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -152.77 155.86 37.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.165 0.507 . . . . 0.0 111.922 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -136.85 106.89 6.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.299 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.89 158.73 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.773 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.37 148.24 45.31 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -143.6 113.95 7.43 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.497 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -88.51 136.07 33.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 54' ' ' GLN . 45.6 t -132.47 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 121.352 0.596 . . . . 0.0 111.951 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -83.0 144.78 29.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.573 179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.01 -24.94 69.01 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -86.39 -22.12 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.621 -0.289 . . . . 0.0 111.515 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 25.7 mttm -60.53 -46.15 91.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.903 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.8 p30 46.52 37.25 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.048 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.55 0.72 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.827 0.346 . . . . 0.0 110.265 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -155.32 151.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.205 0.526 . . . . 0.0 110.564 178.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.42 HG22 ' OG ' ' A' ' 17' ' ' SER . 45.2 mm -120.06 112.67 37.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.091 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.82 105.17 16.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.83 152.7 21.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 111.846 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 76.86 58.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.715 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 66' ' ' GLN . 80.6 mt -103.17 -4.84 23.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 65' ' ' LEU . 47.5 mt-30 55.24 159.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.477 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -99.11 -16.01 18.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.194 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.3 p -108.86 19.1 20.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.3 mtp -141.47 141.98 33.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.134 0.493 . . . . 0.0 110.541 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.82 153.4 19.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -138.83 138.02 37.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.95 164.54 12.86 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.63 146.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.142 0.496 . . . . 0.0 110.393 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -137.89 106.36 5.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.465 0.65 . . . . 0.0 109.672 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.593 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -93.82 134.96 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.6 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -137.25 120.69 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -91.77 125.26 36.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.52 110.82 22.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 9.6 p-10 -112.12 -163.33 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.298 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -32.19 55.37 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 81' ' ' LEU . 9.3 mp -64.55 -42.32 95.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.712 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.86 -46.61 1.07 Allowed Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -154.93 132.51 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -161.56 147.19 13.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.695 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.14 58.14 4.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.19 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.99 151.1 30.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.372 2.048 . . . . 0.0 111.223 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.5 m -131.16 118.62 20.73 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.457 0.646 . . . . 0.0 111.142 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 m -97.97 92.71 2.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.221 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -95.01 151.72 18.93 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -153.29 135.37 14.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.324 0.583 . . . . 0.0 111.571 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -164.92 156.9 15.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.903 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.51 163.98 12.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.633 0.254 . . . . 0.0 110.358 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.4 mmm -89.69 143.96 31.12 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.395 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.63 164.85 31.48 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.755 2.303 . . . . 0.0 110.981 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -65.99 154.91 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.987 1.792 . . . . 0.0 111.696 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -35.37 132.59 0.5 Allowed Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.191 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 121.867 1.711 . . . . 0.0 112.373 178.784 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo . . . . . 0 N--CA 1.494 1.539 0 N-CA-C 112.596 0.191 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -39.4 164.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.408 2.072 . . . . 0.0 114.597 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -154.75 51.16 0.62 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.824 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -128.43 127.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.518 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -122.29 119.1 30.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.137 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.29 158.38 20.52 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -162.78 132.9 3.34 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.85 98.47 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.357 1.371 . . . . 0.0 111.818 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 14' ' ' SER . 87.6 p -80.77 -116.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.659 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 13' ' ' SER . 91.5 p -80.99 112.66 18.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.971 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.03 -133.63 43.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -78.41 -11.28 59.94 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 m -60.8 135.18 57.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.317 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.08 140.42 48.49 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.538 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -99.38 94.85 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.7 90.7 7.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.2 t -66.65 124.46 22.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.217 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.459 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -87.47 113.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.2 m -97.01 114.03 25.61 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.412 0.625 . . . . 0.0 110.091 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -39.09 107.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.593 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.4 OUTLIER -97.79 151.17 20.47 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 85.8 m-20 -43.34 97.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.732 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' GLY . 19.3 m-20 -63.01 152.76 35.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.433 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -38.95 -21.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.773 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 135.42 -3.24 3.94 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.69 146.68 62.22 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.59 138.48 59.44 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.335 1.357 . . . . 0.0 111.133 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.606 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.5 mt -80.46 126.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.514 0.673 . . . . 0.0 112.39 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -68.47 -41.06 80.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -161.18 168.05 24.94 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.794 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.459 ' CD2' HG21 ' A' ' 22' ' ' ILE . 9.7 m-85 -114.3 119.4 36.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.219 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.47 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 80.9 mt -96.45 110.83 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.536 HG22 HG13 ' A' ' 75' ' ' ILE . 47.3 t -110.86 125.68 68.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.136 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -120.61 128.91 53.48 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -135.63 151.36 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.587 ' NE ' ' O ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -145.49 -177.87 5.79 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.705 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.587 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 25.4 m -90.72 146.43 24.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.874 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.36 -18.36 52.59 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.7 -49.66 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.535 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HB2' HH22 ' A' ' 40' ' ' ARG . 73.8 mmtt -110.53 -164.36 0.92 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -174.58 75.87 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -154.79 -8.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.075 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.0 129.23 21.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -116.18 131.14 57.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.144 0.497 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.73 160.32 18.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.45 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 54.5 mp0 -114.6 147.82 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.101 0.477 . . . . 0.0 111.44 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.16 113.99 5.39 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 72.0 mmtt -99.32 146.59 26.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.911 0.386 . . . . 0.0 111.99 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.46 160.45 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.482 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' A' ' 56' ' ' ASN . 47.9 tp60 -83.07 148.46 27.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.857 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.13 5.72 3.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 54' ' ' GLN . 64.0 t30 -122.69 -14.45 7.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.027 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 21.3 mttp -67.47 -49.79 61.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.182 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 59.03 35.45 23.98 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.974 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -176.35 155.49 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.763 -0.585 . . . . 0.0 111.386 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -151.18 146.09 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.59 102.7 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.882 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.9 mp -87.67 105.62 17.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 79.4 mt-10 -86.77 139.16 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.346 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 2.0 t-160 83.92 79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.375 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.8 mt -131.86 77.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 42.4 tt0 -34.9 143.71 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.344 0.592 . . . . 0.0 111.151 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -70.08 -22.46 63.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.496 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 p -100.76 22.95 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.1 ttm -141.77 132.98 26.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.34 0.59 . . . . 0.0 110.981 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.26 153.4 20.5 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -148.61 133.36 17.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.571 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.94 151.75 23.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.753 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.07 133.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -125.98 108.9 11.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 0.0 109.872 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.536 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -91.35 135.86 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.285 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -134.82 117.73 16.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -90.85 126.06 35.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.233 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.33 107.88 18.89 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.7 p-10 -109.64 -174.09 2.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.897 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -45.64 -26.28 0.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.608 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.647 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -71.84 -40.27 69.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.935 0.397 . . . . 0.0 110.125 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.465 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 128.61 -49.22 0.93 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -153.66 131.74 11.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 t -167.78 162.97 14.09 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.836 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 26' ' ' ASP . 8.3 tp10 50.27 53.89 14.8 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.188 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 92.3 Cg_endo -74.84 156.09 43.69 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.977 2.452 . . . . 0.0 110.943 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.417 HG23 HE22 ' A' ' 25' ' ' GLN . 0.1 OUTLIER -130.01 110.42 11.64 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.03 0.443 . . . . 0.0 110.785 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 t -94.01 95.76 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.549 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -102.92 133.59 47.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.22 136.95 42.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.17 0.509 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.5 p90 -171.72 132.92 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.199 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.19 167.09 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.8 mmm -96.04 144.22 27.45 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.75 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.14 165.27 28.28 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.776 2.317 . . . . 0.0 110.903 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.98 162.89 33.28 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.992 1.795 . . . . 0.0 111.433 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -40.74 133.21 1.74 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.492 1.391 0 C-N-CA 121.985 1.79 . . . . 0.0 111.085 177.759 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' PRO . 88.8 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 N-CA-C 112.719 0.238 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' PRO . 15.7 Cg_exo -37.41 163.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.872 2.381 . . . . 0.0 113.707 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 m -151.38 52.2 0.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.444 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -130.18 128.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -122.46 117.11 25.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.1 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.02 161.53 21.75 Favored Glycine 0 N--CA 1.464 0.543 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.968 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -161.95 128.78 2.52 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.92 88.26 0.94 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.3 t -66.87 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -71.29 133.07 45.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.172 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 -160.11 49.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.864 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -79.82 -4.98 54.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.642 -0.279 . . . . 0.0 111.227 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.8 p -68.72 147.39 51.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.121 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.0 124.69 43.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -84.29 100.12 11.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.399 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.65 97.97 9.8 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -71.56 126.28 29.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.037 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.44 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -88.93 113.79 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 m -85.5 139.07 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.063 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -72.29 104.92 3.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.655 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 168.21 9.42 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.3 t70 -56.85 110.01 0.73 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.31 165.37 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.125 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.37 -23.09 33.0 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.42 16.69 0.08 OUTLIER Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.247 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.91 152.48 20.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 117.169 0.485 . . . . 0.0 109.789 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.51 145.04 86.86 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.86 1.707 . . . . 0.0 111.112 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.613 HG21 ' CE1' ' A' ' 35' ' ' TYR . 4.4 mt -91.59 129.24 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.467 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.21 -44.56 14.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.24 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.6 161.64 39.34 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 32' ' ' ILE . 10.4 m-85 -113.88 122.19 46.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.98 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.4 mt -94.25 108.44 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.549 HG22 HG13 ' A' ' 75' ' ' ILE . 58.1 t -113.77 130.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.113 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -127.95 147.23 50.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.473 ' CE2' HD12 ' A' ' 49' ' ' LEU . 42.8 p90 -148.55 155.69 41.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.074 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.793 HH21 ' H ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -152.49 -172.83 4.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.032 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -92.74 146.48 23.61 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.792 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.61 15.7 0.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -132.45 -45.92 0.9 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.739 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.561 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.79 37.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.684 0.278 . . . . 0.0 110.821 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 6.7 tm-20 -49.68 84.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 110.753 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 44' ' ' LYS . 73.0 m-20 -153.93 -16.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.966 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.793 ' H ' HH21 ' A' ' 40' ' ' ARG . 19.7 pt20 -156.74 155.68 32.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.063 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -124.39 136.01 53.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.084 0.469 . . . . 0.0 111.898 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.473 HD12 ' CE2' ' A' ' 39' ' ' TYR . 97.7 mt -84.9 158.71 20.5 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -118.35 146.51 44.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.097 0.475 . . . . 0.0 111.319 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -147.45 117.78 7.38 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -100.94 143.53 30.97 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.95 161.38 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.357 0.598 . . . . 0.0 110.646 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -79.14 147.71 32.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.606 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.62 0.29 5.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -118.62 -6.73 10.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.556 0.217 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -63.6 -47.83 79.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.31 0.576 . . . . 0.0 109.638 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 53.02 30.17 9.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.686 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 178.69 153.39 0.36 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.968 0.414 . . . . 0.0 110.737 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -151.96 145.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.542 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.56 107.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 mt -92.7 133.06 36.38 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 83.4 tt0 -119.77 152.94 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.008 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 36.3 t-80 88.88 49.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.712 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.22 86.96 2.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -41.65 137.88 1.52 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.452 0.644 . . . . 0.0 111.122 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -65.0 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.755 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -98.32 21.42 11.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.384 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 8.8 ttm -145.17 128.64 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 110.145 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.76 161.9 46.48 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.61 129.61 23.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -90.55 154.39 19.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.875 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -135.1 136.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 67.2 tt0 -127.25 107.86 10.37 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.549 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -95.78 131.39 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.283 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -135.54 120.21 18.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.63 127.4 35.9 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.21 111.01 23.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.248 0.547 . . . . 0.0 112.248 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.5 p30 -112.08 -166.44 1.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.237 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -53.0 -30.91 38.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.027 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -66.37 -41.31 89.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.165 0.507 . . . . 0.0 109.736 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 129.93 -49.07 0.94 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -154.88 137.77 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.6 t -165.38 155.48 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.701 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 26' ' ' ASP . 18.5 tt0 50.06 56.94 17.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.232 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.81 154.37 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.68 2.253 . . . . 0.0 111.367 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -132.34 119.01 20.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 0.0 111.089 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.94 94.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.54 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 40.2 t80 -98.22 131.1 44.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.124 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -133.1 131.5 40.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.54 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 20.9 p90 -161.73 134.73 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.63 160.23 25.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.366 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 91.1 mmm -94.49 140.93 22.86 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.804 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.71 162.81 40.22 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.035 1.823 . . . . 0.0 110.861 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.33 151.99 83.46 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.499 2.133 . . . . 0.0 111.816 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -38.28 133.18 0.96 Allowed Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 N--CA 1.494 1.519 0 C-N-CA 121.477 1.452 . . . . 0.0 111.681 179.118 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 6' ' ' PRO . 80.7 Cg_exo . . . . . 0 N--CA 1.502 1.977 0 N-CA-C 112.545 0.171 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.2 Cg_exo -38.75 163.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.331 2.021 . . . . 0.0 114.276 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.33 33.54 0.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.695 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.58 120.49 60.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.553 0.692 . . . . 0.0 110.788 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -116.26 116.86 28.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.039 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.24 150.44 19.68 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 13' ' ' SER . 21.6 mt-30 -153.62 113.46 2.59 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.41 85.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.171 1.248 . . . . 0.0 111.636 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 11' ' ' GLN . 10.8 t -53.92 -88.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.647 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.25 140.33 41.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.808 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.01 -127.9 39.11 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.499 ' CE ' ' O ' ' A' ' 65' ' ' LEU . 10.4 mtmm -99.39 -2.84 35.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 p -67.01 149.21 50.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.11 135.38 48.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.824 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -96.39 95.18 7.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -90.86 92.28 8.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -68.9 122.59 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.221 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.438 HG21 ' CE2' ' A' ' 35' ' ' TYR . 2.2 mm -85.95 112.6 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -91.68 117.76 30.04 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.19 105.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.391 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.41 HE22 HG23 ' A' ' 87' ' ' THR . 72.9 mt-30 -88.96 157.61 18.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -48.62 106.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -58.1 142.69 46.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.649 0.737 . . . . 0.0 111.965 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.99 -20.71 6.7 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.6 -1.65 0.73 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.75 25.78 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.87 133.33 38.41 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.86 1.707 . . . . 0.0 111.992 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.563 HG21 ' CE1' ' A' ' 35' ' ' TYR . 4.5 mt -78.59 130.27 36.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.172 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 33' ' ' LEU . 11.3 mp -80.99 -44.67 17.79 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -142.18 163.72 32.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.515 0.674 . . . . 0.0 111.434 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.563 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.2 m-85 -116.71 113.88 23.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.166 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.578 HG23 ' HZ3' ' A' ' 52' ' ' LYS . 95.0 mt -87.83 109.94 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.538 HG22 HG13 ' A' ' 75' ' ' ILE . 44.9 t -114.08 130.55 68.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -125.84 133.32 52.01 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.457 ' CE2' HD12 ' A' ' 49' ' ' LEU . 54.4 p90 -138.47 150.73 46.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.839 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.3 ptt85 -143.65 174.78 10.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.027 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 44' ' ' LYS . 16.5 m -84.99 142.57 29.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -63.31 -35.53 80.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.471 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.33 -10.52 59.53 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.564 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 41' ' ' SER . 28.4 mmtt -125.99 154.6 42.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.633 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.2 19.83 1.09 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.708 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.93 1.06 52.64 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -159.89 158.07 30.2 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.94 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -136.44 106.13 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 39' ' ' TYR . 50.8 mt -67.59 145.77 54.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.81 151.86 25.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.22 0.533 . . . . 0.0 111.138 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' VAL . 11.2 tppt? -150.58 113.24 4.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.427 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.578 ' HZ3' HG23 ' A' ' 36' ' ' ILE . 72.2 mmtt -97.81 139.85 33.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.362 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.77 160.42 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.371 0.605 . . . . 0.0 110.997 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 65.2 tp60 -78.67 142.55 37.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.362 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.68 -3.74 16.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.417 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 10.7 m120 -110.26 -21.36 12.27 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.723 -0.28 . . . . 0.0 110.622 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -61.55 -52.48 64.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.021 0.438 . . . . 0.0 110.687 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 56.57 41.67 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.809 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.81 150.44 0.8 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.525 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -149.05 140.7 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.2 mm -111.45 103.96 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.407 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 62' ' ' LEU . 10.3 mp -92.57 107.57 19.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 171.11 10.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 m80 66.57 48.12 1.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.364 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.499 ' O ' ' CE ' ' A' ' 16' ' ' LYS . 23.8 mt -100.16 164.71 11.85 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 68' ' ' THR . 50.6 tt0 -119.97 143.07 48.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.201 0.524 . . . . 0.0 110.625 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -68.87 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.432 ' H ' ' HG2' ' A' ' 66' ' ' GLN . 43.1 p -102.44 17.93 22.37 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.6 mtp -143.41 134.12 25.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.41 166.44 31.88 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.147 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -142.82 131.73 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.54 . . . . 0.0 110.351 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.1 mt-10 -88.32 151.47 22.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.58 131.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.574 ' OE1' HG22 ' A' ' 88' ' ' VAL . 10.0 tp60 -124.34 108.08 11.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.611 0.72 . . . . 0.0 110.371 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 1.6 mp -90.58 134.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.098 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.46 120.36 19.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -92.25 127.03 37.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.58 107.24 18.07 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.019 0.438 . . . . 0.0 111.812 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.721 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.61 -170.58 1.8 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -44.09 -32.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.789 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -64.12 -41.52 97.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.64 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 123.52 -49.04 0.92 Allowed Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 7.0 m-85 -156.45 125.71 6.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.7 t -160.64 169.68 22.37 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.651 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 60.3 mm-40 52.0 49.3 6.65 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.869 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 74.3 Cg_endo -71.35 152.37 60.85 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.068 1.845 . . . . 0.0 111.146 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.41 HG23 HE22 ' A' ' 25' ' ' GLN . 0.1 OUTLIER -133.31 113.51 12.69 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 110.378 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.574 HG22 ' OE1' ' A' ' 74' ' ' GLN . 61.6 t -95.87 93.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -101.53 145.32 29.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.224 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.66 138.34 32.43 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 91' ' ' PHE . 16.7 p90 -164.39 127.61 2.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.0 p -83.76 143.06 30.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 94.6 mmm -74.29 140.32 76.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.144 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.05 164.76 34.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.92 152.7 80.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.431 2.087 . . . . 0.0 111.748 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -39.89 129.89 1.54 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.487 1.119 0 C-N-CA 121.498 1.465 . . . . 0.0 112.254 178.778 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 6' ' ' PRO . 14.3 Cg_exo . . . . . 0 N--CA 1.503 2.066 0 CA-C-O 120.581 0.159 . . . . 0.0 112.204 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -35.89 166.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 123.6 2.867 . . . . 0.0 115.384 -179.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.51 43.15 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.518 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.02 132.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.323 0.582 . . . . 0.0 111.318 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -128.89 117.39 20.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.595 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.1 145.72 17.8 Favored Glycine 0 N--CA 1.464 0.562 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.031 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -148.03 118.18 4.29 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -48.96 109.15 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.097 1.198 . . . . 0.0 112.111 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 t -84.4 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.6 m -82.0 134.56 35.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.191 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.46 -135.05 41.76 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.763 ' HZ2' ' HE1' ' A' ' 67' ' ' TRP . 33.7 mttm -77.78 -8.64 58.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.838 0.351 . . . . 0.0 110.994 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.509 ' OG ' HG22 ' A' ' 61' ' ' ILE . 4.6 t -64.74 141.57 58.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.027 0.442 . . . . 0.0 111.946 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.3 124.3 44.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.898 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -87.57 104.49 16.55 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.251 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 mt -97.26 91.62 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.0 t -65.4 120.48 12.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.039 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.13 123.29 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -93.91 113.65 25.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.423 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -42.17 104.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.322 0.582 . . . . 0.0 110.841 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.509 HE22 HG23 ' A' ' 87' ' ' THR . 76.2 mt-30 -85.82 171.34 11.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.093 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.46 108.66 0.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.18 142.4 56.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.444 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -40.88 -74.36 0.16 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.36 13.09 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.87 158.61 29.27 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -57.03 141.81 94.08 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.15 1.234 . . . . 0.0 111.069 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.659 HG21 ' CE1' ' A' ' 35' ' ' TYR . 3.6 mt -83.95 122.13 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.104 0.478 . . . . 0.0 111.233 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.0 -41.97 85.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.278 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.6 163.17 24.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.255 0.55 . . . . 0.0 111.241 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.659 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.5 m-85 -107.5 114.61 28.72 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.836 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -88.09 114.72 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.581 HG22 HG13 ' A' ' 75' ' ' ILE . 63.7 t -115.44 129.81 71.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.976 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -125.24 136.08 53.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.552 ' CE2' HD12 ' A' ' 49' ' ' LEU . 27.8 p90 -140.42 155.82 46.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.041 0.448 . . . . 0.0 110.514 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.554 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 11.1 ptt180 -149.9 178.99 8.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.377 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 p -91.1 140.64 29.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.223 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -68.67 -24.59 64.54 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -33.97 74.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.585 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -158.85 -175.48 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.854 0.835 . . . . 0.0 112.344 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 10.8 pt-20 -142.72 122.06 13.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.753 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.7 m-20 -161.15 38.01 0.14 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 26.1 mt-30 115.88 126.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.853 1.971 . . . . 0.0 110.927 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.554 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 21.6 m95 -87.89 135.78 33.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.842 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.552 HD12 ' CE2' ' A' ' 39' ' ' TYR . 76.3 mt -72.59 159.83 33.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.75 151.76 40.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.071 0.462 . . . . 0.0 111.567 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.15 113.44 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.506 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -92.8 144.17 25.55 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.01 150.47 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.446 ' C ' ' H ' ' A' ' 56' ' ' ASN . 52.2 tt0 -67.49 140.6 57.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.512 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.01 7.7 0.27 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.57 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 54' ' ' GLN . 8.3 t-20 -132.93 -8.92 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.364 0.582 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 14.7 mttp -64.65 -46.0 84.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.607 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.7 p30 50.04 39.5 19.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.799 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.45 151.95 0.63 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.7 140.87 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 0.0 110.707 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.509 HG22 ' OG ' ' A' ' 17' ' ' SER . 33.1 mm -111.87 98.4 6.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.119 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 mt -87.23 105.27 17.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 54.7 mp0 -86.58 175.31 8.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.3 m80 60.91 57.82 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -105.15 -171.68 1.96 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.09 129.57 22.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.579 0.704 . . . . 0.0 110.954 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.763 ' HE1' ' HZ2' ' A' ' 16' ' ' LYS . 68.0 m95 -63.81 -30.39 71.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.977 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 p -100.45 21.0 13.86 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.99 135.03 19.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.301 . . . . 0.0 110.458 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.77 166.17 42.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -144.97 135.0 23.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.501 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 7.5 mt-10 -98.11 151.77 20.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.43 136.95 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.938 0.399 . . . . 0.0 110.678 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -129.62 114.38 15.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -98.94 136.33 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.923 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -138.8 117.78 12.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.519 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.21 129.04 35.45 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.87 116.17 31.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.284 0.564 . . . . 0.0 112.454 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.9 p-10 -117.18 -169.57 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -50.89 -27.96 8.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.611 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -66.24 -37.6 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.529 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 121.52 -52.19 0.75 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.467 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.2 m-85 -151.67 138.22 18.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -161.71 171.68 17.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.407 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 32.03 64.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.408 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.66 151.91 32.72 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.297 1.998 . . . . 0.0 110.691 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.509 HG23 HE22 ' A' ' 25' ' ' GLN . 0.1 OUTLIER -128.75 110.3 12.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.128 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -96.72 98.76 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -104.47 147.45 27.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.19 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.6 131.67 20.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.934 0.397 . . . . 0.0 111.182 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 38.1 p90 -165.81 142.34 5.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -90.01 161.05 16.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.375 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 92.3 mmm -87.77 137.62 31.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.552 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.38 165.43 31.79 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.306 2.004 . . . . 0.0 111.284 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.92 152.88 80.25 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.035 1.823 . . . . 0.0 110.888 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.615 ' CE ' ' NE1' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -44.49 130.93 4.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 N--CA 1.496 1.665 0 C-N-CA 121.71 1.606 . . . . 0.0 113.196 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 6' ' ' PRO . 84.0 Cg_exo . . . . . 0 N--CA 1.501 1.927 0 N-CA-C 113.088 0.38 . . . . 0.0 113.088 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.3 Cg_exo -38.71 163.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.693 2.262 . . . . 0.0 113.339 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.8 m -157.49 58.92 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.8 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.44 130.44 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.228 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -118.99 113.76 21.48 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA2' HD23 ' A' ' 20' ' ' LEU . . . -96.26 138.65 14.05 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -152.41 146.88 18.76 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.655 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.64 88.02 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.278 1.985 . . . . 0.0 111.792 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 t -67.98 -68.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.779 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' GLY . 20.0 m -136.88 156.66 48.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . . . 31.99 -116.22 0.1 OUTLIER Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.088 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HE2' ' HE1' ' A' ' 67' ' ' TRP . 61.1 mttt -96.86 -8.32 31.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.962 0.41 . . . . 0.0 110.274 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.47 136.47 58.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.95 118.65 31.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.326 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.18 109.39 14.6 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.066 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD23 ' HA2' ' A' ' 10' ' ' GLY . 11.5 mt -100.93 89.7 3.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -70.3 121.85 18.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.38 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.415 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.2 mm -82.65 114.95 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 m -94.72 116.29 28.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.627 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.552 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.29 105.76 0.05 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.531 ' NE2' ' OE1' ' A' ' 85' ' ' GLU . 3.6 pt20 -117.87 101.21 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' GLN . 95.7 m-20 33.1 -154.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 29' ' ' GLY . 46.5 p-10 -165.11 161.61 19.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.37 5.6 2.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 117.13 9.28 10.74 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.61 151.3 23.38 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 117.01 0.405 . . . . 0.0 110.156 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.32 141.69 76.08 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.926 1.751 . . . . 0.0 111.781 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.568 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -88.06 130.93 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.183 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.9 mp -85.79 -41.82 14.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.283 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -146.67 162.12 39.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.299 0.571 . . . . 0.0 111.775 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.534 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.3 m-85 -114.2 121.61 44.27 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.963 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.1 mt -95.45 110.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.528 HG22 HG13 ' A' ' 75' ' ' ILE . 60.8 t -112.26 130.88 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.563 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -128.56 133.06 48.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.413 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.533 ' CE2' HD12 ' A' ' 49' ' ' LEU . 37.7 p90 -137.8 153.3 49.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.446 . . . . 0.0 110.389 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -140.4 -174.1 3.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.459 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -100.68 137.36 39.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.029 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -66.77 -30.63 70.89 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.08 -33.43 73.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.569 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 41' ' ' SER . 12.1 ptpt -131.87 168.75 17.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 111.273 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.91 106.8 3.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.188 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 25.2 p-10 -164.74 -26.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -144.99 162.52 36.71 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -131.9 133.54 44.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.133 0.492 . . . . 0.0 110.939 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.533 HD12 ' CE2' ' A' ' 39' ' ' TYR . 90.8 mt -77.15 160.48 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.67 152.27 36.42 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.09 0.472 . . . . 0.0 111.8 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.72 113.71 2.27 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -98.83 145.98 26.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.598 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 157.4 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.115 0.483 . . . . 0.0 110.528 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 56' ' ' ASN . 40.6 tt0 -77.05 137.08 38.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.488 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.95 0.02 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.522 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 54' ' ' GLN . 97.1 m-20 -121.09 -6.26 9.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.875 0.338 . . . . 0.0 110.615 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -64.63 -49.7 70.0 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.53 0.681 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 56.41 34.9 25.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.188 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.45 151.18 0.59 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.03 146.29 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.535 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.5 mm -117.06 108.89 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.578 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 62' ' ' LEU . 1.9 mm? -93.13 105.82 17.86 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 45.4 tt0 -91.63 152.04 20.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.805 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 12.3 t60 80.74 62.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.371 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' GLN . 66.8 mt -119.74 88.37 2.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.861 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' LEU . 86.4 mt-30 -36.91 152.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.151 0.501 . . . . 0.0 111.735 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.409 ' HE1' ' HE2' ' A' ' 16' ' ' LYS . 85.2 m95 -83.17 -5.9 59.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.404 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -115.04 15.13 17.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.689 0.28 . . . . 0.0 111.608 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 67.7 mtp -146.0 136.6 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 111.332 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.37 162.22 25.65 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.94 132.38 26.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.595 0.236 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -87.76 149.93 23.89 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.78 137.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -129.32 106.42 8.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.467 0.651 . . . . 0.0 109.423 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.528 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -92.51 134.97 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.968 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -138.79 116.01 11.07 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -86.26 128.16 34.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.189 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.26 107.27 18.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 1.2 p30 -110.7 -168.18 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -49.49 -31.65 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.0 mm? -63.07 -41.15 99.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 124.37 -44.2 1.31 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.47 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.8 m-85 -153.17 139.99 19.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.8 p -157.37 162.01 39.05 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.853 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.531 ' OE1' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 32.33 59.1 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.459 178.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.5 150.26 69.55 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 121.567 1.512 . . . . 0.0 110.548 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.8 m -128.21 116.51 20.0 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.492 0.663 . . . . 0.0 111.047 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.9 94.67 4.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.235 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -95.86 147.95 23.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.595 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -144.11 135.88 26.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.054 0.454 . . . . 0.0 110.83 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 18' ' ' PHE . 3.9 p90 -167.54 133.77 2.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -89.01 173.77 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.503 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.88 144.38 28.79 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.093 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.03 165.62 27.97 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.614 2.209 . . . . 0.0 110.41 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.59 152.45 81.74 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.749 1.633 . . . . 0.0 111.741 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -36.1 129.49 0.63 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.764 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 N--CA 1.49 1.277 0 C-N-CA 121.965 1.777 . . . . 0.0 110.939 177.391 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.438 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 49.0 Cg_exo . . . . . 0 N--CA 1.506 2.227 0 N-CA-C 112.389 0.111 . . . . 0.0 112.389 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 5' ' ' PRO . 86.6 Cg_exo -54.7 145.4 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.089 2.526 . . . . 0.0 114.237 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.03 50.44 1.91 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.541 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.2 mm -126.21 128.5 71.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.241 0.543 . . . . 0.0 110.896 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -122.15 114.53 21.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.428 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.2 147.5 18.62 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.531 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -156.74 135.34 7.62 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 107.77 2.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.063 1.175 . . . . 0.0 111.51 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -78.18 -81.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.3 m -143.18 133.91 25.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.406 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.6 -145.68 35.97 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.765 ' NZ ' ' H ' ' A' ' 66' ' ' GLN . 2.6 mtmp? -87.76 -3.67 58.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.332 . . . . 0.0 110.71 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 82.6 p -71.72 145.66 48.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.749 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.79 125.75 48.36 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -85.77 104.01 15.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.808 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.89 97.49 8.37 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.4 t -72.39 120.16 17.61 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.689 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.494 HG21 ' CE2' ' A' ' 35' ' ' TYR . 3.1 mm -80.11 119.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.6 m -85.32 128.26 34.63 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.906 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.461 ' H ' ' HE2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.98 110.93 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.209 1.004 . . . . 0.0 109.584 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 27' ' ' ASP . 7.3 mm100 -92.79 169.05 10.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.076 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 17.1 t70 -53.75 -9.28 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.262 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 p30 47.92 34.97 4.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.848 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.2 -13.06 0.17 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 114.52 4.3 21.82 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . -131.44 152.5 80.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 122.633 -0.333 . . . . 0.0 110.358 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.79 144.08 58.02 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.213 1.942 . . . . 0.0 111.837 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.507 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.6 mt -98.44 125.66 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.504 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 mt -72.92 -39.53 66.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.104 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -160.58 170.46 20.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.91 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.505 ' CE1' HG21 ' A' ' 32' ' ' ILE . 11.7 m-85 -117.38 122.43 43.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.582 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -93.02 108.84 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 75' ' ' ILE . 61.4 t -111.12 127.13 68.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.067 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.23 138.22 54.11 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.952 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.527 ' CE2' HD12 ' A' ' 49' ' ' LEU . 28.8 p90 -142.4 151.04 41.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.086 0.47 . . . . 0.0 111.436 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 37.2 ptt85 -143.94 174.27 10.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.864 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.8 p -80.04 150.98 30.17 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.204 0.315 . . . . 0.0 110.261 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -75.12 12.15 0.97 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.425 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.69 -35.03 2.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.489 0.185 . . . . 0.0 110.776 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -103.01 109.64 21.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.491 0.662 . . . . 0.0 110.741 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -105.07 15.95 26.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.695 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.91 3.39 53.62 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -161.38 136.26 7.36 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.214 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 43.0 m95 -119.59 123.56 44.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.527 HD12 ' CE2' ' A' ' 39' ' ' TYR . 82.6 mt -81.76 160.24 23.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.017 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -120.18 154.68 34.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.428 0.632 . . . . 0.0 111.916 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.14 114.67 3.12 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.75 141.15 32.94 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.354 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.33 161.72 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.355 0.598 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 7.3 tp-100 -78.11 146.94 34.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.432 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.0 5.64 7.76 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.828 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.429 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 5.1 t-20 -120.7 -15.82 8.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.737 0.304 . . . . 0.0 110.31 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -65.16 -52.06 57.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.238 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 55.9 38.45 30.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.283 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.35 150.96 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.528 0.204 . . . . 0.0 110.535 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.36 152.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.398 0.618 . . . . 0.0 111.667 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 mm -121.57 111.73 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.82 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 17' ' ' SER . 51.0 mt -97.61 112.88 24.57 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -84.93 153.54 22.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 0.0 112.47 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.718 ' HA ' ' HZ1' ' A' ' 16' ' ' LYS . 70.3 t60 59.57 81.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.029 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 66' ' ' GLN . 75.1 mt -118.03 -4.15 11.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.765 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . 22.6 mt-30 57.13 149.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.405 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -90.64 -14.46 32.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.782 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 p -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.75 117.34 15.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.136 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.9 157.83 50.69 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.936 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -139.73 128.03 22.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.309 -0.445 . . . . 0.0 110.259 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -86.48 153.14 22.08 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.61 134.97 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -123.77 106.93 10.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.538 0.685 . . . . 0.0 109.414 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.565 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -94.11 133.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.489 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -139.9 116.2 10.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.659 ' HB3' ' OE2' ' A' ' 85' ' ' GLU . . . -89.37 127.75 35.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.28 110.62 22.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.29 0.567 . . . . 0.0 112.008 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.713 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -116.63 -176.45 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.839 178.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -42.52 -31.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.3 mp -64.75 -41.79 95.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.451 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 124.6 -45.38 1.18 Allowed Glycine 0 N--CA 1.465 0.573 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.484 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.7 m-85 -154.52 138.86 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.433 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 73.5 m -148.17 161.53 41.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.564 0.697 . . . . 0.0 111.87 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.659 ' OE2' ' HB3' ' A' ' 77' ' ' ALA . 0.7 OUTLIER 22.75 60.94 0.34 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.417 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.8 150.27 86.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.154 1.236 . . . . 0.0 110.414 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.7 m -125.27 117.92 24.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.577 0.703 . . . . 0.0 111.712 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -93.92 93.6 4.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.584 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 36.7 t80 -95.81 132.67 40.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.704 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.83 136.46 46.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 111.221 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.1 p90 -172.24 133.44 0.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.165 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.4 p -80.52 162.76 24.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.343 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.6 mmm -89.29 143.31 30.72 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.285 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.93 164.98 34.06 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.684 2.256 . . . . 0.0 111.203 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.1 152.36 81.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.414 2.076 . . . . 0.0 111.507 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.75 131.22 1.83 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.208 1.939 . . . . 0.0 111.525 178.19 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' H ' ' HA2' ' A' ' 28' ' ' GLY . 38.0 mt-10 -135.06 81.87 43.95 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -101.2 -164.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 124.008 3.139 . . . . 0.0 110.057 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.441 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -167.83 -179.79 0.81 Allowed Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.149 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 30.1 Cg_exo -59.96 171.01 3.22 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.592 2.195 . . . . 0.0 111.884 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -39.21 164.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 122.696 2.264 . . . . 0.0 114.732 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 m -163.74 48.97 0.13 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.635 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -126.12 127.4 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.621 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -113.35 113.98 26.0 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.06 141.54 15.59 Favored Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -150.37 148.63 24.65 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.767 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.75 88.29 1.39 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.167 1.911 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 14' ' ' SER . 79.7 p -58.12 -87.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.024 0.44 . . . . 0.0 109.971 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.463 ' N ' ' OG ' ' A' ' 13' ' ' SER . 37.9 m -139.29 127.97 23.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.58 -131.31 14.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -93.13 -10.67 35.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.634 0.254 . . . . 0.0 111.226 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -63.95 146.56 53.84 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.874 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.17 130.33 52.36 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.08 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -88.2 104.83 17.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.371 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.63 97.4 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 t -73.76 126.94 31.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.114 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 mm -87.49 110.44 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.0 m -88.89 115.61 26.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.49 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -36.98 105.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.297 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.607 HE22 HG23 ' A' ' 87' ' ' THR . 66.1 mt-30 -91.92 170.5 9.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.614 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.94 109.21 1.2 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.12 142.81 58.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.092 0.472 . . . . 0.0 110.695 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.417 ' HA2' ' H ' ' A' ' 2' ' ' GLU . . . -46.38 -19.52 0.45 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.461 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.71 1.24 1.42 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.92 151.87 57.36 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.82 137.82 55.26 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.772 1.648 . . . . 0.0 111.385 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.617 HG21 ' CE1' ' A' ' 35' ' ' TYR . 3.5 mt -83.41 131.39 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.357 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.1 mm? -85.48 -42.71 14.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.32 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -146.66 161.06 41.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.266 0.555 . . . . 0.0 111.618 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.617 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.2 m-85 -114.98 125.01 53.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.101 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.628 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 80.6 mt -98.3 114.34 35.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.607 HG22 HG13 ' A' ' 75' ' ' ILE . 75.0 t -112.39 127.74 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.784 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -129.12 128.7 44.01 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CE2' HD12 ' A' ' 49' ' ' LEU . 36.3 p90 -136.64 153.19 50.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -142.36 172.93 12.02 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.753 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' LYS . 15.4 m -84.25 137.96 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -63.13 -38.26 90.47 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.847 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.76 -43.04 97.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.529 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 41' ' ' SER . 36.8 mmtt -102.54 117.76 35.39 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.407 0.622 . . . . 0.0 110.961 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.77 54.91 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.63 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -142.37 5.66 1.65 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.258 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -144.31 152.85 41.34 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.014 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -141.57 110.6 6.23 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.232 0.539 . . . . 0.0 110.65 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.515 HD12 ' CE2' ' A' ' 39' ' ' TYR . 83.9 mt -73.13 160.08 32.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.72 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -121.71 148.02 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.07 0.462 . . . . 0.0 111.713 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.79 113.61 4.13 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.628 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 72.9 mmtt -97.3 146.16 25.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.667 0.27 . . . . 0.0 110.707 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 160.95 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.436 0.636 . . . . 0.0 111.092 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 55.6 tt0 -82.86 136.11 34.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.51 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.06 -8.12 1.37 Allowed Glycine 0 N--CA 1.466 0.676 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.263 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.489 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 81.8 m-20 -107.12 -9.17 16.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.673 0.273 . . . . 0.0 110.32 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -64.62 -49.16 72.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.1 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 51.83 33.03 10.56 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.429 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.8 152.93 0.46 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.833 0.349 . . . . 0.0 110.562 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.594 HD13 HG21 ' A' ' 37' ' ' VAL . 1.5 pt -150.33 141.39 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.145 0.498 . . . . 0.0 110.608 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mm -112.13 112.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.145 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.2 mt -98.38 136.31 38.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.09 159.52 20.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.999 0.428 . . . . 0.0 111.547 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 t60 71.04 62.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.781 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.657 HD13 ' OH ' ' A' ' 71' ' ' TYR . 54.0 mt -119.26 82.59 1.89 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.4 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' LEU . 49.8 mt-30 -36.35 152.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.134 0.493 . . . . 0.0 111.711 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -83.57 -9.65 58.79 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.81 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.4 p -113.64 13.36 18.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 61.8 mtp -139.25 136.44 34.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 111.492 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -99.85 161.29 19.42 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.131 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.657 ' OH ' HD13 ' A' ' 65' ' ' LEU . 3.8 p90 -150.66 139.37 20.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 109.992 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -87.5 148.9 24.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.1 t -125.47 132.72 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -123.39 112.58 17.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.186 0.517 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.607 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -95.97 135.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.13 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -138.5 116.03 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -87.01 125.47 34.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.333 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.34 111.73 24.48 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.4 p30 -111.6 -164.92 0.95 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -54.45 -30.98 54.57 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.599 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.4 mm? -65.02 -41.77 94.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.697 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.22 -48.16 0.98 Allowed Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.5 m-85 -153.75 137.76 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -161.55 170.49 19.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.237 0.541 . . . . 0.0 110.943 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 34.63 57.73 2.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.298 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.47 151.62 59.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.382 2.054 . . . . 0.0 110.898 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.607 HG23 HE22 ' A' ' 25' ' ' GLN . 0.1 OUTLIER -127.33 110.57 12.96 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 110.5 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.6 m -95.02 95.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.555 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.6 t80 -102.46 138.64 39.12 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.603 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -139.5 136.0 34.08 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.744 0.306 . . . . 0.0 110.593 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.2 p90 -171.52 129.58 0.69 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -81.55 162.68 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 77.5 mmm -88.82 149.11 43.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.61 162.94 29.83 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.414 2.076 . . . . 0.0 110.338 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.1 154.8 72.64 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.092 1.861 . . . . 0.0 110.961 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.89 131.47 0.92 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.434 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.32 141.18 55.6 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.435 1.423 . . . . 0.0 112.427 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.26 -12.65 17.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 101' ' ' LYS . 38.9 pt -105.26 -7.92 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.686 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.6 pt 39.36 16.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.343 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 99' ' ' ILE . 88.4 tttt -86.99 -72.81 0.49 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.22 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.567 179.8 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 34.84 84.84 0.17 Allowed Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.757 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.41 -163.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.252 2.635 . . . . 0.0 109.28 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.42 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -168.86 179.55 0.83 Allowed Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 119.609 -0.837 . . . . 0.0 110.852 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 49.8 Cg_exo -55.25 161.05 7.51 Favored 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 122.647 2.231 . . . . 0.0 112.973 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.0 Cg_exo -39.79 175.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.286 2.657 . . . . 0.0 114.545 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.53 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -160.11 39.85 0.18 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.568 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 87' ' ' THR . 5.9 mm -126.02 128.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.326 0.584 . . . . 0.0 111.76 -177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -124.84 117.05 23.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.753 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.38 147.04 17.9 Favored Glycine 0 N--CA 1.465 0.603 0 CA-C-O 121.472 0.485 . . . . 0.0 112.568 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -145.48 132.29 9.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.47 100.22 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.475 1.45 . . . . 0.0 112.402 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 9.7 p -80.18 167.23 20.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.2 p -43.88 112.11 0.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.67 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.59 -171.72 20.44 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -75.15 -9.31 58.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.508 0.194 . . . . 0.0 111.284 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 7.4 p -66.23 142.56 57.66 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.713 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.07 125.87 50.33 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -86.64 100.24 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.262 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.7 mt -96.83 98.25 9.97 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.4 t -71.36 129.29 38.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.986 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.471 HG21 ' CD2' ' A' ' 35' ' ' TYR . 2.1 mm -92.36 111.34 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 m -77.4 128.16 33.79 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.211 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.655 ' HD3' ' H ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -34.57 105.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.878 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 85' ' ' GLU . 88.4 mt-30 -83.6 118.15 23.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.493 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.61 -10.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.358 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.529 ' OD1' ' ND2' ' A' ' 79' ' ' ASN . 25.8 t70 58.05 172.51 0.05 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.917 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.31 -48.14 72.54 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.22 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.82 25.7 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -152.17 151.87 28.48 Favored Pre-proline 0 CA--C 1.529 0.142 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.72 146.5 60.63 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.88 1.72 . . . . 0.0 111.437 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.598 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -91.05 127.48 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.949 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.3 mm? -75.72 -45.14 38.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.25 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -151.99 167.07 29.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.536 ' CE1' HG21 ' A' ' 32' ' ' ILE . 10.4 m-85 -115.16 124.41 51.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.401 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.501 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 91.9 mt -95.65 109.53 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.603 HG22 HG13 ' A' ' 75' ' ' ILE . 48.9 t -111.51 128.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -125.81 137.93 53.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.421 ' CE2' HD12 ' A' ' 49' ' ' LEU . 47.1 p90 -140.99 155.74 46.16 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.935 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.77 175.32 11.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 44' ' ' LYS . 10.1 m -88.52 137.69 32.1 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.206 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -65.46 -34.19 77.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -10.88 8.32 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.615 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' SER . 40.5 mtmt -140.84 161.22 38.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 109.959 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -149.03 51.46 0.97 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.037 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -139.96 4.96 2.11 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.674 0.274 . . . . 0.0 111.001 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -138.56 144.11 39.72 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.494 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -141.38 112.18 7.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 110.546 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.421 HD12 ' CE2' ' A' ' 39' ' ' TYR . 96.1 mt -76.43 159.89 30.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.18 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -119.67 150.38 40.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.383 0.611 . . . . 0.0 112.026 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? -153.04 114.45 4.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.219 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.501 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 71.8 mmtt -95.29 144.36 25.93 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.09 159.08 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.185 0.517 . . . . 0.0 110.875 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 67.5 tp60 -78.43 143.78 36.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.893 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.06 -25.01 59.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.433 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 21.1 m120 -95.3 -12.25 26.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 16.9 mttm -64.06 -45.3 89.4 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.3 p30 47.78 38.61 9.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.819 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.04 154.0 0.65 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.785 0.326 . . . . 0.0 110.822 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -155.07 150.89 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 121.253 0.549 . . . . 0.0 110.758 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.34 109.51 27.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.035 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.75 106.23 18.2 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -84.67 149.26 25.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.685 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 36.5 t60 79.42 70.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.753 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 mt -126.25 81.35 1.99 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' A' ' 68' ' ' THR . 16.5 tt0 -38.1 140.98 0.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 111.336 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -68.9 -29.53 67.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.797 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.429 ' H ' ' HG2' ' A' ' 66' ' ' GLN . 5.8 p -97.22 22.1 9.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 42.3 mtp -147.97 128.67 14.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.835 0.35 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.54 167.38 50.34 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -144.26 132.65 22.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.545 0.212 . . . . 0.0 110.685 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -92.11 150.73 20.78 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.18 132.83 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -122.86 109.85 14.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.603 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -98.7 131.1 46.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.136 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -134.67 120.33 19.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.94 125.96 35.56 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.72 110.09 22.04 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.643 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.98 -171.51 2.0 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.949 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -41.99 -35.11 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.406 . . . . 0.0 110.217 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.2 mm? -64.14 -40.49 96.26 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 120.86 -41.76 1.85 Allowed Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.0 m-85 -155.96 135.53 12.47 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -163.03 155.98 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.789 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.537 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 18.8 tt0 45.04 56.19 14.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.25 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.23 154.89 56.72 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.738 2.292 . . . . 0.0 111.119 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.46 HG21 HG12 ' A' ' 8' ' ' ILE . 35.4 m -130.46 121.15 25.3 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 121.62 0.724 . . . . 0.0 111.018 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.81 94.44 3.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 37.7 t80 -99.86 125.35 45.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.724 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.07 130.38 49.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.73 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.623 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.7 p90 -163.79 134.19 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.601 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -80.56 164.46 22.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.6 mmm -94.76 145.75 30.17 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.918 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -73.39 163.49 37.6 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.323 2.015 . . . . 0.0 110.937 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -66.22 154.95 72.14 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.455 2.103 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -40.37 132.77 1.63 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.801 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.85 155.04 48.74 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.805 1.67 . . . . 0.0 111.697 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -80.73 -75.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.988 0.423 . . . . 0.0 110.123 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 100' ' ' ILE . 6.2 tt -151.7 -48.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.417 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.434 ' N ' HG23 ' A' ' 99' ' ' ILE . 11.5 tt -44.88 152.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.558 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 102' ' ' ASP . 63.6 mmtt -51.15 175.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.068 0.461 . . . . 0.0 111.008 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 101' ' ' LYS . 67.5 t0 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.777 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.549 ' HD2' ' H1 ' ' A' ' 1' ' ' ARG . 10.8 mpt_? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 1' ' ' ARG . 5.3 pt-20 -25.41 86.75 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.684 0 O-C-N 123.879 0.737 . . . . 0.0 112.283 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' N ' ' O ' ' A' ' 1' ' ' ARG . 48.2 Cg_endo -101.93 -164.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.679 2.919 . . . . 0.0 110.517 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -169.29 154.12 5.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.486 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' SER . 76.4 Cg_exo -36.1 162.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 123.261 2.641 . . . . 0.0 112.793 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.0 Cg_exo -37.38 164.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.768 2.312 . . . . 0.0 113.629 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.57 53.15 0.78 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.689 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 mm -130.04 128.4 64.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -119.09 114.71 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.47 145.64 17.75 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.659 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.38 116.46 3.99 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -50.02 104.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.248 1.299 . . . . 0.0 112.252 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.6 t -80.76 167.32 20.1 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.1 t -43.27 118.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.369 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.38 -150.21 21.15 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -82.18 -6.09 58.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 110.576 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 t -66.37 143.26 57.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.53 121.76 37.3 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -83.7 108.73 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.437 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 mt -101.81 108.83 20.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -83.4 121.96 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.004 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.3 mm -86.06 115.03 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -86.83 127.18 35.02 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.191 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -47.16 105.2 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.412 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 27' ' ' ASP . 78.7 mt-30 -81.44 158.35 24.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.858 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 35.1 t0 -51.16 -9.47 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.603 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER 64.83 131.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 1' ' ' ARG . . . -40.05 -19.73 0.02 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 138.46 17.87 0.57 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -157.69 152.47 21.01 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.53 138.91 61.79 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.811 1.674 . . . . 0.0 111.732 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.565 HG21 ' CE1' ' A' ' 35' ' ' TYR . 6.4 mt -89.22 133.33 31.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.218 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.7 mp -89.51 -25.18 21.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.177 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -164.64 164.62 21.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.176 0.512 . . . . 0.0 111.436 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.565 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.4 m-85 -119.37 117.49 28.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.076 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.7 mt -91.54 116.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG13 ' A' ' 75' ' ' ILE . 75.2 t -115.36 130.0 70.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.542 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -129.22 129.07 44.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CE2' HD12 ' A' ' 49' ' ' LEU . 39.1 p90 -134.1 155.92 49.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.49 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 26.9 ptt85 -149.58 171.1 17.18 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.428 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.504 ' HG ' ' HE2' ' A' ' 71' ' ' TYR . 4.4 m -80.8 138.07 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -63.94 -32.17 73.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.702 0.287 . . . . 0.0 111.447 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -60.99 -29.36 69.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.646 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' SER . 38.5 mtmt -130.96 166.61 20.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.488 0.661 . . . . 0.0 110.996 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -144.74 16.21 1.6 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.558 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -90.14 -0.25 57.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.881 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -149.36 152.14 35.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.207 0.527 . . . . 0.0 111.727 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.434 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 49.9 m95 -141.26 114.37 8.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.863 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.506 HD12 ' CE2' ' A' ' 39' ' ' TYR . 91.5 mt -75.08 159.55 31.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.915 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -117.65 153.64 32.96 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.18 0.514 . . . . 0.0 111.508 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.47 113.59 2.88 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -95.89 143.73 26.84 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.567 0.223 . . . . 0.0 110.576 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.4 160.78 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 110.591 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 6.5 tt0 -79.1 148.68 32.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.026 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.21 2.31 14.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.46 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 9.4 t-20 -121.54 -15.66 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.67 0.271 . . . . 0.0 110.962 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -62.81 -47.98 81.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 110.233 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 54.89 34.8 22.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.333 0.587 . . . . 0.0 111.319 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.44 156.66 2.01 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.705 -0.622 . . . . 0.0 110.94 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.516 HD13 HG21 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -156.06 155.46 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.634 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.7 107.55 20.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.831 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 62' ' ' LEU . 2.0 mm? -92.5 107.47 19.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.06 157.44 18.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.592 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 m170 73.23 68.6 0.11 Allowed 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.712 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.5 mt -125.07 82.18 2.03 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.064 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 73.3 mt-30 -36.16 141.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.115 0.484 . . . . 0.0 111.555 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -74.75 -7.57 53.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.673 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.7 p -112.55 16.67 19.69 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 0.0 111.48 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtp -143.5 142.31 31.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.965 0.412 . . . . 0.0 110.188 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.17 164.19 25.83 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.504 ' HE2' ' HG ' ' A' ' 41' ' ' SER . 92.2 m-85 -146.49 137.19 24.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.763 0.316 . . . . 0.0 111.277 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.4 mt-10 -97.96 149.86 21.97 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.87 133.83 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.48 106.96 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.592 0.71 . . . . 0.0 109.812 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.596 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -93.03 132.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.539 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 m -134.79 121.74 21.12 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -94.55 126.54 39.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.3 112.58 24.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.418 0.627 . . . . 0.0 112.181 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.9 p-10 -119.07 -165.71 1.17 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.986 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.42 -30.53 19.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD22 HD21 ' A' ' 79' ' ' ASN . 8.6 mp -63.46 -39.15 93.7 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 118.64 -46.65 1.11 Allowed Glycine 0 N--CA 1.463 0.474 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 5.2 m-85 -155.8 128.75 8.03 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.502 ' O ' ' C ' ' A' ' 85' ' ' GLU . 3.7 m -113.06 148.32 35.44 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 84' ' ' SER . 1.2 mp0 -12.6 98.03 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 124.225 0.953 . . . . 0.0 111.846 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.55 158.36 53.96 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.133 1.222 . . . . 0.0 111.325 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.8 m -105.71 114.19 28.21 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.534 0.683 . . . . 0.0 110.105 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.6 t -91.36 94.46 4.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.471 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 38.2 t80 -98.5 128.16 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.827 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.21 129.76 48.4 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 111.207 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 14.8 p90 -159.38 126.87 4.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.73 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.62 161.12 23.59 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.057 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.4 mmm -90.67 139.12 26.29 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.933 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.29 163.05 35.44 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.38 2.053 . . . . 0.0 111.103 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 152.12 82.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.071 1.847 . . . . 0.0 111.04 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -39.71 131.6 1.43 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.408 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.08 144.4 63.41 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.501 1.467 . . . . 0.0 112.317 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -117.88 -77.99 0.58 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.828 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.8 pt -126.19 -1.42 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.424 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 101' ' ' LYS . 20.9 tt -65.72 -41.35 90.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.495 ' N ' HG23 ' A' ' 100' ' ' ILE . 24.1 ttpt 73.9 167.81 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.601 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.511 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.442 ' NH2' HD12 ' A' ' 81' ' ' LEU . 2.9 ttm180 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 1' ' ' ARG . 15.8 mt-10 -27.9 92.13 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.809 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -101.36 -164.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.951 0 C-N-CA 123.902 3.068 . . . . 0.0 109.959 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -168.36 155.32 7.3 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.634 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 4' ' ' SER . 81.7 Cg_exo -38.5 170.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.402 2.735 . . . . 0.0 113.245 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.78 151.25 26.5 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.125 1.883 . . . . 0.0 114.275 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.02 30.29 3.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.955 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.36 120.06 54.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.283 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -115.73 116.23 27.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.302 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.55 156.29 21.52 Favored Glycine 0 N--CA 1.462 0.397 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -157.68 133.41 5.9 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.29 82.73 1.06 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.322 1.348 . . . . 0.0 112.136 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -58.4 -173.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.5 p -56.48 122.36 11.76 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.272 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.06 -154.03 31.45 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.911 -0.475 . . . . 0.0 111.911 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HE2' ' H ' ' A' ' 66' ' ' GLN . 15.4 mtmm -78.1 -9.09 58.99 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.473 -0.363 . . . . 0.0 110.897 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.6 p -64.66 143.4 57.95 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.114 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.91 126.34 49.77 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -87.84 98.39 11.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.598 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mt -93.71 99.83 12.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -73.96 119.23 17.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.266 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.441 HG21 ' CD2' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -84.88 108.69 17.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -87.62 129.07 35.24 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -44.62 105.69 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.39 153.53 20.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.03 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -57.84 103.01 0.11 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 55.1 p-10 -57.52 145.39 33.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.103 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -43.63 -46.71 7.31 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.29 18.68 0.02 OUTLIER Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.397 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -158.78 156.43 26.89 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.41 0.605 . . . . 0.0 110.231 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.35 144.2 85.17 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.136 1.891 . . . . 0.0 110.967 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.583 HG21 ' CE1' ' A' ' 35' ' ' TYR . 5.7 mt -91.82 124.37 44.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.248 0.547 . . . . 0.0 111.454 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.3 mt -71.78 -41.05 68.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.029 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.33 171.85 19.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.27 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.583 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -120.78 114.28 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.832 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -89.45 115.4 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG22 HG13 ' A' ' 75' ' ' ILE . 96.4 t -111.91 128.54 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -124.34 128.12 48.62 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' CE2' HD12 ' A' ' 49' ' ' LEU . 35.3 p90 -135.32 153.74 51.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.691 0.281 . . . . 0.0 110.875 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE1' ' A' ' 72' ' ' GLU . 29.3 ptt85 -147.23 171.72 14.95 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.479 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.4 m -81.4 137.77 35.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.494 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.36 -29.14 70.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.554 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.15 -31.05 72.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.244 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -119.82 171.73 8.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.769 0.795 . . . . 0.0 111.546 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -152.22 4.68 0.39 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.722 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -90.55 -1.33 57.88 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.426 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -140.62 138.45 34.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.131 0.491 . . . . 0.0 111.239 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 44.9 m95 -134.62 108.45 8.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.907 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.486 HD12 ' CE2' ' A' ' 39' ' ' TYR . 84.6 mt -71.65 159.39 34.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.56 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 1.3 pm0 -124.42 147.19 48.44 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -145.45 111.89 5.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -84.79 142.35 29.85 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 35' ' ' TYR . 38.8 t -136.41 156.03 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.434 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 7.9 tp-100 -78.42 146.66 34.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.768 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.05 -6.4 45.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -111.47 -15.6 13.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.51 0.195 . . . . 0.0 111.296 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HD2' ' H ' ' A' ' 54' ' ' GLN . 23.0 mttm -62.06 -49.1 77.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.285 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 53.34 36.07 21.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.412 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.98 154.07 0.67 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -154.68 146.13 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 110.587 179.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mm -114.82 115.52 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.7 mt -102.26 105.59 16.26 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.6 154.19 25.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.7 t60 69.97 67.0 0.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.961 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' GLN . 57.4 mt -107.84 -7.92 16.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 65' ' ' LEU . 74.6 mt-30 55.72 147.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 111.646 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -91.94 -18.4 23.77 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.038 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.3 p -106.48 18.8 21.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 10.8 ttm -146.5 138.84 25.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 170.47 34.34 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -149.35 134.27 17.96 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 5.1 mt-10 -98.87 152.81 19.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.06 135.37 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.017 0.437 . . . . 0.0 110.767 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -128.22 108.27 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.983 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.612 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -92.18 137.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.543 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -137.19 117.86 13.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.11 126.64 35.54 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.68 112.23 25.24 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.315 0.578 . . . . 0.0 112.184 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.6 p-10 -114.73 -168.25 1.35 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.804 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -51.31 -30.48 18.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.621 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.0 mm? -63.18 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.11 -47.45 1.02 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -155.53 139.02 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 85' ' ' GLU . 1.3 t -131.84 135.46 46.73 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.75 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.6 mm-40 11.9 94.04 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 124.365 1.041 . . . . 0.0 112.091 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.38 154.26 55.91 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 120.995 1.13 . . . . 0.0 111.679 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.82 111.76 24.05 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 88' ' ' VAL . 28.6 m -94.64 96.62 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.165 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.481 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -101.8 130.43 48.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.264 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -130.52 130.68 44.44 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.167 0.508 . . . . 0.0 111.729 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 13.0 p90 -165.94 140.14 4.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.064 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -91.27 171.29 9.33 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.453 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.0 mmm -96.61 139.74 21.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 121.29 -0.164 . . . . 0.0 111.08 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.21 163.18 37.12 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.22 1.947 . . . . 0.0 110.955 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.95 147.61 91.89 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.39 2.06 . . . . 0.0 111.764 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -41.45 134.52 2.03 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.344 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.02 158.19 46.11 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 121.61 1.54 . . . . 0.0 111.435 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -66.81 0.77 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 99' ' ' ILE . 9.0 tt -177.86 92.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.209 0.528 . . . . 0.0 110.711 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.453 ' CG1' ' N ' ' A' ' 101' ' ' LYS . 6.4 tt -177.77 161.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.824 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 21.2 tptm -51.19 113.86 1.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.086 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.7 m-20 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.936 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 26' ' ' ASP . 1.2 mm-40 -152.33 93.06 3.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.663 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -97.42 -163.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 123.449 2.766 . . . . 0.0 109.142 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 1.9 p -177.26 156.5 1.22 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.542 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' PRO . 54.4 Cg_exo -36.21 161.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.96 2.44 . . . . 0.0 112.73 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -33.96 167.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 123.714 2.943 . . . . 0.0 116.155 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.491 ' OG ' ' NE2' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -165.06 46.47 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.917 -177.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 mm -127.99 129.28 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 111.579 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -119.26 116.91 27.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.184 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.55 155.95 19.4 Favored Glycine 0 N--CA 1.467 0.712 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.331 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -158.56 132.61 5.08 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 89.5 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.376 1.384 . . . . 0.0 110.923 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.9 t -60.73 -85.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.349 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 17' ' ' SER . 90.7 p -128.12 127.74 43.59 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.752 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.08 -128.67 31.48 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 65' ' ' LEU . 40.5 mttt -89.5 -5.6 57.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.925 0.393 . . . . 0.0 110.456 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 14' ' ' SER . 85.7 p -61.75 144.87 54.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.425 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.62 120.78 27.26 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -88.03 101.18 13.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.272 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 mt -96.5 96.56 8.77 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 t -67.62 130.68 43.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.451 HD12 HG12 ' A' ' 75' ' ' ILE . 5.2 mm -91.74 117.16 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.3 m -84.17 128.33 34.49 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.762 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -63.05 105.23 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' NE2' ' OG ' ' A' ' 7' ' ' SER . 76.0 mm-40 -101.31 167.18 10.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.299 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' GLU . 99.3 m-20 -59.63 95.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 26.6 t70 -42.38 -64.55 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.657 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.62 -23.36 0.22 Allowed Glycine 0 C--N 1.318 -0.47 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.36 5.08 0.09 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.684 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.431 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -156.79 142.68 12.85 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 118.187 0.994 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.71 150.73 60.1 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.067 1.178 . . . . 0.0 111.927 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.588 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.4 mt -91.79 128.19 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.491 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.8 mt -72.95 -42.56 63.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -155.53 163.66 39.7 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.635 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.8 m-85 -110.98 127.12 55.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.058 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.51 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 85.9 mt -99.95 110.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.577 HG22 HG13 ' A' ' 75' ' ' ILE . 99.6 t -109.21 127.09 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.855 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -126.17 128.67 47.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 49' ' ' LEU . 41.7 p90 -132.9 151.51 52.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.419 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -142.34 172.82 12.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.397 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.9 p -84.17 147.24 27.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.557 ' HZ2' ' N ' ' A' ' 92' ' ' SER . 95.4 mttt -75.24 4.64 6.69 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -120.74 -49.88 2.21 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 45' ' ' GLU . 11.2 mmpt? -60.92 -45.42 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.932 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 46' ' ' ASP . 81.8 tt0 36.18 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.449 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' O ' ' NE2' ' A' ' 47' ' ' GLN . 1.9 m-20 167.15 -15.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 O-C-N 123.571 0.545 . . . . 0.0 110.493 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 46' ' ' ASP . 96.0 mm-40 -137.24 117.74 13.81 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.56 0.219 . . . . 0.0 110.923 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -99.95 116.67 32.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.851 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.423 HD12 ' CE2' ' A' ' 39' ' ' TYR . 92.4 mt -73.45 160.07 32.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.182 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 25.0 mp0 -117.0 150.55 38.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.341 0.591 . . . . 0.0 112.47 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.24 115.33 4.06 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.51 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 73.0 mmtt -97.52 146.0 25.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.701 0.286 . . . . 0.0 110.612 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.42 155.67 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.194 0.521 . . . . 0.0 110.034 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.516 ' C ' ' H ' ' A' ' 56' ' ' ASN . 33.3 tt0 -78.08 137.24 38.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.208 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 7.07 0.16 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 54' ' ' GLN . 66.0 t30 -122.18 -13.97 8.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.793 0.297 . . . . 0.0 110.755 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -69.72 -53.08 20.16 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.811 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 58.28 40.06 24.98 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.648 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -178.05 153.15 0.78 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.564 HD13 HG21 ' A' ' 37' ' ' VAL . 1.4 pt -152.45 143.31 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.204 0.526 . . . . 0.0 111.428 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.6 mm -114.56 115.79 50.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.14 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.0 mt -103.73 105.52 15.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.5 152.2 23.37 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.225 0.536 . . . . 0.0 112.188 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 66.06 76.68 0.31 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.28 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.747 HD13 ' OH ' ' A' ' 71' ' ' TYR . 86.2 mt -111.52 -4.12 14.91 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' O ' ' SD ' ' A' ' 93' ' ' MET . 83.3 mt-30 52.49 120.69 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.877 0.846 . . . . 0.0 112.241 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -61.31 -32.04 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.093 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.7 p -94.52 22.87 5.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.3 tpt -144.46 114.73 7.51 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.395 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.78 155.59 32.09 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.747 ' OH ' HD13 ' A' ' 65' ' ' LEU . 48.5 p90 -151.29 138.29 19.1 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.54 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.96 156.21 19.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.642 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 132.71 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -126.12 110.82 13.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.221 0.534 . . . . 0.0 110.373 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.577 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -91.76 137.24 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.768 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.82 117.24 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.59 124.38 34.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.26 113.43 26.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.268 0.556 . . . . 0.0 112.358 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -116.62 -163.38 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -52.75 -33.33 47.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 81' ' ' LEU . 8.5 mp -64.12 -40.98 97.37 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 126.09 -49.64 0.91 Allowed Glycine 0 N--CA 1.463 0.452 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 6.8 m-85 -154.46 133.96 12.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 t -159.85 170.28 21.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.162 0.506 . . . . 0.0 111.125 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 25' ' ' GLN . 16.6 pt-20 39.91 51.41 3.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.392 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.76 148.37 82.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.941 1.76 . . . . 0.0 111.263 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.425 ' CG2' ' H ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -125.32 110.35 13.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 99.25 8.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.523 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -104.56 131.75 51.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.956 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -131.84 132.58 43.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.906 0.384 . . . . 0.0 111.06 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 6.6 p90 -173.69 125.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.208 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.557 ' N ' ' HZ2' ' A' ' 42' ' ' LYS . 11.9 p -80.77 166.29 21.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 110.668 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.3 mtp -88.41 147.47 40.01 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.956 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.07 162.66 28.76 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.421 2.081 . . . . 0.0 110.211 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 96' ' ' LYS . 38.2 Cg_endo -65.6 153.64 77.29 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.912 1.741 . . . . 0.0 110.822 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 95' ' ' PRO . 4.1 tppp? -36.62 133.05 0.65 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.555 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.47 144.48 50.39 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.465 1.443 . . . . 0.0 111.818 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -98.13 -17.4 19.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.011 0.434 . . . . 0.0 110.135 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' LYS . 26.7 pt -104.98 -8.26 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.097 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.4 pt 39.23 16.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.327 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' ILE . 88.6 tttt -82.32 -68.84 0.67 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.387 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 64.1 t0 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.092 -179.3 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 2' ' ' GLU . 83.7 mtt85 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 1' ' ' ARG . 1.5 pm0 6.26 76.32 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 124.204 0.94 . . . . 0.0 112.936 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -100.13 -165.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.608 2.872 . . . . 0.0 110.82 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -169.76 151.56 4.26 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.637 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.3 Cg_exo -39.8 162.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.508 2.139 . . . . 0.0 112.629 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 32.8 Cg_exo -38.7 166.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.85 2.367 . . . . 0.0 113.322 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.25 41.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.683 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.08 124.38 71.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.578 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -116.14 118.96 34.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.462 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.64 140.91 15.06 Favored Glycine 0 N--CA 1.466 0.638 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.474 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -143.73 146.51 35.21 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.2 80.46 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.828 1.685 . . . . 0.0 111.447 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.4 t -48.03 -84.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.1 m -139.63 136.99 34.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.064 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.6 -130.76 37.34 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -95.17 -4.01 46.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.817 0.341 . . . . 0.0 110.497 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 t -68.81 144.11 54.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.001 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.48 128.2 47.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 110.246 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -88.08 103.62 15.91 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mt -99.13 91.98 5.25 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.7 t -66.86 124.8 23.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.494 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.422 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.4 mm -86.97 115.72 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -95.13 119.3 33.4 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.488 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -38.28 105.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.49 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -95.0 148.87 21.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 97.9 m-20 -54.67 95.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.53 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 30' ' ' ALA . 28.3 t70 -48.02 169.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.609 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.08 -33.43 84.08 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.67 22.91 0.03 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.811 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -159.05 151.66 17.96 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.58 140.62 57.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.435 1.423 . . . . 0.0 110.529 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.577 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.5 mt -83.48 127.71 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.82 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 33' ' ' LEU . 9.4 mp -75.18 -43.11 53.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.287 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -152.83 163.33 39.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.387 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.493 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -111.39 122.83 48.87 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.954 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.46 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 87.3 mt -96.47 107.93 20.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 75' ' ' ILE . 74.3 t -107.37 125.03 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.26 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -122.35 136.82 54.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 49' ' ' LEU . 33.0 p90 -143.18 152.15 41.46 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.679 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.474 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 35.6 ptt85 -148.39 173.43 13.09 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-O 120.937 0.399 . . . . 0.0 111.634 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -79.08 147.83 32.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.266 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -69.36 -32.03 70.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.679 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -75.15 -47.31 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -57.51 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 111.856 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 58.18 76.66 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.762 0.791 . . . . 0.0 110.116 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 61.2 t0 -175.61 -21.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.3 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -138.47 158.13 44.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.2 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 63.4 m95 -136.12 134.29 38.17 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.211 0.529 . . . . 0.0 112.209 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 39' ' ' TYR . 96.7 mt -84.79 160.38 20.25 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -118.07 149.1 41.57 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.26 0.552 . . . . 0.0 112.091 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.09 114.36 4.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 71.4 mmtt -98.92 144.7 27.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.668 0.27 . . . . 0.0 110.959 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.76 157.77 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.11 0.481 . . . . 0.0 110.648 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -70.6 149.53 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.448 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.89 -7.09 14.42 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.189 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -121.47 0.13 9.9 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.088 0.444 . . . . 0.0 111.346 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -61.83 -46.77 88.05 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.442 0.639 . . . . 0.0 109.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 52.99 31.52 11.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.835 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.36 150.55 0.44 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.775 0.321 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.34 146.86 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.111 0.481 . . . . 0.0 111.243 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mm -113.9 117.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.7 mt -105.35 105.65 15.79 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.612 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 65.5 mt-10 -96.93 119.7 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.612 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 28.9 m-70 122.65 54.07 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 124.997 1.436 . . . . 0.0 111.018 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.593 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 23.1 mt -111.89 105.24 13.64 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.488 ' N ' HE21 ' A' ' 66' ' ' GLN . 0.0 OUTLIER -59.06 135.85 57.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.237 0.542 . . . . 0.0 111.204 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -66.21 -23.81 66.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.075 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 p -104.82 18.23 22.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.9 mtp -149.79 129.97 13.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.027 0.442 . . . . 0.0 110.706 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.33 44.3 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.593 ' CZ ' HD13 ' A' ' 65' ' ' LEU . 9.3 p90 -157.46 132.11 8.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.286 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -87.27 154.29 20.82 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.007 0.432 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.53 134.0 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -124.62 110.46 14.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.496 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.572 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -95.82 132.4 40.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -136.76 118.29 14.84 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.577 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -90.13 126.24 35.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.61 108.41 19.68 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.603 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -114.5 -175.11 2.61 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.303 178.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -40.3 -33.71 0.27 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -63.96 -42.8 97.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.496 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.93 -48.5 0.97 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -155.83 131.63 9.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.04 162.39 20.35 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER 52.88 51.87 9.83 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 98.0 Cg_endo -74.01 152.83 46.57 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.381 2.054 . . . . 0.0 111.258 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.4 m -133.93 117.74 17.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.368 0.604 . . . . 0.0 110.714 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -96.6 94.49 4.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.422 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 34.0 t80 -98.61 134.82 41.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.538 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -137.89 130.5 29.6 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.039 0.447 . . . . 0.0 111.489 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 23.1 p90 -163.97 131.44 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.982 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -79.83 167.85 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 28.0 mtp -97.89 151.79 37.75 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.966 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.96 163.9 22.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.536 2.157 . . . . 0.0 110.012 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.35 156.38 63.59 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.774 1.649 . . . . 0.0 111.068 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -38.51 130.22 1.08 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.505 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.7 142.82 49.23 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.726 1.617 . . . . 0.0 112.725 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -95.52 -80.64 0.42 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.5 pt -73.57 -22.37 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.759 0.79 . . . . 0.0 109.066 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.7 mt 72.22 136.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 113.844 -1.526 . . . . 0.0 111.035 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -139.2 152.58 47.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.399 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.642 -179.752 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 26' ' ' ASP . 31.7 mt-10 -151.85 73.89 7.87 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -102.03 -165.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.677 2.918 . . . . 0.0 111.636 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.4 166.2 2.9 Favored Pre-proline 0 C--N 1.326 -0.451 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.474 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' PRO . 95.6 Cg_exo -39.94 161.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.977 2.451 . . . . 0.0 112.601 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.5 Cg_exo -37.3 167.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 123.305 2.67 . . . . 0.0 114.091 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.97 54.78 0.52 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.541 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.401 HG12 HG21 ' A' ' 87' ' ' THR . 6.0 mm -132.91 130.14 58.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.108 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -123.84 114.31 19.69 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.81 138.35 14.53 Favored Glycine 0 N--CA 1.46 0.297 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.45 116.95 8.6 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.556 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -52.03 103.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 120.945 1.096 . . . . 0.0 111.664 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.9 p -85.37 172.02 11.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.1 m -41.55 106.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.819 0.342 . . . . 0.0 110.739 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.29 -154.01 21.28 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.005 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -77.23 -19.65 56.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.516 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.434 ' OG ' HG22 ' A' ' 61' ' ' ILE . 13.6 t -59.01 139.11 57.17 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.171 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.92 122.11 46.67 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.598 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -86.1 109.0 18.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.792 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -102.27 105.72 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 119.09 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.192 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.45 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.4 mm -84.08 112.47 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 5.9 m -79.35 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.034 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.516 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.84 104.89 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.513 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -100.59 158.85 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 2' ' ' GLU . 45.9 m-20 -61.88 95.38 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 32.4 t70 -43.41 168.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.135 0.493 . . . . 0.0 111.183 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' HA2' ' H ' ' A' ' 2' ' ' GLU . . . -55.71 -42.44 85.15 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 15.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.905 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.43 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -159.64 151.36 16.77 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.886 0.843 . . . . 0.0 110.356 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.45 142.52 80.36 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 120.988 1.125 . . . . 0.0 111.59 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.524 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.5 mt -86.56 125.17 40.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.354 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -72.06 -40.76 68.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.805 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.39 167.27 26.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.07 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.462 ' CE1' HG21 ' A' ' 32' ' ' ILE . 14.6 m-85 -112.06 119.93 40.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.875 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.6 mt -92.18 113.07 26.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 75' ' ' ILE . 61.2 t -113.57 129.34 69.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.286 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -127.78 133.82 49.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CE2' HD12 ' A' ' 49' ' ' LEU . 29.7 p90 -139.26 154.05 47.91 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.044 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.0 174.02 11.65 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.533 ' OG ' ' CE2' ' A' ' 71' ' ' TYR . 4.3 m -84.21 136.76 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.007 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.83 -35.36 78.01 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.879 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -63.11 -35.49 80.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.288 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -98.68 178.05 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.801 0.81 . . . . 0.0 111.432 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -160.05 -5.54 0.06 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.777 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -91.6 9.02 33.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -149.72 150.45 32.1 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.805 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -141.43 109.06 5.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.722 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.492 HD12 ' CE2' ' A' ' 39' ' ' TYR . 56.4 mt -72.61 159.91 33.11 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.506 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -121.72 151.72 40.2 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.09 0.472 . . . . 0.0 111.558 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.44 114.66 3.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -96.2 142.3 28.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.29 138.25 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.25 0.548 . . . . 0.0 111.038 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' C ' ' H ' ' A' ' 56' ' ' ASN . 48.9 tt0 -59.71 142.53 52.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.796 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.5 14.8 0.93 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.135 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 m120 -132.09 9.88 4.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 21.3 mttt -91.74 -46.3 7.97 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.663 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 49.69 39.13 16.88 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.64 0.588 . . . . 0.0 111.887 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -179.57 151.9 0.48 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.707 0.289 . . . . 0.0 110.798 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -151.61 146.58 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.383 0.611 . . . . 0.0 111.092 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.434 HG22 ' OG ' ' A' ' 17' ' ' SER . 45.1 mm -114.86 111.65 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.83 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -100.03 107.75 19.76 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 98.8 mt-10 -84.88 156.06 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.523 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 6.3 t-80 78.76 52.39 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.6 mm? -107.71 88.22 2.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -51.0 135.96 23.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.646 . . . . 0.0 111.335 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -64.39 -34.13 77.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.444 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.8 p -96.33 20.81 9.89 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 111.76 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 49.7 mtp -143.34 140.0 30.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.206 0.527 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.8 162.61 24.26 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.312 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.533 ' CE2' ' OG ' ' A' ' 41' ' ' SER . 43.3 m-85 -144.34 135.5 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.046 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -94.69 149.86 20.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.33 133.42 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -123.24 108.41 12.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.475 0.655 . . . . 0.0 109.705 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -96.87 131.21 44.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.923 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -135.47 119.47 17.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.98 126.21 35.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.07 116.05 31.3 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 112.46 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.543 ' ND2' ' OD2' ' A' ' 27' ' ' ASP . 4.1 p-10 -115.9 -166.55 1.15 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.6 mtt180 -51.78 -31.48 27.19 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.625 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.9 mm? -64.05 -42.54 97.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.488 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 125.82 -45.05 1.19 Allowed Glycine 0 N--CA 1.464 0.556 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.488 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.1 m-85 -153.64 140.67 19.31 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.5 t -163.76 153.86 15.16 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.574 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' CD ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER 44.32 60.13 12.46 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.593 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.44 152.4 43.73 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.242 1.961 . . . . 0.0 110.965 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.401 HG21 HG12 ' A' ' 8' ' ' ILE . 23.0 m -131.23 118.44 20.4 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.65 0.738 . . . . 0.0 111.467 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.7 94.22 4.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.701 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -98.96 127.15 44.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.148 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.6 132.97 45.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.253 0.549 . . . . 0.0 110.967 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.581 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.1 p90 -166.49 140.07 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.334 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.9 156.49 19.33 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 85.8 mmm -85.88 147.4 45.67 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.598 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.48 162.76 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.343 2.029 . . . . 0.0 110.98 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.07 158.73 50.23 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.244 1.963 . . . . 0.0 111.121 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -37.91 129.89 0.95 Allowed Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.447 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.453 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 37.1 Cg_endo -66.37 143.51 70.25 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.327 1.351 . . . . 0.0 112.425 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 100' ' ' ILE . 96.3 m-20 -148.72 99.36 2.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.632 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.4 pt 40.52 16.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.723 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.73 HD13 ' N ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -100.13 128.74 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.295 0.569 . . . . 0.0 109.85 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.73 ' N ' HD13 ' A' ' 100' ' ' ILE . 48.8 tttm -61.87 136.69 58.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.997 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 11.8 p30 . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.863 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -167.49 85.52 0.79 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -99.46 -164.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 123.65 2.9 . . . . 0.0 110.335 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.54 169.33 2.15 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.485 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' PRO . 79.0 Cg_exo -39.66 161.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.559 2.173 . . . . 0.0 111.913 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' PRO . 22.3 Cg_exo -38.49 169.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.662 2.241 . . . . 0.0 114.93 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.453 ' H ' HG21 ' A' ' 87' ' ' THR . 15.2 m -156.56 46.19 0.43 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.347 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -127.27 127.11 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.331 0.586 . . . . 0.0 110.554 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -117.53 116.55 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.142 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.0 147.35 18.56 Favored Glycine 0 N--CA 1.464 0.517 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.3 130.43 8.05 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.94 81.97 1.59 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.43 1.42 . . . . 0.0 111.988 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.452 ' OG ' ' N ' ' A' ' 14' ' ' SER . 47.2 t -60.05 -159.73 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.452 ' N ' ' OG ' ' A' ' 13' ' ' SER . 33.4 t -63.33 134.52 55.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.246 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.53 -146.16 33.87 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -93.0 -2.53 55.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.766 0.317 . . . . 0.0 110.62 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -64.97 148.89 50.76 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.775 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.3 121.17 33.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.693 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -83.97 98.51 9.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 90.21 7.25 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -69.72 117.55 11.46 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.754 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.443 HG21 ' CE2' ' A' ' 35' ' ' TYR . 4.6 mm -77.63 126.36 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -104.2 116.51 32.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 110.472 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -39.47 104.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.787 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.26 165.18 11.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 43.0 t0 -57.94 109.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.897 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -71.58 165.65 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.98 31.98 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.54 -0.28 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.1 151.58 75.54 Favored Pre-proline 0 N--CA 1.463 0.22 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.21 143.58 65.3 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.865 1.71 . . . . 0.0 111.278 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.583 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.1 mt -86.74 126.44 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.761 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.9 mp -72.81 -41.38 64.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.138 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.02 165.67 35.76 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.375 0.607 . . . . 0.0 111.481 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.534 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.9 m-85 -115.38 119.98 38.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.221 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -93.93 115.11 31.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 75' ' ' ILE . 38.7 t -118.89 131.08 72.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.072 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -125.56 139.76 53.33 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.465 ' CE2' HD12 ' A' ' 49' ' ' LEU . 37.2 p90 -143.6 156.25 44.52 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.464 -0.495 . . . . 0.0 111.278 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.48 ' NH2' ' CD ' ' A' ' 72' ' ' GLU . 34.5 ptt85 -149.54 174.8 12.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 m -82.23 143.04 31.65 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -63.64 -39.46 94.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 7.0 t0 -76.6 -46.13 27.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.102 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' CE ' ' HE1' ' A' ' 69' ' ' MET . 1.4 mppt? -89.03 91.38 8.8 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -98.58 65.94 1.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.292 179.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -136.29 -5.87 2.06 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.441 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -146.59 155.87 42.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.991 0.424 . . . . 0.0 111.36 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -136.23 114.28 11.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.156 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.465 HD12 ' CE2' ' A' ' 39' ' ' TYR . 79.9 mt -77.55 160.31 28.69 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.908 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -111.04 155.62 22.5 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.788 0.328 . . . . 0.0 111.136 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -159.09 112.39 2.29 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -98.71 143.16 29.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.749 0.309 . . . . 0.0 111.289 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.66 156.54 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.42 0.629 . . . . 0.0 110.542 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HG2' ' H ' ' A' ' 56' ' ' ASN . 48.4 tt0 -82.09 144.35 30.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.307 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.6 81.42 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.523 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 32.8 m-20 -67.1 -39.3 86.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.295 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 54' ' ' GLN . 74.0 mttt -55.27 -71.87 0.08 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.549 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 60.34 49.37 7.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.437 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -176.04 140.13 0.4 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -141.85 151.83 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.393 0.616 . . . . 0.0 112.329 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.5 mm -122.47 101.49 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.924 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 62' ' ' LEU . 9.1 mp -92.06 107.24 19.07 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 64' ' ' HIS . 6.5 tm-20 -96.57 148.76 22.51 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.236 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.489 ' N ' ' CD ' ' A' ' 63' ' ' GLU . 19.2 t-80 93.0 48.29 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.073 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' O ' ' SD ' ' A' ' 93' ' ' MET . 20.9 mt -112.95 94.0 4.69 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.528 ' O ' ' SD ' ' A' ' 93' ' ' MET . 47.1 tt0 -45.48 148.47 0.68 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.135 0.493 . . . . 0.0 110.95 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.18 -8.65 56.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.767 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.2 p -113.44 19.13 17.19 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.43 ' HE1' ' CE ' ' A' ' 44' ' ' LYS . 49.3 mtp -144.22 133.86 23.56 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.806 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.7 157.37 27.46 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -137.56 133.31 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.794 0.33 . . . . 0.0 110.789 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' CD ' ' NH2' ' A' ' 40' ' ' ARG . 2.5 mt-10 -92.4 147.94 22.51 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.63 134.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.93 0.395 . . . . 0.0 109.96 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -124.2 108.27 12.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.267 0.556 . . . . 0.0 109.983 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.513 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -93.38 135.95 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.955 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -136.37 116.57 13.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.76 126.6 35.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.88 112.7 25.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.325 0.583 . . . . 0.0 112.541 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.75 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -114.53 -165.89 1.05 Allowed 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -49.52 -33.12 13.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.834 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.5 mm? -64.7 -42.65 95.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.248 0.547 . . . . 0.0 109.635 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 128.35 -48.79 0.95 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.475 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.1 m-85 -154.01 137.71 16.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.2 m -160.22 164.24 32.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.348 0.594 . . . . 0.0 111.799 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 26' ' ' ASP . 16.9 pt-20 33.38 59.29 1.7 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.403 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 152.02 80.03 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.102 1.868 . . . . 0.0 109.963 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.453 HG21 ' H ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -124.57 111.24 15.42 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.145 0.498 . . . . 0.0 110.714 -179.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.47 95.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -102.28 136.31 42.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -138.3 134.95 34.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 7.0 p90 -162.05 152.83 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.728 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.9 170.85 8.45 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.974 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 65' ' ' LEU . 36.4 mtp -105.62 145.6 31.17 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.426 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.17 161.95 31.91 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.375 2.05 . . . . 0.0 110.751 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.32 155.39 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.12 1.88 . . . . 0.0 110.872 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -37.94 132.16 0.91 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.541 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.37 146.75 69.84 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.677 1.585 . . . . 0.0 112.796 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -144.31 -43.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 100' ' ' ILE . 34.0 pt -91.47 -5.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.463 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' O ' ' O ' ' A' ' 99' ' ' ILE . 48.1 pt 43.64 124.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.281 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -175.26 120.34 0.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.96 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 2.9 p30 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.564 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.461 ' NH2' ' OE2' ' A' ' 85' ' ' GLU . 35.9 ptt180 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 1' ' ' ARG . 4.4 tp10 -15.8 82.36 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.751 0.82 . . . . 0.0 112.78 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.433 ' N ' ' O ' ' A' ' 1' ' ' ARG . 16.5 Cg_endo -104.09 -163.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 124.302 3.334 . . . . 0.0 111.292 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -171.15 157.06 4.8 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.96 178.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' SER . 89.6 Cg_exo -39.14 171.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 123.45 2.766 . . . . 0.0 113.036 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.49 147.68 37.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.785 1.656 . . . . 0.0 114.449 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.5 34.88 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.201 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mm -107.51 122.49 61.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.999 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.66 117.14 28.57 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.606 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.9 147.34 18.56 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -159.83 115.82 1.51 Allowed Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -50.98 94.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.202 1.268 . . . . 0.0 111.984 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -76.55 -48.7 18.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.63 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.551 ' H ' ' HG ' ' A' ' 17' ' ' SER . 69.2 p -144.49 166.77 24.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.037 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -35.99 128.67 0.89 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 39.78 48.37 1.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.167 0.508 . . . . 0.0 111.071 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.551 ' HG ' ' H ' ' A' ' 14' ' ' SER . 11.8 p -142.1 150.89 41.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.484 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.12 120.91 14.41 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -84.81 97.9 9.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.04 89.82 7.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 t -66.88 125.83 27.17 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.542 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.438 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.2 mm -85.82 114.89 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.4 m -98.77 117.24 32.79 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.576 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.74 108.14 0.08 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.359 1.076 . . . . 0.0 110.518 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 26' ' ' ASP . 2.6 pt20 -115.63 101.54 8.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.152 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.494 ' C ' ' O ' ' A' ' 25' ' ' GLN . 4.5 m-20 19.12 82.18 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.9 0.75 . . . . 0.0 111.779 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 29' ' ' GLY . 85.9 m-20 -50.67 131.47 25.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.046 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' ASP . . . -27.05 -35.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.961 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 163.93 0.08 0.05 OUTLIER Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.728 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.12 155.61 29.35 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 117.848 0.824 . . . . 0.0 110.692 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -54.02 138.25 70.13 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 121.094 1.196 . . . . 0.0 111.767 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.567 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.2 mt -81.66 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.384 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.91 -40.07 69.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.847 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -162.19 170.63 18.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.718 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE2' HG21 ' A' ' 22' ' ' ILE . 21.3 m-85 -116.37 122.33 44.54 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.989 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.4 mt -96.93 114.17 33.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 75' ' ' ILE . 74.0 t -115.09 130.41 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.604 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CE2' HD12 ' A' ' 49' ' ' LEU . 23.8 p90 -140.77 152.55 45.31 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.637 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.523 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.2 ptt85 -145.64 172.9 12.59 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.521 ' HG ' ' HE1' ' A' ' 71' ' ' TYR . 11.0 m -79.92 139.86 36.92 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -62.3 -36.27 81.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.249 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -62.97 -37.38 86.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.543 0.211 . . . . 0.0 110.718 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.3 mmtt -101.13 150.95 22.4 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.499 0.666 . . . . 0.0 110.502 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -138.27 19.82 2.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.186 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 20.8 p-10 -128.19 18.33 6.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 0.0 110.519 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -142.04 112.7 7.25 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.501 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -119.29 118.16 30.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.588 0.708 . . . . 0.0 110.917 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.492 HD12 ' CE2' ' A' ' 39' ' ' TYR . 60.3 mt -79.9 159.77 26.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.462 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 51.5 mp0 -117.93 151.91 36.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.97 113.1 2.68 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -97.64 146.4 25.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.469 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.35 158.4 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.223 0.535 . . . . 0.0 110.081 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 56' ' ' ASN . 6.2 tp-100 -71.23 146.54 48.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.451 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.45 3.55 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.924 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 54' ' ' GLN . 18.0 t-20 -133.2 0.77 3.44 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.647 -0.325 . . . . 0.0 111.446 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 10.6 tptp -64.07 -43.22 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.7 p30 48.56 31.62 3.0 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.717 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 178.74 152.49 0.34 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.191 0.307 . . . . 0.0 110.744 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 37' ' ' VAL . 2.7 pt -151.29 129.38 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.4 mm -99.38 103.26 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.3 mt -91.58 104.54 17.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 40.1 tt0 -95.77 151.18 19.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.254 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.479 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 3.9 t-160 89.11 60.84 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.253 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.95 91.84 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.91 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -39.15 143.58 0.17 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.422 0.63 . . . . 0.0 111.419 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -75.29 -9.07 58.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.039 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.8 p -114.34 19.7 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.604 0.24 . . . . 0.0 111.414 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -142.92 136.97 29.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.22 163.08 25.15 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.521 ' HE1' ' HG ' ' A' ' 41' ' ' SER . 98.3 m-85 -144.69 129.49 18.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.581 0.229 . . . . 0.0 111.603 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.9 mt-10 -88.6 153.62 20.98 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.77 135.55 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -125.71 108.59 11.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.217 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -96.54 134.58 33.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.081 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.3 m -136.09 124.26 23.08 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.567 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -98.38 124.94 43.33 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.83 114.06 26.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 112.558 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -122.22 -175.63 3.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.33 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -39.8 -33.01 0.17 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.041 0.448 . . . . 0.0 110.409 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 81' ' ' LEU . 9.6 mp -63.53 -42.55 98.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.414 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 125.81 -49.94 0.89 Allowed Glycine 0 N--CA 1.463 0.461 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 13.1 m-85 -153.73 122.07 6.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 77' ' ' ALA . 82.7 p -88.15 176.89 7.07 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.143 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.461 ' OE2' ' NH2' ' A' ' 1' ' ' ARG . 11.3 mm-40 -49.11 112.96 2.76 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.45 159.43 49.2 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.049 1.166 . . . . 0.0 111.669 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.79 113.75 25.98 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.519 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -97.05 98.33 7.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.469 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 39.4 t80 -103.43 138.2 40.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -135.27 134.55 40.06 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.252 0.548 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.4 p90 -171.33 129.63 0.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.577 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -82.51 165.46 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.531 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.9 mmm -90.66 146.26 33.83 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.0 164.71 29.35 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.364 2.043 . . . . 0.0 111.22 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.45 160.04 41.32 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.35 2.033 . . . . 0.0 111.513 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -40.39 132.8 1.63 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.677 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.86 121.18 7.39 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.73 1.62 . . . . 0.0 112.757 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.33 -22.3 20.59 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.2 pt -142.36 -160.45 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 113.823 -1.535 . . . . 0.0 106.94 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.1 pt -146.98 137.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.501 0.667 . . . . 0.0 111.682 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -177.3 -45.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.598 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.0 t0 . . . . . 0 C--O 1.219 -0.545 0 CA-C-O 117.898 -1.049 . . . . 0.0 110.312 179.807 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 2' ' ' GLU . 79.2 mmt-85 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 1' ' ' ARG . 6.7 tp10 -29.68 97.69 0.09 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.937 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -99.61 -163.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 123.253 2.635 . . . . 0.0 109.547 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.88 167.39 7.86 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.134 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 6' ' ' PRO . 71.0 Cg_exo -47.94 157.71 1.02 Allowed 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.489 2.126 . . . . 0.0 112.571 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' A' ' 5' ' ' PRO . 12.5 Cg_exo -37.42 175.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.311 2.674 . . . . 0.0 115.441 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.43 46.83 0.13 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.646 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -127.94 123.48 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.24 0.543 . . . . 0.0 110.632 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -114.82 116.52 28.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.213 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.06 141.16 15.44 Favored Glycine 0 N--CA 1.464 0.51 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.952 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -139.71 134.46 16.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.02 88.25 1.34 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.655 1.57 . . . . 0.0 112.501 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 4.7 p -68.27 -179.3 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 m -55.82 118.22 4.38 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.516 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.1 -166.76 21.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.5 ' HE3' ' H ' ' A' ' 66' ' ' GLN . 15.8 mtmt -77.13 -5.75 50.26 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 13' ' ' SER . 84.6 p -66.86 150.81 48.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.35 115.31 18.06 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -77.3 109.59 11.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.29 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.1 101.23 10.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -72.02 122.6 21.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.738 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.427 HD12 HG12 ' A' ' 75' ' ' ILE . 2.7 mm -87.34 113.38 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.0 m -86.09 127.2 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.543 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' H ' ' HE2' ' A' ' 24' ' ' LYS . 1.9 mppt? -44.26 105.38 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.808 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' OE1' ' OE1' ' A' ' 85' ' ' GLU . 74.2 mt-30 -80.68 159.38 25.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.47 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' ASP . 5.4 m-20 -78.35 78.61 4.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 26' ' ' ASP . 22.2 t70 -39.23 162.18 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.405 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.32 64.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.2 24.31 0.02 OUTLIER Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.903 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.411 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -153.4 151.49 25.69 Favored Pre-proline 0 C--N 1.333 -0.152 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.96 143.61 55.33 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.687 1.591 . . . . 0.0 111.462 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.592 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.5 mt -89.87 135.55 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.868 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.91 -48.98 10.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.706 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -146.48 162.04 39.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.282 0.563 . . . . 0.0 111.522 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -109.46 120.19 41.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.185 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.33 107.3 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' LYS . 24.2 t -109.05 127.08 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.01 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -125.22 129.22 49.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.133 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.56 ' CE2' HD12 ' A' ' 49' ' ' LEU . 38.9 p90 -133.05 148.56 52.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.965 0.412 . . . . 0.0 110.876 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' NH1' ' CB ' ' A' ' 45' ' ' GLU . 4.8 ptt180 -144.71 167.34 22.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.74 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 43' ' ' ASP . 5.1 m -76.16 143.58 41.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.1 0.41 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.881 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 41' ' ' SER . 71.7 m-20 -122.01 -9.74 8.7 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.361 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -122.76 110.49 15.54 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.744 0.307 . . . . 0.0 110.307 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.46 ' CB ' ' NH1' ' A' ' 40' ' ' ARG . 25.4 pt-20 -115.1 -8.4 12.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.8 -7.72 23.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.535 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -161.08 128.67 4.23 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.476 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -107.61 128.56 54.65 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.56 HD12 ' CE2' ' A' ' 39' ' ' TYR . 70.8 mt -77.16 158.21 30.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 3.4 pm0 -121.59 148.54 44.38 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.205 0.526 . . . . 0.0 111.882 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -150.74 113.53 4.74 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.885 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.48 142.52 27.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.91 158.71 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.281 0.562 . . . . 0.0 110.391 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 56' ' ' ASN . 57.9 tt0 -74.17 130.9 40.67 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.474 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.58 0.17 0.3 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.822 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 54' ' ' GLN . 23.5 m120 -116.18 -26.19 7.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.729 0.264 . . . . 0.0 110.814 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 20.5 mttm -50.35 -68.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER 79.46 35.04 0.17 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.83 149.17 0.44 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.137 -0.352 . . . . 0.0 110.485 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.5 pt -147.58 144.85 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -111.98 115.99 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.1 mt -104.95 108.92 20.69 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.137 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.33 162.15 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.762 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.9 m80 60.6 67.68 0.81 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.852 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.4 mt -107.91 -9.42 15.71 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.828 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.5 ' H ' ' HE3' ' A' ' 16' ' ' LYS . 49.9 tp60 60.13 152.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.969 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -96.81 -7.2 34.23 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.411 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 77.3 p -119.41 19.96 12.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.6 mmm -143.96 127.86 17.38 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.58 157.59 32.98 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -150.96 153.97 36.23 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.8 156.14 19.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.866 0.365 . . . . 0.0 110.278 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.7 130.08 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -122.63 107.28 11.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.306 0.574 . . . . 0.0 110.329 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.427 HG12 HD12 ' A' ' 22' ' ' ILE . 1.7 mp -90.27 134.97 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.796 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -136.27 123.77 22.17 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.592 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -96.17 120.48 36.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.486 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.31 105.06 16.56 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.6 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -108.53 -175.94 2.91 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -41.22 -31.5 0.22 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.278 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.2 mm? -65.54 -41.66 92.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.959 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 126.51 -48.61 0.96 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.485 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.2 m-85 -157.31 131.68 8.46 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -165.49 160.3 17.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.938 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 3.3 mm-40 53.2 50.43 7.59 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.292 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 84.8 Cg_endo -72.61 149.65 49.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.149 1.9 . . . . 0.0 111.147 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.63 109.31 13.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.157 0.503 . . . . 0.0 110.624 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.21 95.97 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 31.2 t80 -102.95 131.5 49.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.496 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -134.18 134.45 42.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.074 0.464 . . . . 0.0 111.129 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 24.1 p90 -168.82 133.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.336 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.5 p -80.25 164.92 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.156 0.503 . . . . 0.0 111.473 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 95.6 mmm -93.23 141.67 24.3 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.474 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.84 162.62 29.44 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.414 2.076 . . . . 0.0 111.205 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.39 152.7 75.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.487 2.125 . . . . 0.0 111.638 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -43.74 132.56 3.94 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.632 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.5 158.99 36.2 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.885 1.723 . . . . 0.0 110.974 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.434 ' CG ' ' N ' ' A' ' 99' ' ' ILE . 18.8 p-10 -148.57 -51.73 0.17 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.751 0.31 . . . . 0.0 110.652 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.583 HG23 ' N ' ' A' ' 100' ' ' ILE . 13.5 tt -114.1 -51.04 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.047 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.583 ' N ' HG23 ' A' ' 99' ' ' ILE . 9.3 tt -56.52 156.15 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.673 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 100' ' ' ILE . 57.7 mttp -53.12 -115.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.557 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.531 -179.539 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -154.38 118.33 2.61 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.709 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -100.2 -163.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 122.954 2.436 . . . . 0.0 109.254 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.545 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -169.57 174.54 1.88 Allowed Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.047 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 6' ' ' PRO . 52.5 Cg_exo -55.1 159.22 10.16 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.115 1.877 . . . . 0.0 112.844 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 5' ' ' PRO . 30.0 Cg_exo -39.33 175.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.309 2.672 . . . . 0.0 114.849 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.8 53.43 0.08 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.082 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -129.51 127.99 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.226 0.536 . . . . 0.0 110.549 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -118.9 116.4 26.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.032 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.72 141.89 15.86 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.472 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -143.6 140.5 17.5 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.45 91.13 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.692 1.595 . . . . 0.0 112.216 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 p -72.16 162.93 28.76 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m -38.44 120.66 0.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.346 0.594 . . . . 0.0 111.516 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.05 -155.48 23.68 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' O ' HD12 ' A' ' 65' ' ' LEU . 32.0 mttp -80.0 -8.8 59.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.107 0.48 . . . . 0.0 110.075 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 p -60.54 136.37 58.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.136 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.57 117.42 28.94 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.87 111.27 18.61 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.457 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -103.42 91.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -66.09 123.78 20.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.171 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.417 HG21 ' CD2' ' A' ' 35' ' ' TYR . 2.4 mm -86.27 112.51 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -81.42 143.43 32.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.949 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -66.43 105.5 1.49 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.349 0.595 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -88.3 174.66 8.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.767 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 96.2 m-20 -62.6 -3.91 1.72 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.205 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 29' ' ' GLY . 2.8 p30 46.27 -172.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -9.81 59.19 Favored Glycine 0 N--CA 1.465 0.625 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.037 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . 128.54 2.78 5.75 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.88 142.36 33.46 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.82 142.65 83.43 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.319 1.346 . . . . 0.0 111.677 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.598 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.4 mt -87.95 134.63 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.368 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 2.6 mm? -91.81 -42.11 10.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.211 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -142.68 152.32 42.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CE1' HG21 ' A' ' 32' ' ' ILE . 9.2 m-85 -109.47 126.15 53.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.613 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.46 110.51 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.534 HG21 ' CD1' ' A' ' 60' ' ' ILE . 69.2 t -107.57 124.86 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -125.16 121.43 34.16 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -126.57 154.65 43.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.22 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.53 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 31.3 ptt85 -146.47 169.45 18.88 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.255 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 p -79.66 141.21 36.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.773 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.91 -32.5 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.673 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.59 -6.65 42.41 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.679 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -139.66 174.4 10.55 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.217 0.532 . . . . 0.0 110.516 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -165.08 27.46 0.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.01 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -107.01 -2.85 20.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.866 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -144.52 145.5 31.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 111.218 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -133.74 117.97 17.56 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.293 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 77.8 mt -79.05 160.39 27.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -118.2 155.01 31.25 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.158 0.504 . . . . 0.0 112.352 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 116.53 2.78 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.7 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -99.56 145.64 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.916 0.389 . . . . 0.0 111.34 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.49 152.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.748 HE21 HD22 ' A' ' 56' ' ' ASN . 31.7 tt0 -79.8 130.4 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.563 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.71 3.75 0.02 OUTLIER Glycine 0 CA--C 1.529 0.958 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.191 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.748 HD22 HE21 ' A' ' 54' ' ' GLN . 14.5 m-20 -112.03 -20.82 11.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 117.174 0.487 . . . . 0.0 110.004 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -63.66 -50.66 68.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.3 39.31 22.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.769 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.23 153.44 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.876 0.369 . . . . 0.0 111.117 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 37' ' ' VAL . 1.5 pt -150.17 145.19 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.128 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.5 mm -117.36 101.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.883 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' H ' HD22 ' A' ' 62' ' ' LEU . 1.8 mm? -83.92 102.94 12.78 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.89 171.0 12.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.967 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.9 m80 51.96 66.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.18 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 16' ' ' LYS . 24.3 mt -102.3 -173.16 2.27 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -131.8 129.67 40.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -70.06 -7.21 39.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.515 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.2 p -122.65 12.93 10.0 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.9 ttm -142.65 124.56 15.18 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.763 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.5 162.43 34.69 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.01 143.55 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -94.14 153.19 18.23 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.81 132.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -122.74 104.11 9.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.765 0.793 . . . . 0.0 110.545 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.486 HG13 HG22 ' A' ' 37' ' ' VAL . 1.6 mp -87.74 130.55 37.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.788 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -134.49 117.63 16.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.598 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.75 127.02 35.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -106.74 106.85 17.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.535 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -110.02 -168.94 1.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -48.06 -29.09 3.24 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.028 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.7 mm? -64.04 -41.79 97.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 123.59 -48.1 0.98 Allowed Glycine 0 N--CA 1.465 0.57 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.46 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.3 m-85 -157.22 132.98 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -169.34 163.86 10.72 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.545 ' OE2' ' N ' ' A' ' 4' ' ' SER . 5.8 tp10 52.43 52.16 10.61 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.506 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 93.1 Cg_endo -74.45 155.3 45.66 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 123.436 2.757 . . . . 0.0 112.083 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 m -136.59 117.95 14.66 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.929 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.4 t -97.25 97.54 6.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.613 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.55 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 33.4 t80 -102.0 135.81 42.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.637 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.63 134.59 37.5 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.55 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 10.4 p90 -169.18 133.35 1.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.18 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 p -79.44 168.64 19.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.428 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 90.5 mmm -95.66 138.51 21.78 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.529 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.39 164.93 32.93 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.62 2.213 . . . . 0.0 111.328 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.18 150.88 87.08 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.292 1.995 . . . . 0.0 111.642 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.82 133.91 1.72 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.154 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.43 158.72 44.12 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.264 1.976 . . . . 0.0 111.807 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 99' ' ' ILE . 2.5 t-20 -79.81 -126.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.41 ' H ' ' CG ' ' A' ' 98' ' ' ASN . 45.2 pt -109.74 -2.78 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.921 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.939 HG23 ' H ' ' A' ' 101' ' ' LYS . 5.3 tp -65.31 -93.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.843 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.939 ' H ' HG23 ' A' ' 100' ' ' ILE . 87.4 tttt -170.71 151.03 3.4 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.322 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.9 t0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.398 179.068 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' GLY . 50.3 mt-10 -132.08 82.54 58.75 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.861 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -105.18 -163.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 124.078 3.185 . . . . 0.0 111.473 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.8 163.13 3.77 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.232 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' PRO . 74.2 Cg_exo -38.46 161.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.861 2.374 . . . . 0.0 112.418 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 16.9 Cg_exo -37.32 165.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.755 2.303 . . . . 0.0 113.769 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.528 ' O ' ' OG ' ' A' ' 7' ' ' SER . 1.8 t -148.4 47.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.617 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.4 HG12 HG21 ' A' ' 87' ' ' THR . 5.9 mm -131.14 131.81 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 111.93 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -108.6 -173.13 2.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.79 118.19 0.65 Allowed Glycine 0 C--N 1.321 -0.256 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.359 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -135.39 144.13 48.24 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.65 85.41 1.61 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.396 1.397 . . . . 0.0 111.184 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.8 t -52.15 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.214 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.8 t -142.58 136.7 29.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.099 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.43 -134.81 33.44 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HE2' ' H ' ' A' ' 66' ' ' GLN . 17.9 mtmm -93.58 -0.86 56.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.642 0.258 . . . . 0.0 110.908 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.3 p -68.86 153.06 44.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.644 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 122.72 22.82 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -83.52 97.94 9.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.166 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mt -95.96 92.22 6.38 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 t -67.02 128.37 36.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.167 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.439 HG21 ' CE2' ' A' ' 35' ' ' TYR . 2.2 mm -88.2 112.14 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -83.18 129.09 34.99 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.079 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.659 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.1 102.87 0.05 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 119.745 -0.782 . . . . 0.0 108.932 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.64 148.56 24.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' GLU . 46.7 t0 -50.43 102.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.64 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 29' ' ' GLY . 5.7 m-20 -57.67 142.22 45.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.48 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 2' ' ' GLU . . . -32.43 -28.41 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 159.78 14.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.871 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . . . -159.5 155.17 22.71 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 118.175 0.987 . . . . 0.0 110.796 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.23 138.6 67.54 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.965 1.777 . . . . 0.0 111.062 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.606 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.0 mt -86.13 135.76 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.14 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 55' ' ' GLY . 77.3 mt -85.79 -43.59 13.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.43 178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -146.21 162.19 38.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.637 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.439 ' CE2' HG21 ' A' ' 22' ' ' ILE . 22.0 m-85 -113.67 122.01 45.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.631 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.57 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 85.4 mt -99.52 112.15 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 75' ' ' ILE . 58.0 t -111.99 126.78 69.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.547 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -124.49 139.45 53.87 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 39' ' ' TYR . 22.1 p90 -145.63 157.74 43.93 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.103 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.09 -176.62 5.43 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.312 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -91.99 138.18 31.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.154 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -66.68 -34.41 77.79 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.67 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 43' ' ' ASP . 67.5 t0 -59.96 -34.64 73.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.787 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' SER . 42.1 mtmt -126.36 -172.01 2.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.508 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -173.78 63.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.682 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -131.06 -7.86 3.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.297 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -140.93 155.12 46.33 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.014 0.435 . . . . 0.0 110.728 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -137.55 108.04 6.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.672 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -70.1 159.79 33.23 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.202 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -117.69 146.45 43.72 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.166 0.507 . . . . 0.0 111.866 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -146.68 112.82 5.82 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.57 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 73.0 mmtt -100.34 142.57 31.64 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.07 160.88 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.211 0.529 . . . . 0.0 110.315 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.5 tp60 -72.75 151.06 42.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.479 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -66.05 12.96 0.38 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 54' ' ' GLN . 65.4 t30 -145.19 2.6 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.007 0.403 . . . . 0.0 111.639 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -63.49 -47.47 81.62 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.593 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER 59.37 31.03 20.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.976 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 179.26 151.41 0.34 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.01 0.433 . . . . 0.0 111.034 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -150.01 147.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.867 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.8 mm -118.52 108.57 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.9 mp -94.41 106.58 18.56 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -85.31 147.55 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.977 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 71.02 77.83 0.18 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.944 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.538 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 91.3 mt -115.0 -3.98 12.59 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.407 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.534 ' O ' ' SD ' ' A' ' 93' ' ' MET . 80.4 mt-30 50.53 122.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.814 0.816 . . . . 0.0 112.792 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -61.28 -26.12 67.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.714 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -103.55 22.66 13.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.7 mmm -146.96 118.57 7.99 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.134 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.85 162.6 45.01 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.538 ' CZ ' HD13 ' A' ' 65' ' ' LEU . 8.8 p90 -155.58 132.03 10.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.853 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.1 152.1 22.65 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.38 134.49 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -124.36 106.85 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.36 0.6 . . . . 0.0 109.722 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -91.68 132.45 36.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.47 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.3 m -134.31 121.39 21.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -94.51 124.15 38.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.26 108.83 21.0 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 5.7 p-10 -115.79 -164.94 0.99 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.24 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -53.17 -30.09 35.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 5.9 mp -62.53 -39.32 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 120.81 -47.91 0.99 Allowed Glycine 0 N--CA 1.463 0.466 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 9.8 m-85 -156.05 122.64 5.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 77' ' ' ALA . 96.7 p -87.43 163.41 16.75 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -44.35 111.78 1.27 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 160.35 48.57 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.304 1.336 . . . . 0.0 112.823 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.4 HG21 HG12 ' A' ' 8' ' ' ILE . 26.3 m -107.24 116.75 32.48 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.641 0.734 . . . . 0.0 109.674 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.01 96.18 5.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.424 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.579 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 43.4 t80 -100.39 121.73 41.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.48 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -122.42 129.94 52.58 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.237 0.541 . . . . 0.0 111.309 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 9.7 p90 -164.79 128.29 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.405 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 p -80.4 167.43 20.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.527 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.534 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 30.0 mtp -93.6 147.86 34.39 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.54 162.16 33.46 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.477 2.118 . . . . 0.0 110.384 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.47 154.29 72.51 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.207 1.938 . . . . 0.0 111.587 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -36.06 132.18 0.59 Allowed Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.31 141.39 51.58 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.599 1.532 . . . . 0.0 112.478 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.78 -36.07 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' ILE . 30.6 pt -130.05 17.88 2.27 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.493 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 99' ' ' ILE . 0.2 OUTLIER 10.82 114.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 124.543 1.152 . . . . 0.0 112.887 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -129.5 -53.58 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.894 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.3 t0 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.152 179.363 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -120.25 89.3 43.17 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.51 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -99.77 -164.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 123.022 2.481 . . . . 0.0 110.608 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.19 160.26 7.73 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.63 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' PRO . 2.1 Cg_endo -44.77 170.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.818 2.345 . . . . 0.0 112.215 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' PRO . 4.1 Cg_exo -37.96 177.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.777 2.985 . . . . 0.0 116.173 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.28 37.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.953 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.0 mm -125.02 136.56 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.537 0.684 . . . . 0.0 110.64 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -116.83 -172.87 2.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.837 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.28 143.0 8.03 Favored Glycine 0 N--CA 1.462 0.392 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.322 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -150.79 115.56 3.24 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -46.83 104.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.493 1.462 . . . . 0.0 112.689 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 14' ' ' SER . 28.7 p -80.7 172.21 14.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' SER . 58.8 m -40.56 107.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 110.798 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.89 -158.32 23.98 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HE3' ' H ' ' A' ' 66' ' ' GLN . 18.8 mtmt -75.71 -11.6 60.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.871 0.367 . . . . 0.0 110.766 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 t -62.5 140.43 58.61 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.303 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.0 137.41 51.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.409 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -97.94 98.53 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mt -97.74 103.17 15.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 t -69.78 126.08 28.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.908 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.07 108.74 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 m -79.84 136.1 36.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.904 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.13 104.64 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.675 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 27' ' ' ASP . 28.3 mt-30 -89.51 137.63 32.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.552 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 27' ' ' ASP . 1.3 m-20 -54.64 93.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' ND2' ' A' ' 79' ' ' ASN . 24.7 t70 -44.54 171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.054 0.454 . . . . 0.0 110.881 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.56 -31.95 76.51 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.5 12.62 0.03 OUTLIER Glycine 0 CA--C 1.533 1.192 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.821 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' O ' ' OD2' ' A' ' 27' ' ' ASP . . . -147.71 151.91 40.02 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 117.619 0.71 . . . . 0.0 109.865 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.0 143.99 68.18 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.82 1.68 . . . . 0.0 111.783 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.586 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.0 mt -93.8 133.06 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.262 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.747 HD22 ' N ' ' A' ' 33' ' ' LEU . 2.3 mm? -95.43 -14.02 24.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.376 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.93 155.96 8.79 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.359 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -113.32 112.88 24.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.789 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.422 HG12 ' HZ2' ' A' ' 52' ' ' LYS . 98.5 mt -89.98 106.99 17.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG22 HG13 ' A' ' 75' ' ' ILE . 21.6 t -109.35 129.78 63.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.415 -177.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -123.84 142.86 50.73 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -143.92 158.46 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.891 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 41' ' ' SER . 1.1 ptm180 -151.3 -173.0 4.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.554 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.472 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 4.9 p -96.18 140.0 31.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -65.25 -17.9 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.639 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.61 -27.12 16.77 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -117.97 120.36 37.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.296 0.569 . . . . 0.0 110.811 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' NH1' ' A' ' 40' ' ' ARG . 83.9 tt0 -125.2 63.73 1.16 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.38 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.53 -14.71 8.17 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.953 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -159.64 161.87 35.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.403 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -128.35 136.39 50.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.654 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 68.7 mt -80.58 159.83 25.31 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -118.68 146.29 44.82 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.134 0.492 . . . . 0.0 111.447 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.9 110.27 5.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' HZ2' HG12 ' A' ' 36' ' ' ILE . 72.7 mmtt -95.65 126.63 41.05 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.585 HG21 ' CG2' ' A' ' 60' ' ' ILE . 43.5 t -132.62 154.89 40.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.995 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 71.3 tp60 -68.8 147.36 51.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.62 0.81 55.01 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.412 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 15.2 m120 -113.67 -14.13 12.64 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.044 0.422 . . . . 0.0 111.339 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -62.28 -45.14 94.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.723 0.297 . . . . 0.0 110.833 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 58.2 37.1 26.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.886 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.73 141.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.585 ' CG2' HG21 ' A' ' 53' ' ' VAL . 6.5 pt -144.01 136.99 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.239 0.542 . . . . 0.0 111.988 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' C ' HD12 ' A' ' 62' ' ' LEU . 34.7 mm -108.22 117.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.226 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 62' ' ' LEU . 10.8 mp -107.01 143.5 35.01 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.589 ' O ' ' CG ' ' A' ' 64' ' ' HIS . 46.4 mt-10 -107.52 169.65 8.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 111.772 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 37.3 p-80 49.06 68.49 0.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.327 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.5 mm? -95.4 -12.3 26.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.296 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.522 ' O ' ' SD ' ' A' ' 93' ' ' MET . 13.0 mm-40 50.76 122.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.864 0.84 . . . . 0.0 112.058 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -61.52 -32.82 72.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.544 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.3 p -97.26 22.29 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.686 0.279 . . . . 0.0 111.63 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.9 ttm -152.17 127.08 9.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.886 0.374 . . . . 0.0 110.83 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.86 34.22 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -136.29 132.71 36.09 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -93.1 152.97 18.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.36 134.9 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 110.825 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -125.98 109.73 12.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.118 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.51 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -93.73 135.24 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m -134.83 121.66 20.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -91.18 123.5 34.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.06 107.8 19.03 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.28 0.562 . . . . 0.0 112.079 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 1.1 p-10 -110.29 -172.07 1.96 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -49.75 -27.71 5.24 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.789 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.8 mm? -65.64 -41.6 92.44 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.54 -50.3 0.89 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -155.81 134.45 11.79 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.7 t -162.83 157.24 21.13 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.867 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 44.48 61.99 10.55 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.088 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.48 155.51 45.48 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.599 2.199 . . . . 0.0 110.724 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.23 108.85 13.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.3 t -95.0 98.05 7.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -103.78 140.26 37.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.742 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -136.49 134.85 38.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.39 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 91' ' ' PHE . 35.3 p90 -165.95 125.36 1.65 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.509 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.2 p -82.44 171.13 14.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.575 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 66' ' ' GLN . 14.8 mtp -99.4 152.59 37.85 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.89 163.53 25.91 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.638 2.225 . . . . 0.0 109.275 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.03 153.45 78.05 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 121.782 1.655 . . . . 0.0 111.533 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -41.47 133.88 2.08 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.757 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.58 148.7 54.13 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.986 1.791 . . . . 0.0 111.931 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -94.48 -83.52 0.34 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.4 pt -108.47 -16.54 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.147 0.499 . . . . 0.0 109.816 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.86 133.83 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.04 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -60.35 -95.36 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.224 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--N 1.325 -0.486 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.276 179.704 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 7.2 tpt180 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 1' ' ' ARG . 2.0 tm-20 81.91 81.28 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 120.708 0.29 . . . . 0.0 110.677 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -99.71 -164.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.733 2.955 . . . . 0.0 109.844 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.421 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -166.5 179.88 0.95 Allowed Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.765 179.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 6' ' ' PRO . 8.1 Cg_exo -67.01 176.33 4.64 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.239 1.959 . . . . 0.0 112.01 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 43.9 Cg_exo -42.53 176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 123.074 2.516 . . . . 0.0 114.109 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -173.41 54.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.743 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 mm -131.25 130.76 63.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -121.3 115.37 22.84 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.49 145.37 17.66 Favored Glycine 0 N--CA 1.463 0.438 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -146.96 111.49 4.12 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.38 98.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.382 1.388 . . . . 0.0 112.702 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -76.82 171.57 14.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -58.2 134.89 56.91 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.799 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.09 -154.54 26.57 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -99.14 46.46 0.98 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 61' ' ' ILE . 5.3 t -120.32 149.71 41.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.728 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.94 119.82 27.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.098 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -80.69 98.73 7.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.595 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.41 100.16 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -73.85 126.2 29.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.947 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.471 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -88.78 112.39 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.4 m -86.13 143.35 28.08 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.289 0.566 . . . . 0.0 110.203 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.86 112.69 10.22 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -112.13 170.28 8.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -50.8 112.34 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.581 ' C ' ' H ' ' A' ' 29' ' ' GLY . 69.1 m-20 -71.83 163.83 27.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.886 -178.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.07 14.05 0.05 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.075 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 101.78 8.81 44.75 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.96 149.42 25.11 Favored Pre-proline 0 C--N 1.333 -0.13 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.47 140.06 61.7 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.803 1.669 . . . . 0.0 111.453 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.585 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.2 mt -86.28 129.11 38.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.073 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -81.3 -39.69 24.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.37 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -148.78 170.13 18.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.705 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.545 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.1 m-85 -123.23 122.15 37.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.457 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.4 mt -96.47 111.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.593 HG22 HG13 ' A' ' 75' ' ' ILE . 55.6 t -112.1 128.09 68.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -121.54 134.58 55.04 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.603 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.86 154.84 46.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.59 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 41' ' ' SER . 2.8 ptm180 -144.41 -172.74 3.86 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.336 0.589 . . . . 0.0 110.972 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.521 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 5.9 p -101.58 135.15 43.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.42 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.12 -11.79 33.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.253 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -90.32 -35.06 15.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.588 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -118.58 129.55 55.39 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.072 0.463 . . . . 0.0 110.351 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.3 2.98 11.37 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.969 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 38.0 p-10 -72.11 -3.57 23.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.389 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -152.77 155.86 37.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.165 0.507 . . . . 0.0 111.922 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -136.85 106.89 6.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.299 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.89 158.73 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.773 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.37 148.24 45.31 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.19 0.519 . . . . 0.0 111.306 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.7 OUTLIER -143.6 113.95 7.43 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.497 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -88.51 136.07 33.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 54' ' ' GLN . 45.6 t -132.47 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 121.352 0.596 . . . . 0.0 111.951 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -83.0 144.78 29.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.573 179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.01 -24.94 69.01 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -86.39 -22.12 26.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.621 -0.289 . . . . 0.0 111.515 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 25.7 mttm -60.53 -46.15 91.21 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.903 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 2.8 p30 46.52 37.25 4.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.048 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.55 0.72 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.827 0.346 . . . . 0.0 110.265 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -155.32 151.16 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.205 0.526 . . . . 0.0 110.564 178.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.42 HG22 ' OG ' ' A' ' 17' ' ' SER . 45.2 mm -120.06 112.67 37.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.091 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.82 105.17 16.9 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.83 152.7 21.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 111.846 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 76.86 58.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.715 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 66' ' ' GLN . 80.6 mt -103.17 -4.84 23.87 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 65' ' ' LEU . 47.5 mt-30 55.24 159.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.066 0.46 . . . . 0.0 110.477 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -99.11 -16.01 18.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.194 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.3 p -108.86 19.1 20.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.62 0.248 . . . . 0.0 111.504 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 28.3 mtp -141.47 141.98 33.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.134 0.493 . . . . 0.0 110.541 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.82 153.4 19.17 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -138.83 138.02 37.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 110.906 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.95 164.54 12.86 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.63 146.1 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.142 0.496 . . . . 0.0 110.393 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -137.89 106.36 5.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.465 0.65 . . . . 0.0 109.672 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.593 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -93.82 134.96 29.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.6 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -137.25 120.69 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -91.77 125.26 36.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.52 110.82 22.88 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 9.6 p-10 -112.12 -163.33 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.298 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -54.24 -32.19 55.37 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 81' ' ' LEU . 9.3 mp -64.55 -42.32 95.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.712 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 127.86 -46.61 1.07 Allowed Glycine 0 N--CA 1.462 0.418 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.478 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.3 m-85 -154.93 132.51 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -161.56 147.19 13.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.695 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 60.14 58.14 4.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.19 178.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.99 151.1 30.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.372 2.048 . . . . 0.0 111.223 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.5 m -131.16 118.62 20.73 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.457 0.646 . . . . 0.0 111.142 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 m -97.97 92.71 2.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.221 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -95.01 151.72 18.93 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -153.29 135.37 14.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.324 0.583 . . . . 0.0 111.571 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -164.92 156.9 15.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.903 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.51 163.98 12.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.633 0.254 . . . . 0.0 110.358 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.4 mmm -89.69 143.96 31.12 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.395 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.63 164.85 31.48 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.755 2.303 . . . . 0.0 110.981 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -65.99 154.91 72.06 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.987 1.792 . . . . 0.0 111.696 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -35.37 132.59 0.5 Allowed Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.191 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.37 155.17 55.9 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.867 1.711 . . . . 0.0 112.373 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -149.33 -48.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.257 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 99' ' ' ILE . 12.1 tt -179.2 101.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.759 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.474 ' CG1' ' N ' ' A' ' 101' ' ' LYS . 6.3 tt -172.22 163.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.367 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' N ' ' CG1' ' A' ' 100' ' ' ILE . 85.6 tttt -71.27 136.2 47.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.809 -179.489 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -113.65 136.97 22.03 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.071 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -101.71 -163.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 122.589 2.193 . . . . 0.0 109.88 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.481 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -163.96 154.82 13.62 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.885 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -34.29 148.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.913 2.409 . . . . 0.0 112.596 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -39.4 164.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.408 2.072 . . . . 0.0 114.597 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -154.75 51.16 0.62 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.824 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -128.43 127.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.518 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -122.29 119.1 30.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.137 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.29 158.38 20.52 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -162.78 132.9 3.34 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 36.3 Cg_endo -67.85 98.47 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.357 1.371 . . . . 0.0 111.818 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 14' ' ' SER . 87.6 p -80.77 -116.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.659 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 13' ' ' SER . 91.5 p -80.99 112.66 18.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.043 0.449 . . . . 0.0 110.971 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.03 -133.63 43.22 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -78.41 -11.28 59.94 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 m -60.8 135.18 57.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.317 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.08 140.42 48.49 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.538 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -99.38 94.85 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.682 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.7 90.7 7.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.2 t -66.65 124.46 22.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.217 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.459 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -87.47 113.38 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.2 m -97.01 114.03 25.61 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.412 0.625 . . . . 0.0 110.091 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -39.09 107.54 0.07 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.593 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.4 OUTLIER -97.79 151.17 20.47 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 85.8 m-20 -43.34 97.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.732 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' GLY . 19.3 m-20 -63.01 152.76 35.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.433 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -38.95 -21.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.773 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' ASP . . . 135.42 -3.24 3.94 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.69 146.68 62.22 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.59 138.48 59.44 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.335 1.357 . . . . 0.0 111.133 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.606 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.5 mt -80.46 126.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.514 0.673 . . . . 0.0 112.39 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -68.47 -41.06 80.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -161.18 168.05 24.94 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.794 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.459 ' CD2' HG21 ' A' ' 22' ' ' ILE . 9.7 m-85 -114.3 119.4 36.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.219 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.47 HG23 ' NZ ' ' A' ' 52' ' ' LYS . 80.9 mt -96.45 110.83 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.536 HG22 HG13 ' A' ' 75' ' ' ILE . 47.3 t -110.86 125.68 68.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.136 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -120.61 128.91 53.48 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -135.63 151.36 50.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 110.871 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.587 ' NE ' ' O ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -145.49 -177.87 5.79 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.705 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.587 ' O ' ' NE ' ' A' ' 40' ' ' ARG . 25.4 m -90.72 146.43 24.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.874 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.36 -18.36 52.59 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -62.7 -49.66 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.535 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HB2' HH22 ' A' ' 40' ' ' ARG . 73.8 mmtt -110.53 -164.36 0.92 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.015 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -174.58 75.87 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.3 p30 -154.79 -8.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.075 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.0 129.23 21.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.881 0.372 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -116.18 131.14 57.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.144 0.497 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.73 160.32 18.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.45 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 54.5 mp0 -114.6 147.82 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.101 0.477 . . . . 0.0 111.44 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.16 113.99 5.39 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' NZ ' HG23 ' A' ' 36' ' ' ILE . 72.0 mmtt -99.32 146.59 26.09 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.911 0.386 . . . . 0.0 111.99 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.46 160.45 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.228 0.537 . . . . 0.0 110.482 178.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.44 ' C ' ' H ' ' A' ' 56' ' ' ASN . 47.9 tp60 -83.07 148.46 27.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.857 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.13 5.72 3.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 54' ' ' GLN . 64.0 t30 -122.69 -14.45 7.72 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.027 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 21.3 mttp -67.47 -49.79 61.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.182 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER 59.03 35.45 23.98 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.974 179.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -176.35 155.49 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.763 -0.585 . . . . 0.0 111.386 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -151.18 146.09 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.59 102.7 13.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.882 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.9 mp -87.67 105.62 17.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 79.4 mt-10 -86.77 139.16 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.346 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 2.0 t-160 83.92 79.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.375 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' GLN . 63.8 mt -131.86 77.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LEU . 42.4 tt0 -34.9 143.71 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.344 0.592 . . . . 0.0 111.151 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -70.08 -22.46 63.05 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.496 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 p -100.76 22.95 11.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.638 0.256 . . . . 0.0 111.483 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.1 ttm -141.77 132.98 26.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.34 0.59 . . . . 0.0 110.981 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.26 153.4 20.5 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -148.61 133.36 17.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.571 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.94 151.75 23.02 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.753 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.07 133.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -125.98 108.9 11.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.325 0.583 . . . . 0.0 109.872 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.536 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -91.35 135.86 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.285 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 m -134.82 117.73 16.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -90.85 126.06 35.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.233 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.33 107.88 18.89 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.7 p-10 -109.64 -174.09 2.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.897 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -45.64 -26.28 0.59 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.608 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.647 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -71.84 -40.27 69.17 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.935 0.397 . . . . 0.0 110.125 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.465 ' C ' ' CD1' ' A' ' 83' ' ' TYR . . . 128.61 -49.22 0.93 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 82' ' ' GLY . 4.8 m-85 -153.66 131.74 11.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.7 t -167.78 162.97 14.09 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.836 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' OE2' ' N ' ' A' ' 4' ' ' SER . 8.3 tp10 50.27 53.89 14.8 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.188 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 92.3 Cg_endo -74.84 156.09 43.69 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.977 2.452 . . . . 0.0 110.943 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.417 HG23 HE22 ' A' ' 25' ' ' GLN . 0.1 OUTLIER -130.01 110.42 11.64 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.03 0.443 . . . . 0.0 110.785 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 t -94.01 95.76 5.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.549 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 35.7 t80 -102.92 133.59 47.77 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.593 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.22 136.95 42.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.17 0.509 . . . . 0.0 111.066 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 16.5 p90 -171.72 132.92 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.199 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.19 167.09 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 96.8 mmm -96.04 144.22 27.45 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.75 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -77.14 165.27 28.28 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.776 2.317 . . . . 0.0 110.903 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.98 162.89 33.28 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.992 1.795 . . . . 0.0 111.433 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -40.74 133.21 1.74 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.46 170.05 20.7 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.985 1.79 . . . . 0.0 111.085 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.441 ' CG ' ' H ' ' A' ' 99' ' ' ILE . 57.9 t30 -97.66 -121.28 0.13 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.441 ' H ' ' CG ' ' A' ' 98' ' ' ASN . 1.5 pp -102.31 3.83 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.229 0.538 . . . . 0.0 109.973 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 102' ' ' ASP . 17.2 tt -51.33 140.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.115 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.14 19.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.22 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 100' ' ' ILE . 37.6 t0 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.299 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 28' ' ' GLY . 9.5 tpt180 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -144.67 104.61 4.57 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.397 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -98.11 -163.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.321 -0.872 0 C-N-CA 122.746 2.298 . . . . 0.0 109.558 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.8 165.8 4.1 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.961 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 6' ' ' PRO . 88.8 Cg_exo -39.29 157.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.965 2.443 . . . . 0.0 112.719 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 5' ' ' PRO . 15.7 Cg_exo -37.41 163.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.872 2.381 . . . . 0.0 113.707 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 m -151.38 52.2 0.84 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.444 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -130.18 128.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.128 0.49 . . . . 0.0 110.579 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -122.46 117.11 25.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.1 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.02 161.53 21.75 Favored Glycine 0 N--CA 1.464 0.543 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.968 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -161.95 128.78 2.52 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.92 88.26 0.94 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.3 t -66.87 -154.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -71.29 133.07 45.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.172 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.43 -160.11 49.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.864 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -79.82 -4.98 54.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.642 -0.279 . . . . 0.0 111.227 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 85.8 p -68.72 147.39 51.9 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.121 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.0 124.69 43.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -84.29 100.12 11.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.399 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mt -96.65 97.97 9.8 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -71.56 126.28 29.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.037 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.44 HG21 ' CD2' ' A' ' 35' ' ' TYR . 1.6 mm -88.93 113.79 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.6 m -85.5 139.07 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.063 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -72.29 104.92 3.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.655 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.74 168.21 9.42 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.3 t70 -56.85 110.01 0.73 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.31 165.37 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.125 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 1' ' ' ARG . . . -55.37 -23.09 33.0 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.42 16.69 0.08 OUTLIER Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.247 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.91 152.48 20.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 117.169 0.485 . . . . 0.0 109.789 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.51 145.04 86.86 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.86 1.707 . . . . 0.0 111.112 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.613 HG21 ' CE1' ' A' ' 35' ' ' TYR . 4.4 mt -91.59 129.24 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.467 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.21 -44.56 14.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.24 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.6 161.64 39.34 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 32' ' ' ILE . 10.4 m-85 -113.88 122.19 46.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.98 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.4 mt -94.25 108.44 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG22 HG13 ' A' ' 75' ' ' ILE . 58.1 t -113.77 130.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.113 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm -127.95 147.23 50.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.473 ' CE2' HD12 ' A' ' 49' ' ' LEU . 42.8 p90 -148.55 155.69 41.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.074 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.793 HH21 ' H ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -152.49 -172.83 4.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.032 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -92.74 146.48 23.61 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.792 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -77.61 15.7 0.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -132.45 -45.92 0.9 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.739 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.561 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.79 37.26 0.52 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.684 0.278 . . . . 0.0 110.821 -179.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 6.7 tm-20 -49.68 84.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.048 0.451 . . . . 0.0 110.753 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 44' ' ' LYS . 73.0 m-20 -153.93 -16.97 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.966 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.793 ' H ' HH21 ' A' ' 40' ' ' ARG . 19.7 pt20 -156.74 155.68 32.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.063 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -124.39 136.01 53.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.084 0.469 . . . . 0.0 111.898 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.473 HD12 ' CE2' ' A' ' 39' ' ' TYR . 97.7 mt -84.9 158.71 20.5 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -118.35 146.51 44.32 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.097 0.475 . . . . 0.0 111.319 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 37' ' ' VAL . 0.5 OUTLIER -147.45 117.78 7.38 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -100.94 143.53 30.97 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.95 161.38 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.357 0.598 . . . . 0.0 110.646 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -79.14 147.71 32.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.606 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.62 0.29 5.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -118.62 -6.73 10.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.556 0.217 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -63.6 -47.83 79.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.31 0.576 . . . . 0.0 109.638 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 53.02 30.17 9.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.686 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 178.69 153.39 0.36 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.968 0.414 . . . . 0.0 110.737 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -151.96 145.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.542 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.56 107.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 mt -92.7 133.06 36.38 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 83.4 tt0 -119.77 152.94 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.008 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 36.3 t-80 88.88 49.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.712 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.22 86.96 2.46 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -41.65 137.88 1.52 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.452 0.644 . . . . 0.0 111.122 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -65.0 -31.09 72.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.755 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -98.32 21.42 11.03 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.384 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 8.8 ttm -145.17 128.64 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.954 0.407 . . . . 0.0 110.145 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.76 161.9 46.48 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.61 129.61 23.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 110.811 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -90.55 154.39 19.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.875 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -135.1 136.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 67.2 tt0 -127.25 107.86 10.37 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.549 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -95.78 131.39 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.283 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.4 m -135.54 120.21 18.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -89.63 127.4 35.9 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.21 111.01 23.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.248 0.547 . . . . 0.0 112.248 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 3.5 p30 -112.08 -166.44 1.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.237 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -53.0 -30.91 38.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.027 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 81' ' ' LEU . 3.3 mm? -66.37 -41.31 89.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.165 0.507 . . . . 0.0 109.736 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 129.93 -49.07 0.94 Allowed Glycine 0 N--CA 1.465 0.604 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.5 m-85 -154.88 137.77 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.6 t -165.38 155.48 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.701 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 26' ' ' ASP . 18.5 tt0 50.06 56.94 17.91 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.232 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.81 154.37 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.68 2.253 . . . . 0.0 111.367 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -132.34 119.01 20.16 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.492 0.663 . . . . 0.0 111.089 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.94 94.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.54 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 40.2 t80 -98.22 131.1 44.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.124 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -133.1 131.5 40.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.54 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 20.9 p90 -161.73 134.73 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.63 160.23 25.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.366 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 91.1 mmm -94.49 140.93 22.86 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.804 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.71 162.81 40.22 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.035 1.823 . . . . 0.0 110.861 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.33 151.99 83.46 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.499 2.133 . . . . 0.0 111.816 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -38.28 133.18 0.96 Allowed Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.97 153.74 76.92 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.477 1.452 . . . . 0.0 111.681 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -84.96 -102.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.5 pt -98.49 -3.93 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.959 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.33 131.58 68.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.942 0.401 . . . . 0.0 110.544 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -80.49 -163.21 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.607 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.691 179.725 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 2' ' ' GLU . 33.1 ptt-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 1' ' ' ARG . 34.5 mt-10 -25.05 88.59 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.003 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.441 ' N ' ' O ' ' A' ' 1' ' ' ARG . 15.5 Cg_endo -106.33 -163.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 124.116 3.211 . . . . 0.0 111.289 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.1 p -166.94 149.74 5.95 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.13 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' SER . 80.7 Cg_exo -37.61 164.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.974 2.449 . . . . 0.0 112.545 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 5' ' ' PRO . 58.2 Cg_exo -38.75 163.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.331 2.021 . . . . 0.0 114.276 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.33 33.54 0.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.695 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.58 120.49 60.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.553 0.692 . . . . 0.0 110.788 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -116.26 116.86 28.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.039 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.24 150.44 19.68 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 13' ' ' SER . 21.6 mt-30 -153.62 113.46 2.59 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.41 85.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.171 1.248 . . . . 0.0 111.636 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 11' ' ' GLN . 10.8 t -53.92 -88.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.647 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -137.25 140.33 41.59 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.808 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.01 -127.9 39.11 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.499 ' CE ' ' O ' ' A' ' 65' ' ' LEU . 10.4 mtmm -99.39 -2.84 35.19 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.3 p -67.01 149.21 50.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.635 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.11 135.38 48.81 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.824 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -96.39 95.18 7.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mt -90.86 92.28 8.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -68.9 122.59 18.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.221 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.438 HG21 ' CE2' ' A' ' 35' ' ' TYR . 2.2 mm -85.95 112.6 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -91.68 117.76 30.04 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.188 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.19 105.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.391 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.41 HE22 HG23 ' A' ' 87' ' ' THR . 72.9 mt-30 -88.96 157.61 18.33 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -48.62 106.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -58.1 142.69 46.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.649 0.737 . . . . 0.0 111.965 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.99 -20.71 6.7 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.6 -1.65 0.73 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.16 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.75 25.78 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.87 133.33 38.41 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.86 1.707 . . . . 0.0 111.992 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.563 HG21 ' CE1' ' A' ' 35' ' ' TYR . 4.5 mt -78.59 130.27 36.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.172 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 33' ' ' LEU . 11.3 mp -80.99 -44.67 17.79 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -142.18 163.72 32.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.515 0.674 . . . . 0.0 111.434 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.563 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.2 m-85 -116.71 113.88 23.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.166 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.578 HG23 ' HZ3' ' A' ' 52' ' ' LYS . 95.0 mt -87.83 109.94 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.538 HG22 HG13 ' A' ' 75' ' ' ILE . 44.9 t -114.08 130.55 68.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.509 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -125.84 133.32 52.01 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.457 ' CE2' HD12 ' A' ' 49' ' ' LEU . 54.4 p90 -138.47 150.73 46.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.839 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 36.3 ptt85 -143.65 174.78 10.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.027 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 44' ' ' LYS . 16.5 m -84.99 142.57 29.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -63.31 -35.53 80.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.471 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.33 -10.52 59.53 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.564 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 41' ' ' SER . 28.4 mmtt -125.99 154.6 42.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.633 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.2 19.83 1.09 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.708 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.93 1.06 52.64 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -159.89 158.07 30.2 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.94 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -136.44 106.13 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.773 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 39' ' ' TYR . 50.8 mt -67.59 145.77 54.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.81 151.86 25.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.22 0.533 . . . . 0.0 111.138 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' VAL . 11.2 tppt? -150.58 113.24 4.72 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.427 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.578 ' HZ3' HG23 ' A' ' 36' ' ' ILE . 72.2 mmtt -97.81 139.85 33.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.362 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.77 160.42 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.371 0.605 . . . . 0.0 110.997 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 65.2 tp60 -78.67 142.55 37.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.362 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.68 -3.74 16.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.417 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 10.7 m120 -110.26 -21.36 12.27 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 122.723 -0.28 . . . . 0.0 110.622 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -61.55 -52.48 64.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.021 0.438 . . . . 0.0 110.687 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 56.57 41.67 28.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.809 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.81 150.44 0.8 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.525 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -149.05 140.7 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.2 mm -111.45 103.96 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.407 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 62' ' ' LEU . 10.3 mp -92.57 107.57 19.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 171.11 10.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.035 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 m80 66.57 48.12 1.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.364 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.499 ' O ' ' CE ' ' A' ' 16' ' ' LYS . 23.8 mt -100.16 164.71 11.85 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG2' ' H ' ' A' ' 68' ' ' THR . 50.6 tt0 -119.97 143.07 48.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.201 0.524 . . . . 0.0 110.625 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -68.87 -33.85 74.47 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.432 ' H ' ' HG2' ' A' ' 66' ' ' GLN . 43.1 p -102.44 17.93 22.37 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.6 mtp -143.41 134.12 25.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.41 166.44 31.88 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.147 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -142.82 131.73 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.119 -0.54 . . . . 0.0 110.351 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.526 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.1 mt-10 -88.32 151.47 22.6 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.58 131.82 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.574 ' OE1' HG22 ' A' ' 88' ' ' VAL . 10.0 tp60 -124.34 108.08 11.83 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.611 0.72 . . . . 0.0 110.371 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 1.6 mp -90.58 134.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.098 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.46 120.36 19.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -92.25 127.03 37.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -104.58 107.24 18.07 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.019 0.438 . . . . 0.0 111.812 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.721 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.61 -170.58 1.8 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -44.09 -32.32 1.17 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.789 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -64.12 -41.52 97.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.64 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 123.52 -49.04 0.92 Allowed Glycine 0 N--CA 1.464 0.531 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.473 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 7.0 m-85 -156.45 125.71 6.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.7 t -160.64 169.68 22.37 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.651 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 60.3 mm-40 52.0 49.3 6.65 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.869 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 74.3 Cg_endo -71.35 152.37 60.85 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.068 1.845 . . . . 0.0 111.146 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.41 HG23 HE22 ' A' ' 25' ' ' GLN . 0.1 OUTLIER -133.31 113.51 12.69 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.187 0.518 . . . . 0.0 110.378 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.574 HG22 ' OE1' ' A' ' 74' ' ' GLN . 61.6 t -95.87 93.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -101.53 145.32 29.17 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.224 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -141.66 138.34 32.43 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 91' ' ' PHE . 16.7 p90 -164.39 127.61 2.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.0 p -83.76 143.06 30.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 94.6 mmm -74.29 140.32 76.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.144 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.05 164.76 34.63 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.303 2.002 . . . . 0.0 111.52 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.92 152.7 80.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.431 2.087 . . . . 0.0 111.748 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -39.89 129.89 1.54 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.8 149.09 42.23 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 121.498 1.465 . . . . 0.0 112.254 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.53 -36.38 2.46 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.1 pt -107.46 3.43 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.485 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.8 pt 42.87 44.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.84 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -69.35 -72.95 0.17 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.448 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.812 -1.089 . . . . 0.0 110.378 -179.364 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' H ' ' HA2' ' A' ' 28' ' ' GLY . 58.3 mm-40 -124.38 82.21 58.34 Favored Pre-proline 0 N--CA 1.465 0.283 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.494 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.429 ' HB3' ' H ' ' A' ' 85' ' ' GLU . 68.3 Cg_endo -99.74 -164.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 123.446 2.764 . . . . 0.0 110.832 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.436 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.6 OUTLIER -167.76 179.78 0.88 Allowed Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.469 179.284 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 14.3 Cg_exo -65.08 173.0 6.5 Favored 'Trans proline' 0 N--CA 1.503 2.066 0 C-N-CA 122.879 2.386 . . . . 0.0 112.204 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -35.89 166.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 123.6 2.867 . . . . 0.0 115.384 -179.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.51 43.15 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.518 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.4 mm -125.02 132.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.323 0.582 . . . . 0.0 111.318 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -128.89 117.39 20.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.595 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.1 145.72 17.8 Favored Glycine 0 N--CA 1.464 0.562 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.031 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -148.03 118.18 4.29 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -48.96 109.15 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.097 1.198 . . . . 0.0 112.111 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 t -84.4 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.6 m -82.0 134.56 35.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.191 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.46 -135.05 41.76 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.916 -0.474 . . . . 0.0 111.916 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.763 ' HZ2' ' HE1' ' A' ' 67' ' ' TRP . 33.7 mttm -77.78 -8.64 58.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.838 0.351 . . . . 0.0 110.994 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.509 ' OG ' HG22 ' A' ' 61' ' ' ILE . 4.6 t -64.74 141.57 58.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.027 0.442 . . . . 0.0 111.946 -177.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.3 124.3 44.25 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.898 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -87.57 104.49 16.55 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.251 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 mt -97.26 91.62 5.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.0 t -65.4 120.48 12.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.039 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.13 123.29 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.0 m -93.91 113.65 25.7 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.423 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -42.17 104.71 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.322 0.582 . . . . 0.0 110.841 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.509 HE22 HG23 ' A' ' 87' ' ' THR . 76.2 mt-30 -85.82 171.34 11.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.093 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -61.46 108.66 0.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.18 142.4 56.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.444 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' HA2' ' H ' ' A' ' 2' ' ' GLU . . . -40.88 -74.36 0.16 Allowed Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.36 13.09 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.87 158.61 29.27 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -57.03 141.81 94.08 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.15 1.234 . . . . 0.0 111.069 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.659 HG21 ' CE1' ' A' ' 35' ' ' TYR . 3.6 mt -83.95 122.13 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.104 0.478 . . . . 0.0 111.233 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.0 -41.97 85.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.278 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.6 163.17 24.55 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.255 0.55 . . . . 0.0 111.241 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.659 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.5 m-85 -107.5 114.61 28.72 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.836 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.4 mt -88.09 114.72 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.581 HG22 HG13 ' A' ' 75' ' ' ILE . 63.7 t -115.44 129.81 71.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.976 -177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -125.24 136.08 53.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.226 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.552 ' CE2' HD12 ' A' ' 49' ' ' LEU . 27.8 p90 -140.42 155.82 46.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.041 0.448 . . . . 0.0 110.514 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.554 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 11.1 ptt180 -149.9 178.99 8.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.377 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.2 p -91.1 140.64 29.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.223 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -68.67 -24.59 64.54 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.38 -33.97 74.55 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.585 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -158.85 -175.48 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.854 0.835 . . . . 0.0 112.344 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 46' ' ' ASP . 10.8 pt-20 -142.72 122.06 13.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.753 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.7 m-20 -161.15 38.01 0.14 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 26.1 mt-30 115.88 126.44 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 125.853 1.971 . . . . 0.0 110.927 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.554 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 21.6 m95 -87.89 135.78 33.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.842 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.552 HD12 ' CE2' ' A' ' 39' ' ' TYR . 76.3 mt -72.59 159.83 33.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.75 151.76 40.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.071 0.462 . . . . 0.0 111.567 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.15 113.44 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.506 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -92.8 144.17 25.55 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 t -139.01 150.47 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.321 0.581 . . . . 0.0 110.839 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.446 ' C ' ' H ' ' A' ' 56' ' ' ASN . 52.2 tt0 -67.49 140.6 57.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.512 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.01 7.7 0.27 Allowed Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.57 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 54' ' ' GLN . 8.3 t-20 -132.93 -8.92 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.364 0.582 . . . . 0.0 111.029 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 14.7 mttp -64.65 -46.0 84.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.607 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 57' ' ' LYS . 3.7 p30 50.04 39.5 19.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.799 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.45 151.95 0.63 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.7 140.87 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 0.0 110.707 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.509 HG22 ' OG ' ' A' ' 17' ' ' SER . 33.1 mm -111.87 98.4 6.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.119 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.2 mt -87.23 105.27 17.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 63' ' ' GLU . 54.7 mp0 -86.58 175.31 8.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.3 m80 60.91 57.82 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.311 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -105.15 -171.68 1.96 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.09 129.57 22.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.579 0.704 . . . . 0.0 110.954 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.763 ' HE1' ' HZ2' ' A' ' 16' ' ' LYS . 68.0 m95 -63.81 -30.39 71.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.977 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 p -100.45 21.0 13.86 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.99 135.03 19.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.731 0.301 . . . . 0.0 110.458 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.77 166.17 42.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -144.97 135.0 23.85 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.186 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.501 ' OE1' ' NH2' ' A' ' 40' ' ' ARG . 7.5 mt-10 -98.11 151.77 20.03 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.43 136.95 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.938 0.399 . . . . 0.0 110.678 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -129.62 114.38 15.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 37' ' ' VAL . 1.7 mp -98.94 136.33 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.923 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 m -138.8 117.78 12.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.519 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -88.21 129.04 35.45 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.87 116.17 31.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.284 0.564 . . . . 0.0 112.454 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 2.9 p-10 -117.18 -169.57 1.68 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -50.89 -27.96 8.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.611 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.1 mm? -66.24 -37.6 85.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.529 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.467 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 121.52 -52.19 0.75 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.467 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 2.2 m-85 -151.67 138.22 18.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -161.71 171.68 17.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.407 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' H ' ' HB3' ' A' ' 3' ' ' PRO . 4.9 pm0 32.03 64.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.408 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.66 151.91 32.72 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.297 1.998 . . . . 0.0 110.691 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.509 HG23 HE22 ' A' ' 25' ' ' GLN . 0.1 OUTLIER -128.75 110.3 12.06 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.128 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 t -96.72 98.76 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.472 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 30.5 t80 -104.47 147.45 27.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.19 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.6 131.67 20.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.934 0.397 . . . . 0.0 111.182 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 38.1 p90 -165.81 142.34 5.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.24 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -90.01 161.05 16.04 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.375 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 92.3 mmm -87.77 137.62 31.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.552 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -74.38 165.43 31.79 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.306 2.004 . . . . 0.0 111.284 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.92 152.88 80.25 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.035 1.823 . . . . 0.0 110.888 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.615 ' CE ' ' NE1' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -44.49 130.93 4.84 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.35 121.97 9.35 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.71 1.606 . . . . 0.0 113.196 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -72.37 -31.65 65.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 99' ' ' ILE . 18.4 tt -136.29 117.28 18.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 114.095 -1.411 . . . . 0.0 108.189 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 22.6 pt -72.81 -168.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.004 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 100' ' ' ILE . 82.6 tttt 100.04 118.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.438 1.086 . . . . 0.0 110.212 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.44 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.632 ' HD2' ' H3 ' ' A' ' 1' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 1' ' ' ARG . 1.3 tp10 94.39 74.92 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.619 0 O-C-N 123.854 0.721 . . . . 0.0 110.479 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -100.52 -164.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.594 2.863 . . . . 0.0 110.928 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.405 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -174.06 149.7 1.51 Allowed Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.005 178.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 6' ' ' PRO . 84.0 Cg_exo -39.93 163.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.072 2.515 . . . . 0.0 113.088 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 5' ' ' PRO . 11.3 Cg_exo -38.71 163.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.693 2.262 . . . . 0.0 113.339 178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.8 m -157.49 58.92 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.8 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.44 130.44 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.228 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -118.99 113.76 21.48 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' HA2' HD23 ' A' ' 20' ' ' LEU . . . -96.26 138.65 14.05 Favored Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -152.41 146.88 18.76 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.655 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.64 88.02 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.278 1.985 . . . . 0.0 111.792 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.3 t -67.98 -68.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.779 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' GLY . 20.0 m -136.88 156.66 48.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.142 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 14' ' ' SER . . . 31.99 -116.22 0.1 OUTLIER Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.088 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HE2' ' HE1' ' A' ' 67' ' ' TRP . 61.1 mttt -96.86 -8.32 31.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.962 0.41 . . . . 0.0 110.274 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.47 136.47 58.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.082 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CD2' ' CE2' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.95 118.65 31.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.326 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -80.18 109.39 14.6 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.066 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD23 ' HA2' ' A' ' 10' ' ' GLY . 11.5 mt -100.93 89.7 3.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -70.3 121.85 18.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.38 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.415 HG21 ' CE2' ' A' ' 35' ' ' TYR . 1.2 mm -82.65 114.95 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.8 m -94.72 116.29 28.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.627 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.552 ' H ' ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -39.29 105.76 0.05 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.531 ' NE2' ' OE1' ' A' ' 85' ' ' GLU . 3.6 pt20 -117.87 101.21 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' GLN . 95.7 m-20 33.1 -154.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 29' ' ' GLY . 46.5 p-10 -165.11 161.61 19.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 1' ' ' ARG . . . -66.37 5.6 2.11 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 117.13 9.28 10.74 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.61 151.3 23.38 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 117.01 0.405 . . . . 0.0 110.156 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.32 141.69 76.08 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.926 1.751 . . . . 0.0 111.781 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.568 HG12 ' HB1' ' A' ' 77' ' ' ALA . 3.6 mt -88.06 130.93 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.183 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.9 mp -85.79 -41.82 14.72 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.283 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -146.67 162.12 39.14 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.299 0.571 . . . . 0.0 111.775 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.534 ' CE1' HG21 ' A' ' 32' ' ' ILE . 8.3 m-85 -114.2 121.61 44.27 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.963 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.1 mt -95.45 110.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.528 HG22 HG13 ' A' ' 75' ' ' ILE . 60.8 t -112.26 130.88 65.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.563 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -128.56 133.06 48.28 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.413 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.533 ' CE2' HD12 ' A' ' 49' ' ' LEU . 37.7 p90 -137.8 153.3 49.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.036 0.446 . . . . 0.0 110.389 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -140.4 -174.1 3.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.459 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.2 p -100.68 137.36 39.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.029 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -66.77 -30.63 70.89 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.08 -33.43 73.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.718 0.294 . . . . 0.0 111.569 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 41' ' ' SER . 12.1 ptpt -131.87 168.75 17.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 111.273 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -151.91 106.8 3.25 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.188 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 25.2 p-10 -164.74 -26.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.959 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -144.99 162.52 36.71 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.74 0.305 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -131.9 133.54 44.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.133 0.492 . . . . 0.0 110.939 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.533 HD12 ' CE2' ' A' ' 39' ' ' TYR . 90.8 mt -77.15 160.48 28.96 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.67 152.27 36.42 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.09 0.472 . . . . 0.0 111.8 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.72 113.71 2.27 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -98.83 145.98 26.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.598 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 157.4 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.115 0.483 . . . . 0.0 110.528 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 56' ' ' ASN . 40.6 tt0 -77.05 137.08 38.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.488 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.95 0.02 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.522 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 54' ' ' GLN . 97.1 m-20 -121.09 -6.26 9.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.875 0.338 . . . . 0.0 110.615 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -64.63 -49.7 70.0 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.53 0.681 . . . . 0.0 109.508 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 56.41 34.9 25.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.188 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.45 151.18 0.59 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -151.03 146.29 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.535 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.5 mm -117.06 108.89 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.578 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 62' ' ' LEU . 1.9 mm? -93.13 105.82 17.86 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 45.4 tt0 -91.63 152.04 20.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.805 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 12.3 t60 80.74 62.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.371 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' GLN . 66.8 mt -119.74 88.37 2.92 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.861 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' LEU . 86.4 mt-30 -36.91 152.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.151 0.501 . . . . 0.0 111.735 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.409 ' HE1' ' HE2' ' A' ' 16' ' ' LYS . 85.2 m95 -83.17 -5.9 59.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.404 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -115.04 15.13 17.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.689 0.28 . . . . 0.0 111.608 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 67.7 mtp -146.0 136.6 24.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 111.332 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.37 162.22 25.65 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -140.94 132.38 26.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.595 0.236 . . . . 0.0 110.493 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -87.76 149.93 23.89 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.78 137.56 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -129.32 106.42 8.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.467 0.651 . . . . 0.0 109.423 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.528 HG13 HG22 ' A' ' 37' ' ' VAL . 1.5 mp -92.51 134.97 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.968 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 m -138.79 116.01 11.07 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' HG12 ' A' ' 32' ' ' ILE . . . -86.26 128.16 34.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.189 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -105.26 107.27 18.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 1.2 p30 -110.7 -168.18 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -49.49 -31.65 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 81' ' ' LEU . 4.0 mm? -63.07 -41.15 99.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' C ' ' CG ' ' A' ' 83' ' ' TYR . . . 124.37 -44.2 1.31 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.47 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 3.8 m-85 -153.17 139.99 19.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.8 p -157.37 162.01 39.05 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.853 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.531 ' OE1' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 32.33 59.1 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.459 178.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.5 150.26 69.55 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 121.567 1.512 . . . . 0.0 110.548 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.8 m -128.21 116.51 20.0 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.492 0.663 . . . . 0.0 111.047 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.9 94.67 4.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.235 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -95.86 147.95 23.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.595 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -144.11 135.88 26.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.054 0.454 . . . . 0.0 110.83 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' CE2' ' CD2' ' A' ' 18' ' ' PHE . 3.9 p90 -167.54 133.77 2.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -89.01 173.77 8.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.503 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.88 144.38 28.79 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.093 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.03 165.62 27.97 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.614 2.209 . . . . 0.0 110.41 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.59 152.45 81.74 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.749 1.633 . . . . 0.0 111.741 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -36.1 129.49 0.63 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.764 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.71 151.13 24.74 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.965 1.777 . . . . 0.0 110.939 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -105.99 -57.58 2.03 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.663 0.268 . . . . 0.0 110.844 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' ILE . 15.6 pt -72.82 -30.8 33.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.561 0.696 . . . . 0.0 109.5 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 99' ' ' ILE . 1.3 mt 51.1 132.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.509 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -173.63 -125.86 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.531 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.349 -179.527 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 3' ' ' PRO . 96.5 mtt-85 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 1' ' ' ARG . 6.2 tp10 -18.88 81.17 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 123.823 0.702 . . . . 0.0 112.381 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.526 ' N ' ' O ' ' A' ' 1' ' ' ARG . 91.3 Cg_endo -102.52 -163.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 124.476 3.451 . . . . 0.0 110.539 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -165.6 155.46 11.38 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.045 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 49.0 Cg_exo -49.49 -171.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.227 0 C-N-CA 122.408 2.072 . . . . 0.0 112.389 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 5' ' ' PRO . 86.6 Cg_exo -54.7 145.4 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.089 2.526 . . . . 0.0 114.237 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.03 50.44 1.91 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.541 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.2 mm -126.21 128.5 71.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.241 0.543 . . . . 0.0 110.896 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -122.15 114.53 21.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.428 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.2 147.5 18.62 Favored Glycine 0 N--CA 1.465 0.61 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.531 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -156.74 135.34 7.62 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 107.77 2.27 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.063 1.175 . . . . 0.0 111.51 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -78.18 -81.66 0.1 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.3 m -143.18 133.91 25.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.406 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.6 -145.68 35.97 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.765 ' NZ ' ' H ' ' A' ' 66' ' ' GLN . 2.6 mtmp? -87.76 -3.67 58.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.332 . . . . 0.0 110.71 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 82.6 p -71.72 145.66 48.66 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.749 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.79 125.75 48.36 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -85.77 104.01 15.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.808 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mt -99.89 97.49 8.37 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.4 t -72.39 120.16 17.61 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.689 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.494 HG21 ' CE2' ' A' ' 35' ' ' TYR . 3.1 mm -80.11 119.02 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.6 m -85.32 128.26 34.63 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.906 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.461 ' H ' ' HE2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.98 110.93 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.209 1.004 . . . . 0.0 109.584 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 27' ' ' ASP . 7.3 mm100 -92.79 169.05 10.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.076 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 17.1 t70 -53.75 -9.28 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.262 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 p30 47.92 34.97 4.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.848 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.2 -13.06 0.17 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 27' ' ' ASP . . . 114.52 4.3 21.82 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.496 ' N ' ' OD1' ' A' ' 27' ' ' ASP . . . -131.44 152.5 80.6 Favored Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 122.633 -0.333 . . . . 0.0 110.358 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.79 144.08 58.02 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.213 1.942 . . . . 0.0 111.837 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.507 HG12 ' HB1' ' A' ' 77' ' ' ALA . 4.6 mt -98.44 125.66 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.504 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.4 mt -72.92 -39.53 66.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.104 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -160.58 170.46 20.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.91 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.505 ' CE1' HG21 ' A' ' 32' ' ' ILE . 11.7 m-85 -117.38 122.43 43.83 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.582 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -93.02 108.84 20.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.565 HG22 HG13 ' A' ' 75' ' ' ILE . 61.4 t -111.12 127.13 68.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.067 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -125.23 138.22 54.11 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.952 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.527 ' CE2' HD12 ' A' ' 49' ' ' LEU . 28.8 p90 -142.4 151.04 41.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.086 0.47 . . . . 0.0 111.436 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' NH2' ' OE2' ' A' ' 72' ' ' GLU . 37.2 ptt85 -143.94 174.27 10.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.864 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.8 p -80.04 150.98 30.17 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.204 0.315 . . . . 0.0 110.261 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -75.12 12.15 0.97 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.425 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.69 -35.03 2.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.489 0.185 . . . . 0.0 110.776 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -103.01 109.64 21.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.491 0.662 . . . . 0.0 110.741 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -105.07 15.95 26.7 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.695 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.91 3.39 53.62 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -161.38 136.26 7.36 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.214 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CZ2' ' NE ' ' A' ' 40' ' ' ARG . 43.0 m95 -119.59 123.56 44.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.527 HD12 ' CE2' ' A' ' 39' ' ' TYR . 82.6 mt -81.76 160.24 23.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.017 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -120.18 154.68 34.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.428 0.632 . . . . 0.0 111.916 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.14 114.67 3.12 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.75 141.15 32.94 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.354 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.33 161.72 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.355 0.598 . . . . 0.0 110.836 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 56' ' ' ASN . 7.3 tp-100 -78.11 146.94 34.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.432 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.0 5.64 7.76 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.828 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.429 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 5.1 t-20 -120.7 -15.82 8.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.737 0.304 . . . . 0.0 110.31 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -65.16 -52.06 57.33 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.238 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 55.9 38.45 30.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.283 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.35 150.96 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.528 0.204 . . . . 0.0 110.535 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.36 152.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.398 0.618 . . . . 0.0 111.667 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.5 mm -121.57 111.73 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.82 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 17' ' ' SER . 51.0 mt -97.61 112.88 24.57 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -84.93 153.54 22.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 0.0 112.47 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.718 ' HA ' ' HZ1' ' A' ' 16' ' ' LYS . 70.3 t60 59.57 81.5 0.17 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.029 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 66' ' ' GLN . 75.1 mt -118.03 -4.15 11.07 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.765 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . 22.6 mt-30 57.13 149.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.405 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -90.64 -14.46 32.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.782 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 p -116.0 10.32 15.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.75 117.34 15.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.136 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.9 157.83 50.69 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.936 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -139.73 128.03 22.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.309 -0.445 . . . . 0.0 110.259 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 2.2 mt-10 -86.48 153.14 22.08 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.61 134.97 61.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -123.77 106.93 10.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.538 0.685 . . . . 0.0 109.414 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.565 HG13 HG22 ' A' ' 37' ' ' VAL . 1.4 mp -94.11 133.55 34.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.489 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -139.9 116.2 10.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.659 ' HB3' ' OE2' ' A' ' 85' ' ' GLU . . . -89.37 127.75 35.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.28 110.62 22.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.29 0.567 . . . . 0.0 112.008 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.713 ' H ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -116.63 -176.45 2.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.839 178.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -42.52 -31.46 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.3 mp -64.75 -41.79 95.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.451 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . 124.6 -45.38 1.18 Allowed Glycine 0 N--CA 1.465 0.573 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.484 ' CG ' ' C ' ' A' ' 82' ' ' GLY . 4.7 m-85 -154.52 138.86 16.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.433 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 73.5 m -148.17 161.53 41.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.564 0.697 . . . . 0.0 111.87 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.659 ' OE2' ' HB3' ' A' ' 77' ' ' ALA . 0.7 OUTLIER 22.75 60.94 0.34 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.417 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.8 150.27 86.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.154 1.236 . . . . 0.0 110.414 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.7 m -125.27 117.92 24.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.577 0.703 . . . . 0.0 111.712 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -93.92 93.6 4.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.584 ' CE2' ' CD1' ' A' ' 91' ' ' PHE . 36.7 t80 -95.81 132.67 40.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.704 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -132.83 136.46 46.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 111.221 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.584 ' CD1' ' CE2' ' A' ' 89' ' ' TYR . 12.1 p90 -172.24 133.44 0.67 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.165 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.4 p -80.52 162.76 24.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.343 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 93.6 mmm -89.29 143.31 30.72 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.285 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.93 164.98 34.06 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.684 2.256 . . . . 0.0 111.203 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.1 152.36 81.43 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.414 2.076 . . . . 0.0 111.507 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -40.75 131.22 1.83 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.64 179.05 6.82 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.208 1.939 . . . . 0.0 111.525 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -155.98 -93.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.099 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.739 ' H ' HD13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -107.37 -1.68 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 122.298 -0.251 . . . . 0.0 111.336 179.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CG1' ' N ' ' A' ' 101' ' ' LYS . 15.5 tt -124.32 163.37 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.325 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.429 ' N ' ' CG1' ' A' ' 100' ' ' ILE . 60.9 tttp 61.84 127.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.063 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.561 179.469 . . . . . . . . 0 0 . 1 stop_ save_